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Persistent non-specific low back pain (NSLBP) is the leading cause of years lived 
with disability globally, and exercise is the most widely recommended treatment 
for persistent NSLBP. Previous randomised controlled trials (RCTs) tend to 
conclude that, on average, exercise has small to medium effects when benefits, 
versus comparison arms, are judged using the primary outcomes of pain and 
function. RCTs should select their primary outcome domain(s) and measure(s) 
based on the rationale of the treatment(s) they are comparing.  
This programme of research aimed to i) identify whether existing RCTs match 
their primary outcome domains to their specified exercise treatment targets, ii) 
explore whether better matching of primary outcome domains with exercise 
treatment targets might change the results and conclusions of existing RCT 
datasets, iii) compare whether composite outcomes composed of multiple 
matched outcome domains might change the estimates of the between-arm 
differences through secondary analysis of existing RCT datasets, and iv) gain 
stakeholder consensus on the treatment targets of exercise interventions in 
RCTs of persistent NSLBP. 
The systematic review included 27 exercise RCTs that, together, stated 31 
treatment targets and included six primary outcome domains. Only 25% of 
included RCTs had primary outcomes that matched their specified treatment 
targets. Standardised mean differences (SMDs) of exercise versus comparison 
arms were larger in the matched (SMD 0.54 (95% CI 0.23 to 0.85), p=0.0006) 
compared to the unmatched category (SMD 0.22 (95% CI 0.01, 0.44) p=0.04), 





Secondary analyses were conducted on a total of nine previous RCT datasets. 
First, matching was investigated in five RCTs (n=1033) that used an unmatched 
primary outcome but included some of their matched outcomes as secondary 
outcomes, and second, by developing composite outcomes in four RCTs 
(n=864). Firstly, of five RCTs, three had greater SMDs and increased between-
arm statistical significance with matched outcomes compared to an unmatched 
primary outcome. Of four composite outcomes: three RCTs had greater SMDs 
and improved statistical precision using the composite outcome compared to the 
primary outcome in favour of exercise. 
Finally, a total of 39 participants contributed to two sequential nominal group 
consensus workshops. The final prioritised targets of exercise were: improving 
function, improving quality of life, reducing pain, targeting patient-specific goals, 
reducing fear of movement and increasing physical activity. 
This programme of research has highlighted the need for improved identification 
and specification of treatment targets of exercise interventions for persistent 
NSLBP. Matching the primary outcome to the treatment targets of the exercise 
intervention appears to be important, but composite matched outcomes may be 





List of Abbreviations 
ANOVA Analysis of variance 
ANCOVA Analysis of variance with covariates 
Appts  Appointments 
BI  Brief intervention 
C  Control 
CBT  Cognitive behavioural therapy 
CERT  Consensus on exercise reporting template 
CG  Control group 
CI  Confidence interval 
COMET  Core outcomes measures in effectiveness trials 
CONSORT  Consolidated standards of reporting trials  
CVD  Cardiovascular disease 
EQ-5D Euroqol-5D 
Ex.  Exercise 
FABQ  Fear-avoidance beliefs questionnaire 
FU  Follow-up 
GP  General practice/ practitioner 
GPE  Global perceived effect 
HADS  Hospital anxiety and depression score 
HCP  Health-care professional 
HEA  Home exercise and advice  
HEP  Home exercise programme 
HRQoL Health-related quality of life 
IMMPACT Initiative on methods, measurement and pain assessment in 
clinical trials 
IV  Inverse variance 
LBP  Low back pain 
MANCOVA Multivariate analysis of covariance 
McK  McKenzie exercise 
MCE  Motor control exercise 
MCID  Minimum clinically important difference 
Min  Minute  
MSK  Musculoskeletal 
NRS  Numeric rating scale 
NS  Non-significant 
NSAIDs Non-steroidal anti-inflammatory drugs  
NSLBP Non-specific low back pain 
OA  Osteoarthritis 
ODI  Oswestry disability index 
OMERACT  Outcome measures in rheumatoid arthritis clinical trials  
PDI  Pain disability index 
PE  Physical exercise 





PRISMA Preferred Reporting Items for Systematic Reviews and Meta-
Analyses 
PROSPERO International Prospective Register of Systematic Reviews 
PSEQ  Pain self-efficacy questionnaire  
PSFS  Patient self-functional scale 
Pts  Participants 
PT  Physiotherapy 
Q  Questionnaire 
QBPDS Quebec back pain and disability scale 
RCT  Randomised controlled trials 
RMDQ Roland and Morris disability questionnaire  
ROM  Range of movement 
RTW  Return to work 
SD  Standard deviation 
SE  Standard error 
SET  Specific exercise therapy 
SF  Short-form Health Survey 
SFA  Solution finding approach 
SMD  Standard mean difference 
SMT  Spinal manual therapy 
SPSS  Statistical package for social sciences 
SWD  Shortwave diathermy 
TIDieR Template for intervention description and replication 
TSK  Tampa scale of kinesiophobia 
UC  Usual care 
UCL  Utrecht Coping List 
UK  United Kingdom 
USA  United States of America 
US  Ultrasound 
VAS  Visual analogue scale 
Wk(s)  Week(s) 
WL  Wait –list 
WMD  Weighted mean difference 
WU  Warm-up 
Yrs  Years 
 
 
Table of Contents  
vii 
 




List of Abbreviations…………………………………………………………………..v 
Table of Contents…………………………………………………………………….vii 
List of Tables…………………………………………………………………………xiii 
List of Figures………………………………………………………………………..xvii 
1 Background and Introduction .................................................................... xxii 
 Low back pain ......................................................................................................... 1 
 Exercise as a Complex Intervention ....................................................................... 3 
 Exercise ................................................................................................................... 5 
1.3.1 Treatment Targets and the Mechanism of Action of Exercise .............................. 7 
 RCTs of Exercise Interventions............................................................................. 10 
 Outcome Domains and Measures in RCTs in NSLBP ......................................... 12 
 Rationale for PhD .................................................................................................. 16 
2 Chapter 2: Aims, Objectives and Research Design ................................... 18 
 Introduction ............................................................................................................ 18 
 Overall Aim and Objectives ................................................................................... 18 
 Summary of Thesis Chapters................................................................................ 21 
 Methodological Overview of Thesis ...................................................................... 24 
 Specific Training Undertaken to Complete this PhD............................................. 24 
Table of Contents 
viii 
 
 Publications, Presentations and Awards ............................................................... 25 
 Summary ................................................................................................................ 29 
3 Chapter 3: Matching treatment targets and outcomes in trials of exercise 
interventions for persistent NSLBP: a systematic review and meta-analysis ... 30 
 Introduction ............................................................................................................ 30 
3.1.1 Study Aim and Objectives ................................................................................... 31 
 Methods ................................................................................................................. 32 
3.2.1 Eligibility Criteria .................................................................................................. 32 
3.2.2 Study Selection ................................................................................................... 35 
3.2.3 Risk of Bias Assessment ..................................................................................... 36 
3.2.4 Data Extraction .................................................................................................... 37 
3.2.5 Descriptive Analysis ............................................................................................ 40 
3.2.6 Meta-analysis of Matched and Unmatched Categories ...................................... 40 
3.2.7 Logic Model ......................................................................................................... 50 
3.2.8 Publication Bias ................................................................................................... 50 
3.3 Results ................................................................................................................... 51 
3.3.1 Search Results .................................................................................................... 51 
3.3.2 Included RCT Characteristics ............................................................................. 52 
3.3.3 Characteristics of Excluded Trials ....................................................................... 69 
3.3.4 Risk of Bias Assessment ..................................................................................... 69 
3.3.5 Descriptive Analysis ............................................................................................ 72 
3.3.6 Categorisation of Matching Status ...................................................................... 75 
3.3.7 SMDs of RCTs: Individual and Grouped ............................................................. 81 
3.3.8 Meta-Analysis: Calculation of Grouped SMDs .................................................... 87 
Table of Contents 
ix 
 
3.3.9 Logic Model ......................................................................................................... 89 
3.3.10 Summary of Results ............................................................................................ 93 
 Discussion ............................................................................................................. 94 
3.4.1 Interpretation of the Results ................................................................................ 95 
3.4.2 Strengths and Limitations of this Review .......................................................... 103 
3.4.3 Implications for Clinical Practice and Research ................................................ 107 
 Conclusion ........................................................................................................... 108 
4 Chapter 4: Exploratory Secondary Data Analysis of RCT Datasets ........ 110 
 Introduction .......................................................................................................... 110 
4.1.1 Study Aim and Objectives ................................................................................. 111 
 Methods ............................................................................................................... 112 
4.2.1 Sample .............................................................................................................. 112 
4.2.2 Data Extraction .................................................................................................. 112 
4.2.3 Data Analysis .................................................................................................... 113 
 Results ................................................................................................................. 117 
4.3.1 Included RCTs ................................................................................................... 117 
4.3.2 Data Analysis .................................................................................................... 123 
 Discussion ........................................................................................................... 142 
4.4.1 Outcome Domains used by RCTs Included in this Analysis ............................. 144 
4.4.2 Data Analysis Method: Linear Mixed Models Compared to ANOVA ................ 145 
4.4.3 Process Evaluation of Exercise Interventions in the Included RCTs ................ 147 
4.4.4 Strengths and Limitations of This Analysis ....................................................... 149 
4.4.5 Implications for Further Research ..................................................................... 151 
 Summary ............................................................................................................. 152 
Table of Contents 
x 
 
5 Chapter 5: Exploratory Development of Composite Outcomes in Exercise 
RCTs for NSLBP ............................................................................................ 154 
 Introduction .......................................................................................................... 154 
5.1.1 Aims and Objectives ......................................................................................... 155 
 Methods ............................................................................................................... 156 
5.2.1 Sample .............................................................................................................. 156 
5.2.2 Data Extraction .................................................................................................. 156 
5.2.3 Data Analysis .................................................................................................... 157 
 Results ................................................................................................................. 163 
5.3.1 Included RCTs ................................................................................................... 163 
5.3.2 Data Analysis .................................................................................................... 169 
5.3.3 Secondary Analyses of Unmatched Datasets ................................................... 181 
 Discussion ............................................................................................................ 195 
5.4.1 How These Findings Compare to Other Studies .............................................. 196 
5.4.2 Strengths and Limitations of this Analysis ........................................................ 201 
5.4.3 Implications for Further Research ..................................................................... 203 
 Conclusion ........................................................................................................... 204 
6 Chapter 6: Gaining Consensus on the Treatment Targets of Exercise 
Interventions ................................................................................................... 206 
 Introduction .......................................................................................................... 206 
6.1.1 Study Aim and Objective ................................................................................... 207 
 Methods ............................................................................................................... 208 
6.2.1 Study Design ..................................................................................................... 208 
6.2.2 Participants: Identification and Invitation ........................................................... 210 
Table of Contents 
xi 
 
6.2.3 Nominal Group Workshop Process ................................................................... 211 
6.2.4 Logic Model of Results ...................................................................................... 215 
 Results ................................................................................................................. 216 
6.3.1 Participants ........................................................................................................ 216 
6.3.2 National Workshop Results ............................................................................... 219 
6.3.3 International Workshop Results ........................................................................ 224 
6.3.4 Updated Logic Model ........................................................................................ 230 
6.3.5 Summary of Results .......................................................................................... 232 
 Discussion ........................................................................................................... 232 
6.4.1 Prioritisation of Treatment Targets .................................................................... 233 
6.4.2 Strengths and Limitations of this Study ............................................................. 239 
6.4.3 Implications for Future Research and Clinical Practice .................................... 241 
 Conclusion ........................................................................................................... 244 
7 Chapter 7: Discussion, Summary and Conclusions ................................. 246 
 Introduction .......................................................................................................... 246 
 Summary of Thesis Findings ............................................................................... 247 
7.2.1 Systematic Review ............................................................................................ 247 
7.2.2 Data Analysis 1: Matching Outcomes to the Treatment Targets ...................... 251 
7.2.3 Data Analysis 2: A Matched Composite in Comparison to a Single Outcome .. 252 
7.2.4 Consensus Workshops ..................................................................................... 255 
 Discussion Points ................................................................................................ 256 
7.3.1 Overall Contribution of this Programme of Research ....................................... 256 
7.3.2 Expected Results Found in this Programme of Research ................................ 257 
7.3.3 Unanticipated Results Found in this Programme of Research ......................... 260 
Table of Contents 
xii 
 
7.3.4 Interpreting this research in the field of complex interventions ......................... 266 
 Strengths and Limitations of this Research ......................................................... 267 
 Implications for Future Research......................................................................... 269 
 Implications for Clinical Practice .......................................................................... 273 
 Summary .............................................................................................................. 274 
8 References .............................................................................................. 276 
9 Appendices .............................................................................................. 323 
a. Systematic Review Search Terms .......................................................................... 323 
b. Excluded Studies from the Systematic Review with Reasons ................................ 329 
c. Extracted Treatment Targets and Outcomes of Included Trials ............................. 330 
d. Extracted Treatment Targets of Included Trials ...................................................... 333 
e. Extracted Secondary Outcome Domains and Measures of Included Trials ........... 335 
f. Sensitivity Analyses Using Other Values ................................................................ 339 
i. Ratio of Means .......................................................................................................... 339 
ii. Sensitivity Analysis Using Follow-up Standard Deviations ....................................... 342 
iii. Meta-Analysis Using Ratio of Means ........................................................................ 343 
iv. Effectiveness Sensitivity Analysis ............................................................................. 344 
v. Sub-group Analyses .................................................................................................. 346 
g. Data Sharing Agreement for Datasets used in Chapter 4 ...................................... 352 
h. Data Sharing Agreement for Datasets used in Chapter 5 ...................................... 358 
i. Linear mixed model results of Miyamoto et al. (2018) trial dataset: all time-points 362 
j. Linear mixed model results of Moffett et al. (2006) trial dataset: all time-points .... 365 
k. Linear mixed model results of Groessl et al. (2017) trial dataset: all time-points ... 367 
Table of Contents 
xiii 
 
l. Additional Information Regarding Consensus Workshops ..................................... 369 
m. Summary of Protocols of 23 Current RCTs ........................................................ 378 
n. Summary of Mediation Analyses in LBP ................................................................. 383 
 
  
List of Tables 
xiv 
 
List of Tables Included in the Text 
Table 3-1: Method for combining arms…………………………………………….45 
Table 3-2: Characteristics of included RCTs (27 RCTs)………………………...54 
Table 3-3: Variation in exercise dosage across included RCTs…………..……68 
Table 3-4: Primary outcome domains and measures (where all designated 
primary outcome domains have been extracted and first mentioned outcomes in 
those not designated)……………………………..…………………………………74 
Table 3-5: Summary of matched RCTs……………………………………………78 
Table 3-6: Summary of unmatched RCTs………………………………………...80 
Table 3-7: SMDs in primary outcomes between exercise and comparison arms 
per RCT……………………………………………………………………………….83 
Table 3-8: Summary table of SMCID and interpretation per RCT……………...86 
Table 4-1: Treatment targets, matched outcome domains, and analysis 
conducted for each included RCT………………………………………………..118 
Table 4-2: The outcome domains and measures used by included RCTs…..121 
Table 4-3: Calculated SMD values comparing the reported primary outcome 
domain and matched secondary outcomes……………………………………...123 
Table 4-4: Published trial results of the primary outcome measure (pain) in 
Bronfort et al. (2011)………………………………………………………………..124 
List of Tables 
xv 
 
Table 4-5: Replication of ANOVA significance results of the change scores in 
comparison to the reported results of Bronfort et al. (2011)…………………….126 
Table 4-6: ANCOVA analysis of matched outcomes in Bronfort et al. (2011).128 
Table 4-7: Linear mixed model results of standardised outcomes in Bronfort et al. 
(2011)………………………………………………………………………………..129 
Table 4-8: Linear mixed model analysis of the original trial results in comparison 
to the replicated secondary outcome (pain) results in Groessl et al. (2017)…...133 
Table 4-9: Linear mixed model analysis of the secondary outcome results in 
Groessl et al. (2017)………………………………………………………………..133 
Table 4-10: Results of chi-square analysis performed in Harris et al. (2017)..136 
Table 4-11: Replication results of ANOVA analysis in Harris et al. (2017)…..136 
Table 4-12: Results of ANOVA analysis performed in Harris et al. (2017)…....138 
Table 4-13: Summary of SMD results for each included RCT and outcome…140 
Table 5-1: Reported treatment targets and matched outcomes of included 
RCTs…………………………………………………………………………………165 
Table 5-2: The outcome domains and measures used by included RCTs…..167 
Table 5-3: The original RCT results and replicated results of the primary 
outcome (pain) in Miyamoto et al. (2018)………..……………………………....170 
List of Tables 
xvi 
 
Table 5-4: Comparison of composite outcome with primary outcome (pain) in 
Miyamoto et al. (2018)……………………………………………………………..171 
Table 5-5: The standard error of the two outcome variables in Miyamoto et al. 
(2018)………………………………………………………………………………..172 
Table 5-6: A comparison of the primary outcome (pain) to a targeted composite 
and co-primary outcome composite in Miyamoto et al. (2018)……………..…174 
Table 5-7: Replication of the trial results of Moffett et al. (2006)……………...177 
Table 5-8: The results of the standardised composite outcome in comparison to 
the standardised primary outcome measure for Moffett et al. (2006)………….178 
Table 5-9: The standard error of the two outcome variables in Moffett et al. (2006) 
.……………………………………………………………………………………….178 
Table 5-10: Table to demonstrate the comparison of the primary outcome (fear-
avoidance beliefs) in comparison to a targeted composite and co-primary 
outcome composite in Moffett et al. (2006)……………………………………….180 
Table 5-11: Published trial results of the primary outcome measure (pain) in 
Bronfort et al. (2011)………………………………………………………………..182 
Table 5-12: ANCOVA analysis of composite outcome in comparison to the 
primary outcome (pain) in Bronfort et al. (2011)………………………………...184 
Table 5-13: Table to show MANCOVA of standardised outcomes comparing 
exercise against manual therapy and home exercise in Bronfort et al. (2011).185 
List of Tables 
xvii 
 
Table 5-14: The linear mixed model analysis of standardised outcomes 
comparing exercise against home exercise and manual therapy in Bronfort et al. 
(2011)………………………………………………………………………………..186 
Table 5-15: Calculated SMD values comparing reported primary outcome 
domain and matched secondary outcomes in Groessl et al. (2017)…..……..189 
Table 5-16: The linear mixed model analysis of the standardised pain outcome 
in comparison to the composite outcome results in Groessl et al. (2017)…….190 
Table 5-17: The standard error of the two models in Groessl et al. (2017)…..191 
Table 5-18: Summary results of all four RCTs primary outcome and targeted 
composite outcome…………………………………………………………………193 
Table 5-19: Summary table of co-primary, targeted composite and primary 
matched outcomes………………………………………………………………….195 
Table 6-1: Recruitment strategies used and their target population…………..212 
Table 6-2: Demographic information of workshop participants………………..218 
Table 6-3: Treatment targets, number and percentage of votes (yes) after voting 
stage …………………………………………………………………………………222 
Table 6-4: Final ranked position of treatment targets from the national workshop 
………………………………………………………………………………………..224 
List of Tables 
xviii 
 
Table 6-5: Final ranked position of treatment targets per participant group in the 
national workshop…………………………………………………………………..225 
Table 6-6: Final list of prioritised treatment targets from the international 
workshop………………………………………………...…………………………..230 
Table 7-1: Comparison of results of treatment target priorities…………………263 
Table 7-2: Treatment targets of matched RCTs…………………………………264 
  
List of Figures 
xix 
 
List of Figures Included in the Text 
Figure 1-1: Example of a mediation model with treatment targets (adapted from 
Mansell et al. (2013))………………………………………………………………….9 
Figure 2-1: Schematic overview of the programme of research, timelines and 
thesis structure……………………………………………………………………….20 
Figure 3-1: Modified graphic representation of interpretation of treatment 
success (adapted from Dent and Raftery (2011))…...…………………………..46 
Figure 3-2: PRISMA flow chart to represent systematic review screening and 
selection……………………………………………………………………………….52 
Figure 3-3: Summary of the risk of bias of the 27 included RCTs……………...70 
Figure 3-4: Summary of the risk of bias components of included RCTs……….71 
Figure 3-5: Frequencies of stated exercise treatment targets in included RCTs 
…………………………………………………………………………………………73 
Figure 3-6: Frequency of outcome domains in included RCTs…………………75 
Figure 3-7: Categorisation of RCTs according to matching status …………….76 
Figure 3-8: Forest plot of SMDs of primary outcome domains, including 
'matched' and 'unmatched' RCT sub-groups……………………………………...88 
Figure 3-9: Logic model depicting reported exercise treatment targets, core 
components and outcome domains ……………………………………………….91 
Figure 3-10: Figure demonstrating the relationship between exercise treatment 
targets and primary outcome domains…………………………………………….92 
List of Figures 
xx 
 
Figure 4-1: Forest plot to demonstrate size and direction of effect of outcomes in 
Bronfort et al. (2011) using ANCOVA……………………………………………..130 
Figure 4-2: Forest plot to demonstrate size and direction of effect of outcomes in 
Bronfort et al. (2011) using linear mixed models…………………………………131 
Figure 4-3: Forest plot to demonstrate size and direction of effect of outcomes in 
Groessl et al. (2017)………………………………………………………………..134 
Figure 4-4: Forest plot to demonstrate size and direction of effect of each 
outcome in Harris et al. (2017)……………………………………………………..139 
Figure 4-5: Forest plot to demonstrate the pooled effect of the SMD for 
unmatched primary outcomes in comparison to matched secondary outcomes 
………………………………………………………………………………………..142 
Figure 5-1: The size and direction of effects of the primary and composite 
outcomes in Miyamoto et al. (2018)………………………………………………173 
Figure 5-2: The effect of primary and composite outcomes in Moffett et al. (2006) 
………………………………………………………………………………………..179 
Figure 5-3: The effect of the primary outcome (pain) in comparison to the 
composite for exercise in comparison to manual therapy using an ANCOVA 
analysis in Bronfort et al. (2011)…………………………………………………..187 
Figure 5-4: The effect of the primary outcome (pain) in comparison to the 
composite for exercise in comparison to spinal manual therapy using a linear 
mixed model analysis in Bronfort et al. (2011)………………………………….187 
 
List of Figures 
xxi 
 
Figure 5-5: The effect of the primary outcome (physical function) in comparison 
to the composite in comparison to waiting list control in Groessl et al. (2017)…191 
Figure 5-6: Summary plot to demonstrate pooled SMD of primary outcome in 
comparison to composite outcome……………………………………………….194 
Figure 6-1: Flow chart of consensus workshop stages (modified from Potter et al. 
(2004)) ………………………………………………………………………………213 
Figure 6-2: Summary of treatment target votes in the international workshop (N 
and %)…..........................................................................................................226 




List of Equations 
xxii 
 
List of Equations 
Equation 3-1: SMD calculation……………………………………………………..41 
Equation 3-2: Mean SD for individual arm………………………………………...41 
Equation 3-3: Pooled variance……………………......……………………………42 
Equation 3-4: Pooled standard error……………………………………………….42 
Equation 3-5: Limits of the confidence interval…………………………………...42 
Equation 3-6: Proportion…………………………………………………………….42 
Equation 3-7: Proportion SD………………………………………………………..42 
Equation 3-8: SMD using proportions……………………………………………..43 
Equation 3-9: Average quartile of medians……………………………………….43 
Equation 3-10: SMD calculation from medians…………………………………..43 
Equation 3-11: Sample size of combined arms…………………………………..45 
Equation 3-12: Mean of combined arms…………………………………………..45 
Equation 3-13: Standard deviation of combined arms…………………………...45 
Equation 3-14: Standardised minimum clinically important difference ………..45 
Equation 3-15: Prediction interval calculation…………………………………….47 
Equation 3-16: Ratio of Means……………………………………………………..48 
Equation 3-17: Standard error of ratio of means………………………………...48 
Equation 3-18: Combined log-transformed ratio of means……………………...49 
List of Equations 
xxiii 
 
Equation 3-19: Confidence interval for ratio or means…………………………..49 
Equation 4-1: SMD calculation……………………………………………………114 
Equation 5-1: SMD calculation……………………………………………………159 
  
Chapter 1: Background and Introduction 
1 
 
1 Background and Introduction 
Summary 
Persistent non-specific low back pain (NSLBP) is the leading cause of disability 
worldwide. Exercise is the most commonly recommended treatment for 
persistent NSLBP, but the treatment targets of exercise are poorly described in 
the literature. Few randomised controlled trials (RCTs) identify their treatment 
targets in the justification for their exercise intervention(s). Consequently, they 
often use primary outcomes that do not reflect the target(s) of the exercise 
intervention(s). The aim of this thesis is to explore the treatment targets and 
outcomes of exercise in RCTs of persistent NSLBP. 
This chapter summarises the clinical challenge of persistent NSLBP, and the use 
of exercise as a complex intervention in the management thereof; the possible 
treatment targets of exercise; the use of RCTs to investigate the effects of 
exercise compared to other interventions; and challenges in the selection of the 
most appropriate outcome for RCTs of exercise interventions in the field of 
persistent NSLBP. 
 
 Low back pain 
Low back pain (LBP) is one of the most common musculoskeletal conditions 
worldwide (1), and most people will experience LBP at some point in their lifetime 
(2). It is a greater contributor to global disability than any other condition (1–3) 
and is defined as pain in the area below the lower margin of the ribs and above 
the gluteal folds, with or without leg pain (4). Non-specific low back pain (NSLBP) 
is the most common type of LBP experienced in the population (believed to 
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account for approximately 90-95% of all cases seen in primary care), in contrast 
to serious spinal pathology such as infection, cancer or fracture (estimated to 
account for less than 1%), or true nerve root compression (5-10%) (5). NSLBP 
has traditionally been classified according to the duration of symptoms: acute (<6 
weeks), sub-acute (6-12 weeks) and chronic or persistent (>12 weeks). United 
Kingdom (UK) guidelines (3) recommend a move away from a time-based 
classification in favour of a continuum where risk factors for poor prognosis are 
more critical than the duration of symptoms. For this thesis, the term persistent 
NSLBP is used, with an awareness that NSLBP is not always time-dependent 
and may describe both persistent NSLBP beyond the initial acute phase (>12 
weeks), as well as fluctuating or recurrent NSLBP presentations over time. 
 
In the UK, most patients consulting health-care with persistent NSLBP are 
managed in primary care, specifically in general practice, where NSLBP accounts 
for more consultations than any other musculoskeletal pain presentation (6). For 
most, acute episodes of NSLBP generally improve within the first six weeks 
regardless of the treatment provided, but some people will experience NSLBP 
that persists over time (7). Variables influencing the progression to persistent 
NSLBP include a complex interaction of physical, psychological and social 
factors (3).   
 
Several clinical guidelines have been produced worldwide regarding the 
diagnosis, assessment and management of persistent NSLBP (3,8,9). They 
provide similar recommendations for the management of acute, subacute and 
persistent NSLBP (10,11). They frequently recommend the use of simple 
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strategies such as education, reassurance, and safe medications, as well as 
more complex interventions, such as exercise, multidisciplinary rehabilitation, 
and cognitive-behavioural therapy interventions (11). Clinical guidelines are tools 
which provide recommendations for the management of conditions, such as 
persistent NSLBP. Guidelines are informed by the interpretation of results of 
RCTs and systematic reviews of RCTs, which provide evidence for the 
effectiveness of one intervention in comparison to another (or a control arm) (12). 
However, synthesis of the evidence from RCTs of complex interventions is 
challenged by the heterogeneous nature of complex interventions, the different 
settings in which the intervention is delivered, the nonlinear pathways between 
the intervention and identified outcomes, and the different intervention 
components (13).  
 
 Exercise as a Complex Intervention  
Complex interventions are created when numerous components interact 
independently and interdependently (14). These components may be difficult to 
define precisely, and therefore it is more challenging to evaluate what the 
interactions and relationships are (15). Intervention programme theory (for 
example, using a logic model) helps to make sense of complex interventions by 
describing visually: a) the intervention components and the relationships 
between them, b) the underlying theories of change and causal assumptions 
between the intervention components and resultant outcomes, and c) the 
interactions between the intervention and the contextual implementation setting 
(13). Logic models are increasingly recommended in the evaluation and 
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assessment of complex interventions, such as exercise, to ensure 
methodological rigour and facilitate high fidelity implementation (16,17). 
 
Exercise is a sub-group of physical activity, which is planned, repeated, 
structured and intends to improve one's physical fitness (18). Therapeutic 
exercise is defined as "the use of active or assisted exercises aimed at improving 
range of motion, strength, or dynamic neuromuscular control of joint motion"(19). 
Therapeutic exercise is an example of a complex intervention due to the 
numerous components that may affect the individual's biological (20), 
psychological and social (21) functioning, as well as the addition of treatment 
interaction between exercise providers/ therapists and patients (22). Within 
exercise interventions, consideration can be given to: the wide variation in the 
type of therapeutic exercise delivered (for example yoga, motor control retraining, 
general conditioning exercise), as well as the setting in which it is delivered and 
undertaken (at a health centre, in a private clinic room, in a community centre, at 
home etc.), the deliverer of the intervention (e.g. a fitness instructor, 
physiotherapist, sports trainer etc.), the style of intervention received (group, 
individual, video format, via the internet), the addition of a home-based 
programme of exercises, as well as the frequency of the exercise(s) and other 
components of exercise dose (23). All of these contribute to the complexity in the 
tasks of synthesising best available evidence about exercise for NSLBP and 
comparing exercise interventions between different RCTs and clinical settings. 
Guidelines for persistent NSLBP and sub-acute NSLBP all recommend exercise; 
however, the advice provided is inconsistent about the type of exercise and mode 
of delivery or the most effective frequency, intensity or dosage (11). Recent 
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clinical guidelines recommend a variety of types of exercise for the management 
of patients with persistent NSLBP, such as tai-chi, sports rehabilitation, strength 
training, aerobic conditioning, yoga, and motor control exercise (11). However, 
patient preference and therapist recommendation are also considered to 
influence the exercise programme prescribed.  
 
 Exercise 
Regular and adequate levels of physical activity have significant health benefits 
at all ages: improving muscular and cardiorespiratory fitness, bone and functional 
health; preventing falls and depression, improving general cardiovascular health; 
and maintaining energy levels and weight control (18). Exercise appears to 
reduce the severity of persistent pain as well as to act more generally, leading to 
improved overall physical and mental health, and physical functioning (21).  
 
In the management of persistent NSLBP, all exercise types have been shown to 
have, on average, some benefit on pain and function, with few adverse effects 
and low associated costs (3). Stabilising and resistance exercise appears to 
result in the greatest improvement in physical function (24).  Strengthening and 
stretching programmes demonstrate the greatest reductions in pain intensity 
compared with other exercise types, in the most recent Cochrane review of 
exercise for LBP (25), while Pilates, aerobic exercise and motor control exercise 
appeared to have the best effect on pain intensity in a more recent network meta-
analysis (24). Individually designed exercise programmes, supervised home 
exercise programmes and individually supervised programmes, compared with 
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home exercises alone, appear to have a more favourable effect on pain scores 
in persistent NSLBP (25). Furthermore, high dosage exercise programmes (more 
than 20 hours’ intervention time) appear to be more effective than low dosage 
programmes and interventions including other types of conservative care (25). 
Exercise therapy appears to positively influence fear-avoidance beliefs, pain 
catastrophising beliefs and self-efficacy expectations (22).  
 
Whilst the above highlights that exercise is beneficial for NSLBP, in general best 
evidence highlights that the size of these benefits are small to modest. Exercise 
for persistent NSLBP yields small benefits when compared to all controls, with a 
pooled mean improvement of 7.3 points (95% CI, 3.7 to 10.9) for pain (out of 100) 
and 2.5 points (1.0 to 3.9) for function (out of 100) at the earliest follow-up time-
point (26). More recently, a systematic review and meta-analysis (of 45 RCTs) 
found a standardised mean difference (SMD) of -0.32 (95% CI -0.44, -0.19) in 
favour of exercise in comparison to all controls (27) (medium effect size (28)). 
Strong evidence has also been found in favour of exercise for NSLBP with small 
to medium effects on pain, physical function and quality of life in comparison to 
controls (29). However, the results of these recent systematic reviews show 
some inconsistency, and the evidence base considered as low quality due to the 
inclusion of small sample sizes and therefore, potentially underpowered studies 
(21,26). So overall, despite strong evidence (i.e. many RCTs testing exercise), it 
appears that, at best, exercise leads to small to medium average benefits 
compared to alternative treatments or no treatment.  
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1.3.1 Treatment Targets and the Mechanism of Action of Exercise 
Although exercise is widely recommended, the treatment targets and 
mechanisms of action of exercise in persistent NSLBP are not fully understood. 
Exercise may work through many potential mechanisms of action, including some 
or all of the following: peripheral effects (such as targeting musculoskeletal 
impairments such as weakness in the muscles in the back or lack of flexibility of 
the spine), central effects (such as through the neural systems), psychological 
effects (such as addressing fear-avoidance beliefs or self-efficacy expectations) 
or social effects (such as reducing social isolation). The mechanisms 
underpinning the persistence of NSLBP are similarly poorly understood, despite 
a variety of models which have attempted to explain its persistence. 
Understanding the process whereby persistent NSLBP is maintained may help 
to identify important targets for interventions. Verbunt et al. (30) describe two 
different models that may explain contributing mechanisms to persistent NSLBP 
via the ‘disuse syndrome’(31): the fear-avoidance model1 (32) and the 
suppressive model2 (33). These both highlight potential mechanisms which may 
sustain persistent NSLBP when disuse is present – including physical, 
psychological and social changes resulting in deconditioning.  
 
                                            
1 The fear-avoidance model was first described by Lethem et al (335) and helped to explain the 
persistence of pain in the absence of pathology whereby individuals have an increasing 
disuse/disability/depression related to avoidance of the aggravating activity initiated by a fear of 
pain.  
2 The suppressive model describes a sub-group of individuals who in addition to the avoidance 
strategies, cope with pain using endurance strategies: they ignore the pain and then overload 
their muscles which leads to muscular hyperactivity (30). 
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Systematic reviews confirm the lack of strong evidence about the relationships 
between specific musculoskeletal impairments (physical changes) and pain and 
disability in persistent NSLBP (22,34,35). It does not appear that strengthening, 
motor control or flexibility improvements in specific ranges and muscles are 
correlated with outcomes, such as pain and physical function (22,34,35). 
Alternative mechanisms for exercise may include neurobiological mechanisms, 
such as through gene expression (36,37), endogenous opioid pathways, 
nociceptive inhibitory pathways (38), anti-inflammatory pathways (39) and 
altered hormone levels (36,40).  
 
Other explanations suggest exercise may work through central effects, through 
correcting an altered body schema, reweighting sensory input which may modify 
motor control patterns, or through a positive patient-therapist relationship 
(22,41,42). Wand et al. (42) suggest that these features may be epiphenomena 
of cortical dysfunction instead of an underlying (spinal) mechanism of persistent 
NSLBP. Exercise may alternatively act through psychological mechanisms, 
through reducing catastrophising, fear-avoidance beliefs or improving self-
efficacy expectations in persistent NSLBP (22,41,42). These different potential 
mechanisms suggest that the specific type of exercise used might be largely 
irrelevant in achieving positive benefits from exercise (22), a suggestion that 
would fit with the best available evidence and clinical guideline recommendations 
(3,9). Still, there is a lack of research that fully explains the mechanisms of action 
and treatment targets of exercise for persistent NSLBP.  
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A treatment target is defined as the aim of the intervention or treatment (43). 
Treatment targets should reflect the active ingredients of the intervention, as 
explained by the mechanisms of action. In certain situations, treatment targets 
may be the same as or similar to surrogate markers, or intermediate variables, 
whereas, in others, they may have more direct effects on the intended 'end' 
outcomes. These terms are conceptually different, yet they are terms that are 
sometimes used interchangeably. For this thesis, the term treatment targets is 
used, with the acknowledgement that it is unknown whether treatment targets 
have an indirect effect on the causal pathway, similar to the action of a mediator 
(44,45) as demonstrated in Figure 1-1.  
Figure 1-1: Example of a mediation model with treatment targets (adapted from 
Mansell et al. 2013) 
 
Despite considerable evidence that exercise is beneficial for patients with 
persistent NSLBP, there is still uncertainty regarding the treatment targets of 
exercise for this population (46–48). Rainville et al. (49) proposed that the clinical 
use of exercise for LBP could be defined in three goals: improving function 
(through affecting strength, flexibility and cardiovascular endurance), reducing 
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back pain and decreasing disability through reducing excessive fears related to 
movement. However, this proposal does not appear to have included any 
stakeholder or patient involvement and is not based on the mechanisms 
literature. Helmhout et al. (48) expanded on the goals suggested by Rainville et 
al. (49) by suggesting three different domains of potential exercise treatment 
targets: i) mechanical (such as spinal strengthening or stabilisation-based 
theories), ii) neurological (such as desensitisation theories), and iii) psychological 
or cognitive theories involving cognitive and or operant conditioning theories 
(such as graded activity). These theoretical frameworks are important in both 
clinical settings as well as research of exercise in NSLBP. 
  
In summary, evidence to date highlights the need for studies to ascertain what 
the active ingredients (and treatment targets) of exercise for persistent NSLBP 
are (47,50,51). Further, it is essential that clear mechanisms of action (with 
identified treatment targets) for exercise interventions in persistent NSLBP are 
developed with a variety of stakeholder voices (patients, clinicians and 
researchers) so that an understanding of how the exercise intervention's impact 
through cause, mechanisms and outcomes configurations is gained (15,52). 
 
 RCTs of Exercise Interventions 
Systematic reviews of RCTs of exercise for persistent NSLBP consistently 
demonstrate small to medium SMDs (26,27,29). RCTs with higher internal 
validity are more likely to demonstrate smaller SMDs, although 95% of LBP RCTs 
have been suggested to be underpowered to detect small to medium SMDs (53). 
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The RCT remains the best research design to compare the effects of 
interventions by reducing the systematic differences between two or more 
intervention groups, minimising bias and allowing the ability to discern true 
difference over that related to chance using statistical means (54,55). The 
evaluation, interpretation and reproduction of exercise interventions (as a 
complex intervention) in pragmatic RCTs are challenging due to the numerous 
components that are involved (55,56): especially when information regarding 
processes and targets of the interventions are not fully described (14). RCTs of 
poor methodological quality more frequently demonstrate greater treatment 
effects (57–60), and LBP RCTs with lower risks of bias have been reported to 
have SMDs up to 0.20 lower than trials with higher risks of bias (61). Errors in the 
design of RCTs can compromise or invalidate the conclusion and results of the 
RCT (62). 
 
In an attempt to improve the quality of reporting of RCTs, the Consolidated 
Standards of Reporting Trials (CONSORT) statement (63) checklists have been 
modified to "improve the completeness of reporting and ultimately the replicability 
of interventions" (63,64). The Template for Intervention Description and 
Replication (TIDieR) checklist was developed specifically for physical therapy 
intervention studies to improve the reporting of interventions in RCTs (64). A 
further exercise-specific reporting checklist, the Consensus on Exercise 
Reporting Template (CERT) (65) aims to increase the reproducibility of exercise 
interventions in RCTs.  These checklists aim to improve the reporting both of 
outcomes and interventions in RCTs to facilitate reproducibility and clinical 
applicability. The CONSORT statement has a category for the explanation of the 
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proposed rationale for the trial (category 2a); however, there is no mention of 
whether this rationale should include a clear match between the treatment targets 
of the intervention(s) and the outcomes utilised (category 6a) (63). Similarly, the 
CERT does not include consideration of the aim or objective of the exercise 
intervention, yet this is an important omission as it influences both the design of 
the exercise intervention and the outcomes used to assess its effectiveness (66). 
A recent review by Wood, Ogilvie and Hayden (67) has demonstrated that a high 
proportion of previous RCTs failed to clearly state their exercise treatment aims 
(64%). Therefore, despite the creation of useful checklists to improve RCT and 
intervention reporting (e.g. CONSORT, TIDieR, CERT), poor reporting of 
exercise interventions, their rationale, their treatment targets and how these 
targets shape decisions about the selection of outcomes, persist (68). 
 
 Outcome Domains and Measures in RCTs in NSLBP 
An outcome (or outcome domain) is the construct of interest to be measured, that 
can be represented by a latent variable such as pain, or physical function, which 
may not be directly observable (69). An outcome measurement instrument (or 
outcome measure) is the means used to quantify the construct (69). There are a 
wide variety of outcome measures and domains used to compare treatments in 
trials in persistent NSLBP: one review identified over 75 different outcome 
measures across six different domains (68). In RCTs of LBP, the most frequently 
reported outcome domains are pain, followed by physical function (70). Whereas 
in trials of rehabilitation in persistent NSLBP, a higher proportion of physical 
function domains are reported (68). 
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Although overall reporting of outcomes of RCTs has improved with time, the 
incompleteness of reporting outcome measures may introduce performance or 
detection bias. Selective outcome reporting bias may also be present when 
authors only report outcomes with favourable result (71,72). Selection bias may 
subsequently bias results of further systematic reviews or interpretation of RCT 
results (73). Hence, a recommended standardised set of outcomes aims to 
reduce performance, selection or detection bias, and therefore improve the 
quality of trials, both for the benefit of those interpreting the results and for use in 
systematic reviews and meta-analysis.  
 
Despite recommendations to standardise outcome measures in RCTs of 
interventions for persistent NSLBP since 1998 (74–78), systematic reviews have 
demonstrated these have had a limited or inconsistent effect on research practice 
(70). The initiative of the Core Outcomes Measures in Effectiveness Trials 
(COMET) provides methodological research and guidance for the development 
of core outcome sets (79). Core outcome sets refer to the minimum outcomes 
that should be collected within RCTs in a certain discipline, thus aiding between 
trial-comparisons, contrasts and meta-analyses (80). Further to the progress of 
the "Outcome Measures in Rheumatoid Arthritis Clinical Trials" (OMERACT) 
group (81), COMET influenced the most recent work on the development of the 
core outcome set for LBP (78) The "Initiative on Methods, Measurement and Pain 
Assessment in Clinical Trials" (IMMPACT) group recommended six core domains 
when designing clinical trials testing treatments for chronic pain: pain, physical 
function, emotional function, participant ratings of improvement and satisfaction, 
symptoms and adverse events, and participant disposition (76). More recently, 
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Chiarotto et al. (78) gained consensus on pain intensity, physical function and 
health-related quality of life (HRQoL) amongst health-care providers, health-care 
researchers and patients as core outcome domains for RCTs comparing 
interventions for persistent NSLBP. Further consensus work by Chiarotto, 
Terwee and Ostelo (82), recommended outcome measures for each agreed 
outcome domain, including the Oswestry Disability Index (ODI) (version 2.1) for 
physical function, the Numeric Rating Scale (NRS) for pain, and the Short-Form 
(SF) 36 for HRQoL.  It is important to note that these recommendations for core 
outcome domains and measures for RCTs in the field of LBP do not stipulate 
which outcome(s) should be used as the primary outcome for an RCT, nor do 
they exclude the additional use of other outcome measures in an RCT (71). 
  
The challenging choice of outcome measure selection is encapsulated by the 
following quote:  
"The ultimate value of a RCT …will be directly tied to how well the selected 
outcome measure matches the researcher's understanding of what he or she 
expects to change, to what degree it is expected to change, over what period of 
time this change will happen and how that change can best be identified" (83). 
Considering exercise as a complex intervention with multiple potential treatment 
targets, it follows that multiple outcomes or an outcome that is multi-domain in 
nature might be more appropriate for RCTs testing exercise. However, the use 
of multiple outcomes in RCTs has been cautioned against (84). The concerns 
expressed include the situation where the intervention yields statistically 
significant benefits over the control on one of the selected outcome measures 
and thus a conclusion of superiority is drawn, even though the intervention was 
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not superior when assessed using the other outcome measures (84). RCT 
analysis plans should test a working hypothesis based on the treatment targets 
of the intervention, which should lead to the selection of the primary outcome 
measure, from which the minimally important difference can be used to calculate 
the sample size (84). Most literature regarding trial design stipulates that the 
primary outcome should match the rationale of the intervention (52,71). However, 
the selection of the primary outcome in a trial may be made based on a variety 
of factors, with increasing pressure to choose outcomes in line with patient 
preference and core outcome domains. Further, in complex interventions such 
as exercise, which frequently have more than one treatment target, the selection 
of one single primary outcome measure may be insufficient to reflect the wide 
range of treatment targets required to investigate superiority (85). A potential 
reason for the small between-arm effect sizes seen in RCTs of exercise 
interventions in persistent NSLBP is the poor matching of RCT outcome domains 
with the exercise treatment targets, highlighted in the past by Chapman et al. 
(86), Gilron and Jensen (87) and Helmhout et al. (48). 
 
A combination of outcome measures may provide a better examination of the 
benefits of exercise versus control for persistent NSLBP, rather than focusing 
only on one primary outcome measure. This has been the approach in the field 
of osteoarthritis (81), as well as in rheumatoid arthritis (88,89) and diabetes (90). 
The OMERACT group (81), for example, reached consensus that in order to 
conclude ‘treatment success' for arthritis, an improvement in pain, physical 
function and global improvement were all required (75). The use of a combination 
of outcome measures may be more clinically meaningful than reporting only the 
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estimate of between-arm difference based on a single outcome measure; 
however, due to the limited evidence on composite measures available for LBP 
future research has been recommended (75). In persistent NSLBP, a composite 
index of response has been proposed and includes items in the domains of pain, 
function and overall impression of health (91). However, this index does not 
appear to be widely used. Ultimately, further studies are required to refine a 
responder index and or advise on composite outcomes in persistent NSLBP, 
potentially incorporating the core outcome sets defined by Chiarotto et al. (82).  
 
 Rationale for PhD 
The previous sections in this chapter have highlighted the gaps in knowledge that 
this thesis has been designed to address. In summary, exercise is a commonly 
recommended 'core' treatment for patients with persistent NSLBP, based on the 
best available evidence from systematic reviews of RCTs. While exercise is an 
excellent example of a complex intervention with multiple treatment targets, most 
RCTs focus primarily on a limited set of primary outcomes driven by international 
consensus, namely reduction in pain and increase in function. The focus on pain 
and physical function as the key primary outcome domains in RCTs may not 
reflect the breadth of benefits that exercise can provide. This focus has resulted 
in a mismatch: the most commonly used outcome domains in RCTs comparing 
treatments for persistent NSLBP do not match the breadth of treatment targets 
of exercise interventions.  
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A clearer understanding of the key treatment targets of exercise interventions for 
patients with persistent NSLBP is required, in line with recommendations for 
further research (92). Research that explores the importance of matching 
exercise treatment targets and the key outcome domains in RCTs is needed as 
is research that tests whether better matching of these might change the results 
and conclusions of exercise RCTs (48,84). The next chapter describes the aims 
and objectives of this PhD programme of research. 




2 Chapter 2: Aims, Objectives and Research 
Design 
Summary 
This chapter provides an overview of the thesis and chapter aims and 
objectives, as well as providing an overview of publications and 
presentations from, and relating to, this thesis.  
 
 Introduction 
This chapter presents the overall aim of the thesis. Included is a brief synopsis 
of each of the subsequent chapters and a schematic overview of the thesis. Four 
stages of research were planned to address the overall aim: each requiring 
different research designs, methods and analyses. The aims, objectives and 
research design for each of these stages and chapters are described. This is 
followed by a list of the dissemination activities, to date, resulting from the 
research described in the thesis and additional publications currently in 
preparation.   
 
 Overall Aim and Objectives 
The overall aim of this doctoral thesis is to investigate whether better matching 
the outcome domains used in RCTs in the field of persistent NSLBP to the 
treatment targets of the exercise interventions being investigated might change 
the results and conclusions of these trials. To achieve this aim, this thesis 
presents work undertaken in four stages, with the objectives for each stage as 
follows: 
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Overall Objectives:  
Stage 1: To identify whether existing RCTs of exercise interventions in persistent 
NSLBP match the primary outcome domains to the identified treatment targets 
of the exercise intervention by systematically reviewing the available literature.  
Stage 2: To explore whether better matching of primary outcome domains with 
exercise treatment targets might change the estimates of the between-arm 
differences in existing RCTs, and therefore change the results and conclusions 
of the RCTs, through secondary analysis of existing RCT datasets. 
Stage 3: To investigate whether the use of composite outcomes composed of 
multiple matched outcome domains in comparison to single primary outcome 
domains might change the estimates of the between-arm differences in RCTs of 
exercise for persistent NSLBP, through secondary analysis of existing RCT 
datasets. 
Stage 4: To gain stakeholder consensus on the treatment targets and 
prioritisation of treatment targets of exercise interventions in RCTs of persistent 
NSLBP through the use of consensus methods. 
 
Each of these stages and the overall structure of this thesis are presented in the 
schematic overview in Figure 2-1.  
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 Summary of Thesis Chapters 
The chapters of this thesis are as follows:  
Chapter 1 – Introduction 
This chapter describes the background and justification for this programme of 
research.  
Chapter 2 – Aims, Objectives and Study Design 
This chapter details the overall aim and specific objectives of the programme of 
research and summarises the content and structure of this thesis.  
Chapter 3 - Matching treatment targets and outcomes in trials of exercise 
interventions for persistent NSLBP: a systematic review and meta-analysis 
This chapter describes a systematic review of RCTs of exercise interventions in 
persistent NSLBP to investigate the role of matching between reported outcome 
domains and exercise treatment targets.   
Specific Objectives:  
i. To systematically identify and select RCTs investigating exercise, as 
an example of a complex intervention, for patients with persistent 
NSLBP to synthesise the evidence regarding treatment targets, 
outcome domains and outcome measures.  
ii. To assess the risk of bias of included RCTs by utilising the Cochrane 
Risk of Bias tool (93).  
iii. To describe the relationships between reported treatment targets and 
outcome domains used in these RCTs.  
iv. To describe the effect sizes of exercise versus comparison/control 
treatment for individual RCTs and calculate these when not reported.   
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v. To define the treatment targets and outcome domains within each 
RCT, using a process-orientated logic model. 
Chapter 4 - Exploratory Secondary Data Analysis of Trial Datasets 
This chapter describes secondary analyses of RCT datasets to explore the 
hypothesis that matching the primary outcomes to the treatment targets of 
exercise in persistent NSLBP trials may alter the results and conclusions of 
RCTs.   
Specific Objectives: 
i. To perform the analysis applied to the primary outcome(s) by the 
authors of the RCTs on the included secondary outcome(s) that match 
their stated exercise treatment targets. 
ii. To compare the results of the calculated standardised mean 
differences (SMDs) using matched secondary outcomes with the 
SMDs of the nominated primary outcomes of RCTs.   
Chapter 5 - Exploratory Development of Composite Outcomes in Exercise Trials 
for NSLBP 
This chapter describes secondary analyses performed on datasets to explore the 
hypothesis that the creation of a composite primary outcome matched to the 
treatment targets of exercise in persistent NSLBP RCTs alters the results and 
conclusions of the RCTs.  
Specific Objectives:  
i. To replicate the analysis applied to the primary outcome(s) by the authors 
of the RCTs or, where these were not available, on the secondary 
outcome(s). 
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ii. To calculate a composite outcome standardised mean difference (SMD) 
using standardised averages of outcomes matched to the treatment 
targets of the exercise intervention per identified RCT. 
iii. To calculate a co-primary composite outcome SMD using standardised 
averages of the primary outcomes where nominated by the trials’ authors. 
iv. To compare composite and co-primary composite outcome SMDs with the 
reported primary outcome SMDs per identified RCT. 
Chapter 6 – Gaining Consensus on the Treatment Targets of Exercise 
Interventions 
This chapter describes the results of two sequential consensus workshops that 
ranked key treatment targets for exercise interventions in persistent NSLBP in 
order of priority, identified from the results of the systematic literature review and 
by prescribers, users of and developers of exercise interventions in the field of 
persistent NSLBP.   
Specific Objective:  
To reach consensus on the treatment targets of exercise interventions in 
persistent NSLBP in order of importance by using nominal group workshops. 
Chapter 7 – Summary of Thesis and Discussion 
This chapter summarises the key findings of all stages of this PhD programme of 
research, discusses what these add to knowledge in the field, highlights the 
strengths and weaknesses of the research, as well as potential implications for 
future research and clinical practice.  
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 Methodological Overview of Thesis 
This PhD programme of research comprises an exploratory body of work using 
different research methods: the first three research stages are quantitative in 
nature, using existing RCT data in the systematic review and secondary data 
analyses. The final stage of this thesis uses both quantitative and qualitative 
methods in the form of consensus workshops. All analyses performed within this 
thesis have been undertaken by the PhD candidate independently, with 
supervision guidance where needed from my statistical supervisor, Dr Martyn 
Lewis. The PRISMA guidelines (94) informed the systematic review (stage one).  
 
 Specific Training Undertaken to Complete this PhD 
During the course of this PhD, the PhD candidate completed two statistical 
training modules (MMedSci Statistics and Epidemiology 2017; MMedSci 
Advanced Quantitative Data Analysis 2018) and a five-day course on Complex 
Evaluation Development and Evaluation in 2018 (DECIPHer Evaluating 
Complex Public Health Interventions). Informal training was undertaken through 
the School for Primary, Community and Social Care on performing systematic 
reviews (a series of three mini-workshops between December 2017 and March 
2018) as well as advanced training workshops on the use of Microsoft Word, 
Excel and Powerpoint.  
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 Publications, Presentations and Awards 
The following summarises the dissemination activities from this research to date, 
along with further dissemination plans.  
 
Peer-reviewed journal papers from this thesis 
Wood L, Foster NE, Lewis M, Bishop A. Exercise interventions for persistent non-
specific low back pain – does matching outcomes to treatment targets make a 
difference? A systematic review and meta-analysis. Journal of Pain, 2020, Jun 
21; S1526-5900(20)30039-0. doi: 10.1016/j.jpain.2020.04.002.  
 
Wood L, Bishop A, Lewis M, Smeets RJEM, Bronfort G, Hayden JA, Foster NE. 
Achieving consensus on the treatment targets of exercise in persistent non-
specific low back pain: a modified nominal group workshop process. Journal of 
Physiotherapy, accepted.  
 
Wood L, Foster NE, Lewis M, Bronfort G, Groessl E, Hewitt C, Miyamoto G, 
Reme SE, Bishop A. Matching the outcomes to treatment targets of exercise for 
low back pain: does it make a difference? Results of secondary analyses from 
individual patient data of randomised controlled trials and pooling of results 
across trials in comparative meta-analyses. Under review. 
 
Published abstracts from this thesis 
Wood L, Foster NE, Lewis M, Bishop A. How well do the treatment targets and 
outcomes match in trials of exercise interventions for chronic low back pain? A 
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systematic review of the literature. Orthopaedic Proceedings, 101-B, Supp_9. 
The Society for Back Pain Research 2018 Meeting, Groningen, the Netherlands, 
15-16 November 2018.  
 
Wood L, Foster NE, Lewis M, Groessl E, Bronfort G, Hewitt C, Miyamoto GC, 
Reme SE, Bishop A. Matching the outcomes to treatment targets of exercise in 
randomised controlled trials in low back pain: does it make a difference? Results 
of secondary analysis of randomised controlled trials. Orthopaedic Proceedings, 
101-B, Supp_10. The Society for Back Pain Research Annual General Meeting, 
2019, Sheffield, United Kingdom, 5-6 September 2019. 
 
Wood L, Foster NE, Lewis M, Bishop A. Achieving consensus on the treatment 
targets of exercise in persistent non-specific low back pain: a modified nominal 
group workshop process. Orthopaedic Proceedings, 101-B, Supp_10. The 
Society for Back Pain Research Annual General Meeting, 2019, Sheffield, United 
Kingdom, 5-6 September 2019. 
 
Research presented from this thesis 
Oral presentations 
Wood L, Foster NE, Lewis M, Bishop A. How well do the treatment targets and 
outcomes match in trials of exercise interventions for chronic low back pain? A 
systematic review of the literature. Orthopaedic Proceedings, 101-B, Supp_9. 
The Society for Back Pain Research 2018 Meeting, Groningen, the Netherlands, 
15-16 November 2018. 
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Wood L. Does matching the primary outcome to the treatment goals of exercise 
treatments change the conclusion of trials in LBP? Institute for Liberal Arts and 
Science, Keele University, 3 Minute Thesis Presentation. 29th April 2019; Post-
graduate Symposium, Research Institute for Primary Care and Health Sciences, 
Keele University, 16th May 2019.  
 
Wood L, Foster NE, Lewis M, Bishop A. Achieving consensus on the treatment 
targets of exercise in persistent non-specific low back pain: a modified nominal 
group workshop process. The International Forum for Back and Neck Pain 
Research in Primary Care, Quebec City, Canada, 3-6 July 2019; Physiotherapy 
UK, Birmingham, United Kingdom, 1-2 November 2019.  
 
Poster presentations 
Wood L, Foster NE, Lewis M, Bishop A. A systematic review and meta-analysis 
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The next chapter details the aims, methods and results of the first stage of the 
PhD, the systematic review.  
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3 Chapter 3: Matching treatment targets and 
outcomes in trials of exercise interventions 
for persistent NSLBP: a systematic review 
and meta-analysis 
Summary 
This chapter describes the methods, results and conclusions of a 
systematic review and meta-analysis investigating treatment targets 
and outcomes in RCTs of exercise interventions for persistent 
NSLBP. The contents of this chapter have been, in part, accepted for 
publication as: 
Wood L, Foster NE, Lewis M, Bishop A. Exercise interventions for 
persistent non-specific low back pain – does matching outcomes to 
treatment targets make a difference? A systematic review and meta -
analysis. Journal of Pain, 2020, Jun 21; S1526-5900(20)30039-0. doi: 
10.1016/j.jpain.2020.04.002.    
  
 Introduction 
As highlighted at the end of the Introduction in chapter 1, the use of a single 
primary outcome domain and measure in RCTs of exercise for persistent NSLBP 
may not adequately reflect the multiple treatment targets of this complex 
intervention. It is unknown whether reports of RCTs of exercise interventions 
adequately describe the exercise treatment targets, or if these targets are 
captured by the outcome domains and measures selected. A systematic review 
of the published literature was conducted to establish what treatment targets, 
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outcome domains and outcome measures have been used in RCTs of exercise 
interventions for persistent NSLBP, and to explore whether the primary outcome 
domains match the treatment targets of the exercise interventions. A systematic 
search was developed and conducted, RCTs were included based on predefined 
criteria, and standardised risk of bias assessment and data extraction were 
completed. A narrative synthesis described the treatment targets, primary and 
secondary outcomes of included RCTs. The RCTs were classified into sub-
groups according to the degree of matching between the primary outcome 
domain(s) and treatment targets. Standardised mean differences (SMDs) in the 
primary outcome between intervention groups in each RCT were calculated, and 
meta-analysis conducted to explore whether matching of outcome domain to 
treatment targets impact on the size of these SMDs.   
 
3.1.1 Study Aim and Objectives 
Aim: The primary aim of this systematic review was to investigate the role of 
matching between reported outcome domains and exercise treatment targets.   
Objectives: 
i. To systematically identify and select RCTs investigating exercise, as an 
example of a complex intervention, for patients with persistent NSLBP to 
synthesise the evidence regarding treatment targets, outcome domains 
and outcome measures.  
ii. To assess the risk of bias of included RCTs by utilising the Cochrane Risk 
of Bias tool (93).  
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iii. To describe the relationships between reported treatment targets and 
outcome domains used in these RCTs.  
iv. To describe the effect sizes of exercise versus comparison/control 
treatment for individual RCTs and calculate these when not reported.   
v. To define the treatment targets and outcome domains within each RCT, 
using a process-orientated logic model. 
 
 Methods 
A protocol of the systematic review was published on the PROSPERO register 
on the 12th December 2017 (reference CRD42017072023). This review is 
reported according to the PRISMA statement for systematic reviews (94), 
ensuring a rigorous approach. 
 
3.2.1 Eligibility Criteria 
The following eligibility criteria were applied to identify RCTs for inclusion in the 
review:  
Types of participants: The definition used for persistent NSLBP was symptoms 
present for more than 12 weeks, with more than 50% of participants having 
NSLBP. Only RCTs with adult populations were included. The following 
populations were excluded: those with specific spinal conditions only (such as 
spinal stenosis, post-surgical pain, pregnancy-related LBP, lumbar instability 
etc.), serious spinal pathologies (such as cauda equina, spinal tumours, spinal 
fractures, axial spondyloarthopathy etc.) and widespread chronic pain or 
systemic pain conditions (such as fibromyalgia and chronic fatigue syndrome). 
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Types of Interventions:  Included exercise interventions were required to be 
supervised or tailored to fulfil the requirement of a complex intervention. To be 
eligible, RCTs had to have a comparator group(s) that included no exercise 
treatment; RCTs may have compared exercise to usual care (e.g. physiotherapy, 
spinal manipulation, education, or GP-led care), placebo interventions, brief 
interventions or waitlist controls as long as they did not include a supervised or 
tailored exercise component. Exercise interventions delivered alongside other 
active interventions such as manual therapy were excluded as it was not possible 
to extract the treatment effect of the exercise intervention alone. Cognitive and 
/or behavioural ('psychological') interventions delivered alongside exercise were 
included as this component was more difficult to separate from an exercise 
intervention (23), and exercise for NSLBP is thought to work at least in part 
through psychological mechanisms of action (see Introduction, section 1.2.1). 
Types of comparators: To be eligible, the comparator group(s) were required to 
have no exercise treatment, and may have received: no health-care, usual care, 
or be on a waiting list for exercise treatment. Usual care may have included other 
conservative care such as non-exercise physiotherapy, osteopathic or 
chiropractic care, manual therapy, drug therapy or other treatments.  
Types of outcomes: All outcomes relevant to the exercise interventions were 
included. Outcome domains encompass the focus of the outcome (e.g. 'what' is 
measured), whereas outcome measures are the measurement instruments for 
each domain (e.g. 'how' it is measured) (69,78,95). All RCT outcomes (primary 
and secondary, where stated) were extracted, if they were judged to be 
potentially relevant to the exercise intervention.  
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Types of settings: To be included, RCTs had to be conducted in a primary or 
community care setting, similar to the UK or equivalent in other countries. 
Secondary care outpatient settings were included, but all in-patient intervention 
settings (i.e. where patients were required to stay overnight in hospital as part of 
the exercise intervention) were excluded.  
Types of studies: Only RCTs were included in this review. Given the reported 
effect sizes of exercise from previous systematic reviews, RCTs that lacked 
sufficient power to detect even a medium effect size between exercise and a 
comparison group were excluded: for a medium effect size of 0.5 (96) in a two-
armed RCT, 120 participants would be required at about 80% power (60 per arm) 
from an unadjusted analysis. Therefore, 180 participants were required for a 
three-armed RCT. Three-armed RCTs where the intervention in one arm was not 
relevant as a comparator arm, or it did not have more than 60 participants, were 
excluded from the meta-analysis but included in the search results. This crude 
calculation, of requiring at least 60 participants per arm in RCTs, was used to 
include trials that were likely to have greater statistical power to detect between-
arm differences in their primary outcome measure. These RCTs were also more 
likely to be of higher quality (53,97).   
 
All titles and abstracts were required to be in the English language to be assessed 
by the reviewers. Where the full-text was in a language other than English, 
translation was pursued where possible. Articles were excluded where full-text 
was not available, or translation was not possible. 
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3.2.1.1 Search Strategy 
A computer-aided electronic database search of PsycInfo and CINAHL (EBSCO); 
Web of Science; AMED, Embase and MEDLINE (Ovid); PEDro and Cochrane 
Central trials registry was developed in consultation with information specialists 
and used all keywords and subject headings to explore the most important key 
concepts: persistent NSLBP, exercise therapy, RCTs. The computer-aided 
search took place from the conception of the databases until the 18th September 
2017. An updated search was performed on the 2nd August 2018 and again on 
the 5th August 2019.  Please see Appendix 9a: Systematic Review Search 
Terms.  
 
3.2.2 Study Selection  
All search results were directly imported into online reference management 
software (Refworks Proquest), which assisted with deletion of duplicates. A pilot 
review of both title and abstract hits and full-text screening stages were 
performed with two reviewers checking five papers each, to pilot test and improve 
the clarity of the eligibility criteria.  
 
Titles were screened and citations excluded when it was apparent that they did 
not meet the inclusion criteria. Screening until this point was performed by the 
PhD candidate (LW). Remaining papers were then exported to the Covidence 
software package for title and abstract screening. To select full-text papers, two 
reviewers independently screened the titles and abstracts (LW and AB). When a 
citation was deemed eligible for inclusion, or a decision was unable to be reached 
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on the information provided in the title and abstract, the full text was retrieved. 
Full-text review was completed by three pairs of independent reviewers, with the 
PhD candidate remaining constant across all pairs - disagreements between 
reviewers were discussed by the supervisory research team (all reviewers).  
 
3.2.3 Risk of Bias Assessment  
The Cochrane Risk of Bias Tool version 1.0 (93) was utilised to assess for risk of 
bias and includes the following domains: randomisation sequence generation, 
allocation concealment, blinding of both participants and personnel, and outcome 
assessors, incomplete outcome data (e.g. drop-outs and withdrawals), and 
selective outcome reporting. Any additional features felt to be important by the 
reviewers were included under the domain 'other', such as adherence, 
compliance, drop-out rates in secondary outcomes. For each domain in the tool, 
a description of the procedures undertaken in the trial with verbatim quotes was 
extracted. Independent judgement of the risk of bias for each category was made 
by two reviewers. In line with instructions for the use of the risk of bias tool, raters 
categorised each domain of the Risk of Bias tool as 'high risk', 'low risk' or 'unclear 
risk' if insufficient detail was felt to be present to record a judgement. Risk of bias 
review was completed by three pairs of independent reviewers, with the PhD 
candidate remaining constant across all pairs - disagreements between 
reviewers were discussed by the supervisory research team (all reviewers).  
 
Each item in the risk of bias assessment was considered independently without 
an attempt to collate or assign an overall score. For incomplete outcome data, 
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trials were categorised as low risk if they used an intention to treat analysis 
(63,98). Where this was reported but not performed, trials were categorised as 
at high risk of bias. Similarly, last observation carried forward, and failure to 
account for missing data resulted in a high risk of bias classification (99). This 
was carried out at the same time as data extraction. Graphic representation of 
the bias judgements was created in an online review manager (RevMan 5.3).  
 
3.2.4 Data Extraction 
Pairs of reviewers independently extracted identified treatment targets, primary 
and secondary outcome domains, and outcome measures from each RCT. Data 
were extracted utilising a bespoke developed Microsoft Excel Spreadsheet. 
Further demographic information was also extracted, comprising:  
i. The country and setting of the RCT;  
ii. Participant characteristics (mean age, proportions of each sex, mean 
duration of pain);  
iii. Total sample size at randomisation, per RCT in total and per arm;  
iv. Inclusion/ exclusion criteria;  
v. Exercise intervention type (such as general, stretching, strengthening, 
specific exercises such as the McKenzie method or yoga etc.) and 
dosage and duration;  
vi. Comparator treatment type (usual care, placebo, waitlist control, manual 
therapy), dosage and duration;  
vii. Outcome domains and measures utilised as primary and secondary 
outcomes;  
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viii. Follow-up time-points: the specified primary time-point was extracted 
(100).  
 
3.2.4.1 Treatment Targets Extracted 
Documented exercise treatment targets (both those described explicitly in the 
RCT published methods section or protocol paper, and those inferred in the 
background section of the RCT with quotations where possible). Treatment target 
extraction was completed by three pairs of independent reviewers, with the PhD 
candidate remaining constant across all pairs - disagreements between 
reviewers were discussed by the supervisory research team (all reviewers) (101). 
Explicit or specific targets were first sought from each RCT paper’s methods 
section under the intervention description. Specific treatment targets were 
extracted when the authors of the RCT stated that "the exercise aimed to…".  If 
treatment targets were not specified in the methods section, then the background 
section was scrutinised to search for a specific or implicit description of the 
exercise intervention targets. If no treatment targets were specified or implied, 
then related exercise intervention development papers or RCT protocols (where 
available) were reviewed. Treatment targets were extracted verbatim from the 
text, and where the identification or specification of treatment targets was unclear 
or vague, the potential treatment target-related text was extracted.  
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3.2.4.2 Outcomes Extracted 
Data extraction focussed on the primary outcomes of each RCT. Outcomes were 
classified as the primary outcome by using the following process, moving to the 
next stage if the former did not identify the primary outcome.  
i. The primary outcome was explicitly stated by the authors  
ii. If more than one primary outcome was used, then the first primary 
outcome mentioned was used  
iii. The outcome measure on which the sample size calculation was based 
iv. The first outcome measure referred to in the abstract or paper 
This approach has been used in several previous reviews (70,102–105). 
Secondary outcomes were also extracted when relevant to the proposed 
treatment targets (e.g. data on adverse events were not extracted). The 
nominated primary follow-up time-point was also captured, and where this was 
not specified by the RCT authors, the earliest follow-up time-point post-
intervention was extracted and used as the primary time-point (70,104,105). For 
each primary and secondary outcome, both the outcome domain and outcome 
measure used were recorded.   
 
3.2.4.3 Matching of Treatment Targets and Outcomes 
Primary outcome domains were assessed as to whether they matched the RCT 
authors' own reported exercise treatment targets. The RCT was classified as 
'matched' if the primary outcome domain was matched to any of the identified 
treatment targets. RCTs were classified as 'unmatched' if the primary outcome 
was not matched to any of the specified treatment targets. Included in the 
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unmatched group, were trials which had captured some secondary outcomes that 
reflected the identified treatment targets. These trials were classified in a 'partial 
matched group' as a sub-group within the unmatched category. This sub-group 
was useful for identification of trials for future analyses in the thesis, but for the 
purposes of this chapter are reported as 'unmatched'. This was a subjective 
process, and was independently judged by two reviewers (of three possible 
pairs). As this categorisation has not been performed before, there was no 
formally validated process. 
 
3.2.5 Descriptive Analysis 
Following data extraction, data were summarised into tables and analysed. 
Descriptive statistics were utilised to summarise the number of trials: a) reporting 
exercise treatment targets, b) measuring outcome domains matched to reported 
exercise treatment targets and c) measuring outcome measures used within 
outcome domains. Descriptive statistics, such as frequency counts and 
percentages, were used to summarise treatment targets, treatment outcome 
domains and outcome measures.  
 
3.2.6 Meta-analysis of Matched and Unmatched Categories 
The primary aim of this systematic review was to investigate the role of matching 
between reported outcome domains and exercise treatment targets. The meta-
analysis was conducted to explore whether matching of outcome domain to 
treatment targets impact on the size of these SMDs. The analysis was 
undertaken using the following stages:  
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i. Individual RCT SMDs for exercise and control arms comparisons 
ii. Grouped SMD comparisons 
iii. Sensitivity and sub-group analyses 
 
3.2.6.1 Standardised Mean Difference Calculations 
SMDs were calculated for each trial for between-arm differences at the primary 
outcome time-point designated by the trial authors, or the earliest time-point post-







Where d represents SMD, Ẋ represents the mean follow-up score, 1 represents the intervention 
arm, and 2 represents the control arm, and 𝑠 represents the average of the baseline standard 
deviations (106). The average was calculated as the sum of the baseline standard deviations 
divided by 2. 
 
Where a confidence interval (CI) was provided for the individual arm baseline 
values without a standard deviation (SD) value, the SD for the individual arm was 
calculated using the following formula (101): 
 s = 
√𝑛×(𝑢𝑝𝑝𝑒𝑟 𝑙𝑖𝑚𝑖𝑡−𝑙𝑜𝑤𝑒𝑟 𝑙𝑖𝑚𝑖𝑡)
3.92
 3-2  
Where S represents the mean standard deviation of the individual arm baseline values and n the 
sample size for the relevant individual arm.  
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(derives a pooled variance) 
3-3  
Where s represents the pooled mean standard deviation of each arm, n represents the sample 
size, and s2 is the pooled variance. 
 







(derives a pooled standard error) 
3-4  
   
The limits of the CI for the between-arm SMD were then calculated: 
 95% 𝐶𝑜𝑛𝑓𝑖𝑑𝑒𝑛𝑐𝑒 𝐼𝑛𝑡𝑒𝑟𝑣𝑎𝑙 = 𝑠𝑒 × 1.96 ± 𝑑  3-5  
Where 𝑑 is the estimated/ observed between-arm standardised mean difference 
 
The limits of the CIs for the SMD were then extracted using the above formula 
for SMD derivation.  
 
Where proportions were reported, the following were used:  
The formulae below are given for proportions, but presentation of results are 
given as percentages (through x100% conversion).   
 Proportion = 
𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑖𝑛𝑡𝑒𝑟𝑣𝑒𝑛𝑡𝑖𝑜𝑛+𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
2
 3-6  
 





Where p is the average proportion of intervention, control; n is the sample size 
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Where medians were used:  
The average lower/upper quartile across the intervention/ control were calculated 
with the formula:  
 Average quartile = 
(
𝐼𝑛𝑡𝑒𝑟𝑣𝑒𝑛𝑡𝑖𝑜𝑛 ((𝑈𝑝𝑝𝑒𝑟 𝑞𝑢𝑎𝑟𝑡𝑖𝑙𝑒−𝑚𝑒𝑑𝑖𝑎𝑛)+(𝑚𝑒𝑑𝑖𝑎𝑛−𝑙𝑜𝑤𝑒𝑟 𝑞𝑢𝑎𝑟𝑡𝑖𝑙𝑒)))
4
+




This was then multiplied by  
34
25
 to gain the difference between an interquartile 
marker and a SD: 1SD covers the middle 68% of the normal distribution, whilst 
an inter-quartile range (upper quartile minus lower quartile) represents the mid-
spread (middle 50%) of the data distribution. The final figure is then comparable 
with a SD value especially the closer the distribution of scores resembles a 
normal distribution3.  
 
For the SMD calculation:  
Median values were used here to approximate the mean values (when means 
are not provided) for purposes of SMD estimation, and will be a good 
approximation the closer the data is symmetric around the median.  
 d= 
𝑚𝑒𝑑𝑖𝑎𝑛 𝑖𝑛𝑡𝑒𝑟𝑣𝑒𝑛𝑡𝑖𝑜𝑛 𝑎𝑟𝑚−𝑚𝑒𝑑𝑖𝑎𝑛 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑎𝑟𝑚
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛
 3-10  
Where d represents the SMD  
                                            
3 For the purposes of comparing available data this method was used, with the 
assumption that this data was of a normal distribution even though the 
likelihood was that it was not normal resulting in the use of medians. 
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Since SMD statistics for all between-arm differences are given based on 
intervention arm minus control arm then positive SMDs indicate higher values for 
the intervention (lower for the control). By contrast, negative SMDs indicate lower 
values for the intervention (higher for the control). Since the direction of scale 
data may be conflicting (i.e. higher values indicate worse health outcome status 
for some scales and better health status for other scales), for the purposes of 
standardisation and ease of evaluation and interpretation within the meta-
analysis all SMDs were scaled such that positive SMDs reflect better outcome 
for the intervention and negative SMDs reflect worse outcome, by multiplication 
with minus one where necessary. SMDs were interpreted according to Cohen's 
(96) recommendations, where an effect size of <0.2 is considered ‘small’, around 
0.5  is considered ‘medium’ and >0.8 ‘large’.  
 
Where more than one intervention or comparator arm was used:  
If an RCT reported results for two separate intervention arms that had similar 
treatment targets, or more than one control arms, the results were combined 
according to the guidance described in the Cochrane Handbook (101) using the 
formulae in   
Chapter 3: Matching treatment targets and outcomes in trials of exercise 






Chapter 3: Matching treatment targets and outcomes in trials of exercise 













n1 n2 n1+n2 3-11 



















3.2.6.2 Treatment Success 
Where possible, SMDs were compared to the reported minimum clinically 
important difference (MCID), which was standardised by: 
 
𝑆𝑀𝐶𝐼𝐷 =
𝑚𝑖𝑛𝑖𝑚𝑎𝑙 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙𝑙𝑦 𝑖𝑚𝑝𝑜𝑟𝑡𝑎𝑛𝑡 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒
𝑟𝑒𝑝𝑜𝑟𝑡𝑒𝑑 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑀𝐶𝐼𝐷
 
3-14  
SMCID is the standardised minimum clinically important difference, and MCID is the minimum 
clinically important difference.  
To determine whether the SMD was clinically meaningful or not, treatment 
success was evaluated according to the recommendations by Dent and Raftery 
(108) as demonstrated in Figure 3-1. This figure was amended with the addition 
of the “clinically and statistically significant” marker which occurs when the SMD 
and its confidence intervals are greater than the MCID.  
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Figure 3-1: Modified graphic representation of interpretation of treatment 
success (adapted from Dent and Raftery, 2011) 
  
*Where d represents the standardised minimum important difference 
 
3.2.6.3 Grouped Standardised Mean Differences 
Sub-group analysis was performed according to the categorisation of ‘matched’ 
and ‘unmatched’ trials using the RevMan 5.3 software, according to the 
guidelines in the current version of the Cochrane Handbook for Systematic 
Reviews of Interventions (101). The Mantel-Haenszel method was used for the 
random-effects model, where statistical heterogeneity was observed (I2>=50% or 
P<0.1). The I2 defines the amount of heterogeneity across trials in the meta-
analysis and is categorised as low (25% or less), moderate (50%) or high (75% 
0
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or more) (109). Sub-group analyses were performed to explore the effect on the 
size of the SMD depending on whether the RCT was matched or unmatched for: 
i. The impact of risk of bias assessment  
ii. The difference in recruitment strategy (e.g. consulters vs non-consulters) 
iii. The impact of specified exercise treatment targets 
iv. The effect of the comparator group. 
A prediction interval for the estimated heterogeneity levels was calculated as 
recommended by the Cochrane Handbook (106) using the calculation: 
 95% 𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛 𝐼𝑛𝑡𝑒𝑟𝑣𝑎𝑙 = M ± 𝑡𝑘−2  × √𝑇𝑎𝑢2 + SE(𝑀)2 3-15  
Where M is the summary mean from the random-effects meta-analysis, tk−2 is the 95% 
percentile of a t-distribution with k–2 degrees of freedom, k is the number of studies, Tau2 is the 
estimated amount of heterogeneity and SE(M) is the standard error of the summary mean. 
 
3.2.6.4 Sensitivity Analyses 
3.2.6.4.1 Sensitivity Analysis: Ratio of Means 
A ratio of means (RoM) value was calculated for the primary outcome of each 
RCT. SMDs were recommended for standardising scales when comparing 
across different outcome scales which measure the same construct (e.g. 
combining the McGill Pain score with the Brief Pain Inventory and the Visual 
Analogue Scale (VAS)) (106). The use of RoM is proposed as an alternative to 
using the SMD as it can combine outcomes measured using different scales 
and domains (110). The RoM expresses the percentage change in the mean 
value of the intervention arm in comparison to the control arm. It has been 
suggested to be a more favourable method as it is easier to interpret and has 
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low levels of bias (111). The results are interpreted, similar to the risk ratio, 
where if the combined ratio is 1.15, then the outcome in the intervention arm is 
15% higher than the control arm. The RoM was calculated by dividing the mean 
outcome of the intervention arm by the mean outcome of the control arm as 







Where RoM represents ratio of means, XT is the mean of the intervention arm, Xc is the mean of 
the control arm.   
 
For meta-analysis, the natural logarithm of each trial RoM and standard error 
(SE) were calculated using the mean values, number of participants (n) and SD 
















Where SE represents standard error, n is the sample size, s is the standard deviation and X is 
the mean of the arm of interest (T is the intervention arm; C is the control arm).  
 
The natural logarithm transformed ratios were then combined across RCTs 
using the standard inverse variance method. In the inverse variance (IV) 
method the weight given to each study is the inverse of the variance of the 
SMD (i.e. the reciprocal (one over) the square of its SE). Hence, within the 
aggregated ratio, the larger studies have more weight than smaller studies (as 
the latter have larger SEs). However, in random effects meta-analysis, as 
heterogeneity increases, the IV weights become more equal, therefore 
increasing the estimator variance (112). A combined ratio and its 95% 
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confidence interval were obtained by back-transforming the combined log-
transformed ratio and its 95% Cl: 
 RoM = exp(log  (𝑅𝑜𝑀)𝑝𝑜𝑜𝑙𝑒𝑑)  3-18  
 95% 𝐶𝐼 = exp log(𝑅𝑜𝑀)𝑝𝑜𝑜𝑙𝑒𝑑 ± 1.96 × 𝑆𝐸(𝑙𝑜𝑔(𝑅𝑜𝑀)𝑝𝑜𝑜𝑙𝑒𝑑) 3-19  
These values were calculated, input into RevMan (5.0) and reviewed in 
comparison to the original SMD values. They were interpreted similarly to SMD 
values with 8, 22 and 37 percentage values corresponding to Cohen’s (96) 
SMD values of 0.2, 0.5 and 0.8 (110).  
 
3.2.6.4.2 Sensitivity Analyses: Pain and Physical Function Scores 
Sensitivity analyses were performed by converting reported pain and physical 
function scores to mean differences on a 0-10 scale for pain and 0-100 scale 
for function. These were interpreted according to MCIDs within sub-groups 
using the recommendations of Ostelo et al. (113). 
 
Pain scores were converted to a 0-10 scale, whereby Visual Analogue (VAS) or 
Numeric Rating Scale (NRS) scores from 0-100 were divided by 10 to translate 
to a 0-10 scale. Ostelo et al. (113) report that 2 points represent the MCID for 
the NRS on a 0-10 scale. 
 
Physical function scales were all converted to a 0-100-point scale by multiplying 
the reported mean score by 100 and dividing by the available scale points (e.g. 
the Roland Morris Disability Questionnaire (RMDQ) ranges from 0 to 24 thus 
scores were divided by 24). Ostelo et al. (113) report an MCID of 10 points for 
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the Oswestry Disability Index (ODI) (0-100), and 20 points for the Quebec Back 
Pain and Disability Scale (QBPDS) (0-100). As all scales were converted to a 
100-point scale, 10 points was the lowest of the above MCIDs and were used 
as a marker of MCID.   
 
3.2.7 Logic Model 
Logic models have been recommended in systematic reviews of complex 
interventions to allow visual depictions of the interacting components (13,114). A 
preliminary draft of a logic model was used to assist with interpretation and 
understanding of the relationships between the treatment targets of exercise and 
the outcomes used in trials of exercise interventions. A logic model for exercise 
as an example of a complex intervention in persistent NSLBP was constructed 
underpinned by the extracted data (13) of the included RCTs. This included the 
setting and deliverers of the exercise intervention, the treatment targets 
identified, the core components of the exercise interventions, and the primary 
outcome domains used to assess the effectiveness of the exercise interventions 
(13,114,115) as extracted by the PhD candidate. Relationships between reported 
treatment targets and treatment outcome domains were mapped and presented 
to the supervision team for refinement. 
 
3.2.8 Publication Bias 
Typically, a funnel plot would be created to test for publication bias, but given that 
small RCTs of exercise for NSLBP were purposely excluded from this review, 
this would be hard to interpret, and thus this was not created.  
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3.3.1 Search Results 
The PRISMA flow diagram demonstrating the flow of information through the 
review is shown in Figure 3-2. After removal of duplicates, 754 remaining titles 
and abstracts were subsequently screened. 119 trials were identified for full-text 
review. 92 trials were excluded for the following reasons:  
i. The trial had an insufficient sample size 
ii. The trial did not include predominantly adults with persistent NSLBP 
iii. The trial did not have an exercise intervention that met the eligibility 
criteria  
iv. The trial did not have a non-exercise comparator arm 
v. The study was not a RCT design 
vi. The trial was not available in the UK. 
A total of 27 RCTs were included. 
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3.3.2 Included RCT Characteristics 
Of the 27 included RCTs, 25 were individually-randomised, and two were cluster-
randomised. Sixteen were two-arm, nine were three-arm RCT designs, one had 
four arms, and one had six arms, tallying 69 RCT arms. The RCTs included a 
total of 5870 participants, giving an average of 85 participants per arm, of which 
2916 were allocated to exercise, and 2954 to non-exercise control interventions. 
Sample sizes per RCT varied from 121 to 768.  Protocols were available in the 
public domain for seven RCTs.  Please see Table 3-2 for full detail.   
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Trial Setting: The 27 RCTs were from 12 different countries: six from the UK, four 
from the USA, three from Australia; and two each from Spain, Norway, the 
Netherlands and Brazil. Denmark, Hungary, Taiwan, Switzerland, Italy and Japan 
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Table 3-2: Characteristics of Included RCTs (27 RCTs) 












et al. (116) 
Primary care, 
Spain 
348 pts; Mean 
age 51.5 yrs, 
duration LBP >12 
wks 79.5% 
Inclusion criteria: 
consulters for LBP, with or 
without referred pain. 
Exclusion criteria: 
illiteracy, bedridden, 
previous physiotherapy in 
the last 12-months, red 
flags, specific LBP; 
inflammatory 
rheumatologic disease; 
fibromyalgia or signs for 





stretching and active 
exercises for 
abdominal lumbar 
and thoracic muscles. 
Standardised but 
intensity adapted to 
the patient’s ability.  
Comparator 1: 
Education and 
booklet on health 
nutrient habits and 
one 15-minute group 
talk 
Comparator 2: ˮBack 
bookˮ and one 15-
minute group talk 
Physical function 
(RMDQ) at 26 weeks 
(wks); pain intensity 




related quality of life 
(Short-Form Health 






200 pts (301 total 
sample); Mean 
age 45.1±11 yrs; 
Median 5 yrs. 
duration LBP 
Inclusion: 18-65yrs; 
mechanical LBP > 6wks 
duration.  
Exclusion: Previous 
lumbar fusion surgery; 
progressive neurological 
deficits; aortic or 
peripheral vascular 
disease; pain scores < 
3/10; pending or current 
litigation; ongoing 
treatment. 
High dose supervised 
low tech trunk 










1-2 x wk for 15-30-
mins.  
(Comparator 2: Low 
dose home 
exercises: two 1-hr 
appointments 
followed up 1-2 wks 
later)5 
Pain (ordinal 11-box 
scale) at 12 wks; 
Physical Function 
(RMDQ); health-related 
quality of life (SF-36); 




                                            
4 The trial was set at the university clinic but recruited from local community settings 
5 Where comparators or interventions in brackets were excluded from the analysis 
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235 pts; Mean 
age 41.55 yrs.  
Inclusion: >18 years, 
primary complaint CLBP, 
no contraindications to 
manual therapy. 
Tenderness over lumbar 
joints; forego NSAID use 
prior to assessment.  
Exclusion criteria: CNS 
disease, psychiatric 
disease or lack of 
cognitive ability, current 
and known substance 
abuse, not fluent or 
illiterate in English, 
morbidly obese, pregnant, 
currently receiving care for 
LBP, treated by 
chiropractor or PT in past 
6 months, unwilling to 
forego other care during 






Pain intensity (VAS), 
Physical Function 
(RMDQ), HRQoL (SF-36) 
at 4 wks; health-care 










Mean age 58.8 
yrs.  
Inclusion: Consulters for 
NSLBP; >24 weeks. 
Exclusion: Neurological 
signs; spondylolisthesis, 




impairment or pain-related 
litigation.  
Back School: 15 1-hr 







Passive and active 
mobilisation, active 
exercise and soft 
tissue treatment. 15 
sessions 1-hr five 
days a week)4 
Manipulation: Whole 
spine approach. 4-6 
(as needed) weekly 
sessions of 20-
minutes each for a 




(RMDQ) 3 wks or 4-
6wks; pain intensity 
(Roland Morris Pain 
Rating Scale);   
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127 pts; LBP; 
Mean age 34.2 
yrs. 
Inclusion: Self-reported 
LBP >6 months; LBP VAS 
>4; 
Exclusion: Prior surgery 




minutes at a time, 3 x 
wk, for 6-months. 
10mins WU, 30-mins 
Back pain ex and 
core muscle training, 
10-mins relaxation. 
Group setting. 
Usual activities for 
50-minutes at a time 
Pain (VAS); Exercise 
Self-efficacy (Exercise 
self-efficacy 






159 pts (239 pts); 
Mean age 43 yrs.  
Inclusion: LBP without leg 
pain > 3 months; > 18 
years.  
Exclusion criteria:  
> 65 years, serious spinal 
disorder, main complaint 
of pain below hip, 
previous spinal surgery, 
additional MSK disorder, 
attendance or referral to a 
specialist pain service, 
medical condition, 
anticoagulant treatment, 
steroid treatment, unable 
to get up from floor 
unaided, physical therapy 
in previous 3 months.  












attendance of 5 







Attendance of 5 
sessions over 3-
months. 
Physical function (ODI) 
at 6 wk and 52 wk follow 
up; HRQoL (EQ-5D); 
fitness (Shuttle walk test). 













Inclusion: Consulters for 
NSLBP; >3 months 
duration; 18-80 yrs. age; 
comprehend English; 
motor control indicated.  
Exclusion: Suspected/ 
confirmed spinal 
pathology; pregnancy or 
lactation; nerve root 
compromise; Previous 
spinal surgery; major 
Motor control: 12 30-
min treatments over 
8-wk period; (2 
sessions a wk in first 
month, one 
session/wk in second 
month); 2 stages 
individualised motor 
control training 
Placebo: 12 30-min 
treatments over 8-
wk period; (2 
sessions/ wk in first 
month, 1 session/ 
wk in 2 month); 20-
mins detuned SWD; 
5-mins detuned US 
Pain (Numeric pain 





impression of recovery 
(Global perceived effect 
(GPE) scale) at 8 wks; 
physical function (RMDQ); 
recovery; recurrence LBP 
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surgery scheduled; any 
contraindication to 













age 39 years 
 
 
Inclusion: 18-65 yrs age; 
NSLBP; Prescribed 
physio; no neurology; LBP 
caused by functional 
overload/ poor postural 
habits; agreed to abstain 
from other treatment 
during study; LBP 2-4 
months.  
Exclusion: Depression; 
cognitive defects affecting 
understanding; imminent 
move, lack of time; 
contraindications to ET; 
red flags or yellow flags 
Godelive Denys-
Struyf Physiotherapy: 
15 sessions of 
articular and 
muscular balancing 
of lumbar spine and 
pelvis. Mix individual 
and group sessions 
spine stabilizing ex. 2 
sessions average 50-
mins duration/ wk 
Conventional PT: 15 
treatment sessions: 
14 40-min sessions 
of TENS plus 10-
mins microwave 
treatment. Last 
session received a 
sheet of exercises.   
Pain (NRS) at 12 wks; 
physical function 
(Oswestry Disability Index 









CLBP; mean age 
53.5yrs 
Inclusion: NSLBP, 18 - 80 
yrs.  
Exclusion: Neurological 
signs, specific spinal 
pathology or previous 
back surgery. 
General exercise: 1-





exercise: 12 training 
sessions of specific 
muscle stabilisation  
Both exercise groups 
delivered by a 
physiotherapist.  
Spinal manipulative 
therapy: 12 sessions 
treatment involving 






point scale) at 8 wks; 













Inclusion: >3/10 Pain, 18-
80yrs, read Portuguese. 
Exclusion: Contra-
indication to exercise/ 





mins long. Repeated 
ex in prescribed 
direction + education. 
Placebo: detuned 
US 5-min; SWD 
detuned 25-min, 
+educational booklet 
"the back book" 
Pain intensity (NRS); 
physical function 
(RMDQ) at 5 wks; 
(PSFS); kinesiophobia 
(Tampa Scale of 
Kinesiophobia (TSK)); 
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spinal pathology, CVD/ 
metabolic disease, 




reps 3-5x day and 
educational booklet 
"the back book" and 








213 pts, referred 
for 
physiotherapy; 
mean age 42yrs; 
average duration 
11.72 ±9.85yrs 
Inclusion: NSLBP >12 
weeks, 18-65yrs, literate 
English.  
Exclusion: Non-





disease; lower limb 
pathology; metastatic 
disease; medically unable 
to participate in exercise; 





Staffed by two 
physiotherapists <12 
patients /1-hour class 








any other exercise. 
Maximum ten 
sessions + Back 
school)4  
 
Pain (NRS); physical 
function (ODI), Handicap 
(Low back outcome 
score) and Impairment 
(lumbar flexion and timed 
walking test), Quality of 
life and dysfunction 
(Nottingham Health 
Profile) at 12 wks 
Minimal intervention. 








150 pts referred 
by clinicians, 
mean age 53.4 
yrs. 
Inclusion: Aged >18 yrs, 
NSLBP >6 months, 
English literacy, no new 
pain treatments in last 
month, willing to attend 
yoga or be assigned to 
delayed treatment, willing 
to not change treatments 
unless medically 
necessary.  
Exclusion criteria: recent 
back surgery (past 12 
months), systemic causes 
of back pain, morbid 
obesity, acute nerve root 
12-wk Yoga 
intervention: 2 60-min 
instructor-led 
sessions a wk. 
Encouraged to do 
home exercises 15-
20-minutes on non-
instructor led days.  
Delayed yoga after 
12-months.  
Physical Function 
(RMDQ) at 12 wks; pain 
intensity (Brief pain 
Inventory); non-study 
treatments and 
medications – use. 
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positive Romberg’s test, 

















Inclusion: Persistent LBP 
(50%)>3 months; sub-
chronic > 4 weeks and 2 
pain episodes /month in 
past 12 months.  
Exclusion: Permanently 
disabled; specific causes 
of LBP including root 
compression; pregnancy 
or lactation excluded; 
Previous spinal fusion 
Intensive dynamic 
back muscle training: 
3 exercises 
performed five series 
10x ea.; 1-min break. 
After 10-min rest 
repeated all ex with 
300 contractions over 
4-weeks 
(Standard PT: soft 
tissue treatment, 
flexibility ex for 
lumbar spine and 
pelvis, coordination 
ex, counselling, 




20 mins  
Pain scores (interval 
scale) at 4 wks; overall 
treatment effect 













/moderate pain or 
moderate activity limitation 
reported; NSLBP+ leg 
pain 
Exclusion: suspected/ 
known spinal pathology; 
contraindications to 
exercise; scheduled for 
spinal surgery. 
Tai chi sessions 40 
mins long; 18 
sessions over 10-
wks, group setting 
(2 x wk for 8-wks 
then 1 x wk for 2-
wks) 
Waitlist controls Bothersomeness of pain 
(NRS)at 10 wks; physical 
function (ODI; Pain 
disability index (PDI); 
Quebec Back Pain and 
Disability Scale (QBPDS); 
PSFS), GPE 










Inclusion: sick leave for 
LBP 2-10 months 
Exclusion:  not fluent 
Norwegian; age >60; 
pregnancy; awaiting 
Brief intervention + 
physical exercise: 3 x 









participation at 52 wks 
(change in sick leave 
status); physical function 
(ODI), anxiety & 
                                            
6 Staff from a large organisation volunteered following an advertisement in an internal company newspaper. 
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insurance trials.  
Individual goals set 




relaxation in group 
setting. 
 
Psychiatrist led and 
lasted 90min 
sessions.)4 
Brief intervention: 2 
sessions over five 
days with option of 2 
booster sessions 
depression (Hospital 
Anxiety and Depression 
Score (HADS)), subjective 
health complaints 
(Subjective health 
complaints index), coping 
(Utrecht Coping List), 
fear-avoidance (Fear-
avoidance beliefs 
questionnaire (FABQ))  
Hildebrandt 










Inclusion: 18-55yrs age; 
NSLBP, >4 episodes in 
past one year.  
Exclusion: prev. Cesar or 
Mensendieck therapy; 
other psychological 




















Improvement of posture 
(thoracic, lumbar spine, 
pelvis) at 12 wks 







201 pts; mean 
age 35 years 
Inclusion: 18-55 yrs.; 
NSLBP; pain> 6 weeks or 
minimum of 4 episodes in 
previous 12 months; not 
had previous intervention; 
No comorbidities; able to 
complete questionnaires 
in Dutch; no other care for 
LBP. 
Both groups received 
treatment for 3-
months 10-14 
sessions, follow up; 
intervention group 





for 3-months (10-14) 
sessions. No further 
intervention  
Self-reported recovery 
from LBP at 26 wks; 
physical function 
(QBPDS); intensity and 
duration of LBP (Van 
Korff Pain scale), general 









pts; mean age 
41.4 years 
Inclusion: Diagnosed with 
persistent NSLBP, 
employed in health-care 
setting, worked as 
bedside nurses for >3 
years.  
Back school: twice 
weekly for 12-weeks 




(consisting of muscle 




WinSpine Triple Lumbar 
biomechanical motion 
analysis); Pain intensity 
over the past week 
(VAS) at 12 wks. 
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Exclusion: One or more 
diagnoses: acute/ 
subacute LBP,  Specific or 
sinister causes of back 
pain; surgical 
recommendations, 
tumour, failed back 
syndrome, rheumatic or 
musculoskeletal disease, 
depression and other 
psychiatric disease, 




current or recent 
physiotherapy, previous 














LBP; mean age 
47.9yrs 
Inclusion: Consulting for 
persistent NSLBP 
Exclusion: previous 
consulting for LBP in past 
6-months; “red flags”, 
pregnancy or recent 
childbirth, comorbidities 
that may prevent full 
participation; previous 
spinal surgery, major 
psychiatric disorder 
diagnosed or under 
investigation, history of 
drug or alcohol abuse in 
past 5 years. 
Both groups mailed 
educational pack 








changing beliefs and 
thoughts.   
Both groups mailed 
educational pack 





Treatment as usual 
by GP.  
Pain severity (VAS); 
physical function 
(RMDQ) at 52 wks; 
HRQoL (Euro-Qol 5D 
(EQ-5D)).  
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Mean age 39 yrs; 
average duration 
pain 12 yrs  
Inclusion: >30d LBP in 
past 1 yr.; 8-30 days LBP 
+reported disability in 
daily tasks >12 months; 
20-55 yrs. age; read and 
write in German/ Italian 




disease of spine; prior 
spinal surgery; regular 
strength training in prior 6 
months; pregnant women 
Low back school as 
per control. 3-month 
programme with 
three phases of 
individual training 
with a duration of 4 -
wks each 
(attendance 1-hr x 
2/wk).  
Low back school: 3 
sessions 1-hour 
each 
Lifting capacity (PILE test) 
at 12 wks; isokinetic trunk 
strength; ROM Lumbar 
spine flexion, extension 
and side bending; 
Isometric muscle 
endurance; aerobic 
capacity (box step); 
frequency and duration 
LBP (Nordic 
questionnaire); physical 
function (RMDQ and 
Waddell Q); Pain intensity 
(NRS, analgesic intake, 
Quantitative pain 
drawing); Pain 




beliefs (sense of 
coherence questionnaire) 
Miyamoto 
et al. (136) 
Primary care, 
Brazil 
295 pts voluntary 
recruitment; 





Inclusion criteria:  NSLBP 
>3months. 
Exclusion criteria: Pilates 
treatment for LBP in prev 
3-months, serious spinal 
pathologies, nerve root 
compromise, previous or 




groups of Pilates: 
 once a wk 
 twice a wk 
 three times a 
wk 
All individualised, one 
to one sessions for 6-
wks. 
Booklet group, 
advice only: receive 
pilates at 12-
months.  
Pain Intensity (NRS); 
Physical function 
(RMDQ) at 6 wks; global 
perceived effect (GPE), 





                                            
7 Staff volunteered and were invited further to questionnaires 
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Primary care,  
UK 
219 pts (315 total 
sample). Mean 
age 44yrs, 67% 
chronic pain.  
Inclusion criteria: >18yrs 
with back pain or neck 
pain >2 weeks’ duration, 
considered to be of non-
systemic origin.  
Exclusion criteria: patients 
with a score < 4 RMDQ or 
< 10 on the Northwick 
Park Neck Pain 
Questionnaire. Previous 
physical therapy within the 
previous 3 months or 
planning to use private 
physical therapy 
alongside the NHS 
physiotherapy. Referral 
from a hospital consultant, 
possibility of serious 
pathology or pregnancy. 
McKenzie treatment: 












the condition.  
Physical Activity 
Avoidance subscale of 
the TSK, and physical 
function (RMDQ or Neck 
Pain questionnaire) at 6 
wks. Health control 
(Multidimensional Health 











768 pts (1334 
total sample); 
mean age 43.1 
yrs; 58.7% had 
back pain 
episode lasting 
more than 90 
days 
Inclusion: 18-65 yrs; 
consulted with simple 
LBP; score of >4 on 
RMDQ. Agree to avoid 
physical treatments for 3 
months.  
Exclusion: Possibility 
serious spinal disorder; 
pain mostly below the 
knee; previous spinal 
surgery; another MSK 
problem more 
troublesome; attended or 
referred to a pain 
management clinic; 
severe psychiatric or 
psychological disorder; 
another medical condition 
Exercise Programme: 
Back to Fitness. 
Initial individual 
assessment followed 
by group classes 
incorporating CBT 
principles. Based in 
local communities. 
Up to 8 60-minute 
sessions over 4-8-




Best Care in general 
practice: “active 
management” of 
back pain, copies of 
Back Book.  
 
Physical function 
(RMDQ) at 12 wks; pain 
(modified van Korff 




(FABQ); HRQoL (SF-36; 
EQ-5D). 
Spinal Manipulation: 
Up to 8 20-minute 
sessions either in 





weeks SMT followed 
by 6-weeks of 
exercise classes 
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that could interfere with 
therapy; moderate to 
severe hypertension; 
taking anticoagulants/ 
long term steroids. Unable 
to walk 100m, get up and 
down from floor unaided. 
Previous physiotherapy in 
past 3 months; RMDQ 
score <3 ; unable to read 
or write fluently in English 
and a refresher 
class)4 










age 45.7 years 
Inclusion: persistent 
NSLBP; 18-64; pain > 
4/10 in previous week; 
English speaking 
Exclusion: specific causes 
LBP 
Yoga 12 weekly 75-




(PT treatment based 
classification, 
graded ex. 15 60-
min appts over 12-
wks; FABQ >29 
provided Back Book 
+ education)4 
Physical function 
(RMDQ); Pain (NRS) at 
12 wks; Pain medication 





The back pain help 
book; 3-wks 
newsletter and brief 












persistent NSLBP; no 
neurological deficit; SLR 
>70deg, negative femoral 
nerve stretch test, muscle 
strength> 4/5.  
Exclusion: red flag causes 
LBP, previous spinal 





HCP. 10 x 2 sets at 
Home.  
1st class 15-30-mins 
to teach, then visit 1-
2x wk x 8 wks 










Pain (VAS); physical 
function (RMDQ); 
HRQoL (Japan LBP 
evaluation 
questionnaire) at 8wks; 
Finger floor distance  
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218 pts identified 




age 44yrs.  
Inclusion: GP diagnosis of 
non-specific neck and 
shoulder pain, LBP or 
LBP with radiation. Time 
since being sick-listed 
>4<12 months.  
Groups met 3 x wk 
for 2-hours over 4- 




exercises provided.   
Treatment as usual 
– referral to 
physiotherapy/ 
chiropractor etc.  
 











LBP; mean age 
46.4 yrs.; 
average duration 
pain 84 months 
Inclusion:  >4 RMDQ; 
consulted for LBP in past 
18 months; ability to 
attend 1 venue.  
Exclusion: yoga in prior 6 
months; unable to get off 
floor unaided or use stairs; 
pregnancy; life-
threatening comorbidities; 




serious spinal neurological 
abnormality (such as 
cauda equina or cord 
compression) 
Yoga: 12 classes 
gradually progressed 
class over 3-months. 
75-mins long; 
encouraged to 
practice at home at 
least 2 x week.  
Back pain education 
booklet with usual 
care; one-time 
session of yoga after 
final follow-up 
Physical function 
(RMDQ) at 12 wks; 
HRQoL (SF-12); Back 
pain scores (Aberdeen 
Back Pain scale); pain 
self-efficacy (PSEQ); 
HRQoL (EQ-5D); number 
days in bed and days of 
restricted activity; 
medication use and 
health-care usage; 
beliefs, expectations and 
preferences for treatment; 
use of yoga at home 
Bold outcome domains signify specified primary outcome domains, measures and primary follow-up points. Abbreviations used: yrs – years; wk(s)- 
week(s); min- minute; MSK – musculoskeletal; SMT- spinal manipulation therapy; CBT – Cognitive behavioural therapy; HCP – Health-care 
professional; GP- General practitioner; pts –participants; US –Ultrasound; SWD – shortwave diathermy; CVD- cardiovascular disease; ex- exercise; 
HEP- home exercise programme; PT- physiotherapy; appts- appointments; NSAIDs – nonsteroidal anti-inflammatory drugs; WU – warmup; C1/2: 
control group ½; ROM – range of movement; q - questionnaire 
                                            
8 Yoga was delivered in nonmedical settings although patients were recruited from GP surgeries 
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Seven RCTs included an exercise arm with a mixed exercise component which 
included a regime of stretching and strengthening exercise and/or education. 
Four RCTs had a strengthening focussed exercise arm, five focussed on spinal 
stabilisation and motor control exercise, and two trials had a stretching focussed 
exercise arm. Three RCTs tested yoga (127,139,142) as the exercise 
intervention, one Pilates (136), and one tested Tai Chi (129). Five RCTs tested a 
specific exercise therapy approach such as McKenzie (125,137), Godelieve 
Denys-Struyf (123) or Cesar exercise therapy (131,132). Most RCTs utilised a 
group exercise format (n=18), fewer trials (n=9) delivered their exercise 
intervention in a one-to-one format. Only one RCT used a mix of both group and 
one-to-one formats (123). Home exercise programmes (HEP) were prescribed in 
12 RCTs (see Table 3-3). Ferreira et al. (124) included two exercise arms, and 
Miyamoto et al. (136) included three exercise arms so in total across the 27 
RCTs, there were 30 exercise arms. The dosage (including frequency and 
duration) of exercise tested in each RCT varied greatly, as seen in Table 3-3, 
with the average exercise intervention comprising one hour, twice per week over 
ten weeks (thus, a high dosage programme as described by Hayden et al. (143)). 
However, only six RCTs delivered a high dosage intervention 
(117,120,123,127,130,133). The intensity of exercise interventions was generally 
not described; thus, these data were not possible to extract.  
 
Comparators9: Fourteen RCTs (116,120,139,141,126,130–135,138) used a 
minimal intervention (no exercise) control group, six RCTs (117–
                                            
9 These figures do not add to the 27 as two trials had more than one comparator arm 
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119,121,124,138) compared exercise to spinal manipulation, four RCTs 
(127,129,136,142) had waiting list control groups, three RCTs (122,125,128) 
compared their exercise intervention to a placebo intervention (see Table 3-2 for 
descriptions of the placebo interventions used), and two RCTs (123,137) 
compared exercise to other forms of usual care physiotherapy (excluding 
exercise) (n=29 comparator arms).    
 
Follow-up End-point: The primary end-point varied across RCTs from 3 weeks 
(119) to 12 months (130,134,141), with an average follow-up time of 15.1 weeks.   
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Table 3-3: Variation in exercise dosage across included RCTs 
Trial Delivered by Length of 
session 
Frequency Duration HEP 
Albaladejo et al. 
(116) 
Physiotherapist 1 hour 4 days N/a 
Yes 
Bronfort et al. (117) Exercise therapist 1 hour 2 x week 12 weeks No* 
Cambron et al. 
(118) 
Physiotherapists Unclear 2-4 x week 4 weeks 
No 
Cecchi et al. (119) Physiotherapist 
(Individual) 
1 hour 5 x week 3 weeks 
No 
Chen et al. (120) Expert in sports, health 
and leisure 
50 mins 3 x week 6 months 
No 
Chown et al. (121) Physiotherapist (Group) 30 mins 5 sessions 12 weeks Yes 
Costa et al. (122) Physiotherapist 30 mins 1-2 x week 8 weeks Yes 
Díaz Arribas et al. 
(123) 
Physiotherapist 50 mins 2 x week 8 weeks 
No 
Ferreira et al. (124) Physiotherapist (Group) 1 hour 12 sessions 8 weeks Yes  
Physiotherapist 
(Individual) 
1 hour 12 sessions 8 weeks 
Yes 
Garcia et al. (125) Physiotherapist 30-40mins 10 sessions 5 weeks Yes  
Goldby et al. (126) Physiotherapist 1 hour 10 sessions 10 weeks No 
Groessl et al. (127) Yoga instructor 1 hour 2 x week 12 weeks Yes 
Hansen et al. (128) Unclear (likely 
Physiotherapist) 
1 hour 2x week 4 weeks 
No 
Hall et al. (129) Tai Chi Instructor 40 mins 18 sessions 10 weeks No 
Harris et al. (130) Physiotherapist 90 mins 3 x week 12 weeks No 




35 mins 2 x week 12 weeks 
No 
Jans et al. (132) Cesar exercise 
therapist 
35 mins 1 x week 12 weeks 
No 
Jaromi et al. (133) Unclear 60 mins 2 x week 12 weeks Yes 
Johnson et al. (134) Physiotherapist 2 hours 8 sessions 6 weeks Yes 
Maul et al. (135) Physiotherapist 1 hour 1-2 x week 12 weeks No 
Miyamoto et al. 
(136) 
Physiotherapist 1 hour 1-3 x week 6 weeks 
No 
Moffett et al. (137) Physiotherapist Unclear 4 sessions Unclear No 
Russell et al. (138) Physiotherapist 1 hour 2 x week 4 weeks No 
Saper et al.  (139) Yoga Instructor 75 mins 1 x week 12 weeks Yes  
Shirado et al. (140) Nurse/ physiotherapist 15-30 mins 1-2 x week 8 weeks Yes 
Storrø, Moen and 
Svebak, (141) 
Multidisciplinary team 2 hours 3x week 12 weeks 
No 
Tilbrook, Cox and 
Hewitt, (142) 
Yoga instructor 75 mins 1 x week 12 weeks 
Yes 
HEP stands for home exercise programme. *Bronfort et al. (2011) did not include a 
HEP in their included exercise arm but did include one arm in their RCT that used HEP 
only.  
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3.3.3 Characteristics of Excluded Trials 
The flowchart (Figure 3-2) summarises the characteristics of the 92 excluded 
studies. Further detail is provided in Appendix 9b: Excluded Studies from the 
Systematic Review with Reasons. 
 
3.3.4 Risk of Bias Assessment 
There was substantial variation in the overall risk of bias across the 27 RCTs. 
The summary of the risk of bias assessment in Figure 3-3 and 3-4 shows that 
only 22% of RCTs (n=6) demonstrated overall low risk of bias with five of the risk 
of bias domains met. Most RCTs described adequate sequence generation 
(n=22/27). No RCTs had low risk of bias for blinding, despite trial-specific 
measures specifically described by Costa et al. (122). The high risk due to 
inadequate blinding was agreed by the reviewers due to the nature of 
participating in an exercise intervention in comparison to a non-exercise control. 
37% (n=10) of RCTs had a low risk of attrition bias. 78% (n=21) of RCTs had low 
risk of bias for selective reporting, whilst 52% (n=14) were at risk of other biases.  
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Figure 3-3: Summary of the risk of bias of the 27 included RCTs 
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Figure 3-4: Summary of the risk of bias components of included RCTs
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3.3.5 Descriptive Analysis 
Treatment targets, outcome domains, and outcome measures were extracted 
from all included 27 RCTs. Further information is provided in Appendix 9c: 
Extracted Treatment Targets and Outcomes of Included Trials; Appendix 9d: 
Extracted Treatment Targets of Included Trials; Appendix 9e: Extracted 
Secondary Outcome Domains and Measures of Included Trials. 
   
3.3.5.1 Treatment Targets 
In total, 18 of the 27 RCTs explicitly specified treatment targets of the exercise 
intervention that they investigated, such as “the goal was to address fear-
avoidance and movement-phobia and help to re-establish normal movement 
patterns” (130). Although Cecchi et al. (119) specified a treatment target relating 
directly to one of their exercise arms, they did not specify a treatment target for 
their other exercise intervention arm. Six RCTs did not specify treatment targets 
but alluded to these in the background section of their papers, resulting in 
“inferred” treatment targets (see Appendix 9 c: Extracted Treatment Targets and 
Outcomes of Included Trials). For example, Hansen et al. (128) did not state any 
specific targets of their exercise intervention but mentioned "tense back muscles 
being stretched through exercise", "bodybuilding", and "hyperextending back 
exercises" in the background section of their paper. Three RCTs did not specify 
or allude to any exercise treatment targets (116,121,132).  
 
In total, 31 different treatment targets were identified in these 18 RCTs, with a 
range of 0 to 7 targets specified or alluded to per RCT (median of 3), but 19 of 
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these were each only mentioned in one RCT. These were extracted verbatim and 
grouped together if they related to similar constructs (such as ‘reducing 
kinesiophobia’ and ‘reducing fear of movement’). However, where the treatment 
targets were felt to be different, constructs were left as separate items (such as 
coordination, posture and normal movement). The most frequently reported 
treatment targets were ‘reducing back pain’ (9 trials), ‘increasing muscle strength’ 
(8 trials), ‘targeting spinal stabilisation or altered spinal control or trunk stability’ 
(8 trials), ‘stretching or improved flexibility’ (7 trials) and ‘improved posture’ (4 
trials). Figure 3-5 shows the frequencies of the stated exercise treatment targets 
highlighting how many were mentioned in only one RCT. More detail is provided 
in Appendix 9d: Extracted Treatment Targets of Included Trials. 
Figure 3-5: Frequencies of stated exercise treatment targets in included RCTs 
 
 
3.3.5.2 Outcome Domain and Outcome Measure Data Extraction  
Eleven RCTs specified one primary outcome domain, seven RCTs specified 
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outcome domains. Six RCTs did not explicitly identify any primary outcome 
domain, and therefore, the first-mentioned outcome domain was taken to be 
their primary outcome domain (120,126,128,131,135). Six primary outcome 
domains were identified, of which the most frequent were physical function 
(n=15), pain (n=14), and global perceived effect (including patient-perceived 
recovery) (n=6). The outcome measures used in the six domains are 
summarised in Table 3-4. 
Table 3-4: Primary outcome domains and measures (where all designated 
primary outcome domains have been extracted and first mentioned outcomes in 





Outcome Measure Number of 
RCTs (n) 
Physical Function  15 Roland and Morris Disability 
Questionnaire 
12 
Patient-Specific Functional Scale 2 
Oswestry Disability Index 1 
Pain 14 Numeric Rating Scale 8 
Visual Analogue Scale 5 
Ordinal 11-box scale  1 
Global Perceived 
Effect  
6 Global Perceived Effect 2 
Self-reported recovery (7-point scale) 2 
Increased work participation 2 
Physical Performance 2 Lifting capacity (PILE test); Analysis of 




2 Japan Low Back Pain Evaluation 
Questionnaire 
1 
Short Form-36 1 
Beliefs and 
Expectations 
1 Tampa Scale of Kinesiophobia 1 
The number of RCTs does not total 27 as some specified more than one primary outcome domain 
 
The most frequently cited secondary outcome domain was HRQoL (n=27) 
followed by pain and physical function (n=26 each). In total, 135 secondary 
outcome measures were also extracted across the 27 included RCTs and 
grouped per domain. On average, 5 secondary outcome measures were used 
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per RCT, with a range from 0 to 14. Figure 3-6 summarises the frequency of 
primary and secondary outcome domains across the included RCTs, with more 
detail in Appendix 9e: Extracted Secondary Outcome Domains and Measures of 
Included Trials. 
Figure 3-6: Frequency of outcome domains in included RCTs 
 
HRQoL is an abbreviation for health-related quality of life 
 
3.3.6 Categorisation of Matching Status 
RCTs were allocated into groups representing ‘matched’ or ‘unmatched’ primary 
outcome domains and treatment targets through discussion and agreement by 
the reviewing team. The ‘partial matched’ sub-group (within the ‘unmatched’ 
group) was useful to identify RCTs for the secondary data analyses later in this 
thesis (chapters 4 and 5). Still, as the primary outcome in the ‘partial matched’ 
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stage of research. For more detail regarding the extracted data, please see 
appendices 9: c-e.   
 
Figure 3-7 shows that seven RCTs (25.9%) were classified as ‘matched’. Most 
of the RCTs (n=20, 74.1%) included in this review could not be classified as 
having matched outcome domains with their exercise treatment targets. The 
number of RCTs with statistically significant and clinically important findings is 
displayed in Figure 3-7 (bold), where the proportion of statistically significant 
findings (p<0.05) is highest in the matched category (71%).  
Figure 3-7: Categorisation of RCTs according to matching status  
 
Items in bold indicate statistically significant (p<0.05) results in favour of the superiority of the 
exercise group for the primary outcome domain, bold and italics indicate statistically significant 
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3.3.6.1 Characteristics of Categorised Groups 
3.3.6.1.1 Matched Category 
In total, 1197 participants were included in seven RCTs judged to be matched 
(i.e. the primary outcome matched at least one of the trial team’s stated exercise 
treatment targets). Table 3-5 provides a summary of the details of these seven 
matched RCTs. They reported a wide variety of exercise treatment targets and 
outcomes. Each RCT had a different primary outcome, although three had 
nominated two primary outcomes (both Garcia et al. (125) and Miyamoto et al. 
(136) specified pain and physical function, whereas, Moffett et al. (137) specified 
fear of movement and physical function). The other four RCTs did not specify 
primary outcomes. An average of 5.1 (range 2-12) outcome measures were 
reported in each of the seven RCT papers.  
 
Garcia et al. (125) and Moffett et al. (137) described their exercise treatment 
targets in the methods, and Miyamoto et al. (136) described their targets in the 
background section of their papers. The other four RCTs implied treatment 
targets in the introduction sections of their papers. For example, Chen et al. (120) 
referred in detail to pain and self-efficacy as treatment targets in their 
introduction, and they measured these two outcome domains only.  
 
Statistically significant findings in favour of exercise therapy in the nominated or 
designated primary outcome domain were noted in five of the seven RCTs (bold 
in Figure 3-7). However, clinically meaningful results (greater than the MCID) 
were only noted in two RCTs: in Miyamoto et al. (112) between one of the 
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exercise intervention arms (Pilates twice weekly) versus usual care, in both 
primary outcomes, as well as in Jaromi et al. (133) in both primary outcomes in 
favour of the exercise arm.  
























Usual activities 2 Inferred 
Garcia et 
al. (125) 
Consulters McKenzie Back School 3 Specified 
Hildebrandt 
et al. (131) 
Consulters Cesar Therapy GP care 2 Inferred 
Járomi et 
al. (133) 
Consulters Back school Brief intervention 2 Inferred 




Strengthening Back School 12 Inferred 
Miyamoto 
et al. (136) 
Non-
consulters 
Pilates  Brief Intervention  8 Specified 
Moffett et 
al. (137) 





3.3.6.1.2 Unmatched Category 
Twenty RCTs with 4510 participants were judged to be ‘unmatched’ (i.e. the 
primary outcome was not matched to any identified treatment targets), and the 
extracted characteristics are summarised in Table 3-6. These RCTs 
predominantly assessed pain as the primary outcome (58%), three assessed 
pain and physical function as primary outcomes (118,134,139). One trial (122) 
assessed pain, physical function and recovery, and another RCT (140) specified 
pain, physical function and HRQoL all as primary outcomes. Four RCTs (20%) 
used physical function as the primary outcome (119,121,127,142), and one 
further used return to work (5%) (130). An average of 4.8 outcome measures was 
used per RCT (range 1-10).  
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The exercise treatment targets of fourteen RCTs were specified in the published 
results papers, apart from Groessl et al. (127) who specified theirs in the 
published protocol paper (144). Four RCTs implied their exercise treatment 
targets in the introduction sections of their papers, and three RCTs did not 
mention any targets at all. Only four (20%) unmatched RCTs showed statistically 
significant results in favour of exercise therapy in the primary outcome (bold in 
Figure 3-7) – and one RCT showed statistically significant results in favour of the 
control group (bold and italics in Figure 3-7). Both the trials by Tilbrook et al. (142) 
and Hall et al. (129) demonstrated a clinically meaningful difference (greater than 
the MCID) in favour of exercise versus the control arm using their primary 
outcome. 
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et al. (116) 






















al. (119)  







Osteopathy 3 None 
Costa et al. 
(122) 



























Consulters Yoga  Waitlist 8 Specified 









Strengthening Placebo 2 Inferred 











Cesar Therapy No further 4 None 
Johnson et 
al. (134) 
Consulters Exercises GP care 3 Inferred 
Russell et 
al. (138)  
Consulters Exercise Class Manual 
Therapy 
5 Specified 












NSAIDs 4 Specified 




Usual Care 1 Specified 
Tilbrook et 
al. (142) 
Consulters Yoga Usual Care 
(booklet) 
10 Specified 
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3.3.7 SMDs of RCTs: Individual and Grouped  
SMDs were calculated for each RCT according to the methods described 
previously in section 3.2.6.1, and the results are summarised in Table 3-7.  
 
3.3.7.1 Calculation of SMDs per trial 
The SMDs between exercise interventions and control/comparison interventions 
in the 27 included RCTs ranged from a negative between-arm difference (in 
favour of the control arm) (-0.96) to very large difference (6.50) in favour of the 
exercise arm, as seen in Table 3-7. The two outliers with very large SMDs 
(120,133) were queried as to their accuracy. Chen et al. (120) was queried 
regarding the accuracy of the reported SDs (pre- and post-intervention) as the 
control group were very different to the other time-points, and to the intervention 
group SDs described in the RCT paper. Given this very unusual and unexpected 
result, the SD was replaced with the SD for the intervention arm at baseline. The 
authors were contacted to clarify this anomaly but did not respond, thus, this SMD 
for this RCT was therefore excluded from the meta-analysis (and the other 
primary outcome was used). Similarly, the very large effect size seen in the 
Járomi et al. (133) RCT was queried. The authors were similarly contacted for 
clarification of their reported results and responded that their figures were correct, 
and this was retained.  
 
Eighteen comparison arms were included in the seven ‘matched’ RCTs: one RCT 
had three arms, and five RCTs (of seven) used two primary outcome domains. 
Chapter 3: Matching treatment targets and outcomes in trials of exercise 




Fifteen (of eighteen, 83%) SMD results were statistically significant in favour of 
the exercise arm when compared to a control arm as seen in Table 3-7.  
In the twenty RCTs comprising the ‘unmatched’ group, 35 comparison arms were 
included. Two RCTs used three primary outcome domains, and four RCTs used 
two primary outcome domains. Two RCTs had three comparison arms, and one 
RCT had two comparison arms. Thirteen comparisons (37%) found statistically 
significant results in favour of the exercise arm in comparison to a control arm, 
and seven comparison arms (20%) found statistically significant results in favour 
of the non-exercise control arm in comparison to exercise as seen in Table 3-7.  
 
SMDs using RoMs and follow-up SDs were compared to SMDs using baseline 
SDs to ensure consistency in the reported figures. Please see Appendix 
9.f.ii.Sensitivity Analysis Using Follow-up Standard Deviations 
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Chen et al. 
(120) 
Pain Ex vs CG 0.82 (0.47, 1.17) 




Ex vs CG 5.01 (4.53, 5.48) 




Recovery  Ex vs CG 0.69 (0.37, 1.0) 
Medium-large in 
favour of exercise 
Járomi et al. 
(133) 
Pain Ex vs CG 6.50 (6.16, 6.83) 




Ex vs CG 0.30 (-0.05, 0.64) 
Medium in favour of 
exercise 




Ex vs CG 0.37 (-0.02, 0.76) 
Small- medium in 
favour of exercise  




Ex1 vs WL 0.84 (0.62,1.06) 
Large in favour of 
exercise 
Ex2 vs WL 0.98 (0.80,1.16)) 
Large in favour of 
exercise 
Ex3 vs WL 1.30 (1.07,1.52) 










Ex1 vs WL 0.66 (0.58,0.74) 
Medium-large in 
favour of exercise 
Ex2 vs CG 0.87 (0.79, 0.95) 
Large in favour of 
exercise 
Ex3 vs WL 1.02 (0.94, 1.10) 
Medium-large in 




Large in favour of 
exercise 




Ex vs UC 0.14 (0.06, 0.22) 




Ex vs UC 0.41 (0.34, 0.48) 
Small-medium in 
favour of exercise 
Garcia et al. 
(125) 
Pain Ex vs CG 0.49 (0.16, 0.81) 




Ex vs CG 0.32 (-0.01,0.66) 


















Small in favour of 
exercise 
Bronfort et al. 
(117) 
Pain Ex vs SMT 0.21 (-0.07, 0.50) 
Small in favour of 
exercise 
Cambron et al. 
(118) 
Pain Ex vs SMT 0.38 (0.13, 0.64) 
Small- medium in 
favour of exercise 
Physical 
Function 
Ex vs SMT 0.11 (-0.14, 0.37) 
Small in favour of 
exercise 




GE vs SMT -0.96 (-1.09, -0.82) 
Large in favour of 
SMT 
IPT vs SMT 
-0.75 ( -0.87, -
0.62) 
Large in favour of 
SMT 
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Ex vs SMT -0.00 (-0.52, 0.51) No effect 
Costa et al. 
(122) 
Pain Ex vs CG 0.49 (0.07,0.90) 




Ex vs CG 0.63 (0.20, 1.05) 
Medium–large in 
favour of exercise 
Effect Ex vs CG 0.53 (0.12, 0.94)  
Medium in favour of 
exercise 
Díaz Arribas et 
al. (123) 
Pain Ex vs UC 1.21 (0.86, 1.56) 
Large in favour of 
exercise 
 





GE vs SMT -0.70 (-1.19, -0.22) 
Medium- large in 
favour of SMT 
MCE vs SMT 0.05 (-0.44, 0.53) 
Small in favour of 
MCE  
Combined Int vs 
SMT 
-0.33 (-0.61, -0.06) 
Small in favour of 
SMT 
Effect 
GE vs SMT -0.67 (-1.05, -0.29) 
Medium- large in 
favour of SMT 
MCE vs SMT 0.23 (-0.07, 0.53) 
Small in favour of 
MCE 
Combined Int vs 
SMT 
0.19 (-0.35,0.72) 
Small in favour of 
exercise 
Goldby et al. 
(126) 
Pain Ex vs CG 0.24 (-0.07, 0.54) 
Small-medium in 
favour of exercise  




Ex vs WL 0.14 (-0.18, 0.46) 
Small in favour of 
exercise 
Hall et al. (129) Pain Ex vs WL 0.52 (0.21, 0.83) 
Medium in favour of 
exercise  
Hansen et al. 
(128) 
Pain Ex vs CG  0.18 (-0.95, 0.02) 
Small in favour of 
exercise 
Harris et al. 
(130) 
Sick leave Ex vs UC -0.16 (-0.48,0.16) 
Small in favour of 
control 
Jans et al. 
(132) 
Recovery Ex vs UC 0.30 (-0.06,0.66) 
Small-medium in 
favour of exercise 
Johnson et al. 
(134) 
Pain Ex vs CG 0.30 (0.04, 0.57) 




Ex vs CG 0.15 (-0.41, 0.11) 
Small in favour of 
exercise  




Ex vs CG 0.33 (0.28,0.39) 
Small-medium in 
favour of exercise 
Ex vs SMT -0.09 (-0.04, -0.15) 




0.11 (0.07, 0.15) 
Very small in favour 
of exercise 
Saper et al. 
(139) 
Pain Ex vs CG 0.21 (-0.09, 0.50) 




Ex vs CG 0.25 (-0.05, 0.54) 
Small in favour of 
exercise  




Ex vs CG 0.27 (-0.02, 0.55) 
Small-medium in 
favour of exercise  
Pain  Ex vs CG 0.18 (-0.12,0.47) 











HRQoL Ex vs CG 0.29 (0.00, 0.57) 
Small in favour of 
exercise 
Storrø et al. 
(141) 
Sick leave Ex vs CG 0.74 (0.55, 0.93)  
Medium-large in 
favour of exercise 
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Ex vs WL 0.50 (0.26, 0.74) 
Medium in favour of 
exercise  
Interpretations highlighted in bold favour the control group; results in italic are statistically 
significant. The outliers are shaded in grey. Abbreviations used: Ex is exercise, CG is control 
group, WL is waiting list, SMT is manual therapy, UC is usual care, MCE is motor control 
exercise, GE is general exercise, Int is intervention.  
 
3.3.7.2 Calculation of Treatment Success per RCT 
Where possible, treatment success was determined using the recommendation 
from Dent and Raftery (108) as detailed in section 3.2.6.2. It was not possible to 
determine a standardised MCID where RCT reports did not include the expected 
SD and MCID required for their sample size calculation. Only ten RCTs included 
this information, and of these, only two provided this for more than one specified 
primary outcome domain (122,136) as seen in Table 3-8.  
 
Of the 22 comparison arms evaluated, only five comparison arms (136) found 
clinically and statistically significant results in favour of the exercise arm in 
comparison to a control arm.  
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Miyamoto et al. 
(136) 
Pain 
Ex1 vs WL 
0.54  
Clinically and statistically significant 
in favour of exercise 
Ex2 vs WL 





Ex1 vs WL 
0.82  
Clinically inconclusive in favour of 
exercise 
Ex2 vs WL 
0.82  
Statistically significant in favour of 
exercise 
Ex3 vs WL 
0.82  
Clinically and statistically significant 




Statistically significant in favour of 
exercise 




Ex vs UC 0.35  
Inconclusive in favour of exercise 
Garcia et al. 
(125) 
Pain Ex vs CG 0.54  Inconclusive in favour of exercise 
Physical 
Function 
Ex vs CG 
0.82  










Díaz Arribas et 
al. (123) 
Pain 
Ex vs UC 
0.60  
Clinically inconclusive and 
statistically significant in favour of 
exercise 
Costa et al. 
(122) 
Pain Ex vs CG 0.50  Inconclusive in favour of exercise 
Effect Ex vs CG 0.59  Inconclusive in favour of exercise 
Physical 
Function 
Ex vs CG 
0.56  
Inconclusive in favour of exercise 













Ex vs CG 0.50  
Truly inconclusive 




Ex vs WL 0.39  
Statistically significant in favour of 
exercise 




Ex vs CG 
0.63  
Statistically significant in favour of 
exercise 
Ex vs SMT 0.63  Inconclusive in favour of SMT 
Ex vs combined 
CG 
0.63  
Inconclusive in favour of exercise 
Italics represent results that were statistically significant in favour of exercise arm, Bold 
represents results in favour of the control arm, and shaded grey cells represent clinically and 
statistically significant results according to the standardised minimum clinically important 
difference (SMCID).  
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3.3.8 Meta-Analysis: Calculation of Grouped SMDs 
3.3.8.1 Combined SMD 
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Figure 3-8 summarises the overall SMD for all included RCTs and shows that the 
combined SMD favoured exercise with a small to medium effect size (0.31 (95% 
CI 0.14; 0.47)) compared to any controls. This result was statistically significant 
(p=0.0002); however, clinical importance was difficult to judge due to the multiple 
scales used. Heterogeneity was very high (I2 = 94%). 
 
3.3.8.2 Categorised SMDs  
When SMDs were compared across the trials according to categorised status, a 
medium effect (Cohen, 1992) was seen in the matched trials (SMD 0.54 (95% CI 
0.23 to 0.85)) which was statistically significant compared to non-exercise 
controls in those trials (p=0.0006) as seen above in Error! Reference source 
not found.0. The trials judged to not match their primary outcome to the 
treatment targets had SMDs of small effect in favour of exercise (SMD 0.22 (95% 
CI 0.01, 0.44), p=0.04) as seen in Error! Reference source not found.0. Total 
sample sizes in the included RCTs varied from 1197 in the matched category, to 
4510 in the unmatched group. The I2 was consistently high across the matched 
and unmatched categories with 90% in the matched, and 95% in the unmatched 
category. This demonstrates that the heterogeneity was high across both groups. 
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Figure 3-8: Forest plot of SMDs of primary outcome domains, including 
‘matched’ and ‘unmatched’ RCT sub-groups 
 
 
SE is standard error; IV is inverse variance; CI is confidence interval; Std. is standard as part of 
SMD.   
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3.3.8.2.1 Sensitivity Analyses 
Sub-group and sensitivity analyses demonstrated similar trends, with the 
‘matched’ group of RCTs continuing to demonstrate a larger between-arm 
effect size with RoM and weighted mean differences (WMD) across pain and 
physical function outcomes, although the differences between ‘matched’ and 
‘unmatched’ groups were not statistically significant. SMDs were also compared 
across participant recruitment strategy, specified (in contrast to inferred) 
treatment targets, risk of bias (low or high) and comparator groups, within 
‘matched’ and ‘unmatched’ categories. Similar trends were demonstrated, with 
the ‘matched’ group of RCTs yielding a larger SMD than the ‘unmatched’ group, 
although, unsurprisingly, none of these sub-group differences were statistically 
significant (please see Appendix 9.f.iv Effectiveness Sensitivity Analysis and 
Appendix 9.f.v Sub-group Analyses for a full description of sensitivity and sub-
group analyses performed). 
 
3.3.9 Logic Model 
As recommended for systematic reviews of complex interventions (13,114), the 
results of the treatment target and outcome domain extraction were used to 
develop a preliminary logic model for exercise interventions for persistent 
NSLBP, summarised in Figure 3-9. The logic model reads from left to right, 
including the treatment targets, core components of the exercise interventions 
using data extracted from the included trials, and primary outcome domains. The 
first column includes the setting and deliverers of the exercise intervention. The 
second column (treatment targets) was developed by synthesising each included 
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trial’s treatment targets. The third column included core components of the 
exercise interventions. The final column (primary outcome domains) was 
developed by synthesising the reported primary outcome domains.   
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Figure 3-9: Logic model depicting reported exercise treatment targets, core components and outcome domains  
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The relationship between each variable was further mapped for greater detail in 
Figure 3-10, demonstrating which primary outcome domains mapped onto which 
stated exercise treatment targets in the included RCTs. For example, the primary 
outcome domains of pain and physical function were both matched to the 
treatment target of increasing spinal stabilisation. Similarly, improving muscle 
strength or muscle function was matched in some RCTs to the primary outcome 
domains of pain, disability and work status.   
Figure 3-10: Figure demonstrating the relationship between exercise treatment 
targets and primary outcome domains 
 
On the left, the different treatment targets have been categorised by colour according to the 
type of construct (mechanical constructs in blue, function in yellow, pain in green, heath related 
quality of life in orange, beliefs/ expectations in grey). On the right, primary outcome domains 
are listed, with increasing font size depicting increased use. Where dashed lines represent 
unmatched relationships and solid lines represent matched relationships; P is pain; HQ is 
HRQoL 
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3.3.10 Summary of Results 
In total, 27 RCTs were included in this systematic review, of which only seven 
RCTs were categorised as having matched their outcomes to their stated 
exercise treatment targets. There was a wide variety in the reported treatment 
targets of exercise in this set of 27 trials, but most treatment targets were 
specified in only a single RCT, highlighting the lack of consensus about exercise 
treatment targets in the management of patients with persistent NSLBP. The 
overall between-arm SMD observed in the RCTs within the ‘matched’ category 
was larger, in favour of exercise, than the ‘unmatched’ category. Whilst 
differences were not statistically significant, the trend was the same across all 
sub-group analyses, suggesting that better matching of the outcomes of RCTs to 
exercise treatment targets may be more likely to achieve better outcomes for 
patients with persistent NSLBP. The logic model demonstrated a visual 
representation of the relationship between the identified primary outcome 
domains and exercise treatment targets, showing in visual form the poor 
matching between these in RCTs to date.  
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This review systematically identified, synthesised and analysed the treatment 
targets and outcomes of exercise RCTs with patients with persistent NSLBP. It 
included only those RCTs with adequate statistical power to detect at least 
medium effect sizes between exercise and comparison interventions.  The 27 
included RCTs reported 31 different exercise treatment targets, 19 of which were 
only mentioned in a single RCT. A total of six different primary outcome domains 
were identified. Only seven of the twenty-seven RCTs (26%) matched the 
primary outcome domain and measure to the treatment targets of the exercise 
intervention. The majority of included RCTs (n=20) did not match any of the 
outcomes to the treatment targets of exercise described.  A much greater 
proportion of RCTs (71%) in the ‘matched’ category reported statistically 
significant findings in favour of exercise versus their comparator intervention, in 
contrast to only 20% of ‘unmatched’ RCTs. Although meta-analysis found a SMD 
of medium size for exercise versus comparison in the matched RCTs (SMD 0.54 
(95% CI 0.23 to 0.85) (p=0.0006)), and a smaller SMD in favour of exercise in 
the ‘unmatched’ RCTs (SMD 0.22 (95% CI 0.02 to 0.44), (p=0.04)), this difference 
was not statistically significant (p=0.10). There was high heterogeneity, and 
despite the attempt to include only higher quality RCTs based on sample size at 
randomisation, RCTs with a high risk of bias were still included. This exploratory 
review provides some initial support for the hypothesis that better matching of 
outcome domains to the treatment targets of exercise interventions in RCTs with 
patients who have persistent NSLBP may be more likely to lead to statistically 
and clinically significant results, in favour of exercise compared to controls.  
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3.4.1 Interpretation of the Results  
3.4.1.1 Objective i and iii: Treatment Targets in Exercise RCTs for 
Persistent NSLBP 
There is clearly a lack of consensus in the published literature about what 
exercise interventions are trying to achieve for patients with persistent NSLBP. 
Although there is much evidence to support the benefits of exercise for physical 
and mental health (26,27,145), the mechanisms of action of exercise and the 
specific treatment targets of exercise for patients with persistent NSLBP are still 
a matter of debate (46,47,146). Exercise has been purported to improve motor 
control, patterns of movement and muscle activation, strength, endurance, 
flexibility, range of motion, general fitness, as well as mood and depression in 
persistent NSLBP (27,147). However, despite these wide and varied targets, few 
RCTs consistently measure these targets, nor report them. This review found 
many physical performance exercise targets identified by the authors of the 
included RCTs (e.g. spinal stabilisation, muscle strengthening, stretching and 
flexibility), which was anticipated given the targeted physical performance 
aspects of many exercise trials (e.g. strength, flexibility) (22,147). Falla and 
Hodges (147) describe the mechanical features of spinal pain that exercise can 
potentially alter such as suboptimal posture or alignment, altered patterns of 
muscle activation, and altered movement strategies resulting in poorly controlled 
motion or over-compression. However, the finding that 19 of the 31 different 
treatment targets were mentioned in only one RCT each demonstrates clear 
uncertainty about the targets of exercise interventions for persistent NSLBP. 
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Even in trials testing similar exercise regimes (e.g. McKenzie exercise approach), 
many different treatment targets were mentioned in the RCT papers (125,137).  
 
There is a discrepancy in the use of outcomes (most frequently pain and 
disability) that are matched to the exercise treatment targets (148). This is further 
reinforced by the poor correlation that has been observed between physical 
performance measures and pain and disability outcomes (22,34,35). Lee et al. 
(148) assert that treatments use indirect pathways (treatment mediators) to 
create an effect on outcomes such as pain and disability. It remains to be 
explored whether better identification of these indirect pathways will provide 
greater overall effects of treatments or potentially more promising conclusions 
about treatments from RCTs in LBP, by using the identified treatment targets as 
treatment mediators. There are few formal tests of the treatment mediators of 
exercise for persistent NSLBP; those that have been tested include pain 
catastrophising, which was shown in one study to partially mediate the effect of 
tai chi exercise on pain intensity, bothersomeness and pain-related disability 
when compared to waitlist controls (149). Pain catastrophising has also been 
shown in a further study to mediate the reduction of disability, pain intensity, main 
complaints and depression in active exercise when compared to no treatment 
(150). In a knee osteoarthritis population, self-efficacy and pain have been shown 
to be partial mediators of the beneficial effect of exercise and dietary weight loss 
on stair climb time in overweight older adults in one study (151). Exploration of 
treatment mechanisms in other psychological interventions in NSLBP have 
identified that pain and physical function outcomes are improved by reduced 
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distress, fear, pain catastrophising and increased self-efficacy (152). Recent 
work suggests that irrespective of the psychological intervention delivered, the 
mechanisms underpinning the intervention remain the same (153,154).  
However, these mediators explain only 20-33% of the relationship between pain 
and disability (148) suggesting there are other, as yet unidentified mediators (and 
treatment targets) in the development of pain-related disability in persistent 
NSLBP. 
 
The mediators that have been tested in studies of exercise for NSLBP are not 
commonly identified as treatment targets (pain catastrophising was identified as 
a treatment target in only one RCT(136)) and are even less commonly identified 
as primary outcomes. The work of Lee et al. (148) and Whittle et al. (44) provides 
support for the use of more appropriate primary outcomes that correspond to the 
treatment targets of the intervention used, whilst recognising the importance of 
patient-specific outcomes. The current systematic review adds exploratory 
evidence to the argument that better matching of the primary outcome domains 
to the hypothesised treatment targets of exercise interventions may lead to 
greater effect sizes in favour of exercise and therefore ultimately change the 
conclusions of exercise RCTs.   
 
3.4.1.2 Objective i and iii: Outcome Domains used in Exercise RCTs for 
Persistent NSLBP  
It is perhaps unsurprising that the most frequently cited primary and secondary 
outcome domains found in this review were those recommended in core outcome 
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sets for RCTs in the field of LBP (pain and physical function) (74,78,155). 
Thirteen included RCTs measured all three of the core domains  (pain, physical 
function and HRQoL) (112-116,121,125,126,131,133,136,137,139), and for all 
three of these domains, the most frequently used outcome measures were in line 
with published recommendations (82). Gianola et al. (68) in their systematic 
review of 185 trials of rehabilitation interventions in LBP similarly reported that 
pain was measured in 89% of trials, and physical functioning in approximately 
64% of trials. In the Delphi study performed by Chiarotto et al. (82) patients and 
clinicians placed particularly high emphasis on psychological functioning, and 
this has been reflected in the included trials in this review that used psychological 
outcomes as the fourth most frequently cited secondary outcome domain. A wide 
variety of psychological constructs and measures were identified in this review, 
in contrast to that reported by Chapman et al. (86) in which fear-avoidance, 
depression and anxiety were the most commonly cited psychological outcomes 
in LBP research. In this review, the psychological treatment targets that were 
most frequently reported were self-confidence (135,138,142) and fear of 
movement (124,130,136), followed by stress reduction (127,139) and self-
efficacy (120,138).  
 
3.4.1.3 Objective ii: Risk of Bias and Quality of Reporting of Included 
RCTs 
This review used eligibility criteria that focused on including trials with adequate 
statistical power to detect at least a medium difference between intervention-
arms, and thus (at least in theory) trials of higher quality (97). Despite the 
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restrictive eligibility criteria, only six trials included in this review met one domain 
of high risk of bias, and only half of the included trials met at least three of the 
seven domains of the risk of bias criteria (14/27).  In support of these criteria, 
Rubinstein et al. (97) found in their post hoc analysis that spinal manipulation 
trials in LBP that had performed a sample size calculation were more likely to 
have lower risks of bias than those who did not perform a sample size calculation. 
Whereas Froud et al. (53) in their review of sample size calculations in trials of 
LBP found that only one-third of trials were powered to detect a SMD of less than 
0.5 and only 5% were powered to detect SMDs of less than 0.3. Hence, the 
majority of trials in this review found small SMDs in favour of exercise.  
 
The recent release of the Cochrane ROB 2.0 provides more detailed guidance 
for assessing both trial per-protocol-analysis as well as their intention-to-treat 
analysis and provides algorithms for reaching a decision on their risk of bias 
(156). This guidance would reclassify many of the trials that were classified as 
high risk of bias in the domain of blinding of participants/ personnel, as this 
guidance establishes whether allocation concealment generated any deviations 
from the intended intervention delivery in the trial. If not, then the trial is 
recommended to be categorised as low risk of bias in this domain. This would 
have resulted a total of twelve of the twenty-seven trials being categorised as low 
risk of bias (44%).  
 
The Consolidated Standards of Reporting Trials (CONSORT) statement (63) 
checklist was designed to improve the reporting and replicability of RCTs 
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(64,157). Alongside this, the Template for Intervention Description and 
Replication (TIDieR) checklist aimed to improve the description of interventions 
included in RCTs. Reporting of both treatment targets and primary outcome 
domains appears to have improved since the publication of the CONSORT (63) 
and TIDieR (64) statements but, it is difficult to draw conclusions based on the 
limited trial data available from this review. In this review, of the eight trials that 
did not specify exercise treatment targets: two were published after 2010, one in 
1993, and the other five between 2000 and 2008. In contrast, all six trials 
published after the publication of the TIDieR guidance (64) specified their 
treatment targets. Point 6a of the CONSORT statement details “pre-specified 
primary and secondary outcome measures”: in this review, four of the five trials 
that did not specify primary outcome measures were published prior to 2010. 
Candy et al. (158) reviewed pre- and post-publication RCTs against the 
CONSORT complex interventions extension (159) and found similar rates of 
reporting, with most trials providing adequate rationale for their intervention: 93% 
pre-2002-2007 and 99% post-2010-2015. However, they found no evidence that 
the overall standards of reporting of the intervention content in complex 
interventions were improving over time. Glasziou et al. (160) and Schroter, 
Glasziou and Heneghan (161) reviewed the reporting of interventions in trials 
published in the British Medical Journal and found that 57% of trials included in 
their review did not provide adequate descriptions of the interventions, with 87% 
of the interventions in back pain trials judged to be non-reproducible (161). They 
highlighted the need for improved descriptions of interventions, in particular the 
sequencing of the intervention, the materials used, the dosage and duration of 
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delivery, and the schedule of delivery. In exercise interventions, these have been 
addressed within the Consensus on Exercise Reporting Template (CERT) (65), 
which has been developed to address these concerns. However, the CERT does 
not specify the need to identify the treatment target(s) of the exercise 
intervention, which is a shortcoming identified by Kent et al. (66) and Wood, 
Ogilvie and Hayden (67). 
 
3.4.1.4 Objective iv: the SMDs of Exercise in Comparison to a Control 
Treatment  
The overall SMD from the included RCTs was 0.31 (classified as small in favour 
of exercise versus controls), which is similar to other systematic reviews of 
exercise for LBP (26,27,29). This demonstrates that the exclusion of small trials 
did not, on the whole, change the result regarding the average effects of exercise 
compared to other interventions. The findings of this systematic review are, 
therefore, likely to have been similar had smaller trials been included (n=29 
excluded on sample size), as smaller trials would have had less power to detect 
SMDs and would likely have had higher risks of bias (97). Searle et al. (27) found 
similar SMDs to these results when comparing pain outcomes of exercise to a 
control or other treatment group (SMD -0.32 (95% CI -0.44,-0.19), (p<0.01)) (in 
favour of exercise); which is comparable to the total SMD of 0.31 ((95% CI 0.14; 
0.47) (p=0.0002)).  
 
SMDs were used in this review as recommended by the Cochrane Handbook 5.1 
(106); however, there is some debate about whether this is recommended for 
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combining different scales measuring the same construct (162). In response to 
these concerns, RoM analysis was also performed (110), as well as pooled WMD 
scores for trials reporting pain and physical function scores. SMDs have been 
found to be more generalizable than the pooled WMD (163). Although SMD has 
the potential for over-or under-estimation depending on the variability of the 
patients (due to the use of the standard deviation), Takeshima et al. (163) 
propose that the SMD has greater generalisability than the use of mean 
difference. In this review, one trial reported results with potentially incorrect 
standard deviations for the control group (120), resulting in the possible 
overestimation of the SMD and leading to the exclusion of this RCT from further 
analysis. The sensitivity analysis performed using the RoM replicated this finding, 
with a medium effect size in the matched category (22% in favour of exercise in 
comparison to a non-exercise control), and a small effect size in the unmatched 
category (7% in favour of exercise in comparison to a non-exercise control).  This 
suggests that using the SMD or the RoM produced similar findings in this review. 
 
3.4.1.5 Objective v: Process-Orientated Logic Model 
A preliminary logic model was developed using the data from the RCTs included 
in this review to assist with interpretation and understanding of the relationships 
between the treatment targets of exercise and the outcomes used in trials of 
exercise interventions. This helped to visualise these relationships. However, 
due to the wide variety of constructs within both the treatment targets and 
outcomes, it was challenging to include them all in a clear logic model. Rohwer 
et al. (13) highlight that the use of a logic model “does not have to be a perfect 
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reflection of the world but should depict the assumptions contained in the review”. 
Further, they recognise the risk that depicting a complex system within a logic 
model may lead to overcrowding of the logic model with information, with the 
result that it is difficult to interpret the graphic without considerable accompanying 
text (13). The logic model presented in Figure 3-9 has potential utility for future 
teams developing exercise interventions as part of RCTs as it encompasses: the 
components contributing to the complexity of the exercise intervention, the 
context (including location and deliverer of the exercise intervention), the 
treatment targets of the intervention as well as the most appropriate outcomes to 
be used. This review highlights the need for future trials of exercise interventions 
to use logic models to underpin their intervention, as the process of developing 
logic models means that the targets of the intervention need to be made explicit, 
thus showing how their choice of outcomes clearly relates to the exercise targets. 
The logic model presented in this text is an example of what factors may be 
important to consider in future trials of exercise interventions. The use of logic 
models allows a visual flow from the treatment targets of the exercise, to the 
exercise selection, dosage and administration, to the most appropriate outcome 
measures and domains. 
 
3.4.2 Strengths and Limitations of this Review 
This review is the first that has explored the potential impact of matching the 
primary outcomes to reported treatment targets in RCTs of exercise for persistent 
NSLBP. This review was performed both according to a published protocol as 
well as the PRISMA guidance, ensuring a rigorous approach (94). Independent 
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reviewer selection, quality assessment and data extraction were performed by 
pairs of reviewers, strengthening the reliability of results (101).  
 
The likelihood of publication bias should be considered in light of the results 
gained from this review, as trials with more favourable results are more likely to 
have been published (164), and therefore included in this review. Excluding 
RCTs on sample size is not established practice in systematic reviews, and may 
have led to the unnecessary exclusion of some smaller, but high-quality RCTs. 
The nature of this exploratory review was limited by the reliance on using 
available published data: a further limitation may be that RCTs might have indeed 
tested exercise interventions that did match their primary outcome(s), but since 
this was not stated in published papers, it was assumed that they did not. The 
fidelity of the exercise interventions was not assessed within this review, and it is 
perhaps possible that exercise interventions which are delivered to high fidelity 
lead to better patient outcomes. This review included a small sample of 
heterogeneous exercise interventions, comparator interventions, population 
characteristics, outcomes used and follow-up periods. This comparison of 
matched versus unmatched RCTs was, by necessity, a non-randomised 
comparison, and the analyses were tested for other potential explanations for the 
results by considering sub-group analysis based on comparator interventions. 
 
The heterogeneity of all meta-analyses performed was high in this systematic 
review. Pooling RCTs when the heterogeneity is high is expected when 
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combining trials of different exercise interventions, in different settings (25). 
However, this was controlled for by using a random-effects model (106). When 
heterogeneity levels are high as was seen in this meta-analysis, the standard 
error of the pooled estimate is likely to be very large, which results in low power 
for the corresponding test to detect a difference between groups (165). The 
majority of included trials in this review found small between-group SMDs in 
favour of exercise, and like all RCTs, there may be other factors that account for 
these effect sizes that are unaccounted for (106). The difference between the 
‘matched’ and ‘unmatched’ groups of RCTs was not statistically significant, 
perhaps related to the relatively small number of included RCTs. This review was 
exploratory in nature, and was likely underpowered to detect a statistical 
difference between the ‘matched’ and ‘unmatched’ groups (165). This limits the 
interpretation of the results due to a lack of strength of evidence, but it would be 
advisable to replicate this analysis in a larger group of RCTs (that was sufficient 
to test for between-group differences) to see if these findings are replicated. Had 
sample size not restricted inclusion into this review, more studies may have been 
included (n=29), which may have been of high quality and low risk of bias, but 
would have been unlikely to be sufficiently powered to detect a between-group 
change. The identification of treatment targets has been replicated in the 
Cochrane review of exercise trials (67)(n=265) with similar results reported to 
those of this review, which suggests the findings for this review may have been 
similar had smaller trials been included.  
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In the calculations for the SMD, average SD were used with average SMD values. 
This may have impacted the calculations of the SMD when sample sizes varied 
across arms which was present in 44% (12/27) of trials included. (Please see 
Appendix 9.f.vi Sample size analysis across arms of included trials).   
 
The categorisation of RCTs into matched categories was a subjective process, 
and should this have been performed by a different team, different conclusions 
may have been drawn. Although each RCT was independently judged by two 
researchers (from a team of four), it was not a formally validated process as none 
exists to our knowledge. The use of logic models in this chapter demonstrates a 
clear visual model of the results of data extraction, developed by the PhD 
candidate. Although, these findings will be strengthened by input from multiple 
stakeholders, the logic model is a preliminary draft that may have value when 
considering further trials of exercise intervention for persistent NSLBP. 
 
A strength of this review was the replication of results within all the sensitivity 
analyses performed. To improve interpretability, WMD of pain and physical 
function scores was also performed. However, these values were interpreted in 
line with the recommendations of Ostelo et al. (113), which were originally 
designed for patient-level improvement not population-level interpretation.  
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3.4.3 Implications for Clinical Practice and Research 
The findings suggest that RCTs that better match their outcomes to their exercise 
treatment targets may, on average, show greater SMDs from exercise compared 
to controls than those that do not, and may be more likely to find a statistically 
significant result in favour of the exercise intervention. This means that the 
effectiveness of exercise interventions for LBP may have been previously 
underestimated, because many trials use primary outcomes that are not 
reflective of the targets of their interventions. 
 
This review identified little consensus about the treatment targets of exercise for 
NSLBP. This may impact the appropriate selection of both exercise programmes 
in patient management as well as the outcomes with which to try to assess the 
effectiveness of exercise programmes. When treating patients with persistent 
NSLBP, the results of this review suggest that if one can use the most appropriate 
outcomes to best reflect the treatment targets of exercise, patients may 
demonstrate greater benefits which will support the use of exercise therapy in 
rehabilitation. Clinicians need to know what an exercise intervention is targeting 
and what the effects are of that targeted intervention to determine whether it is 
worth applying clinically. 
 
The wide variety of treatment targets included in the RCTs in this review 
emphasises a lack of consensus. This lack of consensus about exercise 
treatment targets in persistent NSLBP needs to be addressed to help ensure 
future RCTs can better target the components felt to be most important, and 
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select the most appropriate outcomes with which to compare clinical 
effectiveness. Mediation analysis may be a useful way to better understand 
whether treatment targets contribute to the mechanisms of action identified, but 
these require RCTs designed to permit this analysis with a range of possible 
targets and/or mediators identified a priori. This should ideally be reflected in a 
logic model so that the treatment targets are clearly specified and their key 
outcomes selected to match those treatment targets. Further analysis is also 
required to understand whether one single outcome, multiple outcomes or a 
composite outcome (85,166) is most appropriate or useful in trials of complex 
interventions, such as exercise in persistent NSLBP. 
 
 Conclusion 
The primary aim of this systematic review was to investigate the role of matching 
between reported outcome domains and exercise treatment targets. This review 
found that matching the primary outcome to the identified exercise treatment 
targets tends to result in greater overall differences between exercise 
programmes and non-exercise controls. Whilst this difference was not statistically 
significant, the same trend was found in 7 sensitivity analyses. 71% of matched 
trials found statistically significant results in favour of exercise, in comparison to 
20% of unmatched RCTs. Most RCTs did not match their primary outcome to the 
treatment targets of the exercise intervention. This review identified a lack of 
consensus about the treatment targets of exercise for patients with persistent 
NSLBP, and improved understanding of these may facilitate clinical practice and 
future research (see Chapter 6). A ‘partially matched’ group of RCTs that 
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included some outcomes that reflected their exercise treatment targets, albeit not 
as their primary outcome, was identified. Further data analysis is required to 
assess whether using a matched outcome might change the conclusion of these 
RCTs. The next chapter describes secondary data analysis of the partially 
matched RCT datasets to compare the results when using a matched outcome 
versus an unmatched outcome. 
 




4 Chapter 4: Exploratory Secondary Data 
Analysis of RCT Datasets 
Summary 
This chapter describes the secondary analyses of five RCTs. In the 
datasets, the matched secondary outcomes were reanalysed in the 
same method as the primary outcome. The analyses compare the 
results of the matched outcomes (in SMD) with the original primary  
(unmatched) outcome, and explore whether the results and conclusions 
of the RCTs may have been different as a result .   
The chapter and results have been written up as part of a paper:  
Wood L, Foster NE, Lewis M, Bronfort G, Groessl E, Hewitt C, 
Miyamoto G, Reme SE, Bishop A. Matching the outcomes to treatment 
targets of exercise for low back pain: does it make a difference? 
Results of secondary analyses from individual patient data of 
randomised controlled trials and pooling of results across trials in 
comparative meta-analyses. Under review. 
 
 Introduction 
The systematic review in the previous chapter (chapter 3) found that most 
previous RCTs of exercise in persistent NSLBP did not match their primary 
outcome to their own identified treatment targets. However, the meta-analysis 
results suggest that in RCTs that did match their primary outcome to their stated 
treatment targets, the SMD of the primary outcome was larger than those in RCTs 
that were unmatched, although this difference was not statistically significant. In 




this chapter, this is further explored by undertaking secondary data analyses of 
several previous RCTs. The identified RCTs included those wherein the primary 
outcome did not match the stated exercise treatment targets, but (some) 
secondary matched outcomes were included that captured (some of) the 
identified treatment targets. It is unknown whether using an outcome matched to 
the treatment targets might alter the findings of these included RCTs. This 
chapter presents the findings from secondary analyses of these identified RCTs 
to explore whether using a matched outcome in place of an unmatched primary 
outcome might alter the results and conclusions of these RCTs.  
 
4.1.1  Study Aim and Objectives 
Aim: This secondary analysis aimed to explore the impact of matching outcomes 
to the treatment targets of exercise in persistent NSLBP trials on the results and 
conclusions of RCTs.   
Objectives:  
i. To perform the analysis applied to the primary outcome(s) by the 
authors of the RCTs on the included secondary outcome(s) that match 
their stated exercise treatment targets. 
ii. To compare the results of the calculated standardised mean 
differences (SMDs) using matched secondary outcomes with the 
SMDs of the nominated primary outcomes of RCTs.   
 
 





4.2.1  Sample 
For this exploratory secondary analysis, the five RCTs that formed the ‘partially 
matched’ category classified in the systematic review (section 3.3.6 in chapter 3) 
formed the sample. These RCTs were included, as some or all of the stated 
exercise treatment targets were captured in the set of secondary outcomes, but 
the primary analysis performed by the RCT authors was based on an unmatched 
primary outcome. For example, in one RCT the authors specified treatment 
targets of improving strength and endurance, the primary outcome was pain, but 
included in secondary outcomes were measures of strength and endurance 
(117). 
. 
4.2.2  Data Extraction 
Pertinent information to inform this data analysis had already been extracted by 
the PhD candidate as part of the systematic review (chapter 3) as a part of 
independent pairs of reviewers, as follows: 
i. The PhD candidate extracted the specified treatment targets of the 
exercise intervention within each RCT report 
ii. The primary and secondary outcome(s) measured and reported for each 
RCT 
iii. The outcomes that matched the stated exercise treatment targets 
iv. The PhD candidate extracted the method of analysis performed using the 
matched secondary and unmatched primary outcomes (e.g. ANOVA, 
linear mixed model etc.) 




4.2.3  Data Analysis 
The secondary analyses reported in this chapter varied across the included RCTs 
and was dependent on whether the RCT dataset was made available for analysis 
or whether sufficient information was provided in the published RCT paper. Of 
the five RCTs included in this analysis, initial SMD analyses were performed on 
three RCT paper results (in one RCT (127), only one secondary outcome was 
included in the published RCT results). Three datasets were obtained for further 
analyses. For each included RCT, the information used was dependent on the 
identified treatment targets and the matched outcome domains extracted in the 
systematic review (chapter 3), as follows: 
i. In RCTs where the analysis performed on the matched secondary 
outcomes was the same as that performed on the primary outcome 
measure, and sufficient information was provided by the authors, the SMD 
was calculated. The resultant SMD was compared to the SMD derived 
from the primary outcome measure. One RCT (142) provided sufficient 
information in their trial publication to achieve this. In RCTs where the 
analysis applied to the primary outcome domains was not repeated on the 
secondary outcomes by the study authors, or insufficient information was 
provided for calculation of the SMDs, the RCT dataset was requested from 
the RCT corresponding author. In total, four datasets were requested 
(117,127,130,140) and three were obtained (117,127,130).  
 




4.2.3.1 Standardised Mean Difference (SMD) Calculation 
SMDs were calculated for each primary and matched secondary outcome for 
between-arm differences at the primary outcome time-point. The primary 
outcome time-point designated by the RCT authors was used, or the soonest 
time-point post-exercise-intervention, if no primary time-point was specified by 








Where d represents the SMD, Ẋ represents the mean follow-up score, 1 represents the 
intervention arm, 2 represents the control arm, and s represents the average of the baseline 
standard deviations (106).  
 
95% CIs were calculated for the SMD, as described in section 3.2.6.1 in chapter 
3. SMD statistics for all between-arm differences were given based on 
intervention minus control: positive SMDs indicate higher values for the exercise 
intervention (lower for the control), and by contrast, negative SMDs indicate lower 
values for the intervention (higher for the control). Since the direction of scale 
scoring may vary, i.e. higher values indicate worse health outcome status (for 
some scales) and better health status (for other scales) – for purposes of 
standardisation and ease of evaluation and interpretation within the meta-
analysis all SMDs were scaled such that positive SMDs reflected better outcome 
for the exercise intervention arm and negative SMDs reflected worse outcome 
for the exercise intervention arm by multiplication with minus one (106). 
  




4.2.3.2 Secondary Analyses Conducted on Obtained Datasets  
This exploratory analysis was conducted on three obtained datasets. All analyses 
used IBM Statistical Package for Social Science (SPSS) Statistics 24. The 
analyses progressed as follows: 
 
4.2.3.2.1 Data Modification 
Data in the obtained datasets were modified in a step-wise approach as follows: 
i. Datasets were checked for missing data by using descriptive analysis to 
check the range of inputs per matched outcome and transformed to 
account for excessive range where necessary (e.g. where missing data 
was coded with 999 or 768, these values were recoded as system 
missing). 
ii. For linear mixed models the data were transformed from wide to long by 
transforming the variables to cases and computing a new variable 
consisting of all time-points relevant to that outcome. For example, the 
outcome of Pain (new long variable) would include Pain Baseline, Pain 6-
week follow-up, 12-week follow-up, and 6-month follow-up. The participant 
ID would remain the same across these time-points, and other values such 
as group allocation would also remain the same.  
iii. Targeted outcomes were then converted to standardised outcomes in 
SPSS so that results were comparable across a variety of outcome 
measurement scales, for example, an outcome “Pain” would be 
standardised and saved as “ZPain”.  
 




4.2.3.2.2 Secondary Analyses 
i. Initial analyses aimed to replicate the published or presented data used 
for the primary outcome(s) and or targeted secondary outcomes where 
possible to do so. The replicated analysis was applied to the matched 
secondary outcome(s).  
a. In two datasets, the analyses replicated were ANOVA (130) and 
ANCOVA (117). These analyses used the primary time-point. 
Neither of these published RCTs specified which post hoc 
corrections were used and a variety of corrections were used when 
trying to replicate the results including Tukey, Scheffé and 
Bonferroni (167). 
b. In a further two datasets (136,137) (and in one dataset as a second 
analysis method (117)) linear mixed model analyses were used on 
the primary outcomes. Linear mixed model analyses include all 
time-points available for the relevant outcome, and therefore values 
for all available time-points for the matched secondary outcomes 
were also used and reported. Models were fitted including patient-
identifiers as a random-effect term and including fixed-effects terms 
in accordance with the trial authors' specification. 
ii. Further analyses were performed using the matched outcomes and the 
method of analysis used for the primary outcome.  
 




4.2.3.3 Meta-analyses performed on Summary Results 
A summary of the results was produced in forest plots using RevMan (5.3). This 
was created by including the first mentioned unmatched primary outcome SMD 
and the first mentioned matched treatment target SMD for each analysed RCT in 
a sub-group comparison using random effects and the generic inverse variance 
method.  
A further between-group difference and associated 95% CI was calculated by: 
i. Generating the difference for each paired between-group difference, and 
the overall mean between-group difference 
ii. Calculating the SD and SE of the mean between-group difference 
iii. Calculating the upper and lower CI limits 
 
 Results  
4.3.1  Included RCTs  
Four datasets were requested, and three were obtained (117,127,130). Shirado 
et al. (140) were not able to provide a dataset for further analysis due to loss of 
contact with the dataset holder, and therefore, a limited analysis only was 
possible using their published data. Tilbrook et al. (142) provided sufficient 
information in their published report for the SMDs to be compared across primary 
and secondary outcomes and therefore, their original trial data were not 
requested. Data sharing agreement for the three trial datasets are included in 
Appendix 9.g:Data Sharing Agreement for Datasets used in Chapter 4. A 
summary of stated treatment targets, matched outcome domains and measures, 
and methods of analysis for each of the included trials is included in Table 4-1.  




Table 4-1: Treatment targets, matched outcome domains, and analysis conducted for each included RCT 
 Trial Identified Treatment 
Targets 






























Increase trunk muscle 












Analysis of covariance 
(ANCOVA) to analyse for 
differences between the 
three groups. Baseline 
values were covariates. 
Linear mixed-model 
longitudinal analyses 
(which accounted for 
correlation over time 
within participants) using 
the MIXED procedure in 
SAS 9.1. 
Change scores for trunk 
performance measures 
calculated using end 
treatment (Week 12) and 
baseline values: analysed for 
group differences with 





Increased strength and 
flexibility  
Stress reduction  




Pain (Brief Pain 
Inventory) 
(reported), range of 
motion (Saunders 
digital inclinometer) 
and core strength 
(prone and supine 
bridge) (not 
reported) 
12-weeks Linear mixed-effects 
modelling to examine the 
change score across 
measured time points. A 
main effect of group (yoga 
versus delayed treatment), 
a main effect of time 
(categorically coded for 
baseline, 6-weeks, 12-
weeks, and 6-months) and 
an interaction between 

















52-weeks Differences between 
groups measured with chi-
square tests for each of 
the 12 months. 
A mixed between–within-
subject analyses of variance 
with one between-group 
factor (BI, BI + group CBT, 




leave to partial 
sick leave or full 
return to work.  
 BI + group PE) and with one 
within-subjects/ repeated 
measures factor (baseline 
and 12 months follow-up 
used. The effect of time and 
the interaction effect (Time x 































8-weeks Unable to replicate primary analysis; only SMD values 












Back Pain Scale) 
12-weeks Unable to replicate primary analysis; only SMD values 
calculated as per 5.2.3.   
*Bronfort et al. (115) did not specify their primary time point thus the first time point post-treatment was used, as per the method used in the systematic 
review. Where RMDQ represents Roland Morris Disability Questionnaire, BPI Brief pain inventory, DT delayed treatment, BI brief intervention, CBT 
cognitive behavioural therapy, PE physical exercise, SF-12 Short Form 12, PSEQ Pain self-efficacy questionnaire, VAS visual analogue scale, JLEQ 
Japanese Low Back Evaluation Questionnaire, NSAID non-steroidal anti-inflammatory drugs.   




4.3.1.1 Outcome Measures Used 
A total of five different patient-reported outcome domains and six different 
outcome measures were used in the five included RCTs. The outcome measures 
used across trials varied, both in the direction of effect, scale and range. For ease 
of interpretation, the outcome measures used in the included trials are 
summarised in Table 4-2. 

































Outcome Measure/ Tool Range Direction 
of Effect 
Interpretation 
Return to Work Department of Labour 
reported value (130) 
Percentage ← Greater proportion indicates greater return to work. 
Physical Function Roland Morris Disability 
Questionnaire 
(RMDQ)(127,140,142) 
0-24 → 0 “no disability” and 24 “maximum disability”.  
Oswestry Disability Index 
(ODI) (130) 
0-100 → 0 “no disability” and 100 “maximum disability”. 
Pain Visual Analogue Scale 
(VAS) (140) 
0-10 → 0 “least” to 10 “most intense pain” over the last few 
days.  
Ordinal 11-point Box scale 
(117) 
0-10 → Pain over the past week, with 0 “no pain” and 10 “worst 
pain possible”. 
Aberdeen Back Pain Scale 
(ABPS) (142) 
0-100 → Higher scores reflect poorer back pain-related function. 
Brief Pain Inventory (BPI) 
(127) 
0-10 → Pain severity subscale: Four 0-10-point numeric rating 
scales: rating pain “at its worst” and “at its least in the 
last 24 hours” and the other two asking about pain “on 
average” and “right now”. For each NRS, the verbal 
descriptors are “no pain” and “pain as bad as you can 
imagine”. 
Seven other questions relating to the pain interference 
subscale.  
Fear-Avoidance Beliefs Fear-avoidance Beliefs 
Questionnaire (FABQ) (130) 
0-112 → A high score indicates a high level of fear-avoidance. 
Two subscales – one related to work and another to 
physical activity.  









Japan Low back pain 
Evaluation Questionnaire 
(JLEQ) (140) 




















← Greater range, greater function.  
Trunk Flexibility Finger-floor distance (140) Measured in 
centimetres 
→ Greater the size the greater the impairment.  
Core strength  Prone and supine bridge 
positions (127) 
Time maintained 
in pose to a 
maximum of 90 
seconds  
← Greater time, the better the function.  
Static endurance 
(flexion, extension) 
Biering-Sorensen test (117) 
Length of time 
able to maintain 
pose 









myograph (DM2000) (117) 
Unclear ← Unclear. 
 




4.3.2 Data Analysis 
4.3.2.1 Standardised Mean Difference Calculations 
SMDs were calculated for the outcomes of interest in three RCTs (127,140,142) 
as described in section 3.2.6.1, in chapter 3. One of the RCT’s primary outcomes 
were reported using the M-est function, median and inter-quartile (140). These 
functions were used in contrast to the mean and SD, which relies on the normal 
distribution of the data, as the data had asymmetrical distribution or were skewed. 
These SMD results are summarised below in Table 4-3. Bronfort et al. (117) and 
Harris et al. (130) did not provide sufficient information in the published trial report 
for SMD calculation of the secondary matched outcomes. 
Table 4-3: Calculated SMD values comparing the reported primary outcome 




(Primary outcome shaded) 
Standardised Mean Difference   
(95% Confidence Interval) 
Groessl et al. (127) Yoga vs 
Waiting list  
Physical Function 0.14 (-0.27, 0.55) 
Pain 0.30 (0.08, 0.52) 
Shirado et al. (140) Exercise vs 
NSAIDS* 
Pain 0.17 (-0.12,0.47) 
Physical Function 0.27 (-0.02, 0.55) 
Health-Related Quality of Life 0.29 (-0.00, 0.57) 
Forward Finger Distance 0.54 (0.26, 0.83) 
Tilbrook et al. (142) Yoga vs Usual 
Care 
Physical Function 0.50 (0.26; 0.74) 
Pain -0.01 (-0.23, 0.22) 
*Where NSAIDS refers to non-steroidal anti-inflammatory drugs; Shaded lines represent each 
trial’s stated primary outcome(s) and results. 
 
Of these three RCTs, two displayed greater SMDs that were statistically 
significant using the matched secondary outcome than using the unmatched 
primary outcome (117,127). Only Tilbrook et al. (142) demonstrated a larger SMD 
in the primary unmatched outcome than in the matched secondary outcome.  




4.3.2.2 Secondary Analyses Performed on Datasets Obtained 
4.3.2.2.1 Secondary analysis of Bronfort et al. (117) 
The Bronfort et al. RCT (115) included four time-points (baseline, 12-weeks, 26-
weeks, and 52-weeks) and six matched outcomes of interest (dynamic 
endurance flexion and extension strength, static endurance flexion and extension 
strength, isometric flexion and extension strength). However, these variables 
were only measured at baseline and 12-weeks (primary time-point). They 
included three comparison arms: a specific exercise arm (SET), spinal manual 
therapy arm (SMT), and a home exercise and advice arm (HEA). The stated 
primary outcome was pain, and no statistically significant between-arm 
differences in the primary outcome were reported at any of the time-points. The 
SMD of each comparison was calculated for the primary time-point using the 
methods described in chapter 3, section 3.2.6.1 and are tabulated in Table 4-4. 
Table 4-4: Published trial results of the primary outcome measure (pain) in 
Bronfort et al. (2011) 
PAIN Wk. 12 (Primary) 
SET* vs SMT 0.1 (-0.6,0.8) 
SMD 0.21 (-0.5, 0.07) 
SET* vs HEA 0.6 (-0.1, 1.4) 
SMD 0.43 (-1.03,2.23) 
SMT* vs HEA 0.6 (-0.2, 1.3) 
SMD 0.20 (-1.29,1.89) 
* Where HEA represents home exercise and advice, SMT represents spinal manual therapy, SET 
represents specific exercise therapy and SMD represents standardised mean difference; 
Negative values favour the intervention group (denoted with an asterisk, where the intervention 
is the active comparator, e.g. mean score (SET) – mean score (SMT) for the first data row); 
italicised data were calculated SMD values.  
 
4.3.2.2.1.1 Data modification 
Of the twelve original variables (six matched outcomes at two time-points, 
baseline and 12-week follow-up), there were no missing data, and all variable 




scales scored in the same direction. For the linear mixed model to be run, the 
dataset was transformed from wide to long, by merging the twelve original 
variables into six standardised variables as described in section 4.2.3.2.1.  
 
4.3.2.2.1.2 Replicating the Original Results: ANOVA Analyses  
It was not possible to repeat the analysis performed on the primary outcome as 
this was not requested in the dataset (as it was not one of the matched exercise 
treatment targets). To replicate the published analysis performed on the 
secondary outcomes, analysis of variance (ANOVA) was used (see Table 4-5). 
The requested secondary outcomes were analysed with an ANOVA on the 
change scores (calculated as the difference between the 12-week follow-up and 
the baseline data). The significance values were reported in the trial paper, and 
these were replicated using a one-way ANOVA using Tukey’s, Scheffé and 
Bonferroni post hoc analysis (the published paper did not specify which post hoc 
correction was used). SMDs of change scores are also presented within Table 4-
5.  
  




Table 4-5: Replication of ANOVA significance results of the change scores in 




















SET* vs SMT <0.0001 <0.00001 <0.00001 0.70 (0.37, 
1.03) 
<0.0001 






SET* vs SMT 0.011 0.012 0.015 0.42 (0.08, 
0.76) 
<0.05 






SET* vs SMT <0.0001 <0.00001 <0.0001 0.75 (0.43, 
1.08) 
<0.0001 






SET* vs SMT <0.0001 <0.00001 <0.0001 1.09 (0.80, 
1.39) 
<0.0001 






SET* vs SMT 0.049 0.057 0.063 0.35 (-0.00, 
0.69) 
NS 






SET* vs SMT 0.057 0.067 0.073 0.34 (-0.01, 
0.68) 
NS 
SET* vs HEA 0.07 0.087 0.092 0.34 (-0.02, 
0.70) 
<0.05 
* Where HEA represents home exercise and advice, SMT represents spinal manual therapy, SET 
represents specific exercise therapy, NS represents non-significant values (at p<0.05). Results 
in bold differ from the published results. The intervention as given by the asterisk, denotes the 
active comparator in the comparison, e.g. mean change SET minus mean change SMT; CI 
represents Confidence Interval.  
 
Almost all the differences between arms in individual outcomes were statistically 
significant in favour of exercise versus comparator arms. However, for 
standardised isometric flexion, there were no statistically significant differences 
between any arms, and for standardised isometric extension there was not a 
statistically significant difference between exercise and manual therapy arms.  
 




4.3.2.2.1.3 Replicating the Primary Outcome Analysis  
The primary outcome analysis was performed using an ANCOVA with Tukey’s 
post hoc analysis and baseline values as covariates. This was performed on the 
matched secondary outcomes (with Bonferroni adjustment). All matched 
outcomes demonstrated a statistically significant between-arm difference in 
favour of exercise, and almost all of the matched outcomes demonstrated greater 
SMDs than the primary outcome of pain. Only two outcomes comparing specific 
exercise to spinal manual therapy did not produce an SMD greater than pain 
(isometric strength flexion and extension) but both of these values were still 
statistically significant in favour of the specific exercise arm. The results are 
summarised in Table 4-6.  
  




Table 4-6: ANCOVA analysis of matched outcomes in Bronfort et al. (2011) 
Adjusted standardised mean difference (12-week follow-up) 
Arm comparison Standardised Mean Difference 
(95% CI) 
Significance  
Primary Outcome Standardised Pain 
SET (vs SMT) 0.21 (-0.07, 0.5) NS 
SET (vs HEA) 0.43 (-1.03, 2.23) NS 
Standardised Static Endurance Flexion 
SET vs SMT 0.57 (0.31, 0.83) <0.0001 
SET vs HEA 0.44 (0.17 ,0.72) <0.0001 
Standardised Static Endurance Extension 
SET vs SMT 0.32 (0.08, 0.57) 0.004 
SET vs HEA 0.40 (0.14, 0.65) 0.001 
Standardised Dynamic Endurance Flexion 
SET vs SMT 0.59 (0.34, 0.83) <0.0001 
SET vs HEA 0.65 (0.40, 0.91) <0.0001 
Standardised Dynamic Endurance Extension 
SET vs SMT 0.84 (0.61, 1.07) <0.0001 
SET vs HEA 0.91 (0.67, 1.16) <0.0001 
Standardised Isometric Strength Flexion 
SET vs SMT 0.20 (0.01, 0.38) 0.03 
SET vs HEA -0.01 (-0.20, 0.18) 1.00 
Standardised Isometric Strength Extension 
SET vs SMT 0.19 (0.00, 0.37) 0.04 
SET vs HEA 0.17 (-0.2, 0.36) 0.10 
Shaded cells represent primary outcome; SET is specific exercise therapy, HEA home exercise 
and advice, SMT spinal manual therapy. CI is confidence interval. P is significant at 0.05, and 
Bonferroni post hoc tests were used.  
 
4.3.2.2.1.4 Linear Mixed Models 
A linear mixed model (replicating the method of analysis for the primary outcome 
at 12-weeks follow-up) was also applied to each matched secondary outcome. 
The results are summarised in Table 4-7 in comparison to the standardised 
primary outcome results. All values except those for standardised isometric 
flexion strength produced a between-arm effect estimate that was statistically 
significant in favour of the specific exercise arm. Further, the SMDs for 
standardised dynamic endurance flexion and extension were greater than the 
SMD for the standardised primary outcome in both the specific exercise arm 
compared to the spinal manual therapy arm and specific exercise compared to 




the home exercise arm. In standardised static endurance extension and flexion, 
the SMD was greater in the specific exercise arm than the spinal manual therapy 
arm but not the home exercise arm. 
Table 4-7: Linear mixed model results of standardised outcomes in Bronfort et al. 
(2011) 
 Adjusted mean difference (95% CI) 
12-week follow-up  Effect estimate (95% CI) t score Sig.  
Standardised Pain (primary outcome - trial results) 
SET (vs SMT) 0.21 (-0.07, 0.5)  Not significant 
SET (vs HEA) 0.43 (-1.03, 2.23)  Not significant 
Standardised Static endurance Flexion 
SET vs SMT 0.55 (0.32, 0.79) 4.606 <0.0001 
SET vs HEA 0.40 (0.16, 0.65) 3.228 0.001 
Standardised Static endurance Extension 
SET vs SMT 0.31 (0.09, 0.52) 2.815 0.005 
SET vs HEA 0.36 (0.14, 0.58) 3.174 0.002 
Standardised Dynamic Endurance Flexion 
SET vs SMT 0.56 (0.34, 0.78) 4.965 <0.00001 
SET vs HEA 0.63 (0.40, 0.86) 5.41 <0.00001 
Standardised Dynamic Endurance Extension 
SET vs SMT 0.84 (0.62, 1.05) 7.635 <0.00001 
SET vs HEA 0.92 (0.70, 1.14) 8.098 <0.00001 
Standardised Isometric Strength Flexion 
SET vs SMT 0.15 (-0.00, 0.31) 1.932 0.54 
SET vs HEA -0.003 (-0.16, 0.16) -0.033 0.973 
Standardised Isometric Strength Extension 
SET vs SMT 0.17 (0.02, 0.32) 2.17 0.031 
SET vs HEA 0.18 (0.02, 0.34) 2.21 0.028 
* Where HEA represents home exercise and advice, SMT represents spinal manual therapy, and 
SET represents specific exercise therapy; Grey shaded blocks demonstrate the original primary 




The results of the secondary analysis of this RCT (117) demonstrated that the 
matched standardised secondary outcomes were statistically significant in favour 
of the specific exercise group in comparison to both control arms, and had SMDs 
greater than the primary outcome (difference in pain at 12-weeks) in all results 
apart from the standardised isometric flexion and extension strength in the 
ANCOVA analysis presented in Figure 4-1. However, although the SMD effect 




estimates were greater in the secondary outcomes, there was only a statistically 
significant difference between dynamic endurance extension and the primary 
outcome of pain. 
Figure 4-1: Forest plot to demonstrate size and direction of effect of outcomes in 
Bronfort et al. (2011) using ANCOVA 
 
Where IV inverse variance, CI is confidence intervals, SE is standard error, SMT is spinal 
manual therapy, Std. is standard as part of SMD.  
 
Similarly, five of seven results showed statistically significant between-arm 
differences, with the greater SMDs favouring specific exercise in comparison to 
spinal manual therapy. The two exceptions were the outcomes of standardised 
isometric flexion (SMD and non-significant results) and extension strength (SMD 
only) in the linear mixed model results in Figure 4-2. As with the ANOVA results, 
there was only a statistically significant difference between dynamic endurance 
extension and the primary outcome of pain SMDs. 
 
  




Figure 4-2: Forest plot to demonstrate size and direction of effect of outcomes in 
Bronfort et al. (2011) using linear mixed models 
 
IV inverse variance, CI is confidence intervals, SE is standard error, SMT is spinal manual 
therapy, Std. is standard as part of SMD. 
 
When comparing the size of the SMDs across outcomes, all were greater for the 
matched secondary outcomes than the reported primary outcome (pain) at 12-
weeks in the ANCOVA and linear mixed model analysis apart from isometric 
flexion and extension strength. In the ANCOVA analysis, all of the matched 
outcomes demonstrated statistically significant results in favour of specific 
exercise over spinal manual therapy. Using the linear mixed model of analysis, 
five of the six matched outcomes were statistically significant in favour of specific 
exercise, apart from standardised isometric flexion strength. In both analyses, 
dynamic endurance extension was the only secondary outcome to demonstrate 
a statistically significant difference with the primary outcome in favour of 
supervised exercise.   
 
4.3.2.2.2 Secondary Analysis of Groessl et al. (127) 
The Groessl et al. RCT (127) included four different time-points (baseline, 6-
weeks, 12-weeks, and 24-weeks) and four secondary outcomes matched their 




stated treatment targets (strength, flexibility (two measures) and pain relief). The 
primary outcome was physical function, and there was no statistically significant 
difference in physical function between yoga (exercise intervention) and waiting 
list (comparator) at the first two follow-ups (primary time-point was 12-weeks), 
but there was a statistically significant difference at 24-weeks in favour of the 
yoga group.  
 
4.3.2.2.2.1 Data Modification 
On reviewing the matched secondary outcomes of interest (four outcomes) via 
descriptive variables, there were no missing data identified. The outcome 
“extension” scored on a negative scale, requiring multiplication by minus one to 
score in the same direction as the other scales. The dataset was converted from 
a wide to a long format as described in section 4.2.3.2.1 by merging all four time-
points included for each targeted outcome.   
 
4.3.2.2.2.2 Replicating the Original Results: Linear Mixed Model Analysis of Pain 
It was not possible to repeat the analysis performed on the primary outcome as 
this was not requested in the dataset (as it was not one of the matched targets). 
The replicated linear mixed model analysis of the published secondary outcome 
measure of pain gave similar results to those of the original (published) results 
(see Table 4-8). Pain was the only targeted secondary outcome that was reported 
in the published paper via the linear mixed modelling approach, but, other 
targeted secondary outcome measures were also available in the requested 
dataset for analysis (results provided later within Table 4-9).  




Table 4-8: Linear mixed model analysis of the original trial results in comparison 
to the replicated secondary outcome (pain) results in Groessl et al. (2017) 
 Adjusted mean difference (95% CI) 
Yoga vs WL Effect estimate (95% CI) t score Sig.  
Pain (trial results) 
12-week follow-up 0.65 (0.2, 1.1)  0.005 
This Analysis of Pain (Using covariate type UN) 
12-week follow-up 0.62 (0.2, 1.1) 2.74 0.007 
*Where WL is waiting list, CI is confidence intervals, Sig is significance at 0.05. All outcomes 
represent mean yoga minus mean waiting list such that negative values favour yoga over the 
control arm.  
 
4.3.2.2.2.3 Linear Mixed Model Analysis 
The individual secondary outcomes tabulated in Table 4-9 demonstrated that 
only pain showed statistically significant differences in favour of the exercise arm 
at the primary time-point. Although standardised pain, plank and flexion ROM 
SMDs were greater than those of the primary outcome estimates at 12-weeks, 
standardised extension ROM was smaller than the primary outcome SMD at 12-
weeks.  
Table 4-9: Linear mixed model analysis of the secondary outcome results in 
Groessl et al. (2017) 
 Adjusted mean difference (95% CI) 
Yoga vs WL Effect estimate (95% CI) t score Sig.  
Standardised Primary Outcome: Physical Function (trial results) 
12-week follow-up 0.14 (-0.18, 0.46)  0.340 
Standardised Pain 
12-week follow-up 0.30 (0.08, 0.52) 2.741 0.007 
Standardised Plank 
12-week follow-up 0.23 (-0.04, 0.51) 1.64 0.105 
Standardised Flexion ROM 
12-week follow-up 0.27 (-0.08, 0.61) 1.538 0.127 
Standardised Extension ROM 
12-week follow-up 0.08 (-0.28, 0.44) 0.456 0.649 
Grey shaded blocks demonstrate the original primary outcome; ROM represents range of 
movement. Where WL is waiting list, CI is confidence intervals, Sig is significance at 0.05. All 
outcomes represent mean yoga minus mean waiting list such that a positive value favours yoga 
over the waiting list.  
 





The results of this analysis demonstrated that only one (pain) of the four matched 
secondary outcomes had a greater SMD and statistical significance than the 
original unmatched primary outcome (physical function) at the primary time-point 
(i.e. at 12-weeks follow-up). However, three of the four matched secondary 
outcomes [standardised pain (SMD 0.30 (95% CI 0.08, 0.52)), standardised 
plank (SMD 0.23 (95% CI -0.04, 0.51)), flexion range of motion (SMD 0.27 (95% 
CI -0.08, 0.61))] demonstrated greater SMDs (without statistical significance) 
than the primary outcome (physical function) (SMD 0.14 (95% CI -0.18, 0.46)) at 
the primary time-point, as seen in Figure 4-3, although these were not statistically 
significantly different to the primary unmatched outcome. 
Figure 4-3: Forest plot to demonstrate size and direction of effect of outcomes in 
Groessl et al. (2017) 
Where ROM is range of motion, IV inverse variance, CI is confidence intervals, SE is standard 
error.  
 
4.3.2.2.3 Secondary Analysis of Harris et al. (130) 
The Harris et al. RCT (130) had two time-points (baseline and 52-weeks) and 
one matched secondary outcome (fear-avoidance beliefs). The RCT compared 
three groups: 1) a brief intervention (BI), 2) brief intervention with the addition of 
physical exercise (BI+PE) or 3) brief intervention with the addition of a cognitive 




behavioural therapy component (BI+CBT). The primary outcome was return to 
work at 52-weeks, and the main trial results showed no statistically significant 
between-arm differences.  
 
4.3.2.2.3.1 Data Modification 
The matched secondary outcome of fear-avoidance beliefs (comprising two 
subscales of beliefs about physical activity, and beliefs about work) and physical 
function were checked with descriptive statistics. Values for these outcomes were 
within the expected ranges, and there were no missing data. All three variables 
trended in the same direction and thus did not require modification.  The dataset 
was suitable to be used in wide format for further analysis.  
 
4.3.2.2.3.2 Calculation of SMD for the Primary Outcome 
The primary outcome used was the proportion of participants who returned to 
work (RTW), and the SMD was calculated according to the methods described 
in chapter 3, section 3.2.6.1. The SMD for RTW was 0.16 (95% CI -0.32, 0.00) in 
favour of the control arm compared to the exercise arm.  
 
4.3.2.2.3.3 Replicating the Original Method: Chi-Square Analysis and ANOVA 
Analysis 
The original primary outcome was analysed with chi-square analysis. This was 
replicated and shown below, in Table 4-10, but one participant’s details appear 
to have been lost in the dataset provided.  
  




Table 4-10: Results of chi-square analysis performed in Harris et al. (2017) 
Reported Results  Intervention Groups 





Count 60 31 30 121 
% within 
groups 
60 51.7 54.6 - 
 Total Count 100 60 55 215 
Chi-square 1.15 
p-value 0.563 
Analysed Results  Intervention Groups 






Count 40 29 25 94 
% within 
groups 
40.4 48.3 45.5% 43.9% 
Returned 
to work 
Count 59 31 30 120 
% within 
groups 
59.6 51.7% 54.5% 56.1% 
Total 
Count 99 60 55 214 
% within 
groups 
100% 100% 100% 100% 
Chi-square 1.024 
p-value 0.599 
Where BI represents brief intervention, BI+PE represents brief intervention and physical 
exercise and BI+CBT represents brief intervention with cognitive behavioural therapy.  
 
For all the secondary outcomes, the authors performed a mixed between- and 
within-subject analysis of variance with one between-group factor (BI, BI + PE, 
BI + CBT) and with one within-subjects/repeated measures factor (baseline and 
12-months follow-up) (see Table 4-11). The effect of time and the interaction 
effect (Time X Group) were reported, and the F and p-values were compared to 
the reported published values, as displayed in Table 4-11.   
Table 4-11: Replication results of ANOVA analysis in Harris et al. (2017) 
 Time*Group Interaction  
BI vs PE vs CBT F-value Sig. Partial Eta Squared  
Fear-Avoidance Beliefs Scores (physical activity) (reported)  
12-month follow-up 2.270 0.107 0.031 
Fear-Avoidance Beliefs Scores (calculated) 
12-month follow-up 2.270 0.107 0.031 
Where BI represents brief intervention, PE represents brief intervention and physical exercise 
and CBT represents brief intervention with cognitive behavioural therapy.  
 




4.3.2.2.3.4 ANOVA Analysis of Standardised Results 
For this secondary analysis, the standardised (treatment-targeted) secondary 
outcome(s) were analysed using ANOVA: the standardised physical function 
scores (unmatched), as well as the matched standardised fear-avoidance beliefs 
scores for physical activity and work (shown in Table 4-12). The only outcome to 
demonstrate a statistically significant difference between arms (group*time 
interaction using the ANOVA) was fear-avoidance beliefs relating to work (F-
value2, 142 2.337, p=0.049). However, post hoc tests comparing arms did not 
demonstrate any statistically significant differences. Although, when comparing 
the mean difference between arms, a greater difference was identified in fear-
avoidance beliefs about work scores when comparing the mean exercise (BI + 
PE) minus mean control (BI) groups (0.289) in comparison to the unmatched 
physical function scores (0.177).  
  




Table 4-12: Results of ANOVA analysis performed in Harris et al. (2017) 
Standardised RTW Score Calculated SMD  
BI + PE vs BI -0.16 (-0.32, 0.00) 
Standardised Physical Function 
Scores   
Time*Group Interaction 
BI vs PE vs CBT F-value Sig. Partial Eta Squared  
12-month follow-up 1.118 0.330 0.016 
Post Hoc Analysis (Tukey HSD) Mean Difference Sig. Std. Error 
BI + PE vs BI 0.18 (-0.2, 0.6) 0.561 0.172 
BI + PE vs BI + CBT 0.28 (-0.2, 0.7) 0.315 0.193 
Standardised Fear-Avoidance 
(Physical Activity) 
F-value Sig. Partial Eta Squared  
12-month follow-up 0.952 0.388 0.013 
Post Hoc Analysis (Tukey HSD) Mean Difference Sig. Std. Error 
BI + PE vs BI 0.01 (-0.4,0.4) 1.000 0.161 
BI + PE vs BI + CBT 0.21 (-0.2, 0.6) 0.458 0.179 
 Standardised Fear-Avoidance 
(Work) 
F-value Sig. Partial Eta Squared  
12-month follow-up 1.895 0.154 0.026 
Post Hoc Analysis (Tukey HSD) Mean Difference Sig. Std. Error 
BI + PE vs BI -0.29 (-0.7, 0.1) 0.250 0.181 
BI + PE vs BI + CBT 0.03 (-0.4, 0.5) 0.992 0.199 
Where RTW represents return to work, BI represents brief intervention, PE physical exercise and 
CBT represents cognitive behavioural therapy. All Post hoc analyses demonstrate the difference 
between intervention minus control arm: e.g. mean (BI + PE) minus mean (BI) (in BI + PE vs BI) 
or BI + PE minus BI + CBT (in BI +PE vs BI + CBT). Positive mean difference values indicate 




This analysis demonstrates that the use of secondary matched outcomes did not 
produce statistically significant results in favour of the exercise arm. When 
assessing SMD results, the matched secondary outcome of fear-avoidance 
beliefs about physical activity generated a greater SMD in favour of the exercise 
arm (BI + PE) in comparison to the brief intervention alone (SMD 0.01 (95% CI -
0.31, 0.33) than the unmatched primary outcome (SMD -0.16 (95% CI -0.32, 
0.00), as seen in Figure 4-4, but these differences were not statistically 
significant.  
  




Figure 4-4: Forest plot to demonstrate size and direction of effect of each 
outcome in Harris et al. (2017) 
 
Where FABQ is the fear-avoidance beliefs questionnaire, IV inverse variance, CI is confidence 
intervals, SE is standard error, Std. is standard as part of SMD.   
 
 
4.3.2.3 Summary of Results 
Out of the five RCT datasets included in this secondary analysis study, three had 
greater SMDs and statistical significance in favour of exercise compared to 
control interventions when a matched secondary outcome was used in 
comparison to an unmatched primary outcome (see summary Table 4-13) 
(117,127,140). Tilbrook et al. (142) was the only RCT of the five re-analysed to 
produce greater between-arm differences in favour of exercise when using an 
unmatched primary outcome. Of the three RCT datasets analysed, two 
demonstrated larger, statistically significant effects in favour of the exercise arm 
with at least one matched secondary outcome at the primary time-point(s), 
compared to an unmatched primary outcome (117,127). The Harris et al. (130) 
dataset did not demonstrate any statistically significant between-arm differences 
using any of the outcomes, but the use of the matched secondary outcome 
generated a greater SMD in favour of the exercise group than when using the 
unmatched primary outcome.  
  




Table 4-13: Summary of SMD results for each included RCT and outcome 
Trial Comparator Outcome  
(Primary outcome shaded in grey) 







Ex vs SMT  Standardised Pain 0.21 (-0.07,0.50) Yes 
  Standardised Static Endurance 
Flexion 
0.57 (0.31, 0.83) 
  Standardised Static Endurance 
Extension 
0.32 (0.08, 0.57) 
  Standardised Dynamic Endurance 
Flexion 
0.59 (0.34, 0.83) 
  Standardised Dynamic Endurance 
Extension 
0.84 (0.61, 1.07) 
  Standardised Isometric Strength 
Flexion 
0.20 (0.01, 0.38) 
  Standardised Isometric Strength 
Extension 




Ex vs WL Standardised Physical Function 0.14 (-0.46, 0.18) Yes 
  Standardised Pain 0.30 (0.08,0.52) 
  Standardised Plank 0.23 (-0.04, 0.51) 
  Standardised Flexion ROM 0.27 (-0.08, 0.61) 
  Standardised Extension ROM 0.08 (-0.28, 0.44) 
Harris et 
al. (130) 
BI +PE vs BI Standardised Return to Work -0.16 (-0.32, 0.00) No 
  Standardised Fear-Avoidance Beliefs 
(Work) 
-0.29 (-0.7, 0.1) 






Ex vs NSAIDS Standardised Pain 0.17 (-0.12,0.47) Yes 
  Standardised Physical Function  0.27 (-0.02, 0.55) 
  Standardised HRQoL 0.29 (-0.00, 0.57) 
  Standardised Forward Finger 
Distance 




Ex vs UC Standardised Physical Function 0.50 (0.26; 0.74) Yes  
  Standardised Pain -0.01 (-0.23, 0.22) 
Positive values favour the exercise intervention; negative values favour the control intervention. 
Grey shaded boxes represent the standardised primary outcome. ROM is range of motion, 
HRQoL is health-related quality of life; Ex is exercise, SMT is spinal manual therapy, WL is waiting 
list, PE is physical exercise, BI is brief intervention, NSAIDS is non-steroidal anti-inflammatories; 
UC is usual care; FU is follow-up. Bold values represent changes not in favour of exercise group. 
 
Figure 4-5 showed an overall effect between the unmatched primary outcome 
and the first-mentioned matched outcomes of the analysed trials. As can be seen 
from the unmatched primary outcomes, the pooled effect (SMD 0.19 (95% CI -




0.03, 0.40) p=0.09) is smaller than that of the first-mentioned matched secondary 
outcome (SMD 0.30 (95% CI 0.04,0.56) p=0.02). As the same trials are included, 
one would expect the heterogeneity values to be similar in both meta-analyses; 
however, the first analysis represents moderate heterogeneity (63%), whereas 
the matched secondary outcomes analysis represents high heterogeneity (77%) 
(106). These forest plots only represent the first-mentioned matched outcomes 
at the primary time-point (or the time-point closest to the end of the exercise 
intervention) as it is recommended that only one-time point for the same sample 
is incorporated in a meta-analysis (168). There was no statistically significant 
difference between the sub-groups (primary outcome compared to the first 
matched outcome) based on the p-value (p=0.51). The between-group SMD 
when calculated was 0.11 ((95% CI -0.34, 0.57) (p=0.51)). Only three of the 
graphed SMD outcomes changed: two from non-significant to statistically 
significant (117,140) and one from statistically significant to non-statistically 
significant (142).  
  




Figure 4-5: Forest plot to demonstrate the pooled effect of the SMD for 
unmatched primary outcomes in comparison to matched secondary outcomes 
 




This exploratory secondary analysis demonstrated in three of the five RCTs  
analysed (117,127,140), and a fourth showed potentially (130) that using an 
outcome matched to the treatment targets of exercise produced larger SMDs, 
when exercise is compared to a non-exercise control, than when using an 
unmatched primary outcome, although this difference was not statistically 
significant between groups. In one RCT, greater between-arm SMDs were 
observed in favour of the control arm with a matched secondary outcome in 
contrast to the primary outcome (130), but these were not statistically significant. 
Only one RCT found greater between-arm differences with an unmatched 




primary outcome in favour of the exercise arm (142). The results of this 
exploratory analysis of five RCTs suggests that the use of an outcome that better 
matches the treatment targets of exercise can result in greater SMDs, more 
statistically significant between-arm differences, and different conclusions 
reached by RCTs in favour of exercise in comparison to a control arm, than when 
an unmatched primary outcome is used. It is, therefore, possible that the results 
and conclusions of exercise RCTs may alter if outcomes are better matched to 
exercise treatment targets.  
 
This results of this secondary data analysis adds support to those from the earlier 
systematic review that matching outcomes to the treatment targets of the 
intervention may result in greater effect sizes than when using an unmatched 
outcome. It is important to note that exercise interventions were favourable 
across nearly all outcomes to varying degrees with the size of the effect varying 
from very small (<0.1) to large (>0.8) but mostly lying within the ‘small-to-medium’ 
range of 0.2 to 0.3 (107)), in line with what has previously been observed in 
reviews of exercise for LBP (26,27,29). Only one RCT reported results that 
favoured the non-exercise control group (130). The overall SMD of the matched 
outcomes from these five RCTs was the same size ((0.30 (95%CI 0.04, 0.56) 
p=0.02) in favour of exercise) as that reported in recent literature of exercise 
interventions in comparison to a brief intervention or minimal control ((0.32, 95% 
CI 0.19, 0.44, p<0.01) in favour of exercise)(27). However, the unmatched 
primary outcomes grouped SMD was even smaller than this result (0.19 (95% CI 
-0.03, 0.40) p=0.09), despite being mostly compared to a minimal intervention 
(only Bronfort et al. (117) included an active comparator arm in these trials). This 




provides exploratory evidence that matching the primary outcome of an RCT to 
the treatment targets of the exercise intervention may influence the effect size of 
the between-arm difference and, therefore, may alter the conclusions of the RCT.  
 
4.4.1 Outcome Domains used by RCTs Included in this Analysis 
One of the challenges of performing this secondary analysis was the wide variety 
of primary outcome domains used across these five RCTs, with the primary 
outcome domain selection tending to reflect recommendations in the core 
outcome domain LBP literature (78,82): three RCTs used physical function 
measures, two used pain intensity measures, one reported return to work rates 
and one reported health-related quality of life10. The CONSORT statement has a 
category for the explanation of the proposed rationale for the trial (category 2a); 
however, there is no mention of whether this rationale matches the treatment 
targets of the interventions or the outcomes utilised (category 6a)(63). There are 
many reasons for the selection of primary outcome domains in RCTs, such as 
the recommendations regarding core outcome sets for RCTs, funders’ 
requirements, patient preferences, ease of measurement, ability to compare 
results with other RCTs, etc. However, the results of this analysis suggests that 
the selection of the primary outcome should also be guided by the rationale for 
the specific intervention (71). Further, the selection of the primary outcome 
specifically impacts on the required sample size, the desired MCID and the 
                                            
10 These numbers do not total 5 as one trial specified 3 primary outcome 
domains (Shirado et al. (140)). 




conclusions of the RCT. Thus, ensuring the most appropriate domain and 
measure selected is paramount.  
The number of matched outcomes to exercise intervention targets varied across 
the five RCTs, with three including only one matched outcome, while the other 
two included four and six matched outcomes respectively. This demonstrates the 
varying exercise intervention targets stated and measured by trial authors. It is 
clear from this study that there is no consensus on what the treatment targets of 
exercise interventions are for patients with persistent NSLBP. This could be due 
to inadequate exercise programme theory, as only recently has greater 
awareness and emphasis been placed on intervention logic models and 
programme theory to demonstrate the proposed mechanisms of the effect of 
interventions (52).  
 
4.4.2 Data Analysis Method: Linear Mixed Models Compared to 
ANOVA 
Although varying outcome measures were used in the sample of five RCTs in 
this study, they were all standardised within the individual datasets wherever 
possible. However, the analysis method varied across RCTs. Many of the more 
recent RCTs used linear mixed modelling approaches which incorporate all time-
points in regression analysis, in contrast to the ANOVA or ANCOVA approach. 
This approach was not always possible to replicate in the secondary analyses 
due to the sometimes limited number of follow-up time-points, such as in Bronfort 
et al. (117), where patient-reported outcomes were captured at four time-points, 
but physical performance outcomes were only captured at two time-points. 




However, two trials used the ANOVA approach, with or without a covariate to 
control for baseline values (117,130). Linear mixed models are often preferred 
over ANOVA due to their ability to control for missing data and unbalanced 
datasets (169). For the results of the ANOVA to be valid, this requires the 
assumptions of compound symmetry and complete data to be met (169). 
Compound symmetry means that the variances and the covariance’s of the 
repeated measures are similar, and if this assumption is violated, then this 
increases the risk of a Type I error, but this can be accounted for by adjusting the 
degrees of freedom (169). This was not performed in this secondary analysis 
which increases the risk of Type I error, but given this was the preferred method 
by the RCT authors, it was utilised as per all other analyses (117,130). 
 
In the meta-analysis of the summary values, one would expect the heterogeneity 
values to be similar in both meta-analyses given that the same trials are included. 
However, the first analysis represented moderate heterogeneity (63%), whereas 
the matched secondary outcomes represented high heterogeneity (79%) (106). 
This difference in heterogeneity values may be due to the use of SMD values 
across a variety of different outcome measures – the first analysis compared the 
primary unmatched outcomes of pain (117,140) physical function (127,142) and 
return to work (130), whereas the second analysis compared measures of 
flexibility (140), pain (127,142), strength (117), and fear-avoidance beliefs (130).  
 




4.4.3 Process Evaluation of Exercise Interventions in the Included 
RCTs 
Process evaluation is an important component of investigating complex 
interventions (15,52), helping to make explicit the theory underlying the 
intervention, assess how the intervention was delivered, whether the targets of 
the intervention were achieved, and how the context may have affected the 
delivery. In this study, it was difficult to assess to what degree treatment targets 
were delivered (and whether some aspects were not mentioned in the published 
reports but nevertheless were still delivered), as although these RCTs specified 
their exercise treatment targets, there may have been elements of underlying 
theory not mentioned (such as the fear-avoidance model) or other treatment 
targets that were not specified in the published text. Groessl et al. (126) targeted 
strength, flexibility (two measures) and pain, and found greater effect estimates 
at the primary time-point in three of these four matched targets than with their 
primary outcome (physical function). Tilbrook et al. (142) similarly targeted their 
yoga intervention at pain, mobility and strength, despite pain being the only 
outcome they measured and reported. Although targets may be defined by the 
authors, they may not be equally implemented in intervention delivery or captured 
in the selection of outcomes. This may be due to the level of tailoring versus 
standardisation of the intervention (15,52), which may affect the weighting of the 
delivery of the intervention targets. Without adequate process evaluation or 
intervention description, it is difficult to assess what impact the context had or the 
mechanisms of action of the intervention (if unexpected results are obtained) 
(52). Descriptions of complex interventions have generally improved since the 




advent of the TIDieR guidance (64), but this may not always be helpful if the 
exercise is not described in relation to the treatment targets, or to a degree that 
is replicable in clinical practice (170). In a review of LBP RCTs, only 13% were 
judged to be reproducible in clinical practice (161).  
 
It may be important to additionally consider not only what exercise intervention 
targets were stated by the RCT authors, but also the dosage and adherence 
levels of the participants within the intervention groups, as well as the type of 
control comparison. For example, both Groessl et al. (127) and Tilbrook et al. 
(142) used yoga as their intervention in their RCTs, yet each described slightly 
different intervention targets. Both found similar effects on pain outcomes, but 
the effects on physical function were very different (SMD of 0.15 in Groessl et al. 
RCT (126) vs 0.50 in Tilbrook et al. RCT (143)) raising the question as to why 
this may be and what differed between the delivery of these two apparently 
similar interventions. Although Groessl et al. (126) had compared yoga with a 
waitlist control, it appears they both compared the yoga arm to a usual care arm. 
Ironically, although Tilbrook et al. (143) reported a greater effect of yoga versus 
usual care on physical function at 12-weeks, the yoga intervention in the RCT by 
Groessl et al. (126) offered almost double the dosage of yoga than in the Tilbrook 
RCT. In Tilbrook et al. (143) the intervention was once weekly for 75 minutes 
over 12 weeks (12 classes), whereas in Groessl et al. (126) the intervention was 
twice weekly for one hour over the same period (24 classes). The mean number 
of yoga classes attended by participants in Groessl et al. (126) was 12.3 classes 
(58%). In the Tilbrook et al. RCT (143), adherence levels differed, requiring the 
attendance of three of the first six classes and any three thereafter, which 60% 




of participants achieved. Thus, there does not appear to be a simple relationship 
between adherence or dosage and between-arm differences in physical function 
in these two RCTs, suggesting that other factors may have played a role in 
generating the between-arm differences of these similar exercise interventions. 
Previous work suggests that simply enrolling LBP patients in RCTs (or other 
studies) may provoke responses reflective of the nonspecific effects of care-
seeking and treatment (7). Without clear process evaluation, it is difficult to 
identify the key factors that may have played an important role in generating such 
different between-arm differences, as seen in these two trials. Adherence, 
duration and dosage of the exercise do not appear to adequately explain the 
differences in outcomes of these two RCT examples. Therefore, more in-depth 
analysis such as process evaluation, including a priori specified mediation 
analysis and qualitative evaluation of the fidelity of the interventions delivered 
may provide valuable guidance for future research.  
 
4.4.4 Strengths and Limitations of This Analysis 
This is the first attempt to explore whether matching the outcome in RCTs of 
exercise for persistent NSLPB to the treatment targets of the exercise 
interventions might change the results and conclusions of RCTs. This work 
utilised the RCTs identified in the previous systematic review (chapter 3) and 
complements the work on core outcome sets for LBP RCTs (71,78,82). The use 
of existing RCT datasets and the close replication of the original RCT data 
analyses are further strengths of this work. In addition, the way the SMDs were 
derived, standardising the outcome measure scales to allow direct comparison 




of the size of the effects across the different outcome measures used in the 
previous RCTs is a strength.  
 
Limitations include the small number of RCT datasets included (determined by 
the RCTs identified by the earlier systematic review that met the criteria for 
inclusion in this secondary analysis study), but this work provides initial 
exploratory evidence that support the need to consider better matching of the 
outcomes in RCTs to the intervention targets. Another limitation is the sheer 
number of additional secondary analyses per trial, which increases the likelihood 
that a statistically significant finding is found when one isn’t actually present (Type 
I error)(171).  
 
Two of the available RCT datasets did not include all the unmatched primary 
outcomes described in the paper and, thus, these analyses were not able to be 
replicated which was an oversight at the time of requesting data. In order to 
request data, a fully worked plan for how the data was to be used was developed, 
in order to clearly detail what was required and why. However, in future, the 
inclusion of the unmatched variables would have made further analysis easier 
and more transparent. In future, requesting a complete dataset with all potentially 
relevant variables and time-points may be advantageous to prevent delays and 
the limitations identified in this analysis happening in the future. This study was 
an exploratory analysis to assess the impact of using a matched secondary 
outcome in place of an unmatched primary outcome. Secondary analyses of 
existing data are less frequently used in research but, are more time-efficient, 
resource-economic and cost-effective (172). It is, however, important to note that 




none of these trial datasets were initially collected with the intention to assess 
whether the matched secondary outcomes would generate a greater SMD and 
statistical significance than the original primary outcome (172). Further, obtaining 
suitable datasets can be a challenge, as noted in the process of acquiring these 
datasets (three of the four requested datasets were obtained). These datasets 
were identified from the previously performed systematic review (chapter 3). The 
search strategy had no lower time limit, allowing for inclusion of trials that may 
have been performed more than twenty years prior, and thus limiting the ability 
to access the datasets or contact the authors. 
 
4.4.5 Implications for Further Research  
The results of this study provide exploratory evidence that matching outcomes to 
the targets of exercise interventions for persistent NSLBP may alter the results 
and conclusions of exercise RCTs, although, further research is needed. This 
was an exploratory study analysing five previous RCTs, and further research 
should be conducted that examines this issue for exercise and persistent NSLBP, 
exercise for other conditions, and indeed more broadly for other complex 
interventions before stronger conclusions can be made. In addition, process 
evaluation should be considered prior to intervention development and 
specification in future trials, to ensure adequate consideration of mechanisms of 
action and treatment targets. This should occur throughout the trial delivery as 
well as on conclusion of the RCT, to evaluate whether the proposed intervention 
was delivered as expected and whether any other theory should be added to the 
intervention logic model. For future exercise RCT designers, the implications are 




that: they should make clear what their exercise treatment targets are, report 
these in the trial protocols and papers, and include appropriate outcome 
measures that can capture the change in these targets over time. 
 
This study further underlines the need to agree on the treatment targets for 
exercise interventions in persistent NSLBP. This would be helpful to facilitate 
future mediation analysis in RCTs, formally testing the variables through which 
the exercise intervention is believed to have effects. When there are multiple 
possible matched outcomes that could be used in an RCT as the nominated 
primary outcome, and without clear intervention programme theory to understand 
how the intervention might affect these identified treatment targets, it may distort 
the overall purpose of the RCT to select only one of these outcomes (85). Watt 
et al. (84) suggest that composite outcomes, comprised of the most appropriate 
individual outcomes, may improve the statistical precision of the trial. As seen in 
this chapter, many RCT authors’ stated more than one treatment target of the 
exercise intervention, and these were captured by different outcomes. Thus, a 
composite outcome composed of these multiple matched outcomes may be more 




The results of this chapter, which focuses on secondary analysis of five RCTs, 
provides exploratory evidence that better matching of the outcomes in RCTs to 
the treatment targets of exercise for NSLBP, may alter the results and 




conclusions reached by these trials. When outcomes are used that are matched 
to the treatment targets of exercise, RCTs may show greater between-arm effect 
sizes and more statistically significant results, in favour of exercise.  The following 
chapter seeks to explore the impact of composite outcomes on the effect sizes 
and statistical significance reported in exercise RCTs.





5 Chapter 5: Exploratory Development of 
Composite Outcomes in Exercise RCTs for 
NSLBP 
Summary  
This chapter reports the secondary analyses of four RCT datasets, 
wherein a composite outcome, comprised of the matched outcomes, 
was created and analysed using the same method as the primary 
outcome. The results of the composite outcomes were compared to the 
primary outcomes, to explore whether the results and conclusions of 
the four RCTs would have altered had a matched composite outcome 
been used.  
Excerpts of this chapter have been written up as part of a paper:  
Wood L, Foster NE, Lewis M, Bronfort G, Groessl E, Hewitt C, 
Miyamoto G, Reme SE, Bishop A. Matching the outcomes to treatment 
targets of exercise for low back pain: does it make a difference? 
Results of secondary analyses from individual patient data of 
randomised controlled trials and pooling of results across trials in 
comparative meta-analyses. Under review.  
 
 Introduction 
Chapter 4 described an exploratory secondary analysis study of five previous 
RCTs testing exercise for NSLBP. The results showed that better matching the 
outcomes to the treatment targets of the exercise intervention can alter the 
results and conclusions of NSLBP RCTs, with most (3/5) RCTs concluding a 





greater between-arm SMD in favour of the exercise intervention. However, Watt 
et al. (85) suggest that nominating one single primary outcome, in an RCT of a 
complex intervention where the intervention has a range of different potential 
outcomes, may distort the overall purpose of the RCT. Composite outcomes, 
including two or more component outcomes (173), maybe more suitable than 
single primary outcomes in RCTs of complex interventions, such as exercise, and 
maybe better able to demonstrate the effects of the intervention on a range of 
key treatment targets. The aim of this study was, therefore, to understand 
whether using a composite outcome in RCTs testing exercise for persistent 
NSLBP might alter the results and conclusions of these RCTs, when the 
composite outcome is composed of multiple individual outcomes matched to the 
authors’ stated exercise treatment targets.  
 
5.1.1 Aims and Objectives 
Aim: This secondary analysis aimed to explore whether the creation of a 
composite primary outcome matched to the treatment targets of exercise in 
persistent NSLBP RCTs alters the results and conclusions of the RCTs.   
Objectives:  
i. To replicate the analysis applied to the primary outcome(s) by the authors 
of the RCTs or, where these were not available, on the secondary 
outcome(s). 
ii. To calculate a composite outcome standardised mean difference (SMD) 
using standardised averages of outcomes matched to the treatment 
targets of the exercise intervention per identified RCT. 





iii. To calculate a co-primary composite outcome SMD using standardised 
averages of the primary outcomes where nominated by the trials’ authors. 
iv. To compare composite and co-primary composite outcome SMDs with the 
reported primary outcome SMDs per identified RCT. 
 
 Methods 
5.2.1  Sample 
Identified RCTs from the “partially matched” and “matched” category classified in 
the systematic review (chapter 3, section 3.3.6) were included where more than 
one outcome domain matched more than one specified exercise treatment target. 
There was no pre-specified target number of datasets as this was exploratory 
analyses based on the results of the systematic review categorisation. 
 
5.2.2 Data Extraction 
Pertinent information to inform this data analysis was already extracted as part 
of the systematic review (chapter 3) as follows: 
i. The treatment targets of the exercise interventions 
ii. The primary and secondary outcome(s) measured and reported within the 
RCTs 
iii. The outcomes that matched the authors’ stated exercise treatment targets 
iv. The type of analysis performed using the outcomes 
 





5.2.3  Data Analysis 
A composite outcome composed of the averaged standardised matched 
outcomes within each RCT was developed using individual participant data. This 
ensures the precision of the composite measure. For each included RCT the 
information used was dependent on the identified treatment targets and the 
matched outcome domains extracted in the systematic review earlier in this 
thesis (chapter 3). Data extraction of the treatment targets and outcome domains 
was performed by pairs of two independent reviewers as described in chapter 3, 
section 3.2.4.  
 
Some of the methods for combining outcomes into a composite outcome aim to 
improve domain coverage, whilst others aim to improve responsiveness (174). 
Optimally, the method used should do both (166). A variety of methods to 
produce a relevant composite outcome exist, simple averaging of standardised 
scores, weighted averaging, principal component analysis and meaningful 
grouping; of which simple averaging is the most commonly used (175). The 
simplest means to attaining a composite outcome of continuous variables is 
through averaging the included outcomes; however, this assumes that equal 
importance is placed on each outcome, and that units from each outcome are 
comparable (166,175). This method intends to preserve the distribution of the 
raw scores. Although weighted averaging is another method reported for 
calculating composite outcomes, in the analyses reported in this chapter this 
would have been difficult to perform, as the percentage weight allocated to each 





targeted outcome would depend on the degree it was targeted within the exercise 
intervention, and information about this was not available in the trial reports.  
 
Given the above, exploratory analyses were performed on the available RCT 
datasets by creating a composite variable at baseline and the primary follow-up 
time-points using simple averaging of standardised variables (175). This varied 
per RCT, where each composite was composed of the outcomes that matched 
the treatment targets that the authors’ described. The type of analysis mirrored 
that used in the published reports of each RCT.  
 
In one dataset the primary analysis method was analysis of variance with a 
covariate (ANCOVA), and thus the method above was used to create a 
composite which was also analysed with ANCOVA, as well as the Multivariate 
ANCOVA (MANCOVA) method. In the other three included RCT datasets, the 
linear mixed model method was used in their primary analyses, and this was then 
used to create a composite in these three datasets. The linear mixed model 
includes data from all time-points captured, whereas the ANCOVA was time-point 
specific.   
 
A further composite was also developed using a “co-primary composite” where 
more than one primary outcome was specified by the RCT authors. These were 
then compared to the original primary outcome and the targeted composite 
outcome generated. All analyses were performed in SPSS v24 (IBM, 2016). 
 





5.2.3.1 Standardised Mean Difference (SMD) Calculations 
Where data were not available for selected outcomes, then SMDs were 
calculated. SMDs were calculated for each primary and composite outcome for 
between-arm differences at the primary time-point designated by the RCT, or the 
soonest time-point post-exercise-intervention if no primary time-point was 







Where d is SMD, Ẋ represents the mean follow-up score, 1 represents the exercise intervention 
group and 2 represents the control group, and s represents the average of the baseline 
standard deviations (106).  
 
95% CI were calculated for the SMD, as described in chapter 3, section 3.2.6.1. 
SMD statistics for all between-arm differences are given based on exercise 
intervention minus control then positive SMDs indicate higher values for the 
exercise intervention (lower for the control), and by contrast, negative SMDs 
indicate lower values for the exercise intervention (higher for the control). Since 
the direction of scale data may be conflicting i.e. higher values indicate worse 
health outcome status (for some scales) and better health status (for other 
scales) – for purposes of standardisation and ease of evaluation and 
interpretation within the meta-analysis all SMDs were scaled such that positive 
SMDs reflect better outcome for the exercise intervention and negative SMDs 
reflect worse outcome (106). SMDs were interpreted according to Cohen's 
(176) recommendations, where an effect size of 0.2 or less is considered small, 
around 0.5 is considered medium and greater than 0.8 large.  
 





5.2.3.2 Secondary Analyses Performed on Obtained Datasets 
5.2.3.2.1 Data Modification 
As for data modification for the analyses described in chapter 4, data from 
obtained RCT datasets were modified in a step-wise approach as follows: 
i. Datasets were checked for missing data by using descriptive analysis to 
check the range of inputs per matched outcome and transformed to 
account for excessive range where necessary (e.g. where missing data 
was coded with 999 or 768 these values were recoded as system 
missing). 
ii. The data were transformed from wide to long (this was not necessary for 
the ANCOVA and MANCOVA) by transforming the variables to cases, and 
computing a new variable consisting of all time-points relevant to that 
outcome: for example, “Pain” (new variable) would include Pain Baseline, 
Pain 6-week follow-up, Pain 12-week follow-up, and Pain 6-month follow-
up. The participant ID would remain the same across these time-points, 
and other values such as group allocation would also remain the same.  
iii. Targeted outcomes were then converted to a standardised outcome in 
SPSS in order for the results to be comparable across a variety of outcome 
measurement scales, for example an outcome “Pain” would be 
standardised and saved as “ZPain”.  
iv. Standardised composite variables were then derived by computing a new 
variable of the mean of the standardised variables of interest at each time-
point (175).  





5.2.3.2.2 Secondary Analyses 
i. Initial analyses aimed to replicate the published or presented data used 
for the primary outcome(s) and/or targeted secondary outcomes where 
possible to do so. The replicated analysis was then applied to the matched 
secondary outcome(s).  
a. In one dataset the analysis replicated was ANCOVA. This analysis 
used the primary time-point (12-weeks). However, the authors did 
not specify which post hoc corrections were used, and thus a 
variety of corrections was used when trying to replicate the results, 
including Tukey, Scheffé and Bonferroni.  
b. Authors of all four RCTs performed a linear mixed model analysis 
on their primary outcomes. Linear mixed model analyses include all 
time-points available for the relevant outcome, and therefore values 
for all available time-points for the matched secondary outcomes 
were used and reported. Models were fitted including patient-
identifiers as a random-effect term and including fixed-effects terms 
in accordance with the trial authors' specification. 
ii. Further analyses were then performed using the standardised composite 
variables and the identified replicated method of analysis used for the 
primary outcome in each RCT.  
iii. Two trials specified two primary outcomes each in their analysis and 
results paper. Exploratory analysis was undertaken to compare the results 
of the first nominated primary outcome in comparison to a targeted 
composite outcome and the co-primary outcome composite. This analysis 





was only possible on the two RCTs which nominated two co-primary 
outcomes (136,137). The identified replicated method of analysis was 
applied to this composite outcome and compared with the original primary 
outcome results and the targeted composite outcome’s results. 
 
5.2.3.3 Meta-analyses Performed on Summary Results 
A summary of the results was produced in forest plots using RevMan (5.3). This 
was created by including the primary outcome SMD in contrast to the matched 
composite outcome SMD for each analysed RCT in a sub-group comparison 
using random effects and the generic inverse variance method to demonstrate 
the size and direction of the effect, although meta-analysis is not possible or 
meaningful from these values (Figure 5-1). The Cochrane Handbook 
discourages the use of forest plots when only one trial’s data are represented 
unless the pooled function is removed due to triplication of the sample size and 
increased risk of type I error (177). 
A further between-group difference and associated 95% CI was calculated to 
summarise the overall between-group difference by: 
i. Generating the difference for each paired between-group difference, and 
the overall mean between-group difference 
ii. Calculating the SD and SE of the mean between-group difference 
iii. Calculating the upper and lower CI limits 
 






5.3.1 Included RCTs 
Of the seven ‘matched’ RCTs identified through the systematic review earlier in 
this thesis (120,125,131,133,135–137), only authors of two trials (136,137) 
responded to email requests to share their datasets. Of the five ‘unmatched’ 
RCTs (117,127,130,140,142), only two contained sufficient outcome domains 
that were matched to the exercise treatment targets for a composite to be 
generated (117,127). Four RCT datasets were therefore included in this analysis 
(n=864) (117,127,136,137). Data sharing agreements for the additional two 
datasets included in this analysis are included in Appendix 9.h:Data Sharing 
Agreement for Datasets used in Chapter 5. 
 
Two of the included RCTs (136,137) had a primary outcome that was considered 
‘matched’ in the systematic review (chapter 3) but identified more than one 
exercise treatment target and measured more than one matched outcome ( as 
well as more than one primary outcome).  The other two included RCTs (117,127) 
were categorised as ‘unmatched’, as their primary outcome was not matched to 
the treatment targets of their exercise intervention, but they included matched 
outcomes as secondary outcomes. A summary of the data extraction of the four 
RCTs is provided below in Table 5-1. Two RCTs used a primary time-point of 12-
weeks, and the other two RCTs used a primary time-point of 6-weeks. Physical 
function was specified as the primary outcome in three of the four RCTs 
(127,136,137), although in two of the RCTs this was specified alongside another 
primary outcome: fear-avoidance beliefs in Moffett et al. (137) and pain in 





Miyamoto et al. (136). Pain was specified as the primary outcome in two RCTs 
(117,136). The average number of outcomes that matched the specified exercise 
treatment targets was 5.5 per RCT (range 4 (127) to 7 (137)). A summary table 
of outcomes used in the included RCTs is given in Table 5-2.




Table 5-1: Reported treatment targets and matched outcomes of included RCTs 
 Trial Treatment 
Targets 




   Primary 
Outcome 














and depression  
Help them take 
control of their 
situation.  
Enable the 
individual to cope 
better  




term disability  
Fear-avoidance 






locus of control),  
Self-efficacy (PSEQ), 




Each of the outcome measures (at 6-weeks, 6- and 12-
months) were analysed jointly, assuming no structure for 
the matrix of correlations for outcomes at the three time-
points. Baseline scores were adjusted by including them 
as covariates. The analyses for each outcome used all 
available data without imputation of missing data. The 
assumption that the missing data were missing at random 
was made. An initial model containing a three-way 
interaction between treatment allocation (McKenzie or 
Solution Finding), booklet allocation (received or not) and 
time (a factor with three levels) was fitted using maximum 
likelihood. Terms representing a main effect of treatment 
preference (a factor with three levels: McKenzie, Solution 
Finding or None), and its interaction with main treatment 
allocation were added to the simplest models permitted 
and tested for statistical significance. These analyses 
were performed using the Mixed Models procedure on 

























Quality of Life (HRQoL) 
(SF6D) 
6-weeks Baseline characteristics were compared between all 
Pilates groups and the booklet group. The mean effects of 
the interventions and the group differences for all 
outcomes were calculated using linear mixed models that 
incorporate terms for the treatment groups, time (follow-
ups) and interaction terms ‘treatment groups’ versus ‘time.’ 
The term ‘time’ was coded as a categorical variable (i.e., 
four variables were created for the categories baseline, 6-
week, 6-month and 12-month follow-ups). The coefficients 
of treatment versus time interactions were equivalent to 






the estimates of the group differences. The analyses 
























Analysis of covariance 
(ANCOVA) was used to 
analyse for differences 
between the three groups in all 
patient-rated outcomes (pain 
was the primary outcome) at 
Weeks 4, 12, 26, and 52 post-
randomisation. Baseline values 
were used as covariates. 
Linear mixed-model 
longitudinal analyses (which 
accounted for correlation over 
time within participants) were 
also used using the MIXED 
procedure in SAS 9.1. 
Change scores for trunk 
performance measures 
were calculated using 
end treatment (Week 
12) and baseline values. 
These were then 














Pain (Brief Pain 
Inventory),  
Range of motion (flexion 
and extension range), 
Core strength at 12 




Linear mixed-effects modelling was used to examine the 
change score across measured time points. A main effect 
of group (yoga versus waiting list), a main effect of time 
(categorically coded for baseline, 6 weeks, 12 weeks, and 
6 months) and an interaction between group X time were 
included in the model.” 
*Bronfort et al. (115) and Moffett et al. (135) did not specify their primary time point thus the first time point post-treatment was used, as per the method 
used in the systematic review. Where TSK is Tampa Scale of Kinesiophobia, NRS is Numeric Rating Scale, RMDQ is Roland Morris Disability 
Questionnaire, PSEQ is Pain Self-Efficacy Questionnaire, HADS is Hospital Anxiety and Depression Score, NRS is Numeric Rating Scale, PCS is Pain 
Catastrophising Score, PSFS is Patient-Specific Functional Scale, SF-6D is the Self-Report 6 Dimension scale; ANCOVA is analysis of covariance and 
ANOVA is analysis of variance. Text in [] denotes unmatched primary outcomes.   































Domain Measured Outcome Measure/ Tool Range Direction 
of Effect 
Interpretation 
Physical Function Roland Morris Disability 
Questionnaire (RMDQ)(136,137) 
0-24 → 0 “no disability” and 24 “maximum disability”.  
Patient-Specific Functional Scale 
(PSFS) (136) 
0-10 ← Identify three important activities, mark on scale how capable 
they feel to perform these activities. 0 ‘unable to perform the 
activity’ and 10 ‘able to perform the activity at preinjury level’. 
The average of the three scores is calculated. A higher score 
indicates greater functional ability.  
Pain Numeric Rating Scale (NRS) 
(136) 
0-10 → 0 “no pain” to 10 “worst possible pain” over the past 7 days. 
The numerical responses are on a discrete/integer scale.  
Ordinal 11-point Box scale (117) 0-10 → Pain over the past week, with 0 being “no pain” and 10 being 
“worst pain possible”  
Brief Pain Inventory (BPI) (127) 0-10 
 
 
→ Pain severity subscale: Four 0-10-point numeric rating scales: 
rating pain “at its worst” and “at its least in the last 24 hours” 
and the other two asking about pain “on average” and “right 
now”. For each NRS, the verbal descriptors are “no pain” and 
“pain as bad as you can imagine”. 




Tampa Scale of Kinesiophobia 
(136,137) 
17-68 → The higher the score the more severe the kinesiophobia.  
Catastrophising Pain Catastrophising Scale (136) 0-52 → Three subscales: rumination, helplessness, and magnification. 
Higher scores indicate higher catastrophising.  
Effect Global Perceived Effect (136) -5 to +5 ← Scores vary from ‘vastly worse’ to ‘completely recovered’. 
Higher scores indicate better recovery.  
Health control Multidimensional health locus of 
control (137)  




The Internal subscale represents the degree to which a person 
believes he or she is in control of his or her own health. The 
external subscale of chance represents the degree to which 








one views fate and luck as controlling one’s health outcomes, 
and the external subscale of the powerful others indicates the 
extent to which a person perceives that others control his or 
her health.   
  
Self-efficacy Pain Self-Efficacy Questionnaire 
(137) 
0-60 ← Higher scores indicate higher self-efficacy beliefs.  
Anxiety and 
Depression 




→ Seven items relate to anxiety, seven items to depression. The 
higher the score the worse the anxiety or depression, and 




















← Greater range, greater function.  








← Greater time the better the function 
Static endurance 
(flexion, extension) 
Biering-Sørensen test (117) 
 
Length of 
time able to 
maintain 
the pose 






← Higher number of repetitions, the better the function 
Isometric strength 
(flexion, extension). 
Computerised digital myograph 
(DM2000) (117) 
 
Unclear ← Unclear 





5.3.2  Data Analysis 
5.3.2.1 Secondary Analysis of the Miyamoto et al. (2018) dataset 
The Miyamoto et al. RCT (112) compared four groups: Pilates once a week 
(Pilates 1), twice a week (Pilates 2), three times a week (Pilates 3) and a brief 
intervention without any exercise (control group). The groups were assessed at 
four different time-points (baseline, 6-weeks, 26-weeks, and 52-weeks) and there 
were six variables of interest (pain, physical function, catastrophising, fear-
avoidance beliefs, global perceived effect, and a patient-specific functional 
scale). The first mentioned primary outcome was pain (matched), and physical 
function was also included as a co-primary outcome. The primary follow-up time-
point was 6-weeks.  
 
5.3.2.1.1 Data Modification 
The patient-specific functional scale, fear-avoidance and catastrophising scales 
all demonstrated lowest values of -999 in the descriptive analyses, indicating the 
possibility of missing data. These values were modified to reflect ‘system missing’ 
as any value less than zero. Four scales were multiplied by minus one (pain, 
physical function, catastrophising and fear-avoidance beliefs) so that all scales 
scored in the direction of a greater value reflecting a better outcome. The dataset 
was transformed from wide to long, and a standardised composite variable was 
created consisting of pain, physical function, catastrophising, fear-avoidance 
beliefs, global perceived effect, and the patient-specific functional scale.  





5.3.2.1.2 Replicating the Original Results: Linear Mixed Model Analysis of 
Pain 
The replicated analysis of the primary evaluation gave very similar results to 
those in the original RCT publication (as shown in Table 5-3 below, where the 
primary outcome is shaded in grey).  
Table 5-3: The original RCT results and replicated results of the primary outcome 
(pain) in Miyamoto et al. (2018) 
 Adjusted mean difference (95% CI) 
 Pilates 
1 vs CG 
Sig.  Pilates 
2 vs CG 
Sig.  Pilates 
3 vs CG 











<0.01 2.3  
(1.4, 
3.2)* 
<0.001 2.1  
(1.1, 
3.0)* 




















CG is control group; Pilates 1 is Pilates once a week, Pilates 2 is Pilates twice weekly, Pilates 3 
is Pilates thrice weekly, CI is confidence interval, Int is all three Pilates exercise intervention 
groups combined. All values are calculated as the mean (intervention) minus the mean (control) 
values, where positive values favour the intervention arm. Shaded values reflect the primary 
outcome. *values reported in the RCT paper were not presented to 2 decimal points. 
 
 
5.3.2.1.3 Linear Mixed Model of a Targeted Composite Outcome 
As shown in Table 5-4, the composite produced SMDs that were smaller than 
the standardised pain outcome at all time-points apart from Pilates 1 compared 
to the control arm at 6-weeks (0.43 vs 0.44). However, the between-arm 
statistical significance was smaller for each of the comparisons at 6-weeks in 
favour of the composite outcome. Please see Appendix 9.i: Linear mixed model 
results of Miyamoto et al. (2018) trial dataset: all time-points. 




Table 5-4: Comparison of composite outcome with primary outcome (pain) in Miyamoto et al. (2018) 
 Pilates 1 vs CG Pilates 2 vs CG Pilates 3 vs CG Intervention (ALL) vs 
CG 













Standardised Pain (PRIMARY)*   
6-week follow-
up 
0.43 (0.04, 0.82) 0.029 2.193 0.88 (0.50, 
1.27) 
<0.0001 4.503 0.74 (0.35, 
1.13) 
<0.001 3.736 0.69 (0.37, 
1.01) 
<0.0001 
Standardised Composite Outcome    
6-week follow-
up 
0.44 (0.21, 0.66) <0.001 3.806 0.77 (1.00, 
0.55) 
<0.0001 6.811 0.59 (0.36, 
0.81) 
<0.0001 5.079 0.59 (0.41, 
0.78) 
<0.0001 
Individual target-related outcomes included within the composite outcome:   





0.081 1.749 0.82 
(0.50,1.14) 
p<0.0001 5.032 0.53 
(0.20,0.85) 
0.001 3.206 0.55 (0.27, 
0.81) 
<0.001 





0.155 1.426 0.49 (-0.18, 
0.81) 
0.002 3.127 0.18 (-0.13, 
0.50) 
0.261 1.127 0.30 (0.05, 
0.56) 
0.021 
Standardised Fear-avoidance beliefs*   
6-week follow-
up 
0.40 (0.09, 0.72) 0.012 2.524 0.50 (0.19, 
0.81) 
0.002 3.159 0.44 (0.12, 
0.75) 
0.007 2.727 0.45 (0.19, 
0.70) 
0.001 
Standardised GPE   
6-week follow-
up 
0.77 (0.35, 1.19) <0.001 3.615 1.23 (0.81, 
1.64) 
<0.00001 5.769 1.11(0.69, 
1.54) 
<0.00001 5.184 1.04 (0.69, 
1.38) 
<0.0001 
Standardised PSFS   
6-week follow-
up 
0.51(0.12, 0.91) 0.01 2.58 0.72 (0.33, 
1.11) 
0.0003 3.651 0.54 (0.14, 
0.93) 
0.01 2.58 0.59 (0.27, 
0.91) 
0.0003 
*represent scales multiplied by minus 1. Bold items indicate where the composite value is greater than that of the single outcome CG is control group; 
Pilates 1 is Pilates once a week, Pilates 2 is Pilates twice weekly, Pilates 3 is Pilates thrice weekly, Intervention ALL is the combined effect of all three 
Pilates exercise intervention arms, CI is confidence interval. GPE is global perceived effect, PSFS is Patient-Specific Functional Scale;  This P-value 
does not match exactly with the 0.007 in Table 3 possibly due to the slightly different correlation structures that are modelled in (perhaps these may 
also have been slightly different in specification i.e. unstructured vs autoregressive). Further detail regarding the other reported time-points can be 
found in Appendix 1





Further, the standard error of the composite outcome was much smaller than that 
of the standardised pain outcome, as seen in Table 5-5. 
Table 5-5: The standard error of the two outcome variables in Miyamoto et al. 
(2018) 




FU1 Pilates 1 vs CG 0.08 0.04 
FU1 Pilates 2 vs CG 0.06 0.03 
FU1 Pilates 3 vs CG 0.09 0.05 
CG is control group; FU is the follow-up time-point where FU1 is 6-weeks 
 
In the included components of the composite outcome, all the individual 
measures demonstrated a between-arm statistically significant difference in 
favour of exercise in the Pilates 2 group at 6-weeks. The standardised 
catastrophising outcome was the only measure not to demonstrate a statistically 
significant difference at 6-weeks between the Pilates 1 and Pilates 3 times-a-
week groups in comparison to the control arm, and the physical function outcome 
was not statistically significantly different in the Pilates 1 at 6-weeks in 
comparison to the control arm.  When all the Pilates exercise intervention arms 
were combined into one group and compared to the control arm, there was a 
statistically significant between-arm difference at the 6-week follow-up time-point 
in favour of exercise, with the composite outcome in comparison to the original 
primary outcome of pain. Further, the SMD was similar between the standardised 
pain score and composite outcome score at the primary time-points, although 
standardised pain at the first time-point (6-weeks) was 0.1 points greater than the 
composite outcome. The results are summarised in Figure 5-1. 





Figure 5-1: The size and direction of effects of the primary and composite 
outcomes in Miyamoto et al. (2018) 
 
Where SE represents the standard error, IV inverse variance, CI is confidence interval, Std is 
standardised as part of SMD 
 
5.3.2.1.4 Linear Mixed Model Analysis of the Co-Primary Composite 
The linear mixed model was used for the analysis, as described in 5.2.3.2. The 
two nominated primary outcomes were pain and physical function. The results 
are summarised below in Table 5-6. This suggests that the co-primary composite 
outcome may perform as well as the single matched primary outcome, in this 
trial, with little loss of SMD size, and increase in statistical significance. Further, 
the co-primary composite demonstrated greater SMD than the composite in three 
of the intervention arms in comparison to the control arm, with similar statistical 
significance to the targeted composite outcome, with only one time-point and 
group generating a statistical significance that was larger than the composite (but 
smaller than the primary outcome).  




Table 5-6: A comparison of the primary outcome (pain) to a targeted composite and co-primary outcome composite in 
Miyamoto et al. (2018) 





















0.029 2.193 0.88 (0.50, 
1.27) 
<0.0001 4.503 0.74 (0.35, 
1.13) 
<0.001 3.736 0.69 (0.37, 
1.01) 
<0.0001 





<0.001 3.806 0.77 (1.00, 
0.55) 
<0.0001 6.811 0.59 (0.36, 
0.81) 
<0.0001 5.079 0.59 (0.41, 
0.78) 
<0.0001 





0.017 2.400 0.85 (0.56, 
1.14) 
<0.0001 5.723 0.64 (0.33, 
0.93) 




Individual target-related outcomes included within the composite outcome: 





0.081 1.749 0.82 
(0.50,1.14) 
p<0.0001 5.032 0.53 
(0.20,0.85) 
0.001 3.206 0.55 (0.27, 
0.81) 
<0.001 
Bold items indicate where the composite value is greater than that of the single outcome. CG is control group; Pilates 1 is Pilates once a week, Pilates 
2 is Pilates twice weekly, Pilates 3 is Pilates thrice weekly, Intervention ALL is the combined effect of all three Pilates exercise intervention arms CI is 
confidence interval. GPE is global perceived effect, PSFS is Patient-Specific Functional Scale





5.3.2.1.5 Summary of Miyamoto et al. (2018) 
The composite outcome variable produced between-arm estimates that are more 
statistically significantly different (Pilates 1 t=3.806, p<0.0001; Pilates 2, t=-6.811, 
p<0.0001; Pilates 3 t=-5.079, p<0.0001) than the original standardised pain 
primary outcome (Pilates 1 t=-2.193, p=0.029; Pilates 2, t=-4.503, p<0.0001; 
Pilates 3 t=-3.736, p<0.0001) with a smaller standard error than the original 
standardised variable (composite 0.04, pain 0.08). When all Pilates exercise 
intervention groups were combined, the composite outcome produced a 
between-arm estimate effect that was comparable to that achieved using the 
original primary outcome and was also statistically significant at the primary time-
point. However, the co-primary composite outcome generated a slightly higher 
SMD than the targeted composite outcome for Pilates 2, Pilates 3 and all 
intervention arms combined, although these values were still slightly smaller than 
the matched primary outcome in all arms at the primary time-point. It appears 
from the results of the secondary analysis of this first RCT (136) that a single, 
matched outcome appeared to generate greater SMDs and statistical 
significance, than a co-primary and targeted composite of multiple exercise 
treatment targets.  
 
  





5.3.2.2 Secondary Analysis of Moffett et al. (2006) Dataset 
The Moffett et al. RCT (137) compared a McKenzie exercise approach with a 
‘solution-finding’ approach (SFA) (comprising goal setting using cognitive 
behavioural methods). McKenzie is a specific method that has a strong emphasis 
on exercise but can contain some manual therapy (178). This RCT had four 
outcome assessment time-points (baseline, 6-weeks, 24-weeks, and 52-weeks) 
and six variables of interest (fear-avoidance beliefs, physical function, health 
control, self-efficacy, anxiety and depression). The first mentioned primary 
outcome was fear-avoidance beliefs (matched), and the second nominated 
primary outcome (physical function) was included in a co-primary composite 
outcome. The authors did not specify their primary time-point, so this was 
extracted as per the process described in chapter 3, section 3.2.6.1, as the first 
follow-up time-point at 6-weeks. 
 
5.3.2.2.1 Data Modification 
The descriptive statistics of all six variables of interest at all four time-points were 
checked, and no missing data were identified. The dataset was transformed from 
wide to long as described in 5.2.3.2.1. The subscales of health control (powerful 
others and chance), anxiety and depression, physical function and the combined 
fear-avoidance beliefs scales were multiplied by minus one, and a standardised 
composite outcome was developed comprising of fear-avoidance beliefs, 
physical function, health control (including subscales of chance, internal and 
external), self-efficacy, anxiety and depression.  





5.3.2.2.2 Testing the Original Results: Linear Mixed Model Analysis of Pain 
The analysis on the primary outcome (fear-avoidance beliefs) was replicated and 
produced results that were similar to the reported figures in the RCT paper, as 
seen in Table 5-7 below. At only one of the time-points were the between-arm 
differences statistically significant (24-weeks), and this was replicated with a p-
value of 0.012.  
Table 5-7: Replication of the trial results of Moffett et al. (2006) 
 Adjusted mean difference (95% CI) 
McKenzie vs SFA Effect Estimate Sig.  
Fear-Avoidance Beliefs (trial results) (TSK-AA) 
6-week follow-up -0.04 (-0.98, 0.90) 
0.032 24-week follow-up 1.12 (0.15, 2.09) 
52-week follow-up 0.39 (-0.62,1.40) 
This Analysis of Fear-Avoidance Beliefs (TSK-AA) 
6-week follow-up -0.04 (-0.99, 0.90) 0.928 
24-week follow-up 1.16 (0.26, 2.06) 0.012 
52-week follow-up 0.43 (-0.52, 1.38) 0.376 
Where SFA represents Solution Finding Approach; TSK represents the Tampa Scale of 
Kinesiophobia Activity Avoidance subscale.  
 
 
5.3.2.2.3 Linear Mixed Model of a Targeted Composite Outcome 
The model was constructed using a composite outcome variable composed of 
the six matched outcomes described earlier. As per the original analysis, the 
baseline variables and booklet allocation were controlled for as covariates. Table 
5-8 demonstrates the results of the composite outcome variable in comparison 
to the standardised fear-avoidance beliefs variable. Although the original primary 
outcome results demonstrated a statistically significant difference between the 
groups at 24-weeks, the composite variable did not demonstrate a greater 
difference nor statistical significance. Please see Appendix 9.j: Linear mixed 
model results of Moffett et al. (2006) trial dataset: all time-points. 





Table 5-8: The results of the standardised composite outcome in comparison to 
the standardised primary outcome measure for Moffett et al. (2006) 
 Adjusted mean difference (95% CI) 
 McKenzie vs SFA 
Standardised Fear-Avoidance 
Beliefs (TSK-AA) * 
Effect Estimate Sig. t-score 
6-week follow-up -0.01 (-0.22,0.20) 0.94 -0.079 
Standardised Composite 
Outcome   
Effect Estimate Sig. t-score 
6-week follow-up -0.01 (-0.11,0.09) 0.868 -0.167 
Individual Components of the Composite  
Standardised fear-avoidance beliefs (TSK-SF and TSK-AA combined) * 
6-week follow-up -0.11 (-0.28, 0.06) 0.214 -1.25 
Standardised physical function * 
6-week follow-up 0.14 (-0.09,0.37) 0.227 1.21 
Standardised health control (internal) 
6-week follow-up -0.03 (-0.16, 0.22) 0.763 0.302 
Standardised health control (chance scale) * 
6-week follow-up 0.08 (-0.11,0.27) 0.413 -0.820 
Standardised health control (powerful others scale) * 
6-week follow-up -0.07 (-0.25,0.12) 0.491 -0.690 
Standardised self-efficacy 
6-week follow-up 0.01 (-0.20, 0.18) 0.925 0.094 
Standardised anxiety * 
6-week follow-up 0.08 (-0.09, 0.24) 0.357 0.92 
Standardised depression* 
6-week follow-up 0.05 (-0.13, 0.22) 0.590 0.540 
Bold italics items indicate where statistical significance; Where SFA represents Solution Finding 
Approach and TSK represents the Tampa Scale of Kinesiophobia; TSK-AA is the Activity 
Avoidance subscale and the TSK-SF is the somatic focus subscale. Asterisks denote the scale 
has been multiplied by minus one to trend in a positive direction. Data for all other time points 
can be found in Appendix 2. 
 
Table 5-9 demonstrates a smaller standard error in the composite outcome 
variable compared to the RCT’s primary outcome variable.  
Table 5-9: The standard error of the two outcome variables in Moffett et al. (2006)  
Parameter Standardised Fear-Avoidance Outcome Standardised Composite 
Outcome 
1,1 0.06 0.02 
2,1 0.06 0.02 
2,2 0.07 0.02 
 





Figure 5-2 demonstrates the SMDs of the primary outcomes and composite 
outcome as seen in Table 5-8 in a forest plot, for comparison of effect size and 
direction at the primary time-point.  
Figure 5-2: The effect of primary and composite outcomes in Moffett et al. (2006) 
 
Std. is standard as part of SMD, SE is standard error, CI is confidence interval, IV is inverse 
variance 
 
5.3.2.2.4 Linear Mixed Model Analysis of the Co-Primary Composite 
The linear mixed model was used for the analysis, as described in section 
5.3.2.2. The two nominated primary outcomes were fear-avoidance beliefs 
(Tampa Scale of Kinesiophobia activity-avoidance subscale) and physical 
function (Roland and Morris Disability Questionnaire). The results are tabulated 
below in Table 5-10. They suggest that the co-primary composite outcome 
generated a greater effect estimate than the targeted composite outcome and 
the single matched outcome, with between-arm SMDs that were greater than the 
targeted composite at the primary time-point.  
  





Table 5-10: Table to demonstrate the comparison of the primary outcome (fear-
avoidance beliefs) in comparison to a targeted composite and co-primary 
outcome composite in Moffett et al. (2006) 
 Adjusted mean difference (95% CI) 
 McKenzie vs SFA 
Standardised Fear-Avoidance 
Beliefs (TSK-AA) 
Effect Estimate Sig. t-score 
6-week follow-up -0.01 (-0.22,0.20) 0.94 -0.079 
Standardised Targeted 
Composite Outcome   
Effect Estimate Sig. t-score 
6-week follow-up 0.00 (-0.08,0.08) 0.89 0.006 
Standardised Co-Primary Composite  
6-week follow-up 0.08 (-0.13,0.29) 0.45 0.756 
Standardised Physical Function  
6-week follow-up 0.14 (-0.09,0.37) 0.227 1.21 
Where TSK-AA represents Tampa Scale of Kinesiophobia activity-avoidance subscale; SFA is 
solution-finding approach.  
 
5.3.2.2.5 Summary 
This analysis of a second RCT, of four in this study, demonstrates that a matched 
primary outcome measure produced the same between-arm effect estimate at 
the first time-point, as a matched composite outcome measure. However, the co-
primary matched composite demonstrated greater effect estimates at the primary 
time-point. Most of the matched outcomes comprising the composite outcome 
(fear-avoidance beliefs, physical function, anxiety and depression, and the 
subscales of health control) demonstrated greater SMDs than the single primary 
outcome at six-weeks (albeit two of the health control scales and the fear-
avoidance scales favoured the control group), but these were not maintained at 
other time-points. The SMD was greatest in the co-primary composite at the 
primary time-point (6-weeks) (SMD 0.08 (95% CI -0.13, 0.29)) in contrast to the 
single matched primary outcome (SMD -0.01 (95% CI -0.22, 0.20)) and the 





targeted composite (SMD 0.00 (95% CI -0.08, 0.08)), but none of these results 
were statistically significant.  
 
5.3.3 Secondary Analyses of Unmatched Datasets 
5.3.3.1 Secondary Analysis of Bronfort et al. (2011) 
The Bronfort et al. RCT (115) had four time-points (baseline, 12-weeks, 26-
weeks, and 52-weeks) and six variables of interest (dynamic endurance flexion 
and extension strength, static endurance flexion and extension strength, 
isometric flexion and extension strength). However, these variables were only 
measured at baseline and 12-weeks. They compared specific exercise therapy 
(SET) with spinal manual therapy (SMT) and home exercise therapy (HEA) 
control. Their primary outcome was pain, and they did not report any statistically 
significant between-arm differences in the primary outcome at any of the time-
points. The primary analysis method was ANCOVA with baseline variables as 
covariates, although the linear mixed model analysis results were reported in the 
published paper. 
 
5.3.3.1.1 Standardised Mean Differences of the Original Analysis Results 
The pain variable was not requested in the dataset as it was not a matched 
outcome; thus, it was not possible to replicate the original analysis on the primary 
outcome. The SMD of each comparison was calculated for each time-point using 
the methods described in section 5.2.3. The results for the primary time-point are 
displayed in Table 5-11. The reported between-arm differences were not 





statistically significant with all CIs including zero (using a general linear mixed 
model). 
Table 5-11: Published trial results of the primary outcome measure (pain) in 
Bronfort et al. (2011) 
PAIN Wk. 12 (Primary) SMD 
SET* vs SMT 0.1 (-0.6, 0.8) 0.21 (-0.07,0.5) 
SET* vs HEA 0.6 (-0.1, 1.4) 0.43 (0.14, 0.72) 
SMT* vs HEA 0.6 (-0.2, 1.3) 0.20 (-0.08, 0.48) 
Where HEA represents home exercise and advice, SMT represents spinal manual therapy, SET 
represents specific exercise therapy and SMD represents standardised mean difference; 
Negative values favour the control group (denoted with an asterisk, where the intervention is the 
active comparator e.g. mean score (SET) – mean score (SMT) for the first data row); italicised 
data are calculated SMD values; italicised data reflects calculated SMD values  
 
5.3.3.1.2 Data modification 
Of the twelve matched outcome variables (six matched outcomes at two time-
points: baseline and 12-week follow-up), there were no missing data and all 
variable scales scored in the same direction. For the linear mixed model to be 
run, the dataset was transformed from wide to long, by merging the twelve 
original variables into six standardised variables as described in section 
5.2.3.2.1.  
 
5.3.3.1.3  Replication of the ANCOVA Analyses 
Replication of the original analyses was performed in chapter 4 (section 
4.3.2.2.1.2) for the secondary outcomes matched to the treatment targets of the 
exercise intervention. Further analysis of the composite outcome was performed 
as per the method used for the primary outcome analysis. MANCOVA was also 
performed to compare the results with the ANCOVA of the standardised 
composite. ANCOVA analyses were used to compare the differences between 





three groups at all time-points with baseline values as covariates – this was 
conducted in two separate analyses to allow for the differing reference group (i.e. 
HEA or SMT) (please see chapter 4, section 4.3.2.2.1.2). The results are 
tabulated in Table 5-12. In comparison to the standardised reported pain scores, 
the composite outcome values provided a greater SMD in comparison to manual 
therapy (0.21 vs 0.26), with smaller confidence intervals, suggesting a more 
precise effect estimate that is statistically significant (p<0.00001). The composite 
outcome was also statistically significant in favour of exercise in comparison to 
home exercise and advice at 12-weeks although the original primary outcome 
generated a greater SMD (0.43 vs 0.29), as seen in Table 5-12. The components 
comprising the composite outcome (isometric extension strength, static 
endurance flexion and extension, dynamic endurance flexion and extension) 
were all statistically significant in favour of the exercise arm apart from 
standardised isometric flexion strength outcome (in comparison to the home 
exercise arm). 
  





Table 5-12: ANCOVA analysis of composite outcome in comparison to the 
primary outcome (pain) in Bronfort et al. (2011) 
Outcome*/ Group 
Comparison  
Mean difference  





Standardised Primary (Pain) Outcome 
SET vs SMT  0.21 (-0.07, 0.5) 0.156 0.148 
SET vs HEA 0.43 (0.14, 0.72) 0.004 0.148 
Standardised Composite 
SET vs SMT  0.26 (0.16,0.36) <0.0001 0.051 
SET vs HEA 0.29 (0.19, 0.39) <0.0001 0.053 
Standardised Variables comprising the Composite Outcome:  
Dynamic Endurance Flexion 
SET vs SMT  0.59 (0.39, 0.79) <0.0001 0.101 
SET vs HEA 0.65 (0.44, 0.86) <0.0001 0.106 
Dynamic Endurance Extension 
SET vs SMT  0.84 (0.71,1.11) <0.0001 0.097 
SET vs HEA 0.91 (0.71, 1.11) <0.0001 0.101 
Static Endurance Flexion 
SET vs SMT  0.57 (0.35, 0.78) <0.0001 0.108 
SET vs HEA 0.44 (0.22,0.67) <0.0001 0.113 
Static Endurance Extension 
SET VS SMT 0.32 (0.13,0.52) 0.001 0.100 
SET VS HEA 0.40 (0.19,0.60) 0.0002 0.105 
Isometric Flexion Strength 
SET VS SMT 0.20 (0.05,0.35) 0.011 0.076 
SET VS HEA -0.01 (-0.16,0.15) 0.929 0.079 
Isometric Extension Strength 
SET VS SMT 0.19 (0.04,0.33) 0.015 0.075 
SET VS HEA 0.17 (0.01,0.32) 0.034 0.078 
All outcome values are for standardised outcomes.  
 
5.3.3.1.4 MANCOVA Analysis 
MANCOVA is an alternative method of analysing multivariate outcomes and was 
used as a secondary multivariate analysis in the trial paper. Thus, the data were 
also analysed in this study using MANCOVA to compare to the composite 
ANCOVA analysis above (see Table 5-13). This demonstrated that the combined 
results of the outcomes of interest were statistically significant across all four 
tests, and all standardised components, although no effect estimate can be 
derived.  
  





Table 5-13: Table to show MANCOVA of standardised outcomes comparing 












Group (SET=1 and SMT=0) (Composite) Group (SET=1 and HEA=2) Composite  
Pillai’s 
Trace 
.344 .344 P<0.000001 Pillai’s 
Trace 
0.318 0.318 P<0.000001 
Wilk’ 
Lambda 
.656 .344 P<0.000001 Wilk’ 
Lambda 
0.682 0.318 P<0.000001 
Hotelling’s 
Trace 
.525 .344 P<0.000001 Hotelling’s 
Trace 




.525 .344 P<0.000001 Roy’s 
Largest 
Root 
0.466 0.318 P<0.000001 
Sig is significance; SET is specific exercise, SMT is spinal manual therapy, and HEA is home 
exercise. 
 
5.3.3.1.5 Replication of the Linear Mixed Model Analyses 
A linear mixed model of the composite was also created to compare against the 
primary outcome (Table 5-14). This demonstrated that the composite outcome 
generated a slightly smaller SMD than the standardised pain outcome when 
comparing specific exercise to home exercise (although this result was 
statistically significant in contrast to the primary outcome). When comparing 
specific exercise to spinal manual therapy, there was a statistically significant and 
greater SMD found with the composite in favour of specific exercise (SMD 0.21 
(95%CI -0.07, 0.5) for pain compared to SMD 0.43 (95% CI 0.31, 0.54) for the 
composite).  
  





Table 5-14: The linear mixed model analysis of standardised outcomes 
comparing exercise against home exercise and manual therapy in Bronfort et al. 
(2011) 
 Adjusted mean difference (95% CI) 
12-week follow-up  Effect estimate (95% CI) t score Sig.  
Standardised Pain (trial results) 
SET* (vs HEA) 0.43 (0.14, 0.72)  Not reported 
SET* (vs SMT) 0.21 (-0.07, 0.5)  Not reported 
Composite Results 
SET* (vs HEA) 0.41 (0.29, 0.54) 6.595 <0.000001 
SET* (vs SMT) 0.43 (0.31, 0.54) 7.076 <0.000001 
Individual Components of the Composite Outcome: 
Standardised Static endurance Flexion 
SET* vs SMT 0.55 (0.32, 0.79) 4.606 <0.0001 
SET* vs HEA 0.40 (0.16, 0.65) 3.228 0.001 
Standardised Static endurance Extension 
SET* vs SMT 0.31 (0.09, 0.52) 2.815 0.005 
SET* vs HEA 0.36 (0.14, 0.58) 3.174 0.002 
Standardised Dynamic Endurance Flexion 
SET* vs SMT 0.56 (0.34, 0.78) 4.965 <0.00001 
SET* vs HEA 0.63 (0.40, 0.86) 5.41 <0.00001 
Standardised Dynamic Endurance Extension 
SET* vs SMT 0.84 (0.62, 1.05) 7.635 <0.00001 
SET* vs HEA 0.92 (0.70, 1.14) 8.098 <0.00001 
Standardised Isometric Strength Flexion 
SET* vs SMT 0.15 (-0.00, 0.31) 1.932 0.054 
SET* vs HEA 0.003 (-0.16, 0.16) 0.033  
Standardised Isometric Strength Extension 
SET* vs SMT 0.01 (-0.15, 0.17) 0.130  
SET* vs HEA 0.18 (-0.02, 0.34) 2.208 0.028 
Where HEA represents home exercise and advice, SMT represents spinal manual therapy, and 
SET represents specific exercise therapy. 
 
5.3.3.1.6 Summary of Bronfort et al. (115) 
Using this third trial’s primary analysis method (ANCOVA), the composite 
outcome generated a greater SMD (0.26 (95% CI 0.16, 0.36), p<0.00001) in 
favour of exercise than the primary outcome (SMD 0.21 (95% CI -0.07, 0.5), ns), 
as seen in the forest plot, Figure 5-3. 
 





Figure 5-3: The effect of the primary outcome (pain) in comparison to the 
composite for exercise in comparison to manual therapy using an ANCOVA 
analysis in Bronfort et al. (2011) 
 
SE is standard error, IV is inverse variance method, CI is confidence interval, Std. is standard as 
part of SMD. All values represent the mean difference between specific exercise and spinal 
manual therapy.  
 
The results of the linear mixed model (see Figure 5-4) also demonstrated that the 
use of a composite variable appear to change the conclusion of the trial in favour 
of specific exercise therapy with a larger effect estimate compared to both home 
exercises and spinal manual therapy, with a SMD of 0.43 ((95% CI 0.31, 0.54), 
p<0.00001) in comparison to the original trial results (SMD 0.21 (95% CI -0.5, 
0.07)).  
Figure 5-4: The effect of the primary outcome (pain) in comparison to the 
composite for exercise in comparison to spinal manual therapy using a linear 
mixed model analysis in Bronfort et al. (2011)   
   
SE is standard error, IV is inverse variance method, CI is confidence interval, Std. is standard as 
part of SMD. All values represent the mean difference between exercise and spinal manual 
therapy.  





Further analysis of a composite derived by MANCOVA demonstrated statistically 
significant results for all values at 12-weeks when comparing supervised exercise 
to manual therapy and supervised exercise to home exercise. The linear mixed 
model, which is the analysis reported in the published paper, is preferential to the 
ANCOVA or repeated measures ANOVA or MANCOVA by making greater use 
of the available data within the analysis and by modelling missing data more 
appropriately to the covariates in the model.  
 
5.3.3.2 Secondary Analysis of Groessl et al. (2017) 
The last of the four RCTs analysed in this study, by Groessl et al. (126) had four 
time-points (baseline, 6-weeks, 12-weeks, and 24-weeks) and three secondary 
outcomes that matched their exercise treatment targets (strength, flexibility and 
pain relief). The primary outcome was physical function (unmatched) at 12-weeks 
and results showed statistically significant differences between yoga and waitlist 
control at the first two follow-ups, with statistically significant differences at 24-
weeks in favour of the yoga arm.   
 
5.3.3.2.1 Standardised Mean Differences of the Original Analysis Results 
The physical function variable was not requested in the dataset as it was not a 
matched outcome; thus, the original analysis was not able to be replicated on the 
primary outcome. SMD values were calculated for the reported primary outcome 
(physical function, shaded in grey) and compared to the only other reported 
matched outcome (pain) as seen in Table 5-15.  





Table 5-15: Calculated SMD values comparing reported primary outcome domain 
and matched secondary outcomes in Groessl et al. (2017) 




Difference   
(95% Confidence Interval) 
Groessl et al. (2017) Yoga vs 
Waiting list  
Physical Function 0.14 (-0.27, 0.55) 
  Pain 0.30 (0.08, 0.52) 
 
5.3.3.2.2 Data Modification 
On reviewing the outcomes of interest (four outcomes) via descriptive variables, 
there were no missing data identified. Both strength and the flexion flexibility 
variables required multiplication by minus one so that the scales all pointed in the 
same direction. The dataset was converted from a wide to a long format as 
described in section 5.2.3.2.1 by merging all four time-points included for each 
targeted outcome.   
 
5.3.3.2.3 Linear Mixed Model of a Targeted Composite Outcome 
The linear mixed model method applied to the primary outcome was tested and 
described previously (chapter 4, section 4.3.2.2.2.2). The composite outcome 
was composed of strength, flexibility and pain outcomes. The composite outcome 
demonstrated effect estimates that are the same as the primary outcome at six 
weeks but are greater than the primary outcome at the primary time-point (12-
weeks), and this was also statistically significant in favour of the exercise group 
(composite outcome SMD 0.25 (95% CI -0.43, -0.05) versus primary outcome 
SMD -0.14 (95% CI -0.46, 0.18)) as seen in Table 5-16. The individual 
components of the composite outcome demonstrate that for three of the four 





variables, greater SMDs were observed than using the standardised primary 
outcome (standardised pain, plank and flexion ROM) at the primary time-point. 
Although, only standardised pain showed differences that were statistically 
significant in favour of the exercise arm. Please see Appendix 9.k: Linear mixed 
model results of Groessl et al. (2017) trial dataset: all time-points. 
Table 5-16: The linear mixed model analysis of the standardised pain outcome 
in comparison to the composite outcome results in Groessl et al. (2017) 
 Adjusted mean difference (95% CI) 
Yoga vs WL Effect estimate (95% CI) t score Sig.  
Standardised Primary Outcome (Physical Function) (trial results) 
12-week follow-up -0.14 (-0.46,0.18)  0.34 
Standardised Composite Analysis 
12-week follow-up -0.25 (-0.43, -0.07) -2.761 0.007 
Individual Components of the Composite Outcome: 
Standardised Pain 
12-week follow-up -0.30 (-0.52, -0.08) -2.741 0.007 
Standardised Plank 
12-week follow-up -0.23 (-0.51, 0.04) -1.64 0.105 
Standardised Flexion ROM 
12-week follow-up -0.27 (-0.61, 0.08) -1.538 0.127 
Standardised Extension ROM 
12-week follow-up -0.08 (-0.44, 0.28) -0.456 0.649 
Where WL is waiting list, ROM is range of motion. All values are calculated as mean difference 
of yoga minus mean difference of waiting list, where negative values favour the yoga intervention. 
Please see appendix B3 for the analysis relating to other reported time-points. Values in italics 
are statistically significant.  
 
The standard error of the composite outcome was much smaller than the 
standardised pain outcome (0.06 vs 0.12) as seen in Table 5-17. 
  





Table 5-17: The standard error of the two models in Groessl et al. (2017) 




1,1 0.12 0.06 
2,1 0.11 0.05 
2,2 0.12 0.05 
3,1 0.11 0.04 
3,2 0.16 0.04 
3,3 0.14 0.05 
4,1 0.10 0.04 
4,2 0.10 0.04 
4,3 0.11 0.04 
4,4 0.11 0.04 
 
Figure 5-5 demonstrates a forest plot of the primary outcome in comparison to 
the composite outcome at the primary time-point. 
Figure 5-5: The effect of the primary outcome (physical function) in comparison 
to the composite in comparison to waiting list control in Groessl et al. (2017) 
 
SE is standard error, IV is inverse variance, CI confidence intervals, Std. is standard as part of 
SMD 
 
5.3.3.2.4 Summary of Groessl et al. (126) 
The results using the standardised composite outcome measure incorporating 
the stated exercise targets in this fourth RCT (127) differed to those observed 
using the original primary outcome. A statistically significant difference was found 
in favour of the exercise arm at 12-weeks in the composite outcome (the primary 
time-point), and a greater SMD was found at the primary time-point in favour of 





the exercise arm with the composite outcome. In the original analysis of this 
RCTs’ primary outcome, a statistically significant difference between exercise 
versus control was only found at 24-weeks. The matched outcomes comprising 
the composite variable found greater SMDs at the primary time-point in 
comparison to the primary outcome (apart from extension ROM), but only pain 
was statistically significantly different at this time-point.   
 
5.3.3.3 Overall summary from secondary analyses of all four RCTs 
Analyses using standardised composite outcomes compared to the initial primary 
outcome domain in this sample of four RCTs demonstrated that in three of four 
trials, the use of a matched composite outcome generated a greater standardised 
between-arm mean difference in favour of the exercise intervention. The new 
analysis changed the results and conclusions of the two ‘unmatched’ RCTs 
(117,127) and one of the two ‘matched’ RCTs (136,137), as seen in Table 5-18. 
Two of the four analyses showed results with the composite outcome variable 
that had slightly smaller SMDs in favour of the exercise intervention, whilst the 
other two found greater SMDs in favour of the exercise intervention. Three of 
these results were (more) statistically significant in comparison to the original 
RCTs’ primary outcome results. All analyses showed a smaller standard error 
when using the composite outcome. However, if one considers the matched 
status, then in the two RCTs with matched primary outcomes, the matched single 
primary outcome performed better than the composite outcome; and in the two 
RCTs with unmatched primary outcomes, the matched composite performed 





better than the unmatched primary outcome, potentially changing the conclusion 
of both RCTs with an unmatched primary outcome.  
Table 5-18: Summary results of all four RCTs primary outcome and targeted 
composite outcome 
 Trial Primary 
Time-Point 

















6-weeks Primary (Pain) 0.69 (0.4, 1.0) <0.0001 No change 





-0.01 (-0.22, 0.20) NS No change  





















0.26 (0.16,0.36) <0.0001 





12-weeks Primary (Physical 
Function) 




Composite 0.30 (0.08, 0.52) 0.007 
Where NS is non-significant, SMD is standardised mean difference, LMM is linear mixed model, 
ANCOVA is analysis of variance with co-variates. 
 
A meta-analysis of the summary results provides further support in favour of 
using the composite outcome given the observed pooled SMD in favour of the 
composite (SMD 0.28 (95%CI 0.05, 0.51) p=0.02), which was statistically 
significant, in contrast to the single primary outcome (SMD 0.24 (95%CI -0.04, 
0.53) p=0.10) as seen in Figure 5-6, although the sub-group differences were not 
statistically significant (p=0.86). The between-group difference when calculated 
was SMD 0.03 (95% CI -0.13, 0.20) p=0.86. This difference may be because 
three of the composite outcomes had statistically significant results in favour of 
the exercise arm, in contrast to only one of the single outcomes, and the standard 





errors were much smaller in the composite outcomes (range -0.041 to 0.102) in 
contrast to the single outcomes (range 0.107 to 0.163). 
Figure 5-6: Summary plot to demonstrate pooled SMD of primary outcome in 
comparison to composite outcome 
  
Std. represents standard as part of SMD, SE is standard error, IV is inverse variance, CI is 
confidence interval.  
 
In the Miyomoto et al. (136) analyses, the co-primary composite generated a 
greater SMD than the targeted composite outcome, but this was still not as large 
as the single matched primary outcome. In the Moffett et al. (137) analysis, the 
co-primary composite generated a greater SMD than both the single matched 
outcome and the targeted composite outcome in favour of exercise in comparison 
to a solution finding approach. These results are summarised in Table 5-19. 
  














Miyamoto et al. 
(136) 
6-weeks 
(Intervention all vs 
CG) 
Primary (Pain) 0.69 (0.4, 1.0) <0.0001 
Composite 0.60 (0.4, 0.8) <0.0001 




Moffett et al. 
(137) 










Co-primary composite 0.08 (-
0.13,0.29) 
NS 
SMD represents standardised mean difference, CI is confidence interval, Sig. is significance, CG 
is control group, McK is McKenzie method, SFA is solution finding approach 
 
 Discussion 
This exploratory secondary analyses of existing RCTs developed and evaluated 
the use of composite primary outcomes, matched to the stated exercise 
treatment targets in four example RCT datasets. The results suggest that, in 
three of the four RCTs, use of a composite primary outcome would have 
potentially altered the results and conclusions reached by these trial teams. 
Using a composite outcome, matched to multiple exercise treatment targets, may 
give greater power to detect superiority of exercise interventions over a non-
exercise comparator. Greater between-arm SMDs in favour of the exercise 
intervention, that were statistically significant compared to the estimates derived 
using the trials’ original primary outcomes, with smaller standard errors, were 
demonstrated in three RCT datasets in favour of exercise in comparison to a 
control arm (117,127,137). Miyamoto et al. (136) was the only RCT that found 
SMD results greater with the original matched primary outcome. It is important to 





note that in this secondary analysis of four RCTs, two included matched primary 
outcomes, compared to matched composites, and two RCTs included 
unmatched primary outcomes compared to matched composites. Despite this, 
the overall pooled mean difference still favoured the use of a matched composite 
to a single outcome (matched/ unmatched) (SMD of 0.28 (95%CI 0.05, 0.51) 
compared to a SMD of 0.24 (95% CI -0.04, 0.53)).  
 
Further analysis of two RCT datasets evaluated whether the use of two matched 
primary outcomes, as nominated by the trial authors, combined as a “co-primary” 
composite, might change the results and conclusions of these RCTs. These 
analyses demonstrated greater SMDs with the co-primary composites than the 
targeted composites in both Miyamoto et al. (136) and Moffett et al. (137). 
Comparing the RCTs with matched outcomes demonstrated that the composite 
outcomes were less likely to generate greater SMDs than the original matched 
outcome, in comparison to the unmatched outcomes where the matched 
composites in both RCTs generated greater SMDs that were more likely to be 
statistically significant in favour of the exercise arm.  
 
5.4.1 How These Findings Compare to Other Studies  
An increasing number of RCTs are now using more than one primary outcome 
(39% of included trials in the systematic review, chapter 3 section 3.3.5.2), and 
thus a composite combining the key primary outcomes may improve the ability 
of an RCT to detect differences in the effects of exercise versus control or 
comparison interventions over time (i.e. improve the responsiveness of the 





outcome) (174,179). In the analyses of the trials with matched primary outcomes 
(136,137) the co-primary composite outcome generated a greater SMD than the 
matched composite, although the matched primary outcome showed greater 
SMDs than the composite in one trial at the primary time-point (136). This result 
suggests that including fewer matched key components in the composite 
outcome may improve responsiveness, perhaps because including more 
components leads to a dilution of effect (as some will change less than others 
from the exercise intervention). This improvement in responsiveness was noted 
by Parkes et al. (166) in rheumatoid arthritis patient data when comparing various 
composite outcomes with a single outcome, however, their analysis did not find 
improved statistical significance with composite outcomes in comparison to a 
single outcome (pain).  
 
Other explanations for why the co-primary composite produced greater SMDs 
than the composite outcome may be that if an intervention does not equally 
address the different targets of the intervention, and the weighting of targets is 
not similarly reflected in the composite outcome, the composite may produce a 
result that falls short of a primary single matched outcome. In complex 
interventions, where multiple treatment targets are considered, weighting may be 
more applicable depending on how the intervention is delivered (175). This would 
require a weighting of the treatment targets of the intervention (e.g. 60% targeting 
pain, 20% targeting fear-avoidance beliefs, 20% targeting physical function), and 
then weighting the matched composite accordingly. The current limited 
understanding of the treatment targets and mechanisms of action of exercise in 





NSLBP would make it difficult to justify such weightings. Further, this weighting 
and the complex calculations that accompany it would likely preclude such 
outcomes from being used in clinical practice. 
 
It is important that in the creation of a composite outcome, components are 
reasonably combined, consistently defined and comprehensively reported (180). 
In this analysis, composite outcomes were generated based on the specified 
treatment targets articulated in the included example trials. Ross (181) 
recommends that composite outcomes should be related to the treatment targets 
of the intervention, have clinical meaning and be biologically plausible. In this 
study, all four RCTs had clearly stated their exercise treatment targets, and thus 
composites were ‘RCT specific’. However, the future a priori identification of 
composite outcomes should in principle be influenced by a clear mechanism of 
change theory so that clinically relevant and meaningful outcomes are selected 
(52) that are directly related to the treatment targets of the intervention. The 
composites used in these exploratory analyses varied from four components 
(127) to eight components (137) (mean n=5). Each constructed composite was 
composed of different standardised outcome measures as identified by the RCT 
papers’ authors. This prohibited comparisons of composite outcomes across 
datasets and would be a key barrier to use in RCTs, as the ability to pool data 
and compare results with other trials is important. The observed between-arm 
estimates of the effect of exercise versus control using the composite outcome 
may also be influenced by the responsiveness of the outcome measures that 
comprise it. In most of the analyses performed, similar outcome measures were 





used to comprise the composite (e.g. RMDQ for physical function, TSK for fear-
avoidance beliefs etc.). However, in some outcome domains such as physical 
function, although the RMDQ was most frequently used, the Patient-Specific 
Functional Scale (PSFS) was also used. Although both measures are known to 
be responsive, Hall et al. (182) report that the PSFS may be more responsive in 
patients with low activity limitation, and this may influence the responsiveness 
across different populations. Two different pain outcome measures were also 
used in the four included RCTs (the Brief Pain Inventory (BPI) and the numeric 
rating scale (NRS)). The BPI is known to have structural validity and internal 
consistency, but the NRS is preferred despite more inconsistent results on 
responsiveness (183). Although the BPI and PSFS outcome measures were 
used less frequently than the RMDQ and NRS, they may have increased 
coverage and therefore be preferable in a composite where a balance between 
responsiveness and coverage is desired. Although recommended core outcome 
measures for use in RCTs in persistent NSLBP have been agreed on (82), there 
is an acknowledgement that these measures are the best available, and not 
necessarily the best outcome measure for assessment (183). 
 
Composite outcomes may be subject to misinterpretation if reporting is 
inadequate regarding the individual components. Further, the treatment effects 
may vary across different components of the composite outcome, or only a few 
components may change due to the exercise intervention which may result in the 
masking of a beneficial or harmful effect for one or more components of the 
composite (184). This again raises questions of what the RCT designers aimed 





to target in their exercise intervention, what was actually targeted (see chapter 4, 
section 4.4.3), and what the treatment fidelity was of the treatment delivered. 
However, none of these RCTs reported a clear process evaluation, and thus it is 
difficult to understand the detail of the exercise interventions actually delivered.  
 
There are many methods available to create a composite outcome. Creation of 
the composite outcomes in this study predominantly used the standardised 
averaging method described by Song et al. (175), but an alternative method is to 
use weight-adjusted averages. The field of cardiovascular research has used 
composite outcomes in varying compositions for many years, and recent reviews 
suggest 56% of cardiac surgery RCTs used a composite outcome as a primary 
outcome, with 14 different composites identified, highlighting the heterogeneity 
in their field (185).  However, recent qualitative work has suggested that patients 
involved in cardiovascular research do not agree with the equal weighting of 
composite outcomes: patients stated they were more concerned about the effects 
of a permanent stroke-causing disability, than death (186). This suggests that 
future RCTs of cardiovascular research may need to incorporate a weight-
adjusted composite to reflect patients’ preferences (186). Weight-adjusted 
composites are more challenging to interpret and standardise, and would have 
been challenging to implement in the analyses used in this study as none of the 
included RCTs allocated percentages to the degree treatment targets were 
targeted with their interventions. If composites are to be used, they should be 
consistently defined, comprised of clinically relevant outcomes, and reported 
both as a whole and with individual components to ensure transparent 





interpretation of results (187) which would be challenging for future research 
implementing a weighted composite. Further, this extends beyond the individual 
RCT wherein a composite was selected to reflect and match the specified 
treatment targets, but therefore would not allow comparisons between studies, 
and would limit the available data to be used in systematic reviews and meta-
analyses. Core outcome domains have already been agreed to be used in all 
RCTs for persistent NSLBP, and the responder burden to participants of RCTs 
may become immense if RCTs include all three core outcome domains, matched 
outcomes and composite outcomes, unless the composite is comprised of many 
of these outcomes. This remains a key challenge in future RCT design and 
implementation. Future research should involve testing whether composite 
outcomes composed of outcomes matched to treatment targets might change 
the results and conclusions of trial datasets in a larger sample of datasets (n>4), 
such as of exercise interventions compared to no-exercise in an osteoarthritis 
population, or of manipulative interventions compared to usual care in a NSLBP 
population. Further research may analyse the precision and coverage of a 
composite outcome using principal component analysis, or alternative methods, 
to compare which method is best in creating a composite outcome with regard to 
effect size, coverage and standard error.  
 
5.4.2 Strengths and Limitations of this Analysis 
A strength of this exploratory secondary analysis was the acquisition of four RCT 
datasets, and the replication of the original analyses performed. The small 
number of RCT datasets analysed makes it difficult to draw firm conclusions; 





however, it does provide initial evidence that a matched composite outcome in 
an RCT of exercise for persistent NSLBP can result in greater between-arm effect 
estimates and greater statistical significance than the use of a single outcome, 
although a co-primary composite outcome may generate greater SMDs than a 
single matched outcome. The analysis methods used replicated the primary 
analysis method used by the trial teams of the individual RCTs, and this ensured 
the results were comparable. These four RCTs were selected from a sample of 
twelve RCTs included in the systematic review, reported previously in this thesis, 
which may have been subject to publication bias.  The limitation is that this was 
an exploratory secondary analyses of a small number of RCT datasets. 
 
In all analyses performed in this secondary analysis the standard error of the 
composite variable was much smaller than that of the single primary outcome. A 
reason for this may be the improved precision related to the use of composites 
(192,193) and repeated measures of individual participants. Precision is likely 
enhanced (i.e. reduced standard error) through smoothing out measurement and 
random error as well as taking into account correlation between the outcomes 
comprising the composite outcome (188).  
 
Reporting guidelines for composite outcomes recommend that the individual 
composite component results should be described with the results of the 
composite to ensure clarity (184,189). This allows the components of the 
composite outcome to be considered as secondary outcomes and allow for clear 
interpretation of the composite outcome results, which negates the need for 





adjustment for multiplicity (184). A strength of this analysis is the reporting of 
individual components comprising the composite outcomes, however, due to the 
numerous outcomes included in the composite in some cases, and the word 
limits imposed by many journals, this level of reporting of composite outcomes is 
likely to be a challenge for RCT authors in future. It is recommended that the 
included components of a composite outcome should be related but not too 
highly correlated, or a single primary outcome domain would be more appropriate 
(184). This premise was not assessed in these analyses, and thus this may be a 
limiting factor when considering the results. The composite variable in these 
analyses was constructed with averaged standardised outcomes identified by the 
authors of each RCT publication.  
 
5.4.3 Implications for Further Research 
This study is exploratory in nature but nevertheless highlights that the results and 
conclusions of exercise RCTs may be changed by using a composite outcome 
that matches the targets of the exercise intervention. Further analysis of a larger 
number of RCTs of exercise interventions in persistent NSLBP is warranted. It 
would be useful to explore whether this is also the case for exercise interventions 
for different conditions, and for other complex interventions. 
In RCTs of exercise interventions in persistent NSLBP, where the intervention 
may have multiple treatment targets due to its complex nature, a matched 
‘targeted’ composite outcome may give the RCT team the best chance of 
detecting the benefits of exercise compared to control or comparison 
interventions. A composite outcome comprised of multiple matched outcomes to 





the specified exercise treatment targets appears to generate a greater SMD in 
favour of exercise in comparison to a control arm. Well-matched co-primary 
outcomes may be preferable to a single matched outcome as they are more likely 
to cover a range of key treatment targets of exercise. However, identifying 
outcomes that are both responsive and have assess the right domains is difficult 
when the underlying treatment targets are poorly described and understood. The 
use of a matched composite outcome is likely to reduce the sample size 
requirements (166) for future RCTs which may have significant impacts on 
budget, resources and time taken to complete RCTs.  
 
This study evidences the lack of consensus among trial teams about the key 
treatment targets of exercise. Even in the two RCTs investigating yoga as an 
exercise intervention (127,137), the authors identified many different targets 
(range from four to seven), of which only the reduction of pain was common to 
both. Thus, there is a clear need for a better understanding of the mechanisms 
of action of exercise (52) in order to be able to specify appropriate treatment 
targets that can be captured by well-matched and well-defined outcomes.  
 
 Conclusion 
This exploratory analysis provides preliminary evidence that the use of a 
composite outcome, matching the multiple identified exercise treatment targets 
would have changed the results and conclusions of three of the four analysed 
RCT datasets. The use of composite matched outcomes in exercise interventions 
may provide a more responsive and meaningful outcome than a single matched 





outcome. The next chapter develops this work further and aims to gain 
consensus on the treatment targets of exercise, and their agreed prioritisation for 
use in future RCTs of exercise interventions in persistent NSLBP.    
 





6 Chapter 6: Gaining Consensus on the 
Treatment Targets of Exercise Interventions 
Summary  
This chapter describes two, sequential, nominal group workshops used 
to gain consensus on the treatment targets of exercise in persistent 
NSLBP. 
The content of this chapter formed part of the peer-reviewed 
publication:  
Wood L, Bishop A, Lewis M, Smeets RJEM, Bronfort G, Hayden JA, 
Foster NE. Treatment targets of exercise for persistent non-specific low 
back pain: a consensus study. Journal of Physiotherapy, accepted.  
 
 Introduction 
There is a paucity of research that focuses on the treatment targets of exercise 
interventions in persistent non-specific low back pain (NSLBP). The systematic 
review that formed part of the earlier phase of this research programme (chapter 
3) demonstrated that there are many and varied direct and indirect treatment 
targets of exercise described in published randomised controlled trials (RCTs) in 
the field of persistent NSLBP. The most frequently reported treatment targets 
were reducing pain, muscle strengthening, improving spinal stabilisation, 
flexibility and improving posture. The review observed that even in trials testing 
exercise programmes that follow a similar approach, such as the McKenzie 
method (125,137), the authors reported different treatment targets. This 
demonstrates clear uncertainty about the treatment targets of exercise, and the 





underpinning mechanisms through which exercise benefits pain, function and 
quality of life (71). 
 
Given this uncertainty, a logical next step is to undertake exploratory research 
that seeks to gain consensus about the treatment targets of exercise 
interventions with key stakeholders (190–192). In this study, key stakeholders 
were considered to be developers of exercise interventions that are tested in 
RCTs, people who use exercise to manage persistent NSLBP, and clinicians who 
prescribe exercise for this patient population. Nominal group workshop 
methodology was selected as the most appropriate approach with which to 
generate consensus, as it allows each participant an equal opportunity to present 
their ideas, discuss all ideas, and rank the generated topics in terms of 
importance. It is a time-efficient process as the panel of participants is kept 
focused and on track throughout the meeting (193). Furthermore, it allows 
confidentiality of ideas, as well as allowing the panel time to clarify thought 
processes and suggestions (193). This chapter describes the use of two 
sequential nominal group workshops to generate agreement on the most 
important treatment targets for exercise interventions in RCTs of persistent 
NSLBP. 
 
6.1.1 Study Aim and Objective 
Aim: The aim of this exploratory study was to identify and rank key treatment 
targets for exercise interventions in persistent NSLBP in order of importance.  
  





Specific Objective:   
To reach consensus on the important treatment targets of exercise interventions 
in persistent NSLBP by using nominal group workshops. 
 
 Methods 
6.2.1 Study Design 
Consensus was obtained by using the nominal group workshop technique in two 
separate, sequential workshops. Nominal group workshops were first described 
as a method through which committees make decisions by Van de Ven and 
Delbecq in 1972 (194), following research funded by NASA and the Institute for 
Research on Poverty for committees making decisions. The nominal group 
workshop methodology has previously been successfully used when 
incorporating multiple stakeholder groups together such as researchers, patients 
and clinicians, and as it ensures the opinions of all participants are identified and 
considered (195). The group is nominal in that it is highly controlled with 
discussion allowed at certain points through the process (196). Throughout the 
process, each participant has an equal opportunity to generate and present 
suggestions and cast their vote (and rank), preventing dominance of the group 
by some participants (195,197). Each nominal group workshop moves through 
five stages: introduction, idea generation, idea sharing, group discussion, voting 
and ranking (198), which were modified for each workshop. The final ranking 
stage generates consensus as a ranked aggregation of the participants’ views 
rather than a communal viewpoint (199).  





The nominal group workshop method was selected over the Delphi technique 
due to its participant interaction, relative speed of process and consensus 
generation, the high degree of task completion and the ability to gain valuable 
insight into discussion points around the ideas and question addressed (200). 
Reported disadvantages of nominal group workshops include the use of small 
numbers of participants (199).  
 
One national workshop11 was held, based at Keele University and a second 
international workshop was held at the International Forum for Back and Neck 
Pain Research in Primary Care in Quebec City, Canada. The initial plan for the 
PhD had only included one workshop (national workshop), but when the potential 
for a second workshop arose, the opportunity was taken to build on the results of 
the first workshop. Ethical approval was obtained from the University Research 
Ethics committee for both workshops: on the 17 August 2018 (reference ERP 
2393) and an amendment was approved on the 15 April 2019 (reference MH-
190019) (see Appendix 9.l: Additional Information Regarding Consensus 
Workshops). The methods for each workshop are described below. Both 
workshops used online systems to facilitate the workshop flow, and the national 
workshop used a mixture of both virtual and face-to-face mediums.  
 
                                            
11 The national workshop was initially the only workshop planned as a part of 
this PhD, and one international attendee responded to an invitation and took 
part. As the first workshop was attended by 93% UK attendees, this was named 
as National despite the inclusion of one international attendee in contrast to the 
second workshop where all attendees were from countries other than the UK.  





6.2.2 Participants: Identification and Invitation 
This study included researchers involved in the development of exercise 
interventions that are tested in RCTs, people who use exercise to manage 
persistent NSLBP, and clinicians who prescribe exercise for this patient 
population. The sample invited from each stakeholder group was a convenience 
sample. A limit of 25 participants per workshop was set to ensure manageable 
group discussion and input as part of the nominal group workshop process (197). 
For the first, national, workshop awareness raising for the nominal group 
workshop included: advertisements, telephone calls, targeted emails, social 
media, and contact with local patient groups for arthritis and back pain (details 
are presented in Table 6-1), in order to target researchers, people who had used 
exercise for their back pain, and clinicians (predominantly physiotherapists). A 
total of 15 participants provided informed consent for the first workshop. The 
second, international, workshop was held eight months later, as part of an 
international conference held in Quebec City, Canada. This workshop targeted 
researchers in the field of LBP who may or may not also be clinicians. The 
abstract for the workshop was submitted, peer-reviewed and accepted for the 
Forum conference programme. Several hundred attended the conference, and a 
total of 20 participants registered for the workshop. During the workshop, 
participants were able to freely join or leave the workshop at any stage.  
  





Table 6-1: Recruitment strategies used and their target population 
Recruitment Strategy Participant Group Targeted 
Social media (twitter and Facebook) People who have used exercise to treat 
persistent NSLBP  
Clinicians who have prescribed exercise for 
persistent NSLBP 
Researchers who have developed exercise 
interventions for persistent NSLBP 
Email invitations to the BackCare and Arthritis 
Musculoskeletal Alliance Groups 
People who have used exercise to treat 
persistent NSLBP  
Advertisements were placed in the Chartered 
Society of Physiotherapy’s Frontline magazine 
for the 2 months preceding the workshop 
Clinicians who have prescribed exercise for 
persistent NSLBP 
Advertisements with pull off strips were placed 
around Keele University campus 
People who have used exercise to treat 
persistent NSLBP  
Flyers were placed in waiting rooms of 
physiotherapists in the Staffordshire area 
People who have used exercise to treat 
persistent NSLBP  
Email invitations sent to authors of trials 
included in systematic review (chapter 3) 
Researchers with experience of developing 
exercise interventions 
Email invitations sent to individuals, centres and 
research institutes that were known to the 
researchers for previously developing exercise 
interventions tested in trials 
Researchers with experience of developing 
exercise interventions 
 
6.2.3 Nominal Group Workshop Process 
Both nominal group workshops began with silent idea generation, as 
demonstrated in Figure 6-1. The national workshop was informed by the previous 
systematic literature review (chapter 3 in this thesis), and the results of the 
national workshop informed the international workshop. The process of achieving 
consensus through the initial voting, discussion and ranking stages followed 
published nominal group workshop guidance (197). The study process is 
demonstrated in Figure 6-1, and each of the stages is outlined thereafter.   
  





Figure 6-1: Flow chart of consensus workshop stages (modified from Potter et al. 
(2004))  
 
6.2.3.1 National Workshop: 
6.2.3.1.1 Pre-workshop (Stage 1 and 2) 
Participants provided written informed consent (see Appendix 9.l: Additional 
Information Regarding Consensus Workshops) and basic demographic 
information using online data collection following their registration for the 
workshop. One week prior to the workshop, access to the online portal was 
provided through GroupMap (https://www.groupmap.com/) to view the list of pre-
generated treatment targets informed by the systematic review (chapter 3, 
section 3.3.5.1). Participants were able to add suggestions to this list before the 
workshop, and participants’ additions were private to the rest of the group until 
the PhD candidate enabled viewing permission during the workshop. Idea 
generation items that were similar were merged by the research team to avoid 





duplication, and a total list of all potential treatment targets generated was 
created at the end of this process. 
 
6.2.3.1.2 Within Workshop (Stages 3-5) 
Participants were able to participate virtually through the use of Skype 
(https://www.skype.com/en/)(Skype Communications) or in-person face-to-face. 
All participants brought a mobile device to engage with the online platform during 
the workshop. The results of the idea generation stage were visually displayed 
to all participants (using the online platform), so each participant had the 
opportunity to add any omitted items to the list (as an extension of the original 
idea generation stage), and to facilitate discussion of the items displayed. Due to 
the range of participants (people with experience of using exercise to manage 
back pain, clinicians and researchers) and the number of additional items added 
in the second stage, discussion of the individual potential treatment targets was 
delayed until after the voting and ranking had reduced the number of targets. 
Participants then privately voted (yes/no) for their ten most important treatment 
targets (stage 3) using the online platform. The potential treatment targets that 
obtained at least one vote were carried through to the next stage and were 
presented to the group via the online platform. No thresholds for consensus were 
used within this workshop as it was the first stage in an exploratory study, so any 
target that received a ‘yes’ vote was carried through to the next stage. Items were 
then individually ranked in order of importance through an online ranking process 
(stage 5), where participants allocated ten points to their most important 
treatment target, descending to one point for the least important. The results of 





this ranking process were discussed within the workshop (stage 4): treatment 
targets were discarded, grouped and amended as required through discussion 
and verbal agreement from the workshop participants. A further ranking stage 
was undertaken online two weeks after the workshop due to the extensive 
discussion and clarification stage.  
 
6.2.3.2 International Workshop: 
6.2.3.2.1 Pre-workshop (Stage 1 and 2) 
Two weeks before the workshop, registered attendees provided informed 
consent (see Appendix 9.l: Additional Information Regarding Consensus 
Workshops) and brief demographic information. They were also supplied with a 
list of the final ranked treatment targets from the national workshop and asked to 
add any other potential treatment targets that were absent using an online form 
developed with Google sheets.  
 
6.2.3.2.2 Within Workshop (Stages 3-5) 
The results of the idea generation were presented to the workshop participants 
visually, allowing the opportunity for potential treatment targets of similar 
constructs to be clarified and grouped, discarded or amended as agreed by the 
group. Voting (stage 3) occurred individually on a document developed on 
Google Sheets (see Appendix 9.l: Additional Information Regarding Consensus 
Workshops), and participants were able to vote for any number of items they felt 
to be potential treatment targets (yes/no). In the voting stage, a pre-specified 
consensus threshold of 75% was set for item removal, where 75% or more of 





participants agreed that the item was not a treatment target of exercise (201). 
These treatment targets were excluded from future voting and ranking rounds. 
Remaining targets were carried through to the next stage of further discussion 
and clarification (stage 4), followed by participants individually ranking the 
treatment targets in order of importance (stage 5). Ranking occurred in order of 
importance from one to ten, with results amended to reflect the same scaling as 
in the national workshop (i.e. the highest score was given to the one they felt was 
the most important). This ranking order was felt to be easier to implement at the 
international conference. The results were then presented to the participants of 
the workshop, who agreed with the order of importance of treatment targets, and 
declined the opportunity to re-rank treatment targets. These were then grouped 
into functional (relating to physical function), psychosocial (including 
psychological and social), behavioural (for example health service use) and 
impairment-based (such as strength or flexibility) targets (49) by the PhD 
candidate and supervisory team based on the nature of the treatment target.  
 
6.2.4 Logic Model of Results 
A logic model has previously been developed earlier in this thesis (chapter 3, 
section 3.2.7) to display the results of the systematic review, wherein the visual 
representation allows multiple relationships to be visualised, and the components 
of complex interventions to be more clearly described (114). The previously 
developed logic model reads from left to right and includes the setting of exercise 
delivery, the exercise deliverer, the treatment targets, the exercise specific 
components and the outcomes used in RCTs of exercise in persistent NSLBP. 





The results of the consensus workshops summarised in this chapter of the thesis 




A total of 15 participants took part in the UK national workshop (7 in-person face-
to-face, 8 virtually using the GroupMap platform) the range of participants was 
12 to 15 due to technical difficulties encountered by three participants which led 
to connection problems for part of the workshop. These three participants in the 
national workshop were unable to participate either due to connection issues or 
diary clashes. Twenty-four participants took part in the international workshop 
(with a range of 20 to 24 at different stages of the workshop). The range in 
number of participants in the international workshop resulted from participants 
moving in and out of the workshop due to the nature of a conference environment. 
Please see Table 6-2 for the baseline demographic information regarding 
participants. Across the two workshops, participants were from ten different 
countries (UK (n=15), Canada (n=6), Brazil (n=4), Finland (n=3), Norway (n=3), 
Australia (n=2), USA, Denmark, Sweden, Netherlands (all n=1)). 90% of 
participants had experienced back pain at some point in their lives.  
  





Table 6-2: Demographic information of workshop participants 
 National (%) International (%) 
Total Participants (n) 15 (range 12-15) 21 (range 20-24)* 
Gender (Female n, %) 13 (87) 13 (62) 
Participation Type:   
In person, face-to-face (n (%)) 7 (47) 21 (20-24) 
Virtual, via the GroupMap platform (n(%)) 8 (53) 0 
Profession:   
People who use exercise (n (%)) 2 (13) 0 
Researchers (n (%)) 5 (33) ** 21 (100) 
Clinical Researchers (n (%)) 2 (13)  
Clinician (n (%)) 6 (40) 19 (90) 
Type:   
Physiotherapist (n (%)) 8 (100) 12 (57) 
Chiropractor (n (%)) 0 2 (10) 
Medical Doctor (n (%)) 0 4 (19) 
Other Clinical (n (%)) 0 1 (5) 
Number of exercise interventions 
developed 
(Of 6)  
<1 3 10 (48) 
2-5 3 9 (43) 
>5 0 2 (10) 
People with lived experience of LBP 14 (93) 18 (86) 
Different countries  2  10  
*Range is represented due to the different number of participants across the stages. The 
percentage shown is of the total participants per workshop. 
**All seven of the researchers involved in the national workshop had a clinical background or 
worked as clinical researchers.  
 
6.3.1.1 National Workshop Participants 
A total of six clinicians (40%), two people with a lived experience of LBP (13%), 
and seven researchers (47%) took part. Of these, two clinicians and one 
researcher were unable to join the workshop due to connection issues or last-
minute diary clashes but they proceeded to complete the final ranking stage. Two 
people (who were neither researchers nor clinicians) who used exercise for their 
back pain took part, they had an average of 7 years (range 3.5 to 10+ years) of 
back pain experience to date, and both described their course of persistent 
NSLBP as ‘recurrent episodic’. Both of these people participated face-to-face in 
person in the workshop. 





Six clinicians took part from a variety of locations across the UK. The average 
time they had been qualified was 18 (range 4 to 40+) years, with an average of 
17 (range 4 to 40+) years involved in the treatment of patients with LBP. Four of 
the clinicians had not completed any formal post-graduate (PG) training course, 
two had MSc degrees, three had PG diplomas. All clinicians apart from one had 
experienced back pain at some point in their lives. 
 
Five researchers and two clinician-researchers participated in the workshop from 
a variety of locations in the UK (n=14) and Canada (n=1). As seen in the methods 
(section 6.2.2, Table 6-1), researchers were invited from across the world, 
however only one international participant accepted. The majority had a 
physiotherapy background (five), with one chiropractor, and one traditional 
Chinese acupuncturist. The average amount of time involved in research was 12 
(range 2-20+) years, and most had been involved with the development of two 
exercise interventions that had been tested within RCTs (range 012 to 4). Of the 
seven researchers involved, all had experienced back pain at some point in their 
lives.   
 
6.3.1.2 International Workshop Participants  
A total of 21 participants signed consent forms and completed the pre-workshop 
idea generation. During the session, three further participants participated in the 
                                            
12 Although researchers known to have developed exercise interventions were 
invited to participate, through invitations to research centres involved in 
exercise trials, and the systematic review authors, not all researcher 
participants had directly developed an exercise intervention.  





voting stage, but only 20 respondents completed the final ranking stage due to 
movement in and out of the workshop during the workshop session. Almost all 
participants were researchers with a clinical background, who may or may not be 
clinicians as well as researchers at present (90.5%). The participants were from 
ten different countries, with the majority from Canada (22.7%) and Brazil (18.2%).  
 
6.3.2 National Workshop Results 
6.3.2.1 Idea Generation (Stage 1-2) 
Fifteen participants completed the pre-meeting idea generation for the workshop. 
A further 25 different treatment targets were added to the original list of 30 
targets, creating a total list of 55 treatment targets (please see Appendix 9.l: 
Additional Information Regarding Consensus Workshops for the full list).  
 
6.3.2.2 Voting of Treatment Targets (Stages 3) 
Discussion and clarification of the potential treatment targets were delayed until 
after the ranking stage (stage 5). Twelve participants voted for their ten most 
important potential treatment targets. At least half of the participants voted for 
‘reducing pain’ (66.7%), ‘reducing fear of movement’ (50%) and ‘increasing 
functional capacity’ (50%). In total, 43 (of 55, 78%) potential targets received ’yes’ 
votes and were carried through to the next stage, as seen in Table 6-3. Items 
that received no votes and were discarded at this stage included: ‘reduce stress’, 
‘improve proprioception’, ‘improve recovery’, ‘improve balance’, ‘reduce muscle 
tension’, ‘aid relaxation’, ‘restore neural mobility’, ‘reduce catastrophising’, 





‘optimise neural function’, ‘improve posture’, ‘improve spinal stability’, and 
‘improved control’. 
  





Table 6-3: Treatment targets, number and percentage of votes (yes) after voting 
stage  




Reduce pain 8 66.67% 
Reduce fear of movement 6 50% 
Improve functional capacity 6 50% 
Increase function 5 41.67% 
Muscle strengthening 5 41.67% 
Increase physical activity and or exercise capacity 4 33.33% 
Decrease barriers to movement 4 33.33% 
Increase range of movement  - spinal and other joints 4 33.33% 
Enhance self-management skills 4 33.33% 
Improve general health and well-being 4 33.33% 
Reduce back pain 4 33.33% 
Reduce other health services use (other treatments/ 
medication/ testing) 
3 25% 
Limit time to return to work (full, partial duties ) 3 25% 
Reduce anxiety and depression 3 25% 
Improve mobility of the spine 3 25% 
Prevent recurrence 3 25% 
Improve fitness 3 25% 
Improve strength 3 25% 
Improve psychosocial factors 3 25% 
Improve coping ability 3 25% 
Improve self-efficacy 3 25% 
Improve physical capability 3 25% 
Decrease threat 2 16.67% 
A tool to teach pacing and graduated increase in activity/ 
exercise 
2 16.67% 
Improve physical activity levels 2 16.67% 
Reduce kinesiophobia 2 16.67% 
Reduce absence from work 2 16.67% 
Encourage normal movement 2 16.67% 
Improve mobility 2 16.67% 
Reduce disability 2 16.67% 
Improve self-confidence 2 16.67% 
Muscle flexibility 2 16.67% 
Ensure mobility into the future 1 8.33% 
Increase exercise compliance 1 8.33% 
Improve work capacity 1 8.33% 
Stretch the connective tissue 1 8.33% 
Reduce the need for surgery 1 8.33% 
Improve motor control 1 8.33% 
Reduce dependence on health service 1 8.33% 
Improve mental positivity 1 8.33% 
Improve body awareness 1 8.33% 
Reduce deconditioning 1 8.33% 
Increase trunk muscle endurance 1 8.33% 
Maximum number of votes 12. 
 





6.3.2.3 Ranking and Discussion of Treatment Targets (Stage 4 and 5) 
Participants then ranked their most important treatment targets in order of 
descending priority using the online platform. As the grouping stage had not been 
performed adequately in stage 4, significant overlap and replication remained 
across the list of treatment targets (e.g. most important was ‘reduce pain’, the 
second most important was ‘reduce back pain’). Three constructs were removed: 
‘increase exercise compliance’, ‘improve body awareness’ and ‘improve 
psychosocial factors’. Discussion concluded that the use of ‘compliance of 
exercises’ to achieve a treatment target was important, but was not the goal of 
exercise in itself. ‘Improve psychosocial factors’ and ‘improve body awareness’ 
was felt to be too broad and not specific enough regarding the targets of exercise. 
Participants highlighted that they felt it important to have an equal number of 
physical and psychological targets in the top ten, and that these should include 
targets encompassing social function including work, and reducing reliance on 
other interventions. Therefore, further grouping of this list of treatment targets 
was undertaken. A reduced list of 18 unique treatment targets was developed 
from the original 43, (see Appendix 9.l: Additional Information Regarding 
Consensus Workshops for more detail). Examples of merged targets include the 
following: ‘reduce fear of movement’ was grouped with ‘decrease barriers to 
movement’, ‘decrease threat’, and ‘reduce kinesiophobia’ so that all of these 
targets were grouped together and called ‘reduce fear of movement’. Re-ranking 
of the 18 potential treatment targets was then performed online two weeks after 
the workshop with all participants who initially consented to participation (n=15), 
with each participant identifying their top 10 most important targets, by allocating 





a score of 10 to the most important target and 9 to the next important and so on. 
The final ranking results are summarised in Table 6-4.  
Table 6-4: Final ranked position of treatment targets from the national workshop 
Rank 
Position 





target in their 
top 10  
% of 
participants 
with target in 
their top 3 
1 Reduce pain 120 14 66.67 
2 Increase function 109 15 60 
3 Reduce fear of movement 100 15 46.67 
4 Encourage normal movement 74 11 26.67 
5 Improve mobility 60 9 26.67 
6 Improve self-efficacy  56 10 20 
7 Enhance self-management skills 54 10 13.33 
8 Prevent recurrence 45 9 13.33 
9 Improve general health and well-
being 
38 10 13.33 
10 Improve strength 29 6 0 
11 Increase exercise capacity 
Increase physical activity 
26 7 0.07 
12 26 7 0.07 
13 Improve work capacity 24 5 0 
14 Reduce anxiety and depression 22 5 0 
15 Improve motor control 17 4 0 
16 A tool to teach pacing and 
graduated increase in exercise/ 
activity 
16 3 0 
17 Increase trunk muscle endurance 11 3 0 
18 Reduce other health services use 2 1 0 
The total score could range from 0 to 150. The maximal number of top ten rankings was 15.  
 
Table 6-5 demonstrates ranking according to participant group. All three groups 
prioritised ‘reduce pain’ as their most important treatment target. The people who 
used exercise and the researcher group ranked ‘increase function’ in second 
place, while the clinician group ranked ‘reduce fear of movement’ over ‘increase 
function’. Interestingly, the constructs of ‘reduce anxiety and depression’, 
‘improve trunk muscle endurance’, ‘increase physical activity’ and ‘increase work 
capacity’ were not reflected in the overall top ten ranking list although they 
featured within grouped rankings.  









People who used 
Exercise (n=2) 




1 Reduce pain Reduce pain Reduce pain 
2 Increase function Reduce fear of movement Increase function 
3 Prevent recurrence Encourage normal 
movement  
Increase function 
Reduce fear of movement 
4 Reduce fear of 
movement  
 
Improve general health 
and well-being 
Improve self-efficacy 
5 Improve mobility Enhance self-
management skills 




Improve mobility  
7 Improve mobility Prevent recurrence  Encourage normal 
movement 
8 Improve work capacity  Improve self-efficacy  Increase physical activity  
Increase work capacity 9 Improve self-efficacy Improve strength  
10 Enhance self-
management skills 
Improve general health 
and wellbeing 
Improve trunk muscle 
endurance 
Constructs 4 and 5 in the patient group, 3 and 4 in the clinician group and in the researcher 
group constructs 8 and 9 were tied and therefore share the same place. Items in italics are not 
reflected in the overall top ten priorities but were prioritised within sub-groups. Shaded blocks 
were common to all three participant groups.  
 
6.3.3 International Workshop Results 
Idea Generation (Stage 1-2) 
Twenty-one participants completed the pre-meeting idea generation for this 
workshop and added a further 15 targets to the original list of 18 treatment targets 
(see Appendix 9.l: Additional Information Regarding Consensus Workshops). 
This provided a total of 33 potential treatment targets for discussion, voting and 
ranking at the international nominal group workshop. 
 
Voting and Discussion of Treatment Targets (Stages 3-4) 
A total of 24 participants voted (yes or no) for treatment targets from the list of 33 
potential treatment targets, within the international nominal group workshop. The 





potential treatment targets that received the most ‘yes’ votes were ‘reducing fear 
of movement’ (91.7%), ‘increasing function’ (87.5%), ‘improving self-efficacy’ 
(87.5%), ‘reducing anxiety and depression’ (87.5%) and ‘improving quality of life’ 
(87.5%) as seen in Figure 6-2. No potential treatment targets were removed at 
this stage. Potential treatment targets of similar constructs were identified, 
discussed and grouped if felt to be appropriate by the participants, and discarded 
or amended as agreed by consensus of the group. Seven potential treatment 
targets were therefore removed at this stage. 





Improve general health and well-being
Reduce anxiety and depression
A tool to teach pacing and graded activity
Reduce health services use
Improve education and/or knowledge
Change attitudes/ cognitions/ beliefs





Discussion centred on trying to group similar targets and clarify those that some 
participants felt were unclear. For example, some participants felt that physical 
exercise was a vehicle to elicit changes within patients and that communication 
was more important, with one participant saying “it is less about the physical 
training and more to do with the relationship…the non-specific effects…it is more 
about changing the patient’s ways of thinking…”. Some participants clarified the 
additional treatment targets they had suggested, an example was the treatment 
target of “performance” which a participant explained related to athletes who may 
have different targets from other (non-athlete) patient populations, but after 
discussion this was felt by participants to better fit with the target of ‘patient-
specific goals’. Some raised their concerns that targets may be misconstrued in 
languages other than English. “Improved body awareness” was discussed as 
some felt it might be beneficial to change the word to ‘normalise body awareness’ 
instead of ‘increase’ body awareness, whilst others felt the key issue of 
importance was more ‘mindful movement’. ‘Work capacity’ was suggested by 
some participants to fit best within the domain of “function”, but other participants 
felt that ‘work capacity’ should be kept separate. The meaning of some targets, 
such as “perceived disability” and how it might differ to the meaning of the term 
“disability” were discussed and resulted in removal of this target, given 
participants felt that if kept in the list, many other treatment targets could be 
reworded to add the prefix of ‘perceived’. Instead, this was felt to be adequately 
reflected in the target “cognitions, attitudes and beliefs”. In total, six potential 
targets were either removed completely or collapsed within other treatment 
targets as part of the same target. 





The temporality of treatment targets was discussed with the possibility of having 
proximal and distant treatment targets, for example, mediators of exercise 
interventions and outcomes from exercise, but this was felt to be difficult as there 
was not enough evidence to know which treatment targets lie on the causal 
pathway (i.e. which are mediators of the outcomes of exercise). For example, 
‘fear-avoidance’ might mediate the pathway of persistent NSLBP to ‘improved 
physical function’ (202), so in this instance, ‘fear-avoidance’ may be the proximal 
treatment target, whilst ‘physical function’ might be the distant treatment target. 
Others suggested that some targets may be bidirectional, but there is not enough 
evidence to suggest which constructs were required to precede others, such as 
‘increasing physical function’ to ‘increase work capacity’, or ‘increasing work 
capacity’ to ‘increase physical function’. It was agreed that potential treatment 
effect modifiers should not be considered as treatment targets as these would be 
less likely to be open to alteration, in contrast to mediators which lie on the causal 
pathway. No treatment targets were removed or altered as a result of these 
discussion points.  From the above stage, a total of 27 treatment targets were 
taken forward for individual ranking in order of importance using a pre-generated 
Google Sheets document.  
 
Ranking of Treatment Targets (Stage 5): 
In total, 25 of the 27 treatment targets received were ranked in order of 
importance13. A total of twenty participants ranked their top ten treatment targets 
by allocating the score of 1 to their most important treatment target and 2 to the 
                                            
13 2 treatment targets received no ranking votes 





next most important target and so on, the summary is displayed in Table 6-6. A 
shuffle function was used on the google sheets so that each participant viewed 
the list of 27 treatment targets in a different order. The top six most important 
treatment targets were ‘increasing functional ability’, ‘improving quality of life’, 
‘reducing pain’, ‘patient-specific targets’, ‘reducing fear of movement’ and 
‘increasing physical activity’. More psychological constructs (n=4) were prioritised 
than functional constructs (n=3) or impairment constructs (n=1) in the top ten. 
Participants declined the opportunity to perform a further ranking.  
  





Table 6-6: Final list of prioritised treatment targets from the international 
workshop 
International Workshop (n=20 participants) 
Rank  Treatment Target Total 
Score 
No. of participants 
that included this 
target in their top 10  
% of participants with 
target in their top 3 
1 Increase functional ability 110 14 50 
2 Improve quality of life 109 16 40 
3 Reduced pain 91 14 40 
4 Patient-specific targets/ 
goals 
82 13 30 
5 Reduce fear of movement 82 15 20 
6 Increase physical activity 81 12 5 
7 Improve self-efficacy 71 13 20 
8 Enhance self-
management skills 
66 12 5 
9 Improve work capacity 53 12 10 
10 Improve attitudes/ 
cognitions/ beliefs 
48 9 5 
11 Reduce catastrophising 44 9 5 
12 Prevent recurrence 42 9 10 




14 Reduce anxiety and 
depression 
25 5 0 
15 Reduce other health 
services use 
24 7 0 
16 Improve sleep 23 5 10 
17 Allow behavioural change 16 5 0 
18 Increase body awareness 15 3 0 
19 Improve strength 14 3 0 
20 Increase exercise 
capacity 
13 4 5 
21 Improve motor control 13 3 5 
22 Increase body image 8 1 5 
23 Improve spinal mobility 4 2 0 
24 Weight loss/ gain 3 1 0 
25 Increase trunk muscle 
endurance 
2 1 0 
26 Improve cognitive function 0 0 0 
27 Lower inflammation 0 0 0 
Treatment targets are broadly grouped into blue (functional), green (behavioural), orange 
(impairment-based), and pink (psychosocial) constructs. Total score ranged from 0 to 200 
(0=worst attainable score, 200= best attainable score); number of top ten rankings ranged from 
0-20 (0= least, 20=highest).  
 





6.3.4 Updated Logic Model  
The results of the final nominal group workshop were used to update the initial 
logic model created by the results of the systematic review (chapter 3, section 
3.3.9). This may provide an example model for future trials to use when 
considering the development and specification of their exercise interventions. 
As seen in Figure 6-3, it includes the top six most highly ranked treatment 
targets, which largely map onto the six primary outcome domains used most 
frequently by RCTs of exercise interventions in persistent NSLBP.  




 Figure 6-3: Updated logic model including prioritised treatment targets of exercise 





6.3.5 Summary of Results 
Two sequential nominal group workshops were held with a total of 39 participants 
from ten countries. In total, 40 treatment targets of exercise for persistent NSLBP 
were generated across both workshops. Eighteen treatment targets were brought 
forward from the first, national, workshop, and by the end of the second 
workshop, 27 treatment targets were ranked as most important. The top six most 
important treatment targets were ‘increasing functional ability’, ‘improving quality 
of life’, ‘reducing pain’, ‘patient-specific targets’, ‘reducing fear of movement’ and 
‘increasing physical activity’. An updated logic model incorporated the six most 
highly ranked treatment targets to present a visual, example, guide for future 
trials to consider when specifying their exercise intervention, including the 
treatment targets and outcomes. 
 
 Discussion  
This study is the first to attempt to develop a consensus about the treatment 
targets of exercise for NSLBP with key stakeholders. The two sequential nominal 
group workshops generated consensus from a group of people with lived 
experiences of NSLBP, clinicians and researchers involved in prescribing or 
developing exercise interventions in clinical practice and in RCTs of persistent 
NSLBP. Many and varied targets were identified, indicating the challenge to 
reach consensus on a small number of treatment targets. From an initial list of 
30 treatment targets informed by a systematic review (chapter 3), participants 
generated 40 treatment targets, and ranked a final list of 27 treatment targets. 
With 39 participants from ten countries, this consensus study found that 





‘increasing functional ability’, ‘improving quality of life’, ‘reducing pain’, ‘patient-
specific goals’, ‘reducing fear of movement’ and ‘increasing physical activity’ were 
the most important treatment targets of exercise interventions for patients with 
persistent NSLBP. Psychosocial constructs (40%) and functional constructs 
(30%) were prioritised in the top ten treatment targets.  
 
6.4.1 Prioritisation of Treatment Targets 
In terms of comparison between the results of this study and those from previous 
research, the top three prioritised treatment targets (‘improving function’, ‘quality 
of life’ and ‘pain reduction’) are similar to the treatment targets of exercise for 
persistent NSLBP suggested by Rainville et al. (49) (addressing functional 
impairments, reducing pain and back pain-related disability). Rainville et al. (49) 
suggested these treatment targets after performing a systematic review, whereas 
this study was the first to include stakeholders as well as a systematic review.  
However, in the systematic review earlier in this thesis (chapter 3), the most 
frequently reported treatment targets identified in RCTs of exercise interventions 
for persistent NSLBP were ‘reducing pain’, ‘muscle strengthening’, ‘improving 
spinal stabilisation’, ‘flexibility’ and ‘improving posture’. Of these, only ‘pain 
reduction’ is reflected as a treatment target of importance in this consensus 
study. ‘Improving strength’ was ranked at number 19 out of 25, ‘improving motor 
control’ (incorporating ‘spinal stabilisation’) was ranked at 21 out of 25, ‘improving 
spinal mobility’ (including ‘improving flexibility’) ranked at 23 out of 25, and 
‘improving body awareness’ (grouped with ‘improving posture’) ranked at 18 out 





of 25. This demonstrates a potential shift in contemporary understanding of how 
exercise may work to reduce NSLBP and improve function and quality of life. 
However, this may also be the result of the different approach to identifying the 
targets (one using a systematic review of published trials, compared to this 
approach of consensus from stakeholder groups). There may also be differences 
in the prioritised treatment targets due to the role of the different stakeholder 
groups. However, in the first workshop, both ‘reducing pain’ and ‘increasing 
function’ were prioritised by all three stakeholder groups in first and second 
position of importance, suggesting that these have similar importance 
irrespective of stakeholder group, where this group included a large amount of 
research active clinicians. 
 
‘Reducing pain’, ‘improving function’ and ‘quality of life’ are well-established as 
important core outcome domains and are the most commonly reported primary 
outcomes in RCTs of persistent NSLBP (68,70). When comparing these results, 
it can be seen that these are the same variables – providing evidence that the 
most important treatment targets of exercise may be those prioritised by the core 
outcome domains. However, these are the core outcome domains for any trial of 
any intervention, not necessarily exercise-specific. Perhaps the dominance of the 
research active clinicians in this consensus exercise who were more likely to be 
aware of the core domains recommendation were influenced by this knowledge 
in their decision-making. Further, the discussion element of the nominal group 
workshop may have meant that those who were not researchers/ clinicians may 
have been influenced by the discussion element. This suggests that the uptake 





and acceptance of the core outcome domains by both clinicians and researchers 
has been widespread, and remain a high priority for people with NSLBP, but their 
role as treatment targets (or mediators) of exercise interventions remains 
unclear. 
 
Although psychological treatment targets were not prioritised in the top three 
targets, a higher proportion of psychological treatment targets was ranked in the 
final workshop (40%) than in the first, national workshop (30%) or from the 
systematic review (10%) (see 3.3.5.1 in Chapter 3). The psychological constructs 
of ‘reducing fear of movement’, ‘improving self-efficacy’ and ‘reducing anxiety and 
depression’ received ‘yes’ votes from many participants in the second, 
international workshop. However, ‘reducing anxiety and depression’ was not 
ranked in the top ten priorities, despite the evidence for exercise in treating 
depressive symptoms (203). These psychological targets may feature more 
strongly in the international nominal group workshop due to the increased 
participation of clinical researchers, who may be more familiar with the literature 
on mediators of the outcomes from exercise in NSLBP. The psychological 
benefits of exercise are well-documented (36,145), so the prioritisation of 
psychological targets over other physical performance targets is perhaps not 
surprising. As the aetiology of persistent NSLBP is increasingly understood to 
comprise psychological, mechanical and social components (147), the emphasis 
placed on the psychological targets of exercise for persistent NSLBP seems to 
make sense. However, they were not prioritised as the most important targets for 
exercise, suggesting that these ‘core outcomes’ are still seen as the most 





important to focus on. Both reducing fear of movement and self-efficacy have 
been shown to partially mediate the relationship between pain and disability in 
persistent NSLBP (204,205). Recent research on the mechanisms of exercise for 
persistent musculoskeletal pain suggests reducing fear of movement, improving 
self-efficacy, enhancing self-management strategies, and improving belief, 
cognitions and attitudes (all in the top ten treatment targets in the final workshop) 
may explain how exercises benefit patients (206). Perhaps surprisingly, although 
reducing pain catastrophising has been shown to mediate physical function with 
exercise in NSLBP (150), this was ranked in eleventh place. Increasingly, 
mediation analyses on these and other psychological constructs are being 
conducted as part of RCTs (45,148,152,207,208) to better establish whether 
these treatment targets lie on the causal pathway between the exercise treatment 
and the outcomes most important to patients (most commonly pain and disability) 
(209). 
 
Including the three different stakeholder groups of developers, prescribers and 
users of exercise, in the first national nominal group workshop, was important to 
ensure all perspectives of exercise for persistent NSLBP were considered. All 
three of these groups prioritised similar treatment targets in their top four: 
‘reducing pain’ was unanimously the most important treatment target, followed 
by ‘increasing function’ (second in people who used exercise and researcher 
groups), and ‘reducing fear of movement’ (second in clinician group, third in 
researcher group and fourth in people who used exercise group). These three 
targets were all prioritised within the second, international workshop within the 





top five (‘pain reduction’ ranked third, ‘increase in function’ ranked first, and 
‘reduction of fear of movement’ ranked fifth). People who used exercise placed 
importance in the first nominal group workshop on preventing the ‘recurrence of 
back pain’ and ‘reducing anxiety and depression’, which were not similarly ranked 
by other stakeholder groups. This suggests that there may still be a discord 
between the treatment targets of exercise prioritised by people who use exercise 
that were not captured within this final, international workshop. However, these 
two nominal group workshops consisted of participants from various stakeholder 
groups, which has been shown to improve the diversity of idea generation and 
richness of discussion (193).   
 
In the final workshop ranking, no great consensus in the prioritised targets was 
achieved. Traditionally, many consensus workshops do not use consensus 
thresholds (197,198,210,211) as the overall ranking result is an amalgamation of 
the aggregate consensus. In contrast, some studies have used a threshold of 
50% during the voting stage (meaning that each construct would require at least 
50% of participants to vote yes), in order for a construct to be carried forward to 
the ranking round (212). If this approach had been used in the national workshop, 
very few treatment targets would have been brought forward to the ranking stage, 
as only three treatment targets had more than 50% ‘yes’ votes (‘reducing pain’ 
(66.7%), ‘increasing physical function’ (50%), and ‘reducing fear of movement’ 
(50%)). However, in the international workshop, many more treatment targets 
had more than 50% ‘yes’ votes, with 28 of 33 (85%) possible treatment targets 
gaining 50% or more, suggesting greater consensus amongst that group. This 





difference may also reflect the difference in methods between the two workshops 
– in the first, national, workshop, participants were asked to vote for ten targets 
they felt were important, whereas in the second, international, workshop, 
participants could vote for as many targets as they felt were important. A 
consensus threshold of 75% (agreeing that the treatment target was not a priority 
in exercise for NSLBP) was used in the international workshop, however, no 
treatment targets met this threshold, and all were carried through to the ranking 
stage. This could perhaps have been a function of the sequential nature of the 
two workshops (given that several targets had already been removed, through 
consensus, in the first workshop). Reviewing the final ranked targets in the 
international workshop, only ‘increasing function’ was included in 50% of 
participants’ top three constructs, and ‘reducing fear of movement’ and ‘improving 
quality of life’ were included in the most individual top ten priorities (ranked by 15 
and 16 out of 20 respectively). This suggests that the overall consensus 
developed about the importance of the treatment targets was not very high. This 
may have happened given the general use of the term ‘exercise intervention’: 
participants may have found it challenging to reach agreement on the treatment 
targets for exercise in its broadest sense, as opposed to very specific exercise 
interventions, however this was not reflected in the discussion comments. Had a 
specific exercise type been selected as the focus, it may have been easier to 
reach agreement across the group. This would have then required the input of 
stakeholders who had developed, prescribed and used that specific type of 
exercise for NSLBP, an approach that may be useful for future research.  
 





Other consensus studies have reviewed the individual votes per treatment target 
in the final ranking stage, by assigning median scores to the overall rank to 
suggest appropriateness (or importance in this instance) to assess whether 
consensus was present on the importance of the target (213,214). Applying this 
method in the current study may have altered the overall ranked positions. The 
method selected was the recommended method for use in nominal group 
workshop technique, and represents an overall consensus of the group (198) 
which has been shown to have validity (215). 
 
6.4.2 Strengths and Limitations of this Study 
This consensus study is the first to develop consensus about the treatment 
targets for exercise interventions in persistent NSLBP with a variety of key 
stakeholders involved in the use of, development, evaluation and prescription of 
exercise interventions. A further strength is the sequential approach taken from 
the systematic review into the two sequential workshops, which ensured 
refinement of the potential treatment targets. Consensus was generated with a 
large number of stakeholders (n=39), including people with lived experience of 
using exercise to manage persistent NSLBP, clinicians prescribing exercise for 
persistent NSLBP, and researchers who design and evaluate exercise 
interventions in RCTs from a number of countries. A limitation of the research 
conference used for the international workshop meant that the clinicians involved 
were largely research active clinicians, which may not therefore reflect the views 
of the many clinicians who manage patients with NSLBP who are not interested 
in nor active in research. This may also explain why the eventual consensus 





reached on the top six targets includes the three recommended core outcome 
domains for research trials in the field of LBP, irrespective of the treatment being 
investigated.  
 
A limitation of this consensus study was that it included only two people, who 
were not researchers nor clinicians, with lived experience of persistent NSLBP 
due to lack of response from invitations to patients and the public. This led to 
imbalance of the views represented by people who had a lived experience of 
persistent NSLBP in the first workshop (2 compared to 7 researchers and 6 
clinicians). However, most of the researchers and clinicians who took part had 
personal experience of back pain. Although this participant group included 
clinicians and researchers from ten different countries, most participants were 
from the discipline of physiotherapy and from higher-income countries with well-
established health-care systems (there were only four medical doctors included 
for example) and none from low and middle-income countries. During the 
international workshop, some participants left or arrived between each stage of 
the nominal group workshop, resulting in different numbers of participants 
completing the idea generation, voting and ranking stages. Due to the lack of 
identifiable data collected, it was not possible to trace which individuals 
completed each stage. Like all consensus studies, the results may have been 
different had different stakeholders been invited and participated.   
 
Although participants in the online environment may feel less inhibited, it has 
been recorded as being 40% less efficient than the traditional method (216). In 





this study, we had three participants drop out due to technology issues in the first 
workshop which may have had an impact on the overall voting and ranking 
stages as these participants were absent from the discussion and voting 
sections. However, due to the final ranking stage completed electronically after 
the workshop, all participants were able to complete this, which negates the 
impact the technological issues raised. The time to train and teach some of the 
participants in how to use GroupMap during the first workshop may have 
hindered the timekeeping, which resulted in an inability to group items during the 
workshop itself. Sending out pre-workshop training on the use of the platform 
may help to prevent problems such as this in the future (216). 
 
6.4.3 Implications for Future Research and Clinical Practice 
This consensus study has identified the most important treatment targets for 
exercise interventions in persistent NSLBP, with priorities including ‘improving 
function’ and ‘quality of life’, ‘reducing pain’, ‘targeting patient-specific goals’, 
‘reducing fear of movement’ and ‘increasing physical activity’. Overall, 25 targets 
were ranked and prioritised, with consensus about the most important overall (top 
five targets), which may be useful for considering within future research data 
collection and mediation analysis within trials, helping to further understand how 
exercise works for patients with NSLBP. These agreed treatment targets may 
guide the design of RCTs of exercise interventions for persistent NSLBP by 
helping to target exercise interventions to achievable, measurable outcomes that 
match the aim(s) of the intervention. Future trial design may benefit from the use 
of intervention logic models to map out the role of treatment targets and select 





the most appropriate outcome domains and measures for complex interventions, 
such as exercise, with multiple intervention targets (13,17). The identified 
treatment targets may, therefore, help in the identification of potential mediators 
of exercise that should be measured in future studies and used in pre-specified 
mediation analysis within RCTs.  
 
Consensus work can be limited by the involvement of stakeholders in each 
workshop, although the aim of the consensus workshops is not to be 
generalizable. Given the change in priorities of the treatment targets identified in 
the two workshops, future workshops would benefit from greater involvement 
from people with a lived experience of persistent NSLBP. Further consensus 
work with different stakeholders comprising similar groups to those included in 
this study (i.e. researchers who develop interventions, clinicians who prescribe 
and people who use exercise for NSLBP) from different backgrounds such as 
low- to middle- income countries may add to the robustness of the results. 
Similarly, a repeat of this consensus study in a different format such as the Delphi 
method may provide different results to these presented here, as the discussion 
element and influence from other members in the group will be removed, which 
may have possibly influenced the final voting and ranking stages of this study.  
Further, a focussed consensus workshop on a specific exercise type (e.g. such 
as yoga or pilates) including various stakeholders to agree the specific treatment 
targets may be useful in designing trials to address these agreed, prioritised 
targets. 
 





The logic model incorporating the six top ranked treatment targets which map 
onto the six primary outcome domains used by RCTs of exercise for persistent 
NSLBP has purposefully been developed to include multiple potential pathways, 
which can then be refined or amended for use in trials in the future. This is 
expected to vary, dependent on the exercise intervention to be tested, as well as 
the treatment targets identified by the trial team, and may in turn affect the 
specific exercise components as well as setting and deliverer considerations.   
 
These targets may be addressed individually when identified at assessment or 
alongside multiple treatment targets when prescribing, designing, and/or 
evaluating exercise interventions for persistent NSLBP. By having a greater 
understanding of the comparable importance of these treatment targets, as 
viewed by a group of different stakeholders, clinicians may be encouraged to 
target their exercise intervention to ensure they select the most appropriate 
exercises to get the most benefit for their patients. However, there is still little 
known about the underlying mechanisms of exercise to affect pain and physical 
function, but as a clinician, there is a growing likelihood that targeting the 
treatment targets identified in these workshops may be of improved benefit to 
patients. As clinicians, by assessing patients for potential treatment targets such 
as strength deficits, fear-avoidance, self-efficacy, etc., they can identify priorities 
for their exercise treatment to target, and thereby select the most appropriate 
exercise. This can be performed within the framework of shared-decision making, 
to allow the selection of the most appropriate treatment targets for each patient.  





Further, the advances of technology allowing objective outcome measurement in 
the forms of physical activity tracking, step counts, heart rate levels for example, 
provide many more cost-effective options for future triallists to consider when 
designing trials with matched outcomes. Given physical activity was ranked at 
sixth in importance, it is a treatment target that is of importance and future trials 




This consensus study incorporating 39 key stakeholders from ten countries, 
involved in exercise use, prescription, delivery and evaluation, added 40 
treatment targets of exercise for persistent NSLBP, ranked 27 of those as the 
most important, of which the six most important were: ‘increasing function’, 
‘improving quality of life’, ‘reducing pain’, ‘targeting patient-specific goals’, 
‘reducing fear of movement’ and ‘increasing physical activity’ as the most 
important treatment targets of exercise interventions in persistent NSLBP. 
Researchers testing the effectiveness of exercise, should be aware that exercise 
has multiple treatment targets, be clearer about which specific treatment targets 
their exercise intervention is focussed on, and consider how they might use this 
information to optimise patients’ outcomes from exercise. Clinicians prescribing 
exercise for NSLBP may use exercise to target the top ranked treatment targets. 
Future studies that test the identified treatment targets (such as by using a logic 
model, as demonstrated within this chapter) that are designed to find out if these 
are indeed mediators of patients’ outcomes from a specific exercise programme 





– either as an individual treatment target or as part of multivariate mediation 
models – are required. 
 
Further research will be useful to repeat this work, possibly with a different 
method such as Delphi that may limit the discussion opportunity, with a broader 
range of clinicians and exercise prescribers, and people who use exercise with 
NSLBP, as well as in settings other than high income countries, and that is 
focussed on more specific exercise approaches or types. 




7 Chapter 7: Discussion, Summary and 
Conclusions  
Summary 
This chapter summarises and discusses the findings of this doctoral 
programme of research and makes recommendations for future 
research and clinical practice.   
 
 Introduction 
This discussion draws together all the stages of this programme of research, 
summarised in the previous chapters of this thesis. The overall aim of the 
research was to explore whether better matching of the outcome domains used 
in RCTs in the field of persistent NSLBP to the treatment targets of the exercise 
interventions might change the results and conclusions of these trials. Having 
identified the gaps in knowledge to date (chapter 1), this thesis aimed to 
understand whether existing RCTs of exercise interventions in persistent NSLBP 
matched their primary outcome domains to the identified (if any) treatment targets 
of the exercise intervention by systematically reviewing the available literature 
(chapter 3). Within this review, RCTs were identified where secondary analyses 
could be undertaken to understand whether matching of primary outcome 
domains to exercise treatment targets might alter the observed between-
treatment arm differences and, therefore, the conclusions of these RCTs (chapter 
4). In chapter 5, composite outcomes composed of multiple matched outcome 
domains were compared to single primary outcome domains to evaluate whether 




these altered observed between-treatment-arm differences and RCT 
conclusions. Finally, this thesis aimed to generate consensus about, and 
prioritise treatment targets of exercise interventions for persistent NSLBP through 
the use of nominal group workshops (chapter 6). The key findings of this thesis 
are summarised below and set in the context of the most recent relevant 
research, particularly more recent RCTs of exercise for persistent NSLBP. The 
chapter concludes with key implications and recommendations for both research 
and clinical practice.  
 
 Summary of Thesis Findings  
7.2.1 Systematic Review 
Existing guidance for the design of RCTs recommends using a primary outcome 
measure that is appropriate, given the key variable that the intervention is trying 
to change (83). In the field of NSLBP there is a paucity of literature that describes 
or defines treatment targets for exercise interventions. A systematic review was 
undertaken to identify what treatment targets and outcomes have been used by 
the authors of previous RCTs testing the effectiveness of exercise interventions 
for persistent NSLBP, where only trials with a minimum sample size of 60 
participants per arm were included. Within this, RCTs were categorised as 
‘matched’ if they had used a primary outcome which reflected the treatment 
targets identified by the RCT authors in their RCT publications. The results of 
these RCTs were then compared to the ‘unmatched’ group in which the primary 
outcome was not judged to be reflective of the treatment targets identified.  
 




A total of 27 RCTs were included in the systematic review, and only 27% of RCTs 
were categorised as ‘matched’, suggesting that most exercise RCT teams have 
previously not selected their primary outcome based on the way it matches the 
treatment targets of their exercise intervention. ‘Matched’ RCTs were more likely 
to show a statistically significant between-treatment arm difference in favour of 
exercise in comparison to a non-exercise control (71% of the ‘matched’ trials 
compared to 15% of the ‘unmatched’ trials). When comparing the SMD of 
‘matched’ to ‘unmatched’ RCTs, the ‘matched’ RCTs demonstrated a greater 
SMD (SMD 0.54 (95% CI 0.23 to 0.85) (p=0.0006)) than the ‘unmatched’ RCTs 
(SMD 0.22 (95% CI 0.01, 0.44), p=0.04), although this difference was not 
statistically significant. This finding was replicated in sensitivity analyses 
including ratio of means, weighted mean differences for pain and physical 
function; and sub-group analyses of comparator groups, recruitment strategies, 
risk of bias and specification of treatment targets. This exploratory review 
provided some initial support for the hypothesis that better matching of outcome 
domains to the treatment targets of exercise interventions in RCTs with patients 
who have persistent NSLBP may be more likely to lead to statistically and 
clinically significant results, in favour of exercise compared to non-exercise 
controls. 
 
This systematic review also identified that most RCTs used similar primary 
outcomes, favouring physical function and pain domains (used in 56 and 52% of 
included RCTs respectively). A wide variety of secondary outcome measures 
was used, with an average count of five outcomes per RCT. Thirty-one different 
treatment targets were identified across the set of 27 RCTs of exercise in 




persistent NSLBP, the majority of which were only cited by one RCT. Only 66.7% 
specified their treatment targets, of which 22.2% inferred treatment targets 
indirectly in the introduction or methods sections of their RCT publications. 
Despite this review using more stringent inclusion criteria of larger sample sizes, 
the findings are similar to a recent review of 403 exercise arms included in 265 
RCTs, in the recent update of the Cochrane exercise trials for LBP. This review 
found that only 59% of RCTs specified treatment targets, of which 23% were 
inferred (67). The most frequently cited treatment targets of exercise were 
improving muscle strength, spinal stabilisation, reducing pain, improving flexibility 
and improving posture; again, similar to that found in the recent Cochrane review 
(67). 
 
A logic model was constructed based on the results of the treatment targets and 
outcomes used in the set of included RCTs. However, due to the high level of 
heterogeneity in the treatment targets and outcomes used by RCTs for NSLBP 
and the combination of treatment targets and outcomes used within each trial, it 
was not possible to identify any clear relationships between and across RCTs in 
the outcomes and most frequent treatment targets used. All of these results, from 
the systematic review, highlight clear uncertainty regarding the treatment targets 
of exercise for NSLBP, with RCTs testing similar exercise interventions 
identifying different treatment targets and using different outcomes, and providing 
different rationales for their choices. Exercise is a good example of a complex 
intervention, and RCT teams might benefit from using logic models to map out 
and articulate more clearly their intervention rationale, intervention targets and 




proposed mechanisms of action, intervention components, and relationship 
between the treatment targets of the intervention and outcomes.  
 
This review highlighted the poor matching of the primary outcome to the identified 
treatment targets of the exercise intervention in previous RCTs for persistent 
NSLBP. RCTs that matched the primary outcome to the treatment targets of their 
exercise interventions were more likely to demonstrate a statistically significant 
between-treatment arm result in favour of exercise and to report larger SMDs 
than those that did not match their primary outcome. Therefore, matching this 
could be an important consideration for future RCT teams to consider as they 
develop the plans for their exercise intervention and outcome selection. RCTs 
are the best design to compare the effectiveness of complex interventions such 
as exercise, as they reduce the potentially biasing effect of confounders through 
the randomisation process (55). As the Medical Research Council (52) describe, 
“a good understanding of how the intervention effects change is required to 
ensure any weak causal links can be identified and strengthened”.  
 
Given that the end date of the search within the systematic review described in 
chapter 2 was August 2019, a brief updated search was undertaken to inform 
this discussion on 1 June 2020. The findings showed that of 23 RCTs currently 
in progress, registered on USA and UK RCT registries and testing exercise 
interventions for persistent NSLBP, only ten (43%) specify their treatment 
target(s). Of these, only four (17%) use a primary outcome that reflects their 
treatment target(s) (please see Appendix 9.m:Summary of Protocols of 23 
Current RCTs). This suggests the systematic review results in chapter 3 




continue to reflect current RCT practice and therefore, the findings and 
implications continue to be relevant. 
 
7.2.2 Data Analysis 1: Matching Outcomes to the Treatment Targets 
This secondary data analysis sought to explore whether matching the primary 
outcome(s) to the identified treatment targets of exercise interventions changed 
the results and conclusions of existing RCTs of exercise for NSLBP. Five RCTs 
from those included in the systematic review were selected for inclusion in this 
secondary data analysis, of which, three RCT datasets were obtained (total of 
n=1033 participants). The other two RCTs were also analysed, but, using 
information from their published papers, comparing the SMD for the primary 
outcome(s) to the SMDs of the matched outcomes with data described within the 
two publications.  
 
Of the five different analyses, three sets of results showed that the use of 
matched outcomes in comparison to unmatched outcomes demonstrated greater 
between-arm SMDs (and three of the four showed statistically significant results 
in favour of the treatment arm but not between the outcomes), in favour of the 
exercise intervention in comparison to a non-exercise control arm. Secondary 
analysis of only one of the five RCTs showed a greater SMD in favour of exercise, 
versus control, when using an unmatched primary outcome. Using the first 
mentioned treatment target from each included RCT to generate a summary 
forest plot demonstrated a greater SMD using the matched outcomes (0.30 
(95%CI 0.04,0.56) (p=0.02)) compared to the unmatched primary outcomes 




(SMD 0.19 (95% CI -0.03, 0.40) (p=0.09)), although the difference between these 
sub-groups was not statistically significant (SMD 0.11 (95%CI -0.34, 0.57)).  
 
In complex interventions where there may be multiple treatment targets (14,15), 
identifying the primary treatment target and therefore the primary outcome can 
be challenging. Thus, it may be more appropriate to use a composite outcome 
consisting of all the outcomes that match all the specified treatment targets. As 
seen in this analysis, many RCT authors specified more than one treatment 
target of their exercise intervention, and these were captured by multiple 
outcomes. Thus, it was hypothesised that a composite outcome composed of 
these multiple matched outcomes might be more responsive than a single 
matched outcome, and more appropriate for a complex intervention such as 
exercise.  
 
7.2.3 Data Analysis 2: A Matched Composite in Comparison to a 
Single Outcome 
This further secondary analysis study aimed to evaluate whether a composite 
outcome consisting of multiple matched outcomes might change the results and 
conclusions of existing RCTs of exercise for NSLBP. Four RCT datasets were 
obtained that included multiple outcomes that matched the RCT authors’ 
specified treatment targets. A total of 864 participants were included in this 
analysis, with two RCTs having two ‘matched’ primary outcomes, and two RCTs 
included with ‘unmatched’ primary outcomes. The results of this analysis 
demonstrated that a matched composite outcome generated a greater SMD than 




a single unmatched primary outcome. Had the included RCTs used a matched 
composite outcome, this would have changed the results and conclusions of 
three of the four RCTs to be more in favour of exercise.  
 
In the sub-group analysis of matched composites compared to unmatched 
primary outcomes (n= 2 trials), a matched composite outcome produced larger 
SMDs than an unmatched primary outcome in favour of exercise in comparison 
to the control arm. However, in the matched primary outcome group (n=2 trials), 
when the composite outcome was compared to the single, first-mentioned, 
matched primary outcome, there was no change in the results. A co-primary 
composite was then created for these two RCTs, to compare the results of a 
more ‘targeted’ composite with a matched outcome and a matched composite. 
In both RCTs, a co-primary composite generated a larger SMD, in favour of 
exercise, than a matched composite of all matched treatment targets. In one of 
these two RCTs, the single primary outcome still generated larger SMDs than the 
co-primary composite (136), whereas in the other RCT the co-primary composite 
generated larger SMDs than the single matched primary outcome (137), in favour 
of exercise. 
 
A summary forest plot demonstrated that a single outcome generated a pooled 
SMD of 0.24 (95% CI -0.04, 0.53) (p=0.10)) in comparison to a composite 
matched outcome which generated a pooled SMD of 0.28 (95% CI 0.05, 0.51) 
(p=0.02)). The between-group difference was not statistically significant (SMD 
0.04 (95% CI –0.13, 0.20). This difference may be because three of the 
composite outcomes had statistically significant results in favour of the exercise 




arm, in contrast to only one of the single outcomes, although the standard error 
was smaller for each of the composite outcomes. Composite outcomes, or well-
matched co-primary outcomes, may be preferable to a single matched primary 
outcome as they are more likely to cover a wider range of treatment targets more 
reflective of the broader benefits from a complex intervention. The results provide 
initial support to suggest that a composite outcome matched to the exercise 
treatment targets may generate larger SMDs in favour of exercise in comparison 
to a non-exercise control.  
 
These secondary analyses suggested that not all treatment targets are equal, or 
potentially targeted to the same degree by the exercise interventions investigated 
in the sample of RCT datasets. Understanding the degree to which an exercise 
intervention changes these targets is still poorly described, and how this can be 
captured effectively within an intervention description and evaluation remains to 
be clarified. Although other research fields such as inflammatory arthritis 
(217,218) and cardiovascular disease (219,220) have been using composite 
outcomes for some time, it is not clear if these are always routinely related to the 
treatment targets of the interventions being tested. Furthermore, identifying 
outcomes to capture these treatment targets, that are both responsive and have 
increased domain coverage is currently difficult given that the underlying 
treatment targets are poorly described and understood. This led to the use of 
consensus workshops to try to agree and prioritise the most important treatment 
targets in RCTs of exercise interventions for persistent NSLBP.  
 




7.2.4 Consensus Workshops 
There is no previously published consensus on the potential treatment targets of 
exercise interventions for NSLBP. Despite a systematic review describing the 
use of physical activity for mental health problems (221), there is little to assist 
RCT developers and authors regarding the treatment targets of exercise 
interventions for persistent NSLBP apart from the poor correlations found 
between pain and disability with strength and flexibility targets (22,34,35). This 
discord is evident when one reviews the results of the systematic review 
performed in this thesis, in which most RCTs specified treatment targets of 
muscle strength (i.e. a stronger spine) (n=8) or spinal stabilisation exercises (i.e. 
more stable spine) (n=8) as their primary goal, despite poor evidence of 
relationships between with these targets and the common outcomes of pain and 
disability (22,34,35). This resulted in a clear need to try to develop consensus on 
what the most important treatment targets in exercise interventions were.  
 
Two sequential consensus workshops were held, incorporating stakeholders of 
researchers developing exercise interventions for testing in RCTs, users of 
exercise for NSLBP, and prescribers of exercise for NSLBP. A total of 39 
participants from 10 different countries participated in the workshops, and used 
both online and face-to-face methods to engage, identify, vote and rank the 
treatment targets for exercise for NSLBP. The very nature of the nominal group 
workshop results in a final ranked list of treatment targets. The first workshop 
was a national workshop with participants from across the UK and was informed 
by the results of the systematic review. The final prioritised treatment targets from 




this workshop were presented to the participants of the international workshop, 
before modifying, voting and ranking according to the outputs of their discussions 
and actions. The overall consensus prioritised ‘improving function’, ‘reducing 
pain’, ‘improving quality of life’, ‘improving patient-specific goals’, ‘reducing fear 
of movement’ and ‘increasing physical activity’ as the most important treatment 
targets in RCTs of exercise for persistent NSLBP. 
 
 Discussion Points 
This section discusses the overall contribution of the research within this thesis, 
to what extent the results might be considered expected or unanticipated, and 
how they compare with contemporary literature. This is followed by consideration 
of the strengths and limitations of the research, the implications for research and 
clinical practice, and the conclusions reached by this body of research.  
 
7.3.1 Overall Contribution of this Programme of Research 
The overall aim of the research was to explore whether better matching of the 
outcome domains used in RCTs to the treatment targets of the exercise 
interventions being investigated might change the results and conclusions of 
these trials in the field of persistent NSLBP. This exploratory programme of 
research found that RCTs that used an outcome that matched the specified 
treatment targets of their exercise intervention were more likely to have results 
demonstrating superiority of exercise in comparison to a non-exercise control. 
Composite outcomes, comprised of multiple outcomes matched to the multiple 
treatment targets, again were more likely to support the superiority of exercise in 




comparison to a single matched or unmatched outcome. These results suggest 
RCT authors should specify the treatment targets of their intervention, and 
consider more carefully matching their primary outcome to the(se) treatment 
target(s) most likely to be changed by their exercise intervention.  
 
The systematic review highlighted the wide variety in treatment targets used in 
RCTs of exercise for persistent NSLBP (n=31). The consensus workshops, 
including multiple stakeholder groups from different countries, found overall 
agreement in the prioritisation of ‘improving function’, ‘reducing pain’, ‘improving 
quality of life’, ‘targeting patient-specific goals’, ‘reducing fear of movement’ and 
‘increasing physical activity’. The logic model including these treatment targets 
provides a model for future trials to use when considering the development and 
specification of their exercise interventions. The prioritised targets from these 
workshop should be explored further in RCTs of exercise for NSLBP with a priori 
specified mediation (or multiple mediation) analyses, possibly by using a logic 
model to demonstrate the relationships between targets and outcomes.  
  
7.3.2 Expected Results Found in this Programme of Research 
7.3.2.1 Exercise has Multiple Treatment Targets 
It was unsurprising that most RCTs identified more than one treatment target 
(median of 3 targets per RCT in the systematic review), given the complexity of 
exercise as an intervention, and thus selecting the most ‘matched’ primary 
outcome measure can be challenging. Without clear programme theory to 
demonstrate the most plausible and important treatment targets, how the 




exercise intervention proposes to target them, and the most appropriate 
outcomes to capture these targets, it is difficult to move forwards as a field. 
Choosing the most important treatment target(s) is difficult, as with a complex 
intervention, such as exercise, the treatment targets may differ according to the 
population, the context and the phase of delivery of the intervention (52). Thus, 
this research prioritising the most important treatment targets may be crucial so 
that trial authors developing exercise interventions can consider these prioritised 
targets when tailoring the intervention to the most important targets that are 
population, context- and delivery-relevant in that RCT.  
 
A composite outcome matched to the multiple treatment targets of the 
intervention may be a good starting point. However, given the heterogeneity 
existing in the field of exercise interventions in persistent NSLBP, it is likely that 
there will be multiple composite outcomes selected and created for this purpose, 
as in the field of cardiovascular disease (185). This research suggests that the 
use of logic models and programme theory to inform the development of exercise 
intervention may provide a helpful framework to ensure appropriate, matched, 
and relevant outcomes are selected that are trial specific.  
 
7.3.2.2 Matching of Outcomes to Treatment Targets Results in Greater 
SMDs 
It was not surprising that RCTs which used an outcome matched to their specified 
treatment targets of their intervention generated larger SMDs, and were more 
likely to demonstrate statistical significance in favour of the exercise arm, in 
comparison to the control arm. RCTs should be designed with the most 




appropriate outcome(s) selected as a primary outcome to capture the change the 
intervention is designed to deliver. “The ultimate value of a RCT …will be directly 
tied to how well the selected outcome measure matches the researcher’s 
understanding of what he or she expects to change, to what degree it is expected 
to change, over what period of time this change will happen and how that change 
can best be identified” (83).  However, it was surprising to see how few RCT 
authors designed their RCTs in this manner (27%). 
 
7.3.2.3 Multiple Outcomes Are Frequently Used in RCTs 
Unsurprisingly, ten (37%) of the included RCTs in the systematic review 
nominated more than one primary outcome, suggesting that the use of composite 
outcomes may have a role in future RCTs of exercise interventions in persistent 
NSLBP. RCTs should use the most important outcomes as their primary outcome 
(15), with no clear guidance on how many are preferable. However, it does 
appear that selection of the outcome components is important to ensure that the 
most responsive outcomes are included, ideally by ensuring a good match 
between the selected outcomes and the identified treatment targets of the 
intervention. In musculoskeletal medicine, responder indices have been 
developed for LBP (91,222) incorporating a benchmark on pain scores (the VAS) 
and physical function scores (RMDQ). Both these outcomes were most 
frequently reported in the systematic review findings (chapter 3) and consensus 
workshops, and given these are both core outcome domains, these two 
outcomes could be measured as a co-primary composite outcome. However, for 
the greatest between-arm difference to be demonstrated, these outcomes should 
be matched to the treatment targets of the exercise intervention. Considering 




which comes first (prioritised treatment targets or outcomes) is a challenge, as it 
appears in much of the work to date in psoriatic arthritis (223), rheumatoid arthritis 
(88), cardiovascular disease (224), and LBP (78) the prioritised outcomes have 
already been the subject of international consensus and recommendations. The 
outcomes chosen for use in RCTs should be both clinically relevant and pertinent 
to both patients and policy-makers (187). As the outcomes are already agreed 
as the most important outcomes, interventions should target these, but the 
question remains as to whether these outcomes are the most important 
outcomes for patients. Simon et al. (91) suggested the use of a responder index 
consisting of the core outcome domains for NSLBP based on a 30% 
improvement in pain, no reduction in function and 30% improvement of global 
effect. These are the same three targets prioritised by the consensus workshops, 
and suggest the use of a composite responder index may be an area for further 
research.  
 
7.3.3 Unanticipated Results Found in this Programme of Research 
7.3.3.1 Uncertainty of the Mechanisms Underlying Exercise for Treating 
Persistent NSLBP 
It was surprising that the most important treatment targets prioritised by the 
consensus workshops appeared to be those internationally recommended as 
core outcome domains for use within LBP trials (78). Core outcome domains are 
not intervention specific, and it might be that research active clinicians and clinical 
researchers (who formed the majority of the workshop participants) may be 
familiar with these published recommendations, without considering the 




temporality or underlying targets (in this case of exercise interventions) that may 
precede these outcomes. These treatment target priorities agree with previous 
suggestions identifying potential treatment targets of exercise (49). However, it 
also highlights the uncertainty associated with how exercise brings about a 
beneficial effect on pain and physical function. 
 
Surprisingly, despite evidence to the contrary (22,34,35), many clinicians and 
RCT authors appeared to select exercises for persistent NSLBP based on a 
biomedical model of LBP. As seen in Table 7-1, the treatment targets prioritised 
across the workshops differed, as did priorities of treatment targets when 
compared to the original list of cited treatment targets from the systematic 
review. Treatment targets such as ‘increased muscle strength’, were prioritised 
by the first, national, workshop, as well as the systematic review, and similarly 
documented by Stenner (225) in interviews with clinicians regarding the 
treatment targets underpinning exercise prescription. The number of physical 
performance targets (shaded grey in Table 7-1) reported in the systematic 
review reduces from six targets to one target in the final, international, 
workshop in the top ten targets. Whereas the number of psychological targets 
(shaded in green) increases from two to four targets in the international 
workshop in the top ten. This suggests a more temporal shift in clinician and 
researcher beliefs since our systematic review including RCTs over a wide time 
period (from 1993- 2018) with just over half the included RCTs dating from 
before 2010 (14/27).  
  




Table 7-1: Comparison of results of treatment target priorities 
Systematic Review National Workshop  International Workshop  
Reduce pain Reduce pain Increase function 
Spinal stabilisation Increase function Improve quality of life 
Improve muscle strength  Reduce fear of movement Reduce pain 
Improve mobility Encourage normal 
movement 
Meet patient-specific goals 
Improve posture Improve mobility Reduce fear of movement 
Improve self-confidence Improve self-efficacy Increase physical activity 
Increase function Enhance self-management 
skills 
Improve self-efficacy 
Increase physical activity Prevent recurrence Enhance self-management 
skills 
Increase muscle endurance Improve general health and 
well-being 
Improve work capacity 
Reduce stress Improve muscle strength Change cognitions/attitudes 
and beliefs 
The colours represent different constructs: green are psychological targets, orange are functional, 
grey are physical/ performance targets, pink is pain, light blue are general health-related quality 
of life targets, and white are work-related targets. 
 
It was unexpected that, over time, from the initial RCTs included in the systematic 
review to the two nominal group workshops, the priority treatment targets of 
researchers, clinicians and users of exercise for persistent NSLBP appear to 
have changed. The most frequently cited treatment target in the ‘matched’ RCTs 
was ‘pain reduction’ (71.4% of RCTs), followed by ‘self-confidence’ (42.9% of 
RCTs) and ‘physical function’ (42.9% of RCTs) as seen in Table 7-2. In 
comparison to the frequency of treatment targets reported by the systematic 
review (in Table 7-1), more psychological targets were specified by the ‘matched’ 
trials (5 in the ‘matched’ trials, 2 in all RCTs most frequently cited ten). Three of 
the ‘matched’ RCTs were published in 2018, whereas the other four were 
published prior to 2014 (2000-2014). This may demonstrate a temporal shift in 
understanding the effects and possible mechanisms of the effect of exercise, with 
some of the ‘matched’ RCT authors considering alternative mechanisms and 
treatment targets for the exercise intervention being tested, as demonstrated by 




the wide variety of treatment targets listed in Table 7-2. This may have been 
influenced by the introduction of the biopsychosocial model, which was widely 
accepted into many areas of clinical practice in the early 2000’s (226) and may 
have facilitated this temporal shift.  
Table 7-2: Treatment targets of matched RCTs 
Treatment Targets Citation count (n=) of 7 
RCTs 
Reduce pain; modify perception pain 5 
Exercise self-efficacy; increasing self-confidence 
Take control of their situation 
3 
Modify perception disability 
Improve disability 
Preventing long-term disability 
3 
Improve physical capability; Increasing level activity 2 
Fear of physical activity  
Kinesiophobia 
2 
Posture and movement patterns 1 
Stretch shortened tissues 1 
Recovery 1 
Improvement in the execution of proper patient lifting techniques 1 
Improve muscular stabilisation  1 
Improve functional capacity 1 
Reduce absence from work 1 
Catastrophising  1 
Reduce anxiety and depression 1 
Cope better  1 
The colours represent different targets: green are psychological targets, orange are functional 
targets, light blue are physical performance targets, pink is pain and white is work-related. 
 
7.3.3.2 Previously Tested Mediators Were Not Prioritised as Treatment 
Targets 
It was unexpected that one of the few tested mediators of exercise for persistent 
NSLBP - pain catastrophising (150)- was not prioritised by this consensus 
exercise (final ranked position 11) but was identified as a treatment target by only 
one of the matched RCTs (136). As mentioned above, more recently 
psychological treatment targets have been tested as potential mediators in the 
use of exercise to change outcomes of physical function and pain in NSLBP. 




Almost all of the mediators tested in previous RCTs of exercise interventions 
were psychological constructs, of which ‘reduced distress’, ‘reduced fear’, 
‘increased self-efficacy’ and ‘reduced pain catastrophising’ have been shown to 
mediate the pain-disability pathway of exercise in people with back and neck pain 
(150,152,227). However, comparison of the final prioritised list of treatment 
targets from the consensus workshops with the research exploring potential 
mediators of exercise interventions in persistent NSLBP (please see Appendix 
9.n: Summary of Mediation Analyses in LBP) shows that many of the prioritised 
psychological targets have been tested as mediators previously. However, the 
psychological targets tested (as mediators of exercise interventions for NSLBP) 
only explained a moderate proportion of the total effect of exercise on pain and 
disability outcomes (between 20-30%) (148). This suggests that there are 
unexplained causal mechanisms that are yet to be identified which would account 
for a significant proportion of the total direct effect of exercise on pain and 
disability outcomes (67-80%).  
 
Mediators of exercise to date have been investigated largely by cross-sectional 
analyses (204,205,228). Mansell, Hill, Main, Vowles and van der Windt (229) 
explored mediators of psychological interventions for LBP, but these have only 
explained 20-30% of the pathway to changing pain-disability outcomes. Pre- and 
post-intervention measures (35) and two systematic reviews (22,34) comparing 
the correlation of physical performance measures and pain and disability 
outcomes have found limited, or no evidence to suggest a relationship with the 
identified measures and the outcomes of pain and disability. Without a clear 
understanding of the treatment targets and mechanisms by which exercise works 




to improve pain and physical function, it is likely that RCTs of exercise 
interventions will continue to use these core outcomes as their primary outcomes. 
However, more work is required to understand the treatment targets and 
mechanisms of action of exercise to ensure the most appropriate and accurate 
outcomes are used. Potential outcomes such as composites (which may include 
pain and functional outcomes), may cover the wider breadth and multiple 
treatment targets of an exercise intervention. Detailed programme theory of how 
the exercise intervention is thought to have its effect on the core outcomes of 
pain, and physical function (if indeed these are prioritised by the RCT designers 
as being the most important) needs to be clearly modelled for transparent 
pathways and likely intermediate targets to be identified (230), such as was 
performed by Sherman et al. (227) and Hurley et al. (17). 
 
As a practicing clinical academic physiotherapist, I note the discrepancy in 
treatment targets prioritised by clinicians and researchers, and those focused on 
by the exercise prescribed. A challenge for future RCTs of exercise to design the 
intervention in such a way that it can affect the specified treatment targets 
(mediators) to a greater extent so that the intervention has a greater impact on 
pain and physical function outcomes (231).  Bronfort et al. (117) prioritised pain 
reduction as their primary outcome based on the views of a group of patients, but 
they specified that their intervention was designed to target strength and 
endurance. Without a clear logic model to demonstrate how the treatment targets 
of strength and endurance would affect a change in pain reduction, it is difficult 
to assume the relationship between this outcome and the treatment targets. As 
mentioned previously (chapter 1), these two components (strength, endurance) 




have been shown to have no correlation with pain and disability outcomes 
(34,35). Thus, we need to ensure that if an outcome of importance is prioritised 
by patients, then the exercise interventions used should be designed to target 
those outcomes. Future research needs to ensure optimal design of exercise 
interventions to affect the treatment targets specified, especially if these are of a 
psychological nature, as exercise design to target psychological or pain 
components is not clearly defined (232).   
 
7.3.4 Interpreting this research in the field of complex interventions 
Exercise, as a complex intervention, can be delivered in many different forms, 
prescribed by different deliverers, with varying dosages, tailoring and in a variety 
of settings (23). The development and testing of interventions and the causal 
theories that underpin these interventions should be subject to rigorous 
development and evaluation as per guidance from the Medical Research Council  
(52). These updated guidelines reinforce the need for exercise to have a clear 
specification of treatment targets, with consideration of the context, exercise 
deliverer and outcomes to be used as demonstrated in the logic model on page 
228. Further, the development of the exercise intervention and the prioritisation 
of its treatment targets should be informed by stakeholder involvement, 
underpinned by programme theory and logic models of the proposed theory, and 
continually modified, as required, in line with evaluation and in light of uncertainty 
surrounding the intervention deliverables (52).  
  
 




 Strengths and Limitations of this Research 
The systematic review was robustly performed in line with PRISMA guidance 
(94), with a rigorous search strategy and multiple pairs of reviewers to reduce 
bias when extracting data. The meta-analyses performed were compared to 
seven different sensitivity analyses, and results were similar across all of these 
meta-analyses. Further, the specification of treatment targets findings are in 
keeping with larger review of Cochrane exercise trials (67) suggesting that these 
results are generalisable across all exercise trials.  
 
A strength of the secondary data analyses is that a good proportion of the 
identified RCT datasets were obtained: the datasets were obtained for three of 
the four RCTs in the first analyses and four of the seven RCTs in the second 
analyses. Another strength of this work is that a sensitivity analysis was 
performed with ratio of means (110) to compare the results, and similar findings 
were obtained. These analyses were performed on a small sample of exercise 
RCTs in persistent NSLBP; thus, it is unknown whether these findings would be 
true for other complex interventions in persistent NSLBP or other conditions. 
However, it would make logical sense that the phenomenon of matching RCT 
outcomes to treatment targets, irrespective of the condition or intervention, would 
potentially yield greater between-arm differences in RCTs of complex 
interventions.  
 
A further strength of the consensus workshops was the participation of people 
from ten different countries, and inclusion of stakeholders from different 




backgrounds: people with a lived experience of using exercise for NSLBP, 
researchers involved in the development of exercise interventions to be tested in 
RCTs with patients with persistent NSLBP, and clinicians prescribing exercise to 
treat persistent NSLBP. A strength of these workshops was the inclusion of 
people who used exercise to manage their NSLBP, as in previous work, patients 
have not been included. The discrepancy between the prioritised treatment 
targets in the workshops, systematic review and matched RCTs’ results, also 
highlights a limitation of the generalisability of these workshop findings: the 
limited number of people with a lived experience of exercise for NSLBP who were 
involved in the consensus workshops. Previous work (225) has highlighted the 
discrepancy that exists between many clinicians and patients in the act of goal 
setting and exercise selection; and in RCTs of exercise interventions, where 
standardisation of the exercise intervention is required, this becomes even more 
difficult to employ.  
 
This was an exploratory programme of research that was limited by sample sizes 
in the systematic review, participant responses in the consensus workshops and 
dataset responses for the dataset analyses. However, this is the first time this 
type of work has been performed, and the results suggest that further work needs 
to be conducted to establish whether matching is important, and what type of 
matching is likely to be practically implementable in RCTs (primary or composite 
outcomes).   
 
The data extraction performed in the systematic review may have been limited 
by the ability to extract exercise intervention fidelity information from the 




published RCTs. This would have been very challenging to undertake, and was 
not possible in the remit of this thesis, but may have helped to understand the 
difference between exercise interventions delivered within the matched and 
unmatched RCTs. This would require future work to compare the protocoled 
exercise intervention in comparison to what was actually delivered, and would 
have required not only clear documentation using the TIDieR guidelines (by RCT 
authors) but perhaps also interviews with practitioners and patients similar to that 
performed by the National Exercise Referral Scheme in Wales (233). However, 
the work undertaken by Stenner (225) in his thesis exploring exercise prescription 
by clinicians and patients with persistent NSLBP, goes some way to providing 
insight into this.  
 
Both secondary data analyses comprised a small sample of datasets limiting the 
contribution of this research. Each RCT used different exercise approaches, with 
varying primary follow-up points, different analysis methods, and differing 
treatment targets. The use of the SMD allowed comparison across different 
outcomes, although a limitation is that the Cochrane group had not intended it be 
used for this purpose: they suggested it may be more appropriate when 
comparing different outcome measures within the same domain (106).  
  
 Implications for Future Research 
This programme of research suggests that matching the primary outcome(s) to 
the identified treatment targets of exercise interventions for persistent NSLBP is 
an important area for further research. Further analyses on a larger sample of 




exercise RCTs, and also other complex interventions for persistent NSLBP is 
recommended. Exercise is an advocated intervention for many different clinical 
conditions (osteoporosis, osteoarthritis, cardiovascular disease, hypertension, 
diabetes etc.) and therefore future research could also explore the potential effect 
of matching outcomes to exercise treatment targets in these other clinical 
conditions. 
 
Understanding how exercise intervention(s) create their effects is an important 
gap that this research has identified. It is important to be able to identify the 
components that will reasonably achieve change in the identified and prioritised 
treatment targets from the consensus workshops, but this requires more detail 
on the intervention itself to be provided in research reports. Given the 
heterogeneity in exercise interventions, delivery settings and styles, the identified 
components are likely to vary from RCT to RCT, both across and within exercise 
intervention delivery. This research programme has highlighted the way in which 
many exercise interventions in RCTs are poorly described (67,234), and the need 
for better description of interventions (64,67,160). A clear structure to achieve 
this would be through the use of logic models or intervention mapping (17,52). 
Future RCTs of exercise interventions in persistent NSLBP should clearly define 
their exercise treatment targets, and this research provides exploratory support 
for trial teams to consider better matching their outcomes to these, in order to 
maximise the potential of the trial to be able to detect the benefits of exercise 
versus control interventions.  
 




A highlighted limitation was the small numbers of true patients involved in this 
programme of research. Future research should involve greater numbers of 
people with a lived experience of using exercise for NSLBP, in both the design 
of future research methodologies, as well as the interpretation thereof (235). 
Further consensus workshops involving greater numbers of people who have 
used exercise to manage and treat NSLBP will be important to identify treatment 
targets of importance, in contrast to that which were prioritised in this study, with 
a group of predominantly clinical researchers.  
 
Future research regarding specific exercise approaches for NSLBP may involve 
realist evaluations of what works for whom, under which circumstances, and why 
(52). Involvement with stakeholders to develop clear programme theory and logic 
models for the proposed rationale is recommended for all specific exercise types 
used to treat NSLBP. These can then be tested and evaluated using RCTs to 
understand what modifications are required before key active ingredients can be 
recommended for implementation across health services. One way to support 
this in research may be through an amendment to the CERT to include a clear 
rationale for the specific exercise (67). 
 
Some of the identified treatment targets may be mediators of exercise 
interventions, and thus variables on the pathway to the key outcomes such as 
pain, physical function and quality of life. Future RCTs of exercise for NSLBP 
should be designed with additional analyses in mind (such as multiple mediation 
analyses) to better understand the role of treatment targets in bringing about the 
observed benefits of exercise, as few RCTs to date have been designed with 




mediation analysis in mind (233,236). However, planned mediation analyses, 
according to a clear rationale, should be included in advance of the RCT delivery, 
such as in the protocols of RCTs, to ensure sample size and other 
methodological challenges are accounted for (237). Further, the updated search 
of ongoing RCTs and protocols of exercise interventions for persistent NSLBP 
(Appendix 9.k) suggests that the identified mismatch of targets and outcomes 
continues to be a problem within this field. 
 
The logic model developed (in chapter 3) and updated (in chapter 6) may provide 
a framework for future RCTs to use when developing and specifying exercise 
interventions for testing. Not all trials will have the funding to perform an in-depth 
intervention mapping approach to design the key components of their 
intervention, such as was performed by Hurley et al. (17). However the use of a 
logic model provides a transparent means to demonstrate the proposed 
pathways, and even a basic model such as that used by Sherman et al. (238) 
may provide justification and a rationale for the use of primary outcomes and 
intervention design. Future trials testing exercise interventions may benefit from 
the use of logic models to describe their underpinning rationale for their 
intervention, the key treatment target(s), treatment components and outcome 
selection.  
 
The use of composite outcomes in future RCTs may play an important role, 
possibly alongside or through the use of responder indices as proposed by Simon 
et al. (91). Clear specification of how exercise should be designed (or prescribed) 
to target these outcomes of pain, function and quality of life, has not been well 




documented in the NSLBP field – unlike strength (239) and endurance exercise 
(240). Future work should investigate and describe how exercise interventions 
should be tailored and implemented to affect these areas of importance to 
patients with NSLBP, as well as other prioritised treatment targets, such as 
psychological constructs.  
 
 Implications for Clinical Practice 
The output of this research programme – namely consensus on the ranked 
importance of treatment targets for exercise - is the first step in gaining 
consensus across patient, clinician and researcher populations. However, these 
priorities may well change dependent on exercise selection, delivery and 
individual goals. Clinicians need to be aware of the importance of shared decision 
making and goal setting with patients, to be selecting treatment targets and 
outcomes that are relevant to the patient, and are likely to change given the 
intervention goals. The results of the systematic review and both secondary data 
analyses suggest that a clear understanding of the treatment targets of the 
exercise intervention delivered is important to select the most appropriate 
outcome measure. In my experience of clinical practice as a physiotherapist, core 
outcome domain questionnaires (such as the ODI, NDI and VAS) were routinely 
used without much further thought to the treatment targets of the prescribed 
exercise interventions, suggesting clinicians should also consider the mechanism 
through which they expect change to occur, and to capture that with the most 
appropriate outcome measure. Furthermore, consideration should be given to 
the design of the intervention in meeting the identified treatment targets. Clear 




guidance is available for intervention development to target aerobic, resistance 
and flexibility deficits (232). 
 
This work provides an initial list of agreed treatment targets which may be helpful 
for clinicians when planning and prescribing exercise interventions for persistent 
NSLBP. It also provides support for the use of outcome measures that are 
specific to the targets of the intervention delivered in clinical practice.  
 
 Summary 
In summary, this exploratory programme of research supports the premise that 
matching the primary outcome of RCTs to the specified treatment targets of the 
exercise intervention in persistent NSLBP may be important. The systematic 
review provided initial support by showing that RCTs that matched their outcome 
to the treatment targets may be more likely to find statistically significant results 
in favour of exercise. The premise was further supported through the secondary 
RCT data analyses which found that the conclusions of most of the included 
RCTs would have changed (4 of 5, and 2 of 4) if they had better matched their 
trial outcomes to their identified treatment targets. Finally, a large and -group of 
researchers, clinicians and people with back pain experience prioritised the most 
important treatment targets of exercise as ‘increasing function’, ‘improving quality 
of life’, ‘reducing pain’, ‘targeting patient-specific goals’, ‘reducing fear of 
movement’ and ‘increasing physical activity’.  
 




This programme of work has demonstrated, for the first time, the potential to 
evidence greater benefits of exercise for NSLBP than has been shown to date, 
by better matching outcomes to treatment targets in RCTs in this field. Further 
work to confirm these findings is needed. In addition, the consensus study on 
treatment targets for exercise has highlighted gaps in knowledge of treatment 
mechanisms and potential mediators, which warrants further study. The effect 
of many interventions, not only exercise in RCTs of persistent NSLBP, may 
have been underestimated if outcomes and treatment targets are poorly 
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a. Systematic Review Search Terms 
MEDLINE 
Search terms for persistent NSLBP  
1 Exp Back/  
2 Spine/ or Coccyx/ or Intervertebral Disc/ or Lumbar Vertebrae/ or Intervertebral disc/ 
or Sacrum/ 
3 (back or spine or spinal or lumb$ or sacr$ or coccy$).ti,ab,kw. 
4 or/1-3 
5 pain/ or chronic pain/ or pain, intractable/ or pain, referred/ 
6 4 and 5 
7 (pain or painful).ti,ab,kw. 
8 1 or 2 
9 7 and 8 
10 6 or 9 
11 exp Back Pain/ 
12 (backache$ or (back adj3 ache$)).ti,ab,kw. 




17 (LBP or cLBP).ti,ab,kw. 
18 or/10-17 
Search terms for Exercise 
19 exp Exercise/ 
20 exp Rehabilitation/ 
21 Osteopathic Physicians/ 
22 Chiropractic/ 
23 (strength$ or isometric$ or isotonic$ or isokinetic$).ti,ab,kw. 
24 (resistance adj3 train$).ti,ab,kw. 
25 exercise$.ti,ab,kw. 
26 ((water$ or aqua$) adj3 (therap$ or treatment$)).ti,ab,kw. 




31 physical therap$.ti,kw,ab. 
32 rehabilitat$.ti,ab,kw. 
33 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 
RCT filter – Cochrane sensitivity & precision max filter (2008 revision)  
34 randomized controlled trial.pt. 
35 controlled clinical trial.pt. 
36 randomi#ed.ab. 
37 Placebo.ab. 
38 clinical trials as topic/ 
39 randomly.ab. 
40 trial.ti. 
41 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 
42 exp animals/ not humans/ 
43 41 not 42 






Search terms for persistent NSLBP   
1 exp back/  
2 spine/ or coccyx/ or intervertebral disk/ or lumbar vertebra/ or sacrum/ 
3 (back or spine or spinal or lumb$ or sacr$ or coccy$).ti,ab,kw. 
4 or/1-3 
5 pain/ or referred pain/ or chronic pain/ or discogenic pain/ or intractable pain/ 
6 4 and 5 
7 (pain or painful).ti,ab,kw. 
8 1 or 2 
9 7 and 8 
10 6 or 9 
11 exp backache/ 
12 exp low back pain/ 
13 (backache$ or (back adj3 ache$)).ti,ab,kw. 




18 (LBP or cLBP).ti,ab,kw. 
19 or/10-18 
Search terms for Exercise  
20 exp physiotherapy/ 
21 exp exercise/ 
22 osteopathic physician/ 
23 chiropractic/ 
24 (strength$ or isometric$ or isotonic$ or isokinetic$).ti,ab,kw. 
25 (resistance adj3 train$).ti,ab,kw. 
26 exercise$.ti,ab,kw. 
27 ((water$ or aqua$) adj3 (therap$ or treatment$)).ti,ab,kw. 













40 (doubl$ adj blind$).tw. 




45 crossover procedure/ 
46 double blind procedure/ 
47 randomized controlled trial/ 
48 single blind procedure/ 
49 or/35-48 
50 animal/ not human/ 
51 49 not 50 





53 limit 52 to embase  
AMED 
Search terms for persistent NSLBP   
1 exp Back/ 709 
2 Spine/ or Intervertebral disk/ or Lumbar vertebrae/ or Sacrum/ 
3 (back or spine or spinal or lumb$ or sacr$ or coccy$).ti,ab. 
4 or/1-3 
5 Pain/ 
6 4 and 5 
7 (pain or painful).ti,ab. 
8 1 or 2 
9 7 and 8 
10 6 or 9 
11 exp Low back pain/ or exp Backache/ 
12 ((back adj3 ache$) or backache$).ti,ab. 




17 (LBP or cLBP).ti,ab. 
18 or/10-17 
 Search terms for Exercise  
19 exp physical therapy modalities/ 
20 exp Exercise/ 
21 exp Rehabilitation/ 
22 Chiropractic/ or Osteopathy/ 
23 (strength$ or isometric$ or isotonic$ or isokinetic$).ti,ab. 
24 (resistance adj3 train$).ti,ab. 
25 exercise$.ti,ab. 
26 ((water$ or aqua$) adj3 (therap$ or treatment$)).ti,ab. 




31 physical therap$.ti,ab. 
32 rehabilitat$.ti,ab. 
33 or/19-33  
 RCT filter  
34 exp clinical trials/ 
35 randomized controlled trial.pt. 






42 exp Animals/ 
43 exp humans/ 
44 42 not 43 
45 41 not 44 
46 18 and 33 and 45 
Web of Science Core Collection 
Search terms for persistent NSLBP  
1 TS=((back OR spine OR spinal OR lumb* OR sacr* OR coccy*) NEAR/3 pain*) 
2 TS= (backache* OR (back NEAR/3 ache*)) 





4 TS=(LBP or CLBP)  
5 #4 OR #3 OR #2 OR #1    
Search terms for Exercise 
6 TS=exercise* 
Search terms for RCTs 
7 TS=random* 
8 TS=placebo* 
9 TS=(clinic* NEAR/3 trial*) 
10 #9 OR #8 OR #7     
11 #10 AND #6 AND #5     
PEDRO  
 Therapy: strength training 
 Problem: Pain 
 Body part: Lumbar spine, sacro-iliac joint or pelvis 
 Subdiscipline: musculoskeletal 
 Topic: Chronic pain 
 Method: Clinical Trial 
 Minimum score 6/10  
  
 Therapy: hydrotherapy, balneotherapy 
 Problem: Pain 
 Body part: Lumbar spine, sacro-iliac joint or pelvis 
 Subdiscipline: musculoskeletal 
 Topic: Chronic pain 
 Method: Clinical Trial 
 Minimum score 6/10 
  
 Therapy: fitness training 
 Problem: Pain 
 Body part: Lumbar spine, sacro-iliac joint or pelvis 
 Subdiscipline: musculoskeletal 
 Topic: Chronic pain 
 Method: Clinical Trial 
 Minimum score 6/10 
 When searching Match all search terms 
COCHRANE SEARCH  
Search terms for persistent NSLBP 
1 MeSH descriptor: [Back] explode all trees 640 
2 MeSH descriptor: [Spine] this term only 
3 MeSH descriptor: [Coccyx] this term only 
4 MeSH descriptor: [Intervertebral Disc] this term only 
5 MeSH descriptor: [Lumbar Vertebrae] this term only 
6 MeSH descriptor: [Sacrum] this term only 
7 (back or spine or spinal or lumb* or sacr* or coccy*):ti,ab,kw  
8 #1 or #2 or #3 or #4 or #5 or #6 or #7  
9 MeSH descriptor: [Pain] this term only 
10 MeSH descriptor: [Chronic Pain] this term only 
11 MeSH descriptor: [Pain, Intractable] this term only 
12 MeSH descriptor: [Pain, Referred] this term only 
13 #9 or #10 or #11 or #12  
14 #8 and #13  
15 (pain or painful):ti,ab,kw  
16 #1 or #2 or #3 or #4 or #5 or #6  
17 #15 and #16  






Search terms for Exercise 
19 MeSH descriptor: [Physical Therapy Modalities] explode all trees 
20 MeSH descriptor: [Exercise] explode all trees 
21 MeSH descriptor: [Rehabilitation] explode all trees 
22 MeSH descriptor: [Osteopathic Physicians] this term only 
23 MeSH descriptor: [Chiropractic] this term only 
24 (strength* or isometric* or isotonic* or isokinetic*):ti,ab,kw  
25 (resistance near/3 train*):ti,ab,kw  
26 exercise*:ti,ab,kw  
27 ((water* or aqua*) near/3 (therap* or treatment*)):ti,ab,kw  
28 (hydrotherap* or aquatherap*):ti,ab,kw  
29 physiotherap*:ti,ab,kw  
30 osteopath*:ti,ab,kw  
31 chiropract*:ti,ab,kw  
32 physical next therap*:ti,ab,kw  
33 rehabilitat*:ti,ab,kw  
34 #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or 
#31 or #32 or #33 
35 #18 and #34  
Search terms for RCTs 
36 Trials only 
CINAHL PLUS (EBSCO)  
Search terms for persistent NSLBP 
S1 (MH "Back") 
S2 TI ( (back or spine or spinal or lumb* or sacr* or coccy*) ) OR AB ( (back or spine or 
spinal or lumb* or sacr* or coccy*) )  
S3 S1 OR S2  
S4 (MH "Pain+") OR (MH "Chronic Pain")  
S5 S3 AND S4  
S6 TI ( (pain or painful) ) OR AB ( (pain or painful) )  
S7 S1 AND S6  
S8 S5 OR S7  
S9 (MH "Back Pain+") OR (MH "Low Back Pain")  
S10 TI ( (backache or (back n3 ache)) ) OR AB ( (backache or (back n3 ache)) )  
S11 TI lumbago OR AB lumbago  
S12 TI dorsalgia OR AB dorsalgia  
S13 TI coccydynia OR AB coccydynia  
S14 TI ( (LBP or CLBP) ) OR AB ( (LBP or CLBP) )  
S15 S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14  
Search terms for Exercise 
S16 (MH "Exercise+") (80,241) 
S17 (MH "Psychotherapy+") OR (MH "Cognitive Therapy+") (137,615) 
S18 (MH "Rehabilitation+") (214,392) 
S19 (MH "Osteopathic Medicine") (331) 
S20 (MH "Physical Therapy+") (104,221) 
S21 TI ( (strength* OR isometric* OR isotonic* OR isokinetic*) ) OR AB ( (strength* OR 
isometric* OR isotonic* OR isokinetic*) ) (71,881) 
S22 TI ("resistance train*") OR AB ("resistance train*") (3,401) 
S23 TI exercise* OR AB exercise* (79,668) 
S24 TI ( (hydrotherap* OR aquatherap*) OR ((aqua* OR water*) n3 (therap* OR 
treatment*))) OR AB ( (hydrotherap* OR aquatherap*) OR ((aqua* OR water*) n3 
(therap* OR treatment*))) (1,679) 
S25 TI physiotherap* OR AB physiotherap* (14,669) 
S26 TI osteopath* OR AB osteopath* (2,374) 
S27 TI chiropract* OR AB chiropract* (11,473) 





S29 (MH "Osteopaths") 317) 
S30 TI ("physical therap*") OR AB ("physical therap*") (14,350) 
S31 TI rehabilitat* OR AB rehabilitat* (66,748) 
S32 S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 
OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 
Search terms for RCTs 
S33 TX randomized OR (MH "Treatment Outcomes") OR PT (clinical trial)   
S34 S15 and S32 and S33  
Psychinfo search 
Search terms for persistent NSLBP 
S1 DE "Spinal Column" 
S2 TI ( (back or spine or spinal or lumb* or sacr* or coccy*) ) OR AB ( (back or spine or 
spinal or lumb* or sacr* or coccy*) ) OR KW ( (back or spine or spinal or lumb* or 
sacr* or coccy*) )  
S3 S1 OR S2  
S4 DE "Pain" OR DE "Chronic Pain" OR DE "Myofascial Pain"  
S5 S3 AND S4  
S6 TI ( (pain or painful) ) OR AB ( (pain or painful) ) OR KW ( (pain or painful) )  
S7 S1 AND S6 
S8 S5 OR S7  
S9 DE "Back Pain"  
S10 TI ( (backache* OR (back n3 ache*)) ) OR AB ( (backache* OR (back n3 ache*)) ) 
OR KW ( (backache* OR (back n3 ache*)) )  
S11 TI ( ((back or spine or spinal or lumb* or sacr* or coccy*) n3 pain*) ) OR AB ( ((back 
or spine or spinal or lumb* or sacr* or coccy*) n3 pain*) ) OR KW ( ((back or spine or 
spinal or lumb* or sacr* or coccy*) n3 pain*) )  
S12 TI lumbago OR AB lumbago OR KW lumbago 
S13 TI dorsalgia OR AB dorsalgia OR KW dorsalgia  
S14 TI coccydynia OR AB coccydynia OR KW coccydynia 
S15 TI ( (LBP or cLBP) ) OR AB ( (LBP or cLBP) ) OR KW ( (LBP or cLBP) )  
S16 S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15  
Search terms for Exercise 
S17 DE "Exercise" OR DE "Aerobic Exercise" OR DE "Weightlifting" OR DE "Yoga" 
(27,916) 
S18 DE "Rehabilitation" OR DE "Physical Therapy" OR DE "Psychosocial Rehabilitation" 
(24,321) 
S19 DE "Osteopathic Medicine" (131) 
S20 DE "Physical Therapy" (2,433) 
S21 TI ( (strength* or isometric* or isotonic* or isokinetic*) ) OR AB ( (strength* or 
isometric* or isotonic* or isokinetic*) ) OR KW ( (strength* or isometric* or isotonic* 
or isokinetic*) ) (110,138) 
S22 TI ("resistance train*") OR AB ("resistance train*") OR KW ("resistance train*") (564) 
S23 TI exercise* OR AB exercise* OR KW exercise* (57,728) 
S24 TI ( (hydrotherap* or aquatherap*) OR ((water* or aqua*) n3 (treatment* or therap*))) 
OR AB ( (hydrotherap* or aquatherap*) OR ((water* or aqua*) n3 (treatment* or 
therap*)))OR KW ( (hydrotherap* or aquatherap*) OR ((water* or aqua*) n3 
(treatment* or therap*))) (694) 
S25 TI physiotherap* OR AB physiotherap* OR KW physiotherap* (2,682) 
S26 TI osteopath* OR AB osteopath* OR KW osteopath* (289) 
S27 TI chiropract* OR AB chiropract* OR KW chiropract* (387) 
S28 TI ("physical therap*") OR AB ("physical therap*") OR KW ("physical therap*") 
(3,124) 
S29 TI rehabilitat* OR AB rehabilitat* OR KW rehabilitat* (54,954) 
S30 S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 
OR S27 OR S28 OR S29 
Search terms for RCTs 





S32 TI random* w1 assigned OR AB random* w1 assigned 
S33 TI control OR AB control 
S34 S31 OR S32 OR S33 





b. Excluded Studies from the Systematic Review with 
Reasons  
Reason for Exclusion References 
Insufficient sample size (n=29) 65,233–260 
Incorrect population (n=23) 259,260,269–278,261,279–281,262–268 
Incorrect Intervention (n=18) 275,295,304–311,296–303 
Active Comparator (n=15) 305,306,315–319,307–314 
Incorrect trial design (n=6)  289–294  






c. Extracted Treatment Targets and Outcomes of Included Trials 
Author Treatment Targets Primary Outcome Matched Specified/ 
Inferred 
Albadejo  et 
al. (116) 
Not mentioned Physical function 
(RMDQ) 
No None 
Bronfort et al. 
(117) 
Exercises designed to increase trunk muscle endurance and trunk stability; Manipulation to 
improve function. 





Aim of the programme was to strengthen the muscles surrounding the sine and increase 
flexibility.  
Pain intensity, Physical 
function, Health-related 
quality of life. 
No Specified 
Chen et al. 
(120) 
Reduce LBP and improve physical capability. Effectiveness of SEP on exercise self-
efficacy 
Pain Yes Inferred 
Chown et al. 
(121) 
Not mentioned Physical function No None 
Costa et al. 
(122) 
Exercises designed to improve function of specific muscles of the LB and the control of 
posture and movement 
Pain intensity No Specified 
Diaz Arribas 
et al. (123) 
Postural or functional overload causes biomechanical alteration Pain No Specified 
Ferreira et al. 
(124) 
General exercise: Reverse deconditioning of the fear of movement associated with pain 
Motor control exercise: Retrain optimal control of spinal motion 
Physical function and 
global perceived effect 
of treatment  
No  Specified 
Garcia et al. 
(125) 
“identified by relief of pain”; “to stretch shortened tissues” Pain and disability Yes Specified 
Goldby et al. 
(126) 
The exercise aimed to rehabilitate the neural control and active subsystems of the lumbar 
spine's stabilising system. Selective retraining of the TrA, Multifidus, pelvic floor, 
diaphragm, and inhibit global muscle substitution mechanisms. 
Pain No Specified 
Groessl et al. 
(127) 
Increased strength and flexibility and indirectly through the effects of breathing and 
meditation techniques that promote stress reduction and increased parasympathetic tone 
which in turn modulates pain tolerance.  
Physical function 
(RMDQ) 
No   Specified 
Hall et al. 
(129) 
Balance, strengthening, stretching, body awareness, general health and well-being Bothersome-ness of 
pain 
No Specified 
Hansen et al. 
(128) 
Unclear but mentions "tense back muscles being stretched through exercise" and "body 
building", "hyperextending back exercises", so muscle tension, muscle strength, load on 





and movement of the spine, muscle coordination and control and static trunk muscle 
endurance? But the targets are not clear.  
Harris et al. 
(130) 
The introduction mentions several targets for brief interventions (biopsychosocial factors, 
believed to lower fear-avoidance and increase belief in recovery). Increase physical 
activity, decrease pain improve function; “the goal was to address fear-avoidance and 
movement phobia, and help to re-establish normal movement patterns.” They later mention 






Posture and movement patterns, recovery Self-recovery No Inferred 
Jans et al. 
(132) 
None mentioned Self-recovery No None 
Jaromi et al. 
(133) 
Improvement in the execution of proper patient lifting techniques, reduce low back pain Lifting techniques and 
Pain intensity 
Yes Specified 
Johnson et al. 
(134) 
Changes in psychosocial factors. The paper states 'chronic LBP and associated disability 
is multifactorial in aetiology and best understood with a biopsychosocial model. Studies 
have shown the main determinants of disability in LBP are psychosocial and changes in 
psychosocial factors appear to be key in reduction of reported disability in people 
undergoing physiotherapy exercise programmes'. 
Physical Function No Inferred 
Maul et al. 
(135) 
Deconditioning syndrome –improve muscular stabilisation and functional capacity; 
increasing level of activity and self-confidence; modifying perception of pain and disability 
Lifting capacity Yes Inferred 
Miyamoto et 
al. (136) 
“goal of improving disability and reducing absence from work due to physical and 
functional recovery. Exercise may also reduce pain by influencing the endogenous 
inhibitory system and inducing hypoalgesia… catastrophising and kinesiophobia appear to 
be related with pain and disability… and exercise may promote benefits to improve these 
psychological factors.”  




Moffett et al. 
(137) 
“It may help patients overcome their fear of physical activity by demonstrating that 
movement can relieve pain; it may reduce anxiety and depression, and help them take 
control of their situation. These factors may enable the individual to cope better and return 




Russell et al. 
(138) 
The aims of the programme were to encourage normal movement; increase participant’s 




Saper et al. 
(139) 
Improved mood, stress reduction and lower health-care costs, increases strength and 
flexibility. 
Physical function; Pain No Specified 
Shirado et al. 
(140) 










Storro et al. 
(141) 
“the exercises… aimed at posture improvement, the improvement of aerobic capacity and 
strength as well as flexibility of skeletal muscles related to pain perception.” 
Work status No Specified 
Tilbrook et al. 
(142) 







d. Extracted Treatment Targets of Included Trials 
Treatment Target Frequency Trials 
Reduce back pain 9 Maul et al., 2005; Ferreira et al., 2007; Tilbrook et al., 2011; Chen et al., 2014; Groessl et al., 2017; Harris 
et al., 2017; Garcia et al., 2018; Járomi et al., 2018; Miyamoto et al., 2018 
Strengthening/ Muscle strength 8 Hansen et al., 1993; Storrø, Moen and Svebak, 2004; Cambron et al., 2006; Shirado et al., 2010; Hall et 
al., 2011; Tilbrook et al., 2011; Groessl et al., 2017; Saper et al., 2017 
Spinal stabilisation / Spinal control altered 
/Trunk stability 
7 Maul et al., 2005; Goldby et al., 2006; Ferreira et al., 2007; Costa et al., 2009; Díaz Arribas et al., 2009; 
Shirado et al., 2010; Bronfort et al., 2011 
Stretching/ Flexibility 7 Storrø, Moen and Svebak, 2004; Cambron et al., 2006; Shirado et al., 2010; Hall et al., 2011; Groessl et 
al., 2017; Saper et al., 2017; Garcia et al., 2018  
Posture 4 Hildebrandt et al., 2000; Storrø, Moen and Svebak, 2004; Costa et al., 2009; Tilbrook et al., 2011 
Self-confidence 3 Russell et al., 2004; Maul et al., 2005; Tilbrook et al., 2011  
Functional capacity/ improve function 3 Storrø, Moen and Svebak, 2004; Maul et al., 2005; Saper et al., 2017 
Improve physical capability / activity 3 Storrø, Moen and Svebak, 2004; Maul et al., 2005; Harris et al., 2017 
Increase trunk muscle endurance 2 Hansen et al., 1993; Bronfort et al., 2011  
Disability 2 Maul et al., 2005; Miyamoto et al., 2018  
Reduce stress 2 Groessl et al., 2017; Saper et al., 2017  
Recovery 2 Hildebrandt et al., 2000, Cecchi et al., 2010 
Self-efficacy; improved control 2 Russell et al.,, 2004; Chen et al., 2014 
Fear of movement associated with pain 1 Ferreira et al., 2007 
Reduce deconditioning 1 Ferreira et al., 2007 
Prevent recurrence and chronicity 1 Storrø, Moen and Svebak, 2004 
Balance 1 Hall et al., 2011 
Body awareness 1 Hall et al., 2011 
General health and well-being 1 Hall et al., 2011 
Muscle tension 1 Hansen et al., 1993 
Relaxation 1 Saper et al., 2017 
Encourage normal movement 1 Russell et al., 2004 
Psychosocial factors 1 Johnson et al., 2007 
Mobility 1 Tilbrook et al., 2011 





Reduce anxiety and depression 1 Moffett et al., 2006 
Reduce absence from work 1 Miyamoto et al., 2018 
Catastrophising 1 Miyamoto et al., 2018 
Kinesiophobia 1 Miyamoto et al., 2018 
Improved coping 1 Moffett et al., 2006 






e. Extracted Secondary Outcome Domains and Measures of Included Trials  
Outcome domain Cites Outcome Measure Cites Refs  
HRQoL (27)  
Health Related Quality of Life  17 Short Form(SF)-36 5 Russell et al., 2004; Cambron et al., 2006*; Díaz Arribas 
et al., 2009; Bronfort et al., 2011; Saper et al., 2017 
EuroQoL-5D(EQ-5D) 5 Russell et al., 2004; Moffett et al., 2006; Johnson et al., 
2007; Chown et al., 2008; Tilbrook et al., 2011 
SF-12 4 Moffett et al., 2006; Albaladejo et al., 2010; Tilbrook et 
al., 2011; Groessl et al., 2017 
Nottingham Health Profile 1 Goldby et al., 2006 
SF6-D 1 Miyamoto et al., 2018 
Self-report 4-point scale 1 Jans et al., 2006 
Health-care Utilisation 5 Self-report 5 Cambron et al., 2006; Jans et al., 2006; Bronfort et al., 
2011; Groessl et al., 2017; Tilbrook et al., 2011 
Fatigue  2 Fatigue Severity Scale 1 Groessl et al., 2017 
Pittsburgh Sleep Quality Index 1 Groessl et al., 2017 
Dysfunction Level  1 Japan Low Back Pain Evaluation Questionnaire 1 Shirado et al., 2010* 
Subjective Health Complaints 1 Subjective Health Complaints Inventory 1 Harris et al., 2017 
General Well Being 1 General Wellbeing Questionnaire 1 Maul et al., 2005 
Pain (26) 
Pain 19 Visual Analogue Scale 7 Ferreira et al., 2007; Albaladejo et al., 2010; Chen et al. 
2014*, Jaromi et al., 2018*; Cambron et al., 2006*; 
Johnson et al., 2007*; Shirado et al., 2010* 
Numeric Rating Scale 5 Maul et al., 2005; Saper et al., 2017*; Miyamoto et al., 
2018*; Costa et al., 2009*; Garcia et al., 2018*    
Van Korff Pain Scale 2 Russell et al., 2004; Jans et al., 2006 





Brief Pain Inventory 1 Groessl et al., 2017 
Short-form McGill Questionnaire 1 Maul et al., 2005 
Aberdeen Back Pain Scale 1 Tilbrook et al., 2011 
Roland and Morris Pain Rating Scale 1 Cecchi et al., 2010 
Frequency Analgesic Use 5 Frequency 5 Maul et al., 2005; Jans et al., 2006; Bronfort et al., 2011; 
Tilbrook et al., 2011; Groessl et al., 2017 
Pain Diagram 2 Pain Diagram 1 Goldby et al., 2006 
Quantitative Pain Drawing 1 Maul et al., 2005 
Physical Function (26) 
Disability / Activity limitation 20 Roland Morris Disability Questionnaire 11 Maul et al., 2005; Cambron et al., 2006*; Moffett et al., 
2006*; Ferreira et al., 2007; Johnson et al., 2007*; Costa 
et al., 2009; Shirado et al., 2010*; Bronfort et al., 2011; 
Hall et al., 2011; Garcia et al., 2018*; Miyamoto et al., 
2018* 
Oswestry Disability Index  4 Goldby et al., 2006; Díaz Arribas et al., 2009; Harris et 
al., 2017; Hall et al., 2011 
Quebec Back Pain and Disability Scale 2 Jans et al., 2006; Hall et al., 2011 
Pain Disability Index 2 Hall et al., 2011; Groessl et al., 2017 
Waddell Index 1 Maul et al., 2005 
Activity / Function 5 Patient-Specific Functional Scale  5 Costa et al., 2009*; Ferreira et al., 2007*; Hall et al., 
2011; Garcia et al., 2018; Miyamoto et al.,  2018; 
Handicap 1 Low Back Outcome Score 1 Goldby et al., 2006 
Beliefs/ Expectations (19) 
Fear-Avoidance Beliefs/ 
Kinesiophobia 
5 Tampa Scale of Kinesiophobia 3 Moffett et al., 2006*; Garcia et al., 2017; Miyamoto et al., 
2018 
Fear-Avoidance Beliefs Questionnaire (work and 
physical activity) 
2 Russell et al., 2004; Harris et al., 2017 





Exercise Self-efficacy  1 Chen et al., 2014* 
6 items on 6-point Likert scale  1 Groessl et al., 2017 
Anxiety and Depression 4 Hospitality Anxiety and Depression Scale 2 Moffett et al., 2006; Harris et al., 2017 
Brief Anxiety Inventory 1 Groessl et al. 2017 
Centre for Epidemiologic Studies Short Depression 
Scale 
1 Groessl et al. 2017 
Coping/ Catastrophising 3 Utrecht Coping List from Coping and Defence Inventory 1 Harris et al., 2017 
Coping Strategies Questionnaire 1 Albaladejo et al., 2010 
Pain Catastrophising Scale 1 Miyamoto et al., 2018 
General Beliefs 2 Sense of Coherence questionnaire 1 Maul et al., 2005 
Back Beliefs Questionnaire 1 Russell et al., 2004 
Control 1 Multidimensional health locus of control 1 Moffett et al., 2006 
Physical Performance (18) 
Dynamic Motion Lumbar Spine 5 Lumbar Range (Forward Flexion Distance) 2 Goldby et al., 2006; Shirado et al., 2010 
Inclinometer Lumbar Range of Movement 2 Maul et al., 2005 Groessl et al., 2017 
CA 6000 Spine Motion Analyser 1 Bronfort et al., 2011 
Strengthening 5 Grip Strength (Hand Held Dynamometer) 1 Groessl et al. 2017 
Core Strength (Prone and Supine Bridge Positions) 1 Groessl et al. 2107 
Lifting capacity 1 Jaromi et al., 2018 
Isometric Trunk Strength (Computerized Digital 
Myograph) 
1 Bronfort et al., 2011 
Isokinetic Strength Cybex Peak Torques 1 Maul et al., 2005 
Aerobic Capacity 3 Box Step Test 3 min 1 Maul et al., 2005 
Shuttle walk test 1 Chown et al., 2008 
Timed Walking Test 1 Goldby et al., 2006 
Posture 2 Qualitatively and Quantitatively 1 Hildebrandt et al., 2000 
Self-reported Improvement 1 Hildebrandt et al., 2000 
Isometric Muscle Endurance 2 Sorensen Test and Flexion, squatting, upper arm and 
shoulder girdle muscles  
1 Maul et al., 2005 
Length of time the patient was able to maintain an 
unsupported upper body in the prone and supine 
position was recorded in seconds. 
1 Bronfort et al., 2011 





Global Assessment (16)  
Patient Perceived Global 
Improvement 
9 Global Perceived Effect Scale (11-point) 6 Russell et al., 2004; Ferreira et al., 2007*; Costa et al., 
2009*; Hall et al., 2011; Garcia et al., 2017; Miyamoto et 
al., 2018 
9-point Ordinal Scale 1 Bronfort et al., 2011 
7-point Scale 1 Saper et al., 2014 
Overall Treatment Effect 2 Visual Analogue Scale  1 Hansen et al., 1993 
Likert Scale change in pain/ functional capacity and 
satisfaction benefit of treatment 
1 Maul et al., 2005 
Recovery 2 Pain free > 1 month 1 Costa et al., 2009 
7-point scale 1 Jans et al., 2006 
Expectancy Improvement 2 0-10 scale 1 Garcia et al., 2017 
Beliefs, expectations and preferences 1 Tilbrook, Cox and Hewitt, 2011 
Recurrence 1 New episode lasting > 24 hours in those who had 
recovered 
1 Costa et al., 2009 
Satisfaction (3)  
Satisfaction 3 7-point ordinal scale 1 Bronfort et al., 2011 
5-point ordinal scale 1 Saper et al., 2014 
4 item scale 1 Costa et al., 2009 
*designates where more than one primary outcome domain was designated, and the other nominated primary outcomes were then counted as secondary 





f. Sensitivity Analyses Using Other Values 
i. Ratio of Means 






SMD with (95% 
confidence 
intervals) 











Chen et al., 2014 Pain Ex vs CG 0.82 (0.47, 1.17) 
Large in favour 
exercise 
0.81 (0.29, 1.33) 
 
The mean of the intervention group is 19 % 
lower than the control group (medium). 
Hildebrandt et al., 
2000 
Recovery  Ex vs CG 0.69 (0.37, 1.0) 
Medium-large in favour 
exercise 
1.26 (0.98, 1.54) 
 
The mean of the intervention group is 26% 
higher than the control group (medium). 
Járomi et al., 
2018 
Pain Ex vs CG 6.50 (6.16, 6.83) 
Very large in favour of 
exercise 
0.44 (0.17, 0.71) 
 
The mean of the intervention group is 66% 
lower than that of the control group (very large).  
Maul et al., 2005 
Lifting 
Capacity  
Ex vs CG 0.37 (-0.02, 0.76) 
Small- medium in 
favour exercise  
1.03 (0.96, 1.10) 
 
The mean of the intervention group is 3% 
higher than the control group (small).   




Ex1 vs CG 0.84 (0.62,1.06) 
Medium-large in favour 
exercise 
0.86 (0.68, 1.05) 
 
The mean of the intervention group is 14% 
lower than the control group (small) 
Ex2 vs CG 0.98 (0.80,1.16)) 
Large in favour 
exercise 
0.79 (0.60, 0.99) 
 
The mean of the intervention group is 21% 
lower than the control group (medium).  
Ex3 vs CG 1.30 (1.07,1.52) 
Very large in favour of 
exercise 
0.78 (0.58, 0.99) 
 





Large in favour of 
exercise 
0.82 (0.70, 0.93) 
 
The mean is 18% lower than the control group 




Ex1 vs CG 0.66 (0.58,0.74) 
Small-medium in favour 
exercise 
0.85 (0.66, 1.05) The mean is 15% lower than the control group 
(small to medium). 
Ex2 vs CG 0.87 (0.79, 0.95) 
Large in favour 
exercise 
0.80 (0.59, 1.02) 
 
The mean is 20% lower than the control group 
(small to medium). 
Ex3 vs CG 1.02 (0.94, 1.10) 
Medium-large in favour 
exercise 









Large in favour of 
exercise 
0.81 (0.65, 0.97) 
 
The mean is 19% lower than the control group 
(small to medium). 
Moffett et al. 2006 
Activity 
Avoidance 
Ex vs CG 0.14 (0.06, 0.22) 
Small in favour 
exercise 




Ex vs CG 0.41 (0.34, 0.48) 
Small-medium in favour 
exercise 
0.90 (0.73, 1.06) The mean is 10% lower than the control group 
(small). 
Garcia et al., 
2017 
 
Pain Ex vs CG 0.49 (0.16, 0.81) 
Medium in favour 
exercise 
0.90 (0.75, 1.06) 
 




Ex vs CG 0.32 (-0.01,0.66) 
Small-medium in favour 
exercise 











Bronfort et al., 
2011 
Pain Ex vs SMT 0.21 (-0.07, 0.50) 
Small in favour 
exercise 
0.95 (0.81, 1.09) The mean is 5% lower than the control group 
(small). 
Díaz Arribas et 
al., 2009 
Pain Ex vs PT 1.21 (0.86, 1.56) 
Large in favour 
exercise 
0.68 (0.37, 0.99) 
 
The mean is 32% lower than the control group 
(medium to large). 
Costa et al., 2009 Pain Ex vs CG 0.49 (0.07,0.90) 
Medium in favour 
exercise 
0.92 (0.79, 1.05) 
 
The mean is 8% lower than the control group 
(small). 
Hall et al., 2011 Pain Ex vs WL 0.52 (0.21, 0.83) 
Medium in favour 
exercise  
0.89 (0.72, 1.06) 
  
The mean is 11% lower than the control group 
(small). 
Goldby et al., 
2006 
Pain Ex vs CG 0.24 (-0.07, 0.54) 
Small-medium in favour 
exercise  
0.91 (0.64, 1.19) 
 
The mean is 9% lower than the control group 
(small). 
Hansen et al., 
1993 
Pain Ex vs CG  0.18 (-0.95, 0.02) Small favours exercise 
0.95 (0.67, 1.22) 
 
The mean is 5% lower than the control group 
(small). 
Johnson et al., 
2007  
Pain Ex vs CG 0.30 (0.04, 0.57) 
Small–medium in 
favour exercise  
0.92 (0.75, 1.09) The mean is 8% lower than the control group 
(small). 
Saper et al., 2017 Pain Ex vs PT 0.21 (-0.09, 0.50) Small favours exercise 
0.95 (0.82, 1.08) The mean is 5% lower than the control group 
(small). 
Shirado et al., 
2010 
Pain  Ex vs CG 0.18 (-0.12,0.47) 
Small in favour 
exercise  
0.90 (0.60, 1.20) 
 
The mean is 10% lower than the control group 
(small). 
HRQoL Ex vs CG 0.29 (0.00, 0.57) 
Small-medium in favour 
exercise 
0.80 (0.24, 1.36) The mean is 20% lower than the control group 
(small to medium). 








Small in favour of 
exercise 
0.92 (0.74, 1.09) 
 
The mean is 8% lower than the control group 
(small). 




Ex vs SMT -0.38 (-0.64, -0.12) 
Medium in favour 
SMT 
1.25 (0.89,1.76) The mean is 25% lower in the control group 
(medium).  




GE vs SMT -0.96 (-1.09, -0.82) Large in favour SMT 






Costa et al., 2009 
Physical 
Function 
Ex vs CG 0.63 (0.20, 1.05) 
Medium–large in favour 
exercise 
1.11 (0.95, 1.27) 
 
The mean is 11% higher than the control group 
(small). 
 





GE vs SMT -0.70 (-1.19, -0.22) 
Medium- large in 
favour SMT 
0.92 (0.78, 1.05) 
 




0.05 (-0.44, 0.53) Small in favour MCE  
1.00 (0.89, 1.12) 
No difference  
Combined 
Int vs SMT 
-0.33 (-0.61, -0.06) Small in favour SMT 
0.96 (0.85, 1.07) 
  
The mean is 4% lower than the intervention 
group (small). 




Ex vs CG 0.15 (-0.41, 0.11) 
Small in favour 
exercise  
0.97 (0.79, 1.15) 
 
The mean is 3% lower than the control group 
(small). 
Saper et al., 2017 
Physical 
Function 
Ex vs PT 0.25 (-0.05, 0.54) 
Small in favour 
exercise  
0.95 (0.83, 1.08) 
 
The mean is 5% lower than the control group 
(small).  




Ex vs CG 0.33 (0.28,0.39) 
Small-medium in favour 
exercise 
0.91 (0.90,0.92)  The mean is 9% lower than the control group 
(small). 
Ex vs SMT -0.09 (-0.04, -0.15) 
Small in favour of 
SMT 
1.03 (1.02, 1.04) The mean of the intervention is 3% higher than 




0.11 (0.07, 0.15) 
Very small in favour of 
exercise 
0.97 (0.85, 1.10)  
 
The mean is 3% lower than the control group 
(small). 
Jans et al., 2006 Recovery Ex vs UC 0.30 (-0.06,0.66) 
Small-medium in favour 
exercise 
1.06 (0.90, 1.22) The mean is 6% higher than the control group 
(small). 
Harris et al., 2017 Sick leave Ex vs UC -0.16 (-0.48,0.16) 
Small in favour 
control 
0.94 (0.65, 1.23) The mean is 6% lower than the control group 
(small). 
 Storrø et al., 2004 Sick leave Ex vs CG 0.74 (0.55, 0.93)  
Medium-large in favour 
of exercise 
1.27 (1.11, 1.42) The mean is 27% higher than the control group 
(medium). 
 represents RoM values that differ by being one or more groups smaller than the SMD interpretation according to Cohen (1992)’s classification of small 
<0.2; medium 0.5 and large effect sizes >0.8 as recommended by Friedrich et al., (2011) and Fu et al., (2013). * represents RoM values that are greater than 
the SMD interpretation using Cohen (1992)’s interpretation as seen above. Values in italics are statistically significant.  Interpretations highlighted in bold 
favour the control group. 95% confidence intervals are bracketed alongside SMD. The outlier is shaded in grey. Chown et al., 2008; Tilbrook et al., 2011; 






ii. Sensitivity Analysis Using Follow-up Standard 
Deviations 
Trial Outcome  SMD (using BL values) SMD (FU values) 
Albaladejo et al. 2010 PF 0.24 (0.01, 0.47) 0.12 (-0.11,0.35) 
Bronfort et al. 2011 Pain 0.21 (-0.07,0.50) 0.15 (-0.13,0.43) 
Cecchi et al. 2010 PF -0.81 (-0.91, -0.70) -0.76 (-0.91, -0.70) 
Chen et al. 2014 Pain 0.68 (0.33,1.02) 0.82 (0.47,1.17) 
Costa et al. 2009 Pain 0.49 (0.17,0.80) 0.37 (0.05,0.69) 
Diaz Arribas et al. 2009 Pain 1.21 (0.86, 1.56) 1.40 (1.05,1.75) 
Ferreira et al. 2007 PF -0.33 (-0.61, -0.06) -0.22 (-0.50,0.05) 
Garcia et al. 2017 Pain 0.49 (0.16, 0.81) 0.32 (0.00,0.64) 
Goldby et al. 2006  Pain 0.24 (-0.07,0.54) 0.17 (-0.24, 0.58)  
Groessl et al. 2017 PF 0.14 (-0.18,0.46) 0.16 (-0.16,0.48) 
Hall et al. 2011 Pain 0.52 (0.21,0.83) 0.52 (0.21, 0.83) 
Hansen et al. 1993 Pain 0.19 (-0.40, 0.20) 0.24 (-0.40, 0.20) 
Johnson et al. 2007 Pain 0.30 (0.04,0.57) 0.34 (0.07,0.62) 
Maul et al., 2005 LC 0.37 (-0.02,0.76) 0.24 (-0.15,0.63) 
Miyamoto et al. 2018 Pain 1.02 (0.77,1.27) 0.98 (0.73,1.22) 
Russell et al. 2004 PF 0.08 (-0.07,0.23) 0.08 (-0.07, 0.23) 
Saper et al. 2017 PF 0.25 (-0.03, 0.52) 0.26 (-0.04,0.56) 
Shirado et al. 2010 Pain 0.18 (-0.12, 0.47) 0.24 (-0.06, 0.53) 
Tilbrook et al. 2011 PF 0.5 (0.26,0.74) 0.41 (0.17, 0.65) 
Bold values demonstrate SMD calculations that increased when using the FU values. () indicate 
95% confidence intervals; SMD is standardised mean difference, BL is baseline, FU is follow-
up. Harris, Hildebrandt, Jans and Storro were not included as they reported proportions, for 
which the standard deviation was calculated using the follow up data. Moffett et al., 2006 did 
not provide enough information for this to be calculated. Hansen et al. 1993, Shirado et al., 
2010 and Albaladejo et al., 2010 values were calculated using median, lower quartile range and 






iii. Meta-Analysis Using Ratio of Means 
 
Where SE is standard error, IV is inverse variance, CI is confidence interval. Two trials were 
excluded from this analysis (Tilbrook et al., 2011, Groessl et al., 2017) as they only reported 






iv. Effectiveness Sensitivity Analysis  
1. Physical Function 
 













v. Sub-group Analyses  





















3. Sub-group Analysis of Specified Treatment Targets 
Category SMD of RCTs including both 
specified and inferred treatment 
targets 
SMDs of RCTs that specified 
treatment targets ONLY 
Matched 0.54 (95% CI 0.23 to 0.85); 
p=0.0006† n=1197; 7 trials 
0.54 (95% CI -0.04, 1.13); p=0.07; 
n=662; 3 trials 
Unmatched 0.22 (95% CI 0.01,0.44); p=0.04†; 
n=4510; 20 trials  
0.23 (95% CI -0.04, 0.49) p=0.09; 
n=3549; 14 trials 
Overall effect 0.31 (95% CI 0.01, 0.44); p=0.0002; 
n=5707; 27 trials;  
0.28 (0.07, 0.48); p=0.008; n=4211; 17 
trials  
Test for Sub-group 
Differences 







4. Sub-group Analysis of Risk of Bias 
Category Category SMD Low Risk of Bias 
Matched 0.54 (95% CI 0.23 to 0.85); 
p=0.0006† n=1197; 7 trials 
0.54 (95% CI -0.04, 1.13); p=0.07 
n=662; 3 trials 
Unmatched 0.22 (95% CI 0.01,0.44); p=0.04†; 
n=4510; 20 trials  
0.26 (95% CI 0.06, 0.45); p= 0.01; 
n=652; 3 trials  
Overall effect 0.31 (95% CI 0.01, 0.44); p=0.0002; 
n=5707; 27 trials;  
0.42 (95% CI 0.11, 0.73); p=0.36; 












5. Sample size analysis across arms of included trials 
Trial Lead Author Sample Intervention 
Arm 
Sample Control Arm 
Albaladejo 100 248 
Bronfort 95 100 
Cambron  112 123 
Cecchi 136 69 
Chen 64 63 
Chown 24 39 
Costa 77 77 
Diaz Arribas 63 63 
Ferreira 74 77 
Garcia 74 73 
Goldby 78 85 
Groessl 75 75 
Hall 80 80 
Hansen 44 55 
Harris 60 99 
Hildebrandt 72 65 
Jans 59 74 
Jaromi 67 70 
Johnson 110 113 
Maul 59 45 
Miyamoto 222 73 
Moffett 112 107 
Russell 225 543 
Saper 127 64 
Shirado 92 83 
Storro 200 200 
Tilbrook 135 139 























































i. Linear mixed model results of Miyamoto et al. (2018) trial dataset: all time-points 
 Pilates 1 vs CG Pilates 2 vs CG Pilates 3 vs CG Intervention (ALL) vs 
CG 













Standardised Pain (PRIMARY)*   
6-week follow-
up 
0.43 (0.04, 0.82) 0.029 2.193 0.88 (0.50, 
1.27) 
<0.0001 4.503 0.74 (0.35, 
1.13) 







0.652 0.452 0.39 (0.00, 
0.77) 
0.051 1.962 0.21 (-0.18, 
0.60) 







0.832 -0.212 0.29 (-0.11, 
0.69) 
0.161 1.407 0.08 (-0.32, 
0.48) 
0.698 0.389 0.11 (-0.22, 
0.44) 
0.524 
Standardised Composite Outcome *   
6-week follow-
up 
0.44 (0.21, 0.66) <0.001 3.806 0.77 (1.00, 
0.55) 
<0.0001 6.811 0.59 (0.36, 
0.81) 







0.704 0.381 0.34 (0.58, 
0.11) 
0.004 2.911 0.23 (0.00, 
0.47) 







0.468 0.726 0.24 (0.01, 
0.49) 
0.057 1.911 0.02 (-0.23, 
0.27) 
0.881 0.150 0.06 (-0.15, 
0.26) 
0.597 
Individual target-related outcomes included within the composite outcome:   





0.081 1.749 0.82 
(0.50,1.14) 
p<0.0001 5.032 0.53 
(0.20,0.85) 







0.794 -0.261 0.39 (0.07, 
0.72) 
0.017 2.406 0.22 (-0.10, 
0.54) 







0.625 -0.489 0.3 (-
0.04,0.63) 
0.085 1.729 0.05 (-0.29, 
0.39) 
0.78 0.279 0.09 (-0.19, 
0.37) 
0.543 





0.155 1.426 0.49 (-0.18, 
0.81) 
0.002 3.127 0.18 (-0.13, 
0.50) 







0.566 0.575 0.38 (0.04, 
0.71) 
0.027 2.224 0.23 (-0.11, 
0.56) 







0.198 -1.291 0.34 (0.01, 
0.67) 
0.046 2.006 0.10 (-0.23, 
0.44) 







Standardised Kinesiophobia*   
6-week follow-
up 
0.40 (0.09, 0.72) 0.012 2.524 0.50 (0.19, 
0.81) 
0.002 3.159 0.44 (0.12, 
0.75) 







0.496 0.682 0.29 (-0.05, 
0.63) 
0.094 1.683 0.04 (-0.30, 
0.39) 







0.672 -0.423 0.20 (-0.18, 
0.58) 
0.299 1.04 -0.33(-0.71, 
0.05) 
0.088 1.713 -0.07 (-0.39, 
0.25) 
0.665 
Standardised GPE   
6-week follow-
up 
0.77 (0.35, 1.19) <0.001 3.615 1.23 (0.81, 
1.64) 
<0.00001 5.769 1.11(0.69, 
1.54) 







0.347 0.943 0.56 
(0.13,0.99) 
0.011 2.569 0.66 (0.23, 
1.09) 







0.864 0.171 0.30 (-0.12, 
0.72) 
0.157 1.421 0.37 (-
0.06,0.79) 
0.09 -1.704 0.21 (-0.14, 
0.56) 
0.238 
Standardised PSFS   
6-week follow-
up 
0.51(0.12, 0.91) 0.01 2.58 0.72 (0.33, 
1.11) 
0.0003 3.651 0.54 (0.14, 
0.93) 







0.179 -1.348 0.12 (-
0.29,0.52) 
0.572 0.566 0.04 (-0.37, 
0.45) 







0.706 -0.378 0.21 (-0.23, 
0.66) 
0.602 0.956 -0.12 (-0.56, 
0.33) 
0.602 -0.523 0.00 (-0.36, 
0.37) 
0.980 
Bold items indicate where the composite value t-score is greater than that of the original primary outcome with a smaller p-value. CG is control group; 
Pilates 1 is Pilates once a week, Pilates 2 is Pilates twice weekly, Pilates 3 is Pilates thrice weekly, Intervention ALL is the combined effect of all three 
intervention arms, CI is confidence interval. GPE is global perceived effect, PSFS is Patient-Specific Functional Scale; All values are calculated as the 
mean (intervention) minus the mean (control) values, where positive values favour the intervention arm. Outcomes with an * have scales running in 
opposite direction to others and have been multiplied by minus one to trend in a positive direction.  This P-value does not match exactly with the 0.007 
in Table 3 possibly due to the slightly different correlation structures that are modelled in (perhaps these may also have been slightly different in 






Table to show the standard error of the two outcome variables 
Parameter Standardised Pain Outcome Standardised Composite Outcome 
FU1 Pilates 1 vs CG 0.08 0.04 
FU1 Pilates 2 vs CG 0.06 0.03 
FU1 Pilates 3 vs CG 0.09 0.05 
FU2 Pilates 1 vs CG 0.06 0.04 
FU2 Pilates 2 vs CG 0.07 0.04 
FU2 Pilates 3 vs CG 0.09 0.05 
FU3 Pilates 1 vs CG 0.06 0.03 
FU3 Pilates 2 vs CG 0.06 0.03 
FU3 Pilates 3 vs CG 0.08 0.03 





j. Linear mixed model results of Moffett et al. (2006) 
trial dataset: all time-points 
 Adjusted mean difference (95% CI) 
 McKenzie vs SFA 
Standardised Fear-Avoidance 
(TSK-AA) * 
Effect Estimate Sig. t-score 
6-week follow-up -0.01 (-0.22,0.20) 0.94 -0.079 
6-month follow-up 0.25 (0.05,0.45) 0.01 2.475 
12-month follow-up 0.09 (-0.30, 0.12) 0.39 0.854 
Standardised Composite 
Outcome   
Effect Estimate Sig. t-score 
6-week follow-up -0.01 (-0.11,0.09) 0.868 -0.167 
6-month follow-up 0.08 (-0.02,0.19) 0.124 1.544 
12-month follow-up 0.01 (-0.11, 0.12) 0.922 0.097 
Individual Components of the Composite  
Standardised fear-avoidance (TSK-SF and TSK-AA combined) * 
6-week follow-up -0.11 (-0.28, 0.06) 0.214 -1.25 
6-month follow-up 0.20 (0.02, 0.37) 0.028 2.21 
12-month follow-up 0.08 (-0.1, 0.26) 0.388 0.87 
Standardised physical function * 
6-week follow-up 0.14 (-0.09,0.37) 0.227 1.21 
6-month follow-up 0.10 (-0.11, 0.31) 0.356 0.93 
12-month follow-up -0.16 (-0.41, 0.09) 0.214 -1.25 
Standardised health control (internal) 
6-week follow-up -0.03 (-0.16, 0.22) 0.763 0.302 
6-month follow-up 0.12 (-0.07, 0.31) 0.225 -1.215 
12-month follow-up -0.04 (-0.25, 0.18) 0.734 -0.340 
Standardised health control (chance scale) * 
6-week follow-up 0.08 (-0.11,0.27) 0.413 -0.820 
6-month follow-up 0.08 (-0.14, 0.30) 0.469 -0.726 
12-month follow-up 0.00 (-0.20, 0.21) 0.984 -0.021 
Standardised health control (powerful others scale) * 
6-week follow-up -0.07 (-0.25,0.12) 0.491 -0.690 
6-month follow-up 0.04 (-0.19, 0.27) 0.743 0.328 
12-month follow-up 0.24 (0.00, 0.47) 0.049 1.977 
Standardised self-efficacy 
6-week follow-up 0.01 (-0.20, 0.18) 0.925 0.094 
6-month follow-up 0.14 (-0.34, 0.06) 0.167 1.385 
12-month follow-up -0.09 (-0.12, 0.30) 0.395 -0.852 
Standardised anxiety * 
6-week follow-up 0.08 (-0.09, 0.24) 0.357 0.92 
6-month follow-up -0.05 (-0.24, 0.14) 0.605 -0.519 
12-month follow-up -0.11 (-0.3, 0.08) 0.269 -1.107 
Standardised depression* 
6-week follow-up 0.05 (-0.13, 0.22) 0.590 0.540 
6-month follow-up 0.04 (-0.14, 0.22) 0.647 0.458 
12-month follow-up -0.04 (-0.23, 0.15) 0.678 -0.416 
*Bold italics items indicate where statistical significance; Where SFA represents Solution 
Finding Approach and TSK represents the Tampa Scale of Kinesiophobia; TSK-AA is the 





the scale has been multiplied by minus one to trend in a positive direction. Positive values 
favour the intervention arm. 
Table to show the standard error of the two outcome variables 
Parameter Standardised Fear-Avoidance Outcome Standardised Composite 
Outcome 
1,1 0.06 0.02 
2,1 0.06 0.02 
2,2 0.07 0.02 
3,1 0.05 0.02 
3,2 0.06 0.02 







k. Linear mixed model results of Groessl et al. (2017) 
trial dataset: all time-points 
Table to show the linear mixed model analysis of the standardised pain 
outcome in comparison to the composite outcome results 
 Adjusted mean difference (95% CI) 
Yoga vs WL Effect estimate (95% CI) t score Sig.  
Standardised Primary Outcome (Physical Function) (trial results) 
6-week follow-up -0.13 (-0.45,0.19)  0.37 
12-week follow-up -0.14 (-0.46,0.18)  0.34 
6-month follow-up  -0.45 (-0.77, -0.13)  0.003 
Standardised Composite Analysis 
6-week follow-up -0.13 (-0.31, 0.05) -1.431 0.155 
12-week follow-up -0.25 (-0.43, -0.07) -2.761 0.007 
6-month follow-up  -0.30 (-0.55, -0.04) -2.324 0.022 
Individual Components of the Composite Outcome: 
Standardised Pain 
6-week follow-up -0.35 (-0.57, -0.14) -3.3 0.001 
12-week follow-up -0.30 (-0.52, -0.08) -2.741 0.007 
6-month follow-up  -0.27 (-0.5, -0.03) -2.217 0.029 
Standardised Plank 
6-week follow-up -0.00 (-0.33, 0.32) -0.025 0.980 
12-week follow-up -0.23 (-0.51, 0.04) -1.64 0.105 
6-month follow-up  -0.33 (-0.68, 0.00) -1.929 0.057 
Standardised Flexion ROM 
6-week follow-up 0.14 (-0.23, 0.51) 0.746 0.457 
12-week follow-up -0.27 (-0.61, 0.08) -1.538 0.127 
6-month follow-up  -0.03 (-0.41, 0.36) -0.151 0.88 
Standardised Extension ROM 
6-week follow-up -0.29 (-0.61, 0.02) -1.86 0.065 
12-week follow-up -0.08 (-0.44, 0.28) -0.456 0.649 
6-month follow-up  -0.21 (-0.64, 0.22) -0.951 0.344 
*Where WL is waiting list, ROM is range of motion. All values are calculated as mean difference 
of yoga minus mean difference of waiting list, where negative values favour the yoga 






Table to show the standard error of the two models 




1,1 0.12 0.06 
2,1 0.11 0.05 
2,2 0.12 0.05 
3,1 0.11 0.04 
3,2 0.16 0.04 
3,3 0.14 0.05 
4,1 0.10 0.04 
4,2 0.10 0.04 
4,3 0.11 0.04 







l. Additional Information Regarding Consensus 
Workshops 
















































List of the treatment targets after idea generation stage in National Workshop 
Treatment Targets from SR (n=30) Added Brainstormed Treatment Targets (n=25) 
Reduce back pain Reduce Pain 
Spinal stabilisation / Spinal control altered /Trunk stability A tool to teach pacing and graduated increase in exercise/ activity 
Strengthening/ Muscle strength Decrease barriers to movement 
Stretching/ Flexibility Decrease threat 
Posture Enhance self-management skills 
Self-confidence Ensure mobility into the future 
Functional capacity/ improve function Improve fitness 
Improve physical capability / activity Improve mobility of the spine 
Increase trunk muscle endurance Improve motor control 
Disability Improve physical activity levels 
Reduce stress Improve proprioception 
Recovery Improve strength 
Fear of movement associated with pain Improve work capacity 
Reduce deconditioning Increase exercise compliance 
Prevent recurrence and chronicity Increase function 
Balance Increase physical activity and or exercise capacity 
Body awareness Increase range of movement  - spinal and other joints 
General health and well-being Limit time to return to work (full, partial duties ) 
Muscle tension Optimise neural function 
Relaxation Reduce dependence on health service 
Encourage normal movement Reduce need for surgery 
Self-efficacy; improved control Reduce other health services use (other treatments/ medication/ testing) 
Psychosocial factors Reduce pain 
Mobility Restore neural mobility 
Mental positivity Stretch the connective tissue 
Reduce anxiety and depression  
Reduce absence from work  
Catastrophising  
Kinesiophobia  





Table to Demonstrate Grouping of Treatment Targets in National Workshop 
Treatment Target Grouped Targets  
Reduce pain Reduce back pain 




Increase function and reduce disability Improve functional capacity 
Reduce disability 
Improve self-efficacy Increase self-esteem 
Improve self-confidence 
Improve coping ability 
Increase physical activity and/ or 
exercise capacity 
Improve fitness 
Improve physical capability 
Improve physical activity levels 
Reduce deconditioning 
Improve recovery  Prevent recurrence 
Improve mobility Increase range of movement - spinal and other 
joints 
Help ensure mobility into the future 
Improve mobility spine 
Muscle flexibility 
Stretch the connective tissue 
Restore neural mobility 
Optimize neural function 
Improve strength Muscle strengthening 
Reduce other health services use 
(medications/ testing/ treatments) 
Reduce need for surgery 
Reduce dependence on health service 
Increase work capacity and ADLs Reduce absence from work 







Treatment targets generated in idea generation stage of international workshop 








































 Reduce pain Reduce back pain 
Increase function Improve functional capacity 
Reduce disability 
Reduce fear of movement Decrease barriers to movement 
Decrease threat 
Reduce kinesiophobia 
Encourage normal movement 
Improve mobility Increase range of motion- spinal and other joints 
Help ensure mobility into the future 
Improve mobility of the spine 
Muscle flexibility 
Stretch the connective tissue 
Restore neural mobility 
Optimise neural function 
Improve self-efficacy Improve self-confidence 
Increase self-esteem 
Improve coping ability 
Enhance self-management skills 
Prevent recurrence Improve recovery 
Improve general health and well-being 
Improve strength Improve muscle strength 
Increase exercise capacity Reduce deconditioning 
Improve fitness 
Increase physical activity Improve physical capability 
Improve physical activity levels 
Improve work capacity Reduce absence from work 
Limit time to return to work (full, partial duties) 
Reduce anxiety and depression Improve mental positivity 
Improve motor control 
A tool to teach pacing and graduated increase in exercise/activity 
Increase trunk muscle endurance 
Reduce other health services use Reduce need for surgery 




























Improve social participation 
Improve quality of life 
Improve sleep 
Improve cognitive function 
Lower inflammation  
Behavioural change 
Weight loss/ gain 





Improve functional mobility 
Improve performance 
Improve attitudes/ cognitions/ beliefs 
Reduce catastrophising 
Increase body awareness 








m. Summary of Protocols of 23 Current RCTs 
Registry 
Updated 




exercises and CBT 
concerning beliefs 
compared to exercises 
for passive spinal 
mobilisation, 
strengthening, 
stretching and postural 
control 




Physical function (ODI); Pain intensity 
(NRS), Kinesiophobia (TSK), unhelpful 
beliefs (Pain Beliefs and Perceptions 
Inventory), Anxiety and depression 
HADS), strategies for coping pain (CSQ-
R); HRQoL (SF-36), RTW, Sick leave 




CT03200509 Supervised exercise 
and health coaching 
with activity monitor 
To identify facilitators and 
barriers to physical 
activity participation and 
to assist participants to 
achieve their physical 
activity goals by 
providing ongoing 
education and support 
Physical activity (counts per min, 
disability, pain intensity); 
objective measures physical activity (step 
counts, time spent in moderate/ light/ 
vigorous activity);  
Self-reported physical activity levels; Self-
reported sedentary behaviour; 
Depression, HRQoL, PSEQ 







ISRCTN12965286 CFT feasibility study  “individualised self-
management intervention 
targets psychological, 
physical and lifestyle 
barriers” 
Physical Function (RMDQ); pain 
intensity (NRS); fear-avoidance (FABQ); 
Keele STarT Back Screening Tool; self-
efficacy (PSEQ); pain catastrophising 
(PCS); Distress, Anxiety and Stress Scale 
(DASS 21); HRQoL (Eq-5D-5L); Global 
Rating of Change (GPE); participant 
satisfaction; Working Alliance Theory of 




ISRCTN17816427 ALL MSK PAIN to increase physical 
activity 
Average daily step count, Pain 






Usual care, pedometer 
care, Ipopp walking 
intervention 
mannequin); Physical function (PF-10 
from the SF-36); Physical activity (IPAQ-
E); Sedentary time, (accelerometry); 
HRQoL (EQ-5D-5L); Non-health aspects 
of quality of life (ICECAP-O); Self-efficacy 
(Self-Efficacy for Exercise Scale); Anxiety 
(GAD-7); Depression (PHQ 8); Health-
care resource use (patient self -reported 
questionnaires); Adverse events; 
Pedometer use (patient self -reported 
questionnaires); Consultation experience 
(iPOPP intervention only) 
March 
2019 
ISRCTN14736486 Usual care 
2. Usual care + internet 
intervention 
3. Usual care + internet 




physical activity (inferred) 
Physical function (RMDQ); health 
economics (HRQoL, over the counter 
medication use, participant borne costs, 
occupational items, health-care resource 
use) Pain (number troublesome days, 
NPRS, risk persistent disability Start Back 
score), Psychological outcomes – fear of 
movement, negative orientation (PCS), 
confidence in managing (PSEQ) MSK HQ, 
PHQ mental health 





ISRCTN94074203 Physical therapy with 
and without an app.  
Improve self-
management, promote 
recovery, resume daily 
activities. Increase 
adherence to physical 
activity.  
Physical function (ODI), long term 
reduction low back pain related costs 
using cost questionnaires – health-
care utilisation, productivity losses. 
Pain intensity, physical activity, 
adherence, psychological function (PCS, 
FABQ), self-efficacy, self-management 





ISRCTN15830360  Chiropractic, PT, 
combined treatment and 
UC 
None specified Physical Function (ODI), Pain intensity 
(NRS), General health, (self-rated health 
questionnaire), HRQoL (EQ-5D), working 








ISRCTN42338218 12 week digital care 
pathway vs UC 
None specified Pain and disability using modified von 
Korff scales and ODI; LBP (VAS), Impact 
of pain on daily life (CAS), surgery interest 




ISRCTN14136384 MDT care, Physio Aiming at full or partial 
RTW 






ISRCTN99926592 Green exercise, 
balneotherapy, 
combination, or CG 
Unclear ? reduce 
symptoms and improve 
wellbeing 
Functional spine mobility (MediMouse), 
Pain (mVAS), status of health (mVAS), 
Back performance scale, torso/spine 
rotation, HRQoL (SF-36), depression 
(WHO-5), claim medical care  
(medication, no of medical consultations), 





ISRCTN11875357 Start back stratified 
care.  
Unclear Physical Function (ODI at 12-months), 
pain and disability (ODI at 3-months, 
RMDQ, PROMIS, frequency LBP during 
past 3 months, LBP intensity (NRS), leg 
pain intensity (NRS), STarT back, 





NCT03424278 Motor control vs 
resistance training 




Pain (NRS), Physical function (RMDQ), 




NCT03753165 High intensity exercise + 
PT, PT only 
Inferred “improving the 
physical fitness, peak 
performance, autonomic 
balance, muscle strength 
and coordination in 
athlete” 
Change in heart rate variability (heart 
rate variability parameters),Heart rate 
recovery (post-exercise), Pain 
intensity(NRS), physical function (ODI), 





NCT03113292 Pilates vs HEP Unclear Pain intensity (VAS) physical function 
(QBPDS), Health status (EQ-5D), 
perception of recovery (GPE), postural 








NCT04000685 Yoga vs stabilisation 
exercise vs aerobic 
walking.  
None Pain severity (VAS), physical functional 
(ODI), HRQoL (Nottingham Health 
Profile), gait parameters (Gait 
assessment), metabolic capacity 
(modified Bruce protocol), cognitive level 
(Montreal Cognitive Assessment 
Questionnaire), alexithymia (Toronto 
Alexithymia scale), kinesiophobia (FABQ), 
back awareness. (Freemantle Back 
Awareness Questionnaire) 
Unmatched 
2016 NCT02703402 Ex vs HEP None Pain (VAS), HRQoL (SF-36), functional 
capacity (six minute walk test), flexibility 




NCT03778970 Ex + pain neuroscience 
education vs Ex + 
Education 
“posture and control of 
movements which are 
impaired and trigger 
pain.” 
Pain intensity (NRS), disability (ODI), 
pain catastrophising (PCS), pain self-
efficacy (PSEQ), fear-avoidance beliefs 
(FABQ), Exercise adherence, global 




NCT02222935 Balance ex vs routine 
back ex programme 
Balance deficits common 
- 
Balance (Starr Edward Balance test) 




NCT03376724 Functional exercise vs 
Back school 
None Pain Intensity (NRS), physical function 
(ODI, RMDQ); fear of movement (FABQ), 
HRQoL (SF-36), functional capacity (6 





NCT02969785 Lumbar stabilisation vs 
strengthening 
postural control and trunk 
neuromuscular activity 
Electromyography measurement (EMG 
estimates, Root mean square); balance 
(Force platform measurement); pain 
intensity (McGill Short version); physical 





NCT02895828 CSE vs General 
strengthening ex 
None HRQoL (SF-36); physical function (ODI);  
Trunk muscle activity (Surface EMG), 
lumbar segmental motion (radiography), 




NCT03324659 Meditation + ex, 
meditation 
None Physical Function: RMDQ 






(FABQ), mindfulness (Freiberg 
mindfulness inventory), pain intensity 
(VAS), anxiety inventory (State-trait 
anxiety inventory), change in pressure 
sensation, heat unpleasantness 
Feb 
2020 
NCT04283409 Graded activity vs motor 
control exercise 
MCE: retrain optimal 
control and coordination 
of the spine.  
Graded activity address 
modifiable contextual 
factors associated with 
pain experience 
(psychological factors). 
Primary goal to increase 
activity tolerance.  
Physical Function: ODI; Physical 
Function (PSFS); Pain (NRS); HRQoL 
(EQ-5D-5L); Impact of Low back pain: 
PROMIS-9; Lumbar spine instability 
questionnaire, OREBRO LBP screening 
questionnaire, TSK, CSQ, Pain Detect 
Questionnaire, SMART clinical checklist, 
PPT Assessment, Publicly funded health-
care costs, patient direct health-care 








n. Summary of Mediation Analyses in LBP 
Summary of mediation analyses performed on trials of exercise interventions for 
back pain (adapted from Lee et al., 2017) 
Study Intervention 
(exposure) 
Mediators tested Outcome 
Focht, Rejeski, 
Ambrosius, 
Katula, & Messier 
(2005) 
Exercise (n=80) 











Leeuw et al. 
(2008) 















































Hall et al. (2016) 
 
Tai chi (n=51) 
WL (n=51) 
Pain catastrophising Pain intensity, pain 
bothersomeness, 
disability 
Mansell et al. 
(2016) 
Stratified care (n=93) 
Current best care 
(n=45) 
Distress (as a latent 
variable characterised 











Use of assistive devices 
Perceived physical 
exertion 
Days with LBP 
LBP intensity 
Bothersome LBP days 
Mansell, Hill, 
Main, Von Korff, 
& van der Windt 
(2017) 
Back in Action Fear-avoidance 
beliefs 
Disability 
 
